<SEC-DOCUMENT>0001104659-24-032407.txt : 20240308
<SEC-HEADER>0001104659-24-032407.hdr.sgml : 20240308
<ACCEPTANCE-DATETIME>20240308161834
ACCESSION NUMBER:		0001104659-24-032407
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20240426
FILED AS OF DATE:		20240308
DATE AS OF CHANGE:		20240308

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Verona Pharma plc
		CENTRAL INDEX KEY:			0001657312
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38067
		FILM NUMBER:		24734620

	BUSINESS ADDRESS:	
		STREET 1:		3 MORE LONDON RIVERSIDE
		CITY:			LONDON
		STATE:			X0
		ZIP:			SE1 2RE
		BUSINESS PHONE:		011-44-0-2032834200

	MAIL ADDRESS:	
		STREET 1:		3 MORE LONDON RIVERSIDE
		CITY:			LONDON
		STATE:			X0
		ZIP:			SE1 2RE
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>tm242772d4_pre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:vrna="http://www.veronapharma.com/20231231" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title>tm242772-2_nonfiling - none - 8.2930384s</title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
  <body><div style="margin-left:auto;margin-right:auto;width:595.31pt;"><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:27pt;width:541.31pt;">
        <div style="text-align:center; width:541.31pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <span style="letter-spacing:-0.28pt;">UNITED STATES
          <br/>
          SECURITIES AND EXCHANGE COMMISSION</span>
        </div>
        <div style="margin-top:2pt; text-align:center; width:541.31pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Washington, DC 20549</span><span style="font-weight:normal;font-size:14pt;">&#8203;<span style="letter-spacing:0.28pt;"> </span></span>
        </div>
        <div style="margin-top:12pt; text-align:center; width:541.31pt; line-height:16pt;font-weight:bold;font-size:14pt;"> <span style="letter-spacing:-0.28pt;"><span style="-sec-ix-hidden: hidden-fact-0">SCHEDULE 14A</span> </span> </div>
        <div style="margin-top:9.167pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:10pt; text-align:center; width:541.31pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(Rule&#160;14a-101)</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:6pt; text-align:center; width:541.31pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">INFORMATION REQUIRED IN PROXY STATEMENT
          <br/>
          SCHEDULE 14A INFORMATION</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:6pt; text-align:center; width:541.31pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Proxy Statement Pursuant to Section&#160;14(a) of the
          <br/>
          Securities Exchange Act of 1934 (Amendment No.&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;)</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:8.5pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:12pt; width:541.31pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Filed by the Registrant&#160;&#160;&#160;&#9746; </span>
        </div>
        <div style="margin-top:8pt; width:541.31pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Filed by a Party other than the Registrant&#160;&#160;&#160;&#9744; </span>
        </div>
        <div style="margin-top:8pt; width:541.31pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Check the appropriate box: </span>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#9746;</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Preliminary Proxy Statement </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#9744;</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Confidential, for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2)) </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#9744;</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Definitive Proxy Statement </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#9744;</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Definitive Additional Materials </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#9744;</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Soliciting Material under &#167;&#160;240.14a-12 </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:6pt; text-align:center; width:541.31pt; line-height:16pt;font-weight:bold;font-size:14pt;"> <span style="letter-spacing:-0.28pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-8480">VERONA PHARMA PLC</ix:nonNumeric> </span> </div>
        <div style="margin-top:1.167pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(Name of Registrant as Specified In Its Charter)</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:8pt; text-align:center; width:541.31pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;&#160;&#160;</span>
        </div>
        <div style="margin-top:2.5pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3pt; text-align:center; width:541.31pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:3pt; width:541.31pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Payment of Filing Fee (Check all boxes that apply): </span>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#9746;</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">No fee required. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#9744;</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Fee paid previously with preliminary materials. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#9744;</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Fee computed on table in exhibit required by Item&#160;25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:18pt;font-weight:bold;font-size:16pt;">
          <span style="letter-spacing:-0.32pt;">Verona Pharma plc</span><span style="font-weight:normal;letter-spacing:0.32pt;"> </span>
        </div>
        <div style="margin-top:25.5pt; width:456pt; line-height:32pt;font-size:30pt;">
          <span style="letter-spacing:0.6pt;">NOTICE &amp; PROXY STATEMENT </span>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:27pt;font-size:25pt;">
          <span style="letter-spacing:0.5pt;">Annual General Meeting <br/>of Shareholders </span></div>
        <div style="margin-top:360pt; width:456pt; line-height:14pt;font-size:12pt;">
          <span style="letter-spacing:0.24pt;">April&#160;26, 2024 </span>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:14pt;font-size:12pt;">
          <span style="letter-spacing:0.24pt;">11:00&#160;a.m. (British Summer Time) </span>
        </div>
        <div style="margin-top:36pt; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">VERONA PHARMA PLC <br/>ONE CENTRAL SQUARE <br/>CARDIFF, CF10 1FS <br/>UNITED KINGDOM</span></div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:3pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;text-align:right; width:456pt;">
          <img alt="[MISSING IMAGE: lg_veronapharma-4c.jpg]" src="lg_veronapharma-4c.jpg" style="height: 76px; width: 197px;"/>
        </div>
        <div style="margin-top:16.4pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">VERONA PHARMA PLC</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Registered office: One Central Square, Cardiff, CF10 1FS, U.K.
          <br/>
          Incorporated in England and Wales with registered no.&#160;5375156</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:8pt; text-align:right; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">March [&#8199;&#8199;], 2024</span>&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Dear Shareholder: </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">2024 Annual General Meeting of Verona Pharma plc (&#8220;AGM&#8221;)</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This letter, the notice of AGM set out in this document (&#8220;Notice&#8221;) and associated materials for the AGM are being sent to you because, as of March [&#8199;&#8199;], 2024 (being the latest practicable date before the circulation of this document), you are registered as a holder of voting ordinary shares in the register of members of Verona Pharma plc (the &#8220;Company&#8221;). However, this letter, the Notice and associated materials will also be available to holders of American Depositary Shares (&#8220;ADSs&#8221;) and contain information relevant to holders of ADSs. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">I confirm that our AGM will be held on Friday, April&#160;26, 2024 at 11:00&#160;a.m. British Summer Time at the offices of Latham &amp; Watkins at 99 Bishopsgate, London, EC2M 3XF, United Kingdom. The Notice is set out in this document and it contains the resolutions to be proposed at the AGM. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Action to be taken by holders of ordinary shares in the Company</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">If you are a holder of ADSs, please ignore this section and refer instead to the section below&#8201;&#8212;&#8201;&#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">Holders of American Depositary Shares</span><span style="letter-spacing:0.2pt;">&#8221;. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Shareholders are entitled to appoint a proxy to exercise all or any of their rights to attend and to speak and vote on their behalf at the AGM. A proxy need not be a shareholder of the Company. A shareholder may appoint more than one proxy in relation to the AGM provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that shareholder. Should you wish to appoint more than one proxy please return the form of proxy and attach to it a schedule detailing the names of the proxies you wish to appoint, the number of shares each proxy will represent and the way in which you wish them to vote on the resolutions that are to be proposed. To be valid, the form of proxy and the power of attorney or other authority (if any) under which it is signed or a certified copy of such power or authority must be lodged at the office of the Company Secretary, Verona Pharma plc, 6th Floor, 60 Gracechurch Street, London EC3V 0HR by hand or by post, or by email to ben.harber@shma.co.uk, so as to be received by </span><span style="font-weight:bold;letter-spacing:-0.2pt;">no later than 11:00&#160;a.m. British Summer Time (6:00&#160;a.m. Eastern Time) on April&#160;24, 2024,</span><span style="letter-spacing:0.2pt;"> or if the AGM is adjourned, not later than 48 hours before the time fixed for the holding of the adjourned meeting (excluding any day that is not a working day). </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">In the case of a shareholder which is a corporation, the form of proxy must be executed under its common seal or executed on its behalf by a duly authorized officer or attorney for the company. Any corporation which is a shareholder may also appoint one or more representatives who may exercise on its behalf all of its powers as a shareholder provided they do not do so in relation to the same shares. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The completion and return of a form of proxy will not preclude you from attending in person at the AGM and voting should you wish to do so, but if you appoint a proxy and attend the AGM in person, the proxy appointment will be terminated. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">To change your proxy instructions, simply submit a new form of proxy as set out above. Note that the cut-off times for receipt of proxy appointments (see above) also apply in relation to amended instructions; any amended proxy instructions received after the relevant cut-off time will be disregarded. Please contact the </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Company Secretary (as noted above) to obtain a new form of proxy. If you submit more than one valid proxy appointment, the appointment validly received last before the latest time for receipt of forms of proxy will take precedence. If the Company is unable to determine which form of proxy was last validly received, none of them shall be treated as valid in respect of that ordinary share. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Further, you may terminate the appointment under the form of proxy prior to the commencement of the AGM (or any adjournment of the AGM). To be valid, the notice of termination of the authority of the person appointed to act as proxy must be deposited at the offices of the Company Secretary, Verona Pharma plc, 6th Floor, 60 Gracechurch Street, London EC3V 0HR, no less than 48 hours before the time fixed for the holding of the AGM or any adjournment thereof (as the case may be). </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In order for your form of proxy to remain valid, you must continue to be registered as a holder of ordinary shares in the Company&#8217;s register of members as of 11:00&#160;a.m. British Summer Time (6:00&#160;a.m. Eastern Time) on April&#160;24, 2024. Therefore, if you sell or transfer your ordinary shares in the Company on or prior to April&#160;24, 2024, your form of proxy can no longer be used and if submitted (whether before or after you sell or transfer your ordinary shares) will be treated as invalid. Please pass this document to the person who arranged the sale or transfer for delivery to the purchaser or transferee. The purchaser or transferee should contact the Company Secretary to request a new form of proxy for its use. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Should you elect to convert your holding of ordinary shares in the capital of the Company into an interest in the capital of the Company represented by ADSs before the AGM, you will cease to be a holder of ordinary shares in your own name and will not be entitled to vote at the AGM as an ordinary shareholder. You will also not be able to use the form of proxy that has been sent to you. However, you may be able to exercise your vote as a holder of an interest in the capital of the Company represented by ADSs&#8201;&#8212;&#8201;please refer to the next section&#8201;&#8212;&#8201;&#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">Holders of American Depositary Shares.</span><span style="letter-spacing:0.2pt;">&#8221; </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Holders of American Depositary Shares</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In order to exercise your vote as a holder of an interest in the capital of the Company represented by ADSs, you or your bank, broker or nominee must be registered as a holder of ADSs in the ADS register </span><span style="font-weight:bold;letter-spacing:-0.2pt;">as of 5:00&#160;p.m. Eastern Time on Wednesday, March&#160;13, 2024 (the &#8220;ADS Record Date&#8221;)</span><span style="letter-spacing:0.2pt;">. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If you hold ADSs through a bank, broker or nominee as of 5:00&#160;p.m. Eastern Time on the ADS Record Date, the AGM documentation, including the ADS voting instructions, will be sent to your broker who should forward the materials to you. Please reach out to your broker to provide your voting instructions. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Please note that ADS voting instructions submitted by ADS holders must be received by Citibank,&#160;N.A. </span><span style="font-weight:bold;letter-spacing:-0.2pt;">no later than 10:00&#160;a.m. Eastern Time on Monday, April&#160;22, 2024</span><span style="letter-spacing:0.2pt;">. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Contact for ADS holders</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If you have queries about how you can deliver voting instructions, please contact Citibank, N.A.&#8201;&#8212;&#8201;ADR Shareholder Services at tel: +1-877-248-4237 (toll free within the United States) or +1-781-575-4555 (for international callers) or by email: citibank@shareholders-online.com or at Citibank Shareholder Services, P.O. Box 43099, Providence, RI 02940-5000. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Contact at Verona Pharma</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If at any point you require guidance, please contact Verona Pharma General Counsel, on email: legal@veronapharma.com. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Recommendation</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">You will find an explanatory note in relation to each of the resolutions in the attached proxy statement. The Directors consider that each resolution is in the best interests of the Company and its shareholders as a whole and is likely to promote the success of the Company. Accordingly, the Directors unanimously recommend that Shareholders vote in favor of the resolutions to be proposed at the AGM, as they intend to do in respect of their own beneficial holdings. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">Thank you for your ongoing support of Verona Pharma plc. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">Yours faithfully, </span>
        </div>
        <div style="margin-left:20pt; margin-top:24pt; width:436pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:-0.2pt;">David Ebsworth, Ph.D.</span>
        </div>
        <div style="margin-left:20pt; margin-top:2pt; width:436pt; line-height:12pt;font-style:italic;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">Chairperson</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:24pt; text-align:center; width:456pt;">
          <img alt="[MISSING IMAGE: lg_veronapharma-4c.jpg]" src="lg_veronapharma-4c.jpg" style="height: 76px; width: 197px;"/>
        </div>
        <div style="margin-top:17.4pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">VERONA PHARMA PLC</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Registered office: One Central Square, Cardiff, CF10 1FS, U.K.
          <br/>
          Incorporated in England and Wales with registered no.&#160;5375156</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS
          <br/>
          TO BE HELD ON FRIDAY, APRIL 26, 2024</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="font-weight:bold;letter-spacing:-0.2pt;">NOTICE IS HEREBY GIVEN</span><span style="letter-spacing:0.2pt;"> that an Annual General Meeting (&#8220;AGM&#8221;) of Verona Pharma plc (the &#8220;Company&#8221;) will be held on Friday, April&#160;26, 2024 at 11:00&#160;a.m. British Summer Time at the offices of Latham &amp; Watkins at 99 Bishopsgate, London, EC2M 3XF, United Kingdom. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">At the AGM, the following business shall be transacted: </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Ordinary resolutions</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Re-election of Directors</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">1.</span>
          <br/>
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To re-elect, as a Director of the Company, Ms.&#160;Lisa Deschamps, who retires in accordance with Article&#160;26.2 of the Company&#8217;s Articles of Association and offers herself for re-election. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">2.</span>
          <br/>
        </div>
        <div style=" margin-top:8.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To re-elect, as a Director of the Company, Dr.&#160;Martin Edwards, who retires in accordance with Article&#160;26.2 of the Company&#8217;s Articles of Association and offers himself for re-election. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">3.</span>
          <br/>
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To re-elect, as a Director of the Company, Dr.&#160;Sven Anders Ullman, who retires in accordance with Article&#160;26.2 of the Company&#8217;s Articles of Association and offers himself for re-election. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">4.</span>
          <br/>
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To re-elect, as a Director of the Company, Ms.&#160;Christina Ackermann, who retires in accordance with Article&#160;21.2 of the Company&#8217;s Articles of Association and offers herself for re-election. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">5.</span>
          <br/>
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To re-elect, as a Director of the Company, Mr.&#160;Michael Austwick, who retires in accordance with Article&#160;21.2 of the Company&#8217;s Articles of Association and offers himself for re-election. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">U.K. statutory Annual Report</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">6.</span>
          <br/>
        </div>
        <div style=" margin-top:8.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To receive and adopt the U.K. statutory annual accounts and Directors&#8217; report for the year ended December&#160;31, 2023 and the report of the auditors thereon (the &#8220;2023 U.K. Annual Report&#8221;). </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">U.K. statutory Remuneration Report and Policy</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">7.</span>
          <br/>
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors&#8217; Remuneration Report for the year ended December&#160;31, 2023, as set out on pages [&#8199;&#8199;] to [&#8199;&#8199;] of the 2023 U.K. Annual Report. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">8.</span>
          <br/>
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To receive and approve the U.K. Directors&#8217; Remuneration Policy, as set out on pages [&#8199;&#8199;] to [&#8199;&#8199;] of the U.K. Annual Report, which, if approved, will take effect upon conclusion of the AGM. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Director Remuneration</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">9.</span>
          <br/>
        </div>
        <div style=" margin-top:8.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To approve an increase in the maximum aggregate level of Non-Executive Director annual remuneration (by way of fee) in accordance with Article&#160;21.4 of the Company&#8217;s Articles of Association to &#163;750,000 per annum on an ongoing basis. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Appointment and remuneration of auditor</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">10.</span>
          <br/>
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To appoint Ernst &amp; Young LLP as the Company&#8217;s auditors, to hold office until the conclusion of the next annual general meeting of shareholders. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">11.</span>
          <br/>
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To authorize the Audit and Risk Committee to determine the auditors&#8217; remuneration for the year ending December&#160;31, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Say-on-pay advisory vote</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">12.</span>
          <br/>
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To approve, on an advisory (non-binding) basis, the compensation of the Company&#8217;s named executive officers. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Authority to allot shares</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">13.</span>
          <br/>
        </div>
        <div style=" margin-top:8.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">To authorize the Directors generally and unconditionally for the purposes of Section&#160;551 of the U.K. Companies Act 2006 (the &#8220;Companies Act&#8221;) to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company (&#8220;Rights&#8221;) up to an aggregate nominal amount of &#163;8,345,745 (being up to a maximum of [&#8199;&#8199;&#8199;&#8199;&#8199;] shares representing [&#8199;&#8199;&#8199;]% of the Company&#8217;s existing ordinary share capital as at the close of business on March [&#8199;&#8199;], 2024 (being the latest practicable date prior to publication of this document)) to such persons at such times and upon such conditions as the directors may determine (subject to the Company&#8217;s Articles of Association). </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">This authority shall replace any existing authorities to the extent not utilized at the date this resolution is passed and shall, unless previously renewed, revoked or varied by the Company in general meeting, expire on June&#160;1, 2025, provided that the Company may, at any time before such expiry, make an offer or enter into an agreement which would or might require shares to be allotted or Rights to be granted after such expiry and the Directors may allot such shares or grant Rights pursuant to any such offer or agreement as if the authority conferred hereby had not expired. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Special resolution</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Disapplication of pre-emption rights</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">14.</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Subject to and conditional upon the passing of resolution 13 above, to authorize the Directors pursuant to Section&#160;570 and 573 of the Companies Act to allot equity securities (as defined in Section&#160;560 of the Companies Act) for cash pursuant to the authority conferred by resolution 13 above and/or to sell ordinary shares held by the Company as treasury shares for cash, as if Section&#160;561(1) of the Companies Act did not apply to any such allotment or sale, provided that this power shall be limited to the allotment of equity securities or sale of treasury shares up to an aggregate nominal amount of &#163;8,345,745 (being up to a maximum of [&#8199;&#8199;&#8199;&#8199;&#8199;] shares representing [&#8199;&#8199;&#8199;]% of the Company&#8217;s existing ordinary share capital as at the close of business on March&#160;[&#8199;&#8199;], 2024 (being the latest practicable date prior to publication of this document)), shall replace any existing disapplication of Section&#160;561 of the Companies Act to the extent not utilized at the date this resolution is passed and shall expire on June&#160;1, 2025 unless previously renewed, varied or revoked by the Company in general meeting, provided that the Company may, before such expiry, make an offer or agreement which would or might require shares in the Company or rights to be allotted or granted or treasury shares to be sold after this authority expires and that the Directors may allot shares in the Company or grant rights or sell treasury shares pursuant to such an offer or agreement as if the authority conferred by this resolution had not expired. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;margin-bottom:5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">
              <div style="font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">By order of the Board:</span>
              </div>
              <div style="margin-top:12pt;">
                <span style="letter-spacing:0.2pt;">Ben Harber</span>
              </div>
              <div style="margin-top:2pt;font-style:italic;">
                <span style="letter-spacing:0.2pt;">Company Secretary</span>
              </div>
              <div style="margin-top:2pt;">
                <span style="letter-spacing:0.2pt;">March [&#8199;&#8199;], 2024 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">
              <div style="font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">Registered Office:</span>
              </div>
              <div style="margin-top:12pt;">
                <span style="letter-spacing:0.2pt;">One Central Square</span>
              </div>
              <div style="margin-top:2pt;">
                <span style="letter-spacing:0.2pt;">Cardiff, CF10 1FS,</span>
              </div>
              <div style="margin-top:2pt;">
                <span style="letter-spacing:0.2pt;">U.K.</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Notes:</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(1)</span>
          <br/>
        </div>
        <div style=" margin-top:11.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <span style="letter-spacing:-0.2pt;">Resolutions and voting</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The proposed resolutions will be put to vote on a poll. This results in a more accurate reflection of the views of Shareholders ensuring that votes by proxy will be fully-counted. On a poll, each Shareholder has one vote for every share held. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Resolutions 1 to 13 are proposed as ordinary resolutions. On a poll, an ordinary resolution is passed if it is approved by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the resolution. Resolution 14 is proposed as a special resolution. On a poll, a special resolution is passed if it is approved by holders representing not less than 75% of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the resolution. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The results of the voting and any other information required by the U.K. Companies Act 2006 will be made available on our website (https://www.veronapharma.com) as soon as reasonably practicable following the AGM and for the required period thereafter. </span>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(2)</span>
          <br/>
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <span style="letter-spacing:-0.2pt;">Appointment of proxies</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Members are entitled to appoint a proxy to exercise all or any of their rights to attend and to speak and vote on their behalf at the AGM. A proxy need not be a shareholder of the Company. A shareholder may appoint more than one proxy in relation to the AGM provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that shareholder. Should you wish to appoint more than one proxy please return the form of proxy and attach to it a schedule detailing the names of the proxies you wish to appoint, the number of shares each proxy will represent and the way in which you wish them to vote on the resolutions that are to be proposed. </span><span style="font-weight:bold;letter-spacing:-0.2pt;">To be valid, the form of proxy and the power of attorney or other authority (if any) under which it is signed or a certified copy of such power or authority must be lodged at the office of the Company Secretary, Verona Pharma plc, c/o&#160;Shakespeare Martineau LLP, 6th Floor, 60 Gracechurch Street, London EC3V 0HR BY HAND or BY POST, or BY EMAIL to ben.harber@shma.co.uk, so as to be received not less than 48 hours before the time fixed for the holding of the AGM or any adjournment thereof (as the case may be), excluding any part of a day which is not a working day.</span><span style="letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The completion and return of a form of proxy will not preclude a member from attending in person at the AGM and voting should they wish to do so, but if a member appoints a proxy and attends the AGM in person, the proxy appointment will be terminated. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The attached proxy statement explains proxy voting and the matters to be voted on in more detail. Please read the proxy statement carefully. For specific information regarding the voting of your ordinary shares, please refer to the proxy statement under the section entitled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">Questions and Answers About the Annual General Meeting</span><span style="letter-spacing:0.2pt;">.&#8221; </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In the case of a member that is a corporation, the form of proxy must be executed under its common seal or executed on its behalf by a duly authorized officer or attorney for the company. Any corporation which is a member may also appoint one or more representatives who may exercise on its behalf all of its powers as a member provided they do not do so in relation to the same shares. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">To change your proxy instructions, simply submit a new form of proxy as set out above. Note that the cut-off times for receipt of proxy appointments (see above) also apply in relation to amended instructions; any amended proxy instructions received after the relevant cut-off time will be disregarded. Please contact the Company Secretary (as noted above) to obtain a new form of proxy. If you submit more than one valid proxy appointment, the appointment validly received last before the latest time for receipt of forms of proxy will take precedence. If the Company is unable to determine which form of proxy was last validly received, none of them shall be treated as valid in respect of that Ordinary Share. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Further, the appointment under the form of proxy may be terminated by the member prior to the commencement of the AGM (or any adjournment of the AGM). To be valid, the notice of termination </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">of the authority of the person appointed to act as proxy must be deposited at the offices of the Company Secretary, Verona Pharma plc, c/o&#160;Shakespeare Martineau LLP, 6th Floor, 60 Gracechurch Street, London EC3V 0HR, no less than 48 hours before the time fixed for the holding of the AGM or any adjournment thereof (as the case may be). </span>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(3)</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <span style="letter-spacing:-0.2pt;">Appointment of proxy by joint members</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In the case of joint holders, where more than one of the joint holders purports to appoint a proxy, only the appointment submitted by the most senior holder will be accepted. Seniority is determined by the order in which the names of the joint holders appear in the Company&#8217;s register of members in respect of the joint holding (the first-named being the most senior). </span>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(4)</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <span style="letter-spacing:-0.2pt;">Issued shares and total voting rights</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">As at the close of business on March [&#8199;&#8199;] , 2024 (being the latest practicable date prior to publication of this document), the Company&#8217;s issued ordinary share capital comprised [&#8199;&#8199;&#8199;&#8199;&#8199;] voting ordinary shares. Each voting ordinary share carries the right to one vote and therefore the total number of voting rights at the close of business on March [&#8199;&#8199;], 2024 is [&#8199;&#8199;&#8199;&#8199;]. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">In accordance with the terms of the deposit agreement by and among the Company, Citibank, N.A. as depositary and holders and beneficial owners of ADSs issued thereunder dated as of May&#160;2, 2017, holders of ADSs as of 5:00&#160;p.m. Eastern Time on March&#160;13, 2024, the ADS Record Date, who do not provide the depositary bank with voting instructions on or before 10:00&#160;a.m. Eastern Time on April&#160;22, 2024, the ADS Voting Cut-Off Time, will be deemed to have instructed the depositary bank to give a discretionary proxy to a person designated by the Company to vote the underlying ordinary shares at the AGM.</span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <table style="width:456pt;height:620.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:427.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Page </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <a href="#tPRST"><span style="letter-spacing:-0.2pt;">Proxy Statement</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPRST">1</a></span> <a href="#tPRST"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <a href="#tQAAA"><span style="letter-spacing:-0.2pt;">Questions and Answers About the Annual General Meeting</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tQAAA">2</a></span> <a href="#tQAAA"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <a href="#tPTBV"><span style="letter-spacing:-0.2pt;">Proposals to be Voted On</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPTBV">8</a></span> <a href="#tPTBV"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR1"><span style="letter-spacing:0.2pt;">PROPOSAL 1. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR1">8</a></span> <a href="#tPR1"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR2"><span style="letter-spacing:0.2pt;">PROPOSAL 2. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR2">8</a></span> <a href="#tPR2"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR3"><span style="letter-spacing:0.2pt;">PROPOSAL 3. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR3">9</a></span> <a href="#tPR3"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR4"><span style="letter-spacing:0.2pt;">PROPOSAL 4. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR4">9</a></span> <a href="#tPR4"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR5"><span style="letter-spacing:0.2pt;">PROPOSAL 5. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR5">10</a></span> <a href="#tPR5"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOBOD"><span style="letter-spacing:0.2pt;">Our Board of Directors </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tOBOD">10</a></span> <a href="#tOBOD"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tBDM"><span style="letter-spacing:0.2pt;">BOARD DIVERSITY MATRIX </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tBDM">13</a></span> <a href="#tBDM"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR6"><span style="letter-spacing:0.2pt;">PROPOSAL 6. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR6">14</a></span> <a href="#tPR6"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR7"><span style="letter-spacing:0.2pt;">PROPOSAL 7. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR7">14</a></span> <a href="#tPR7"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR8"><span style="letter-spacing:0.2pt;">PROPOSAL 8. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR8">15</a></span> <a href="#tPR8"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR9"><span style="letter-spacing:0.2pt;">PROPOSAL 9. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR9">15</a></span> <a href="#tPR9"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR10"><span style="letter-spacing:0.2pt;">PROPOSAL 10. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR10">16</a></span> <a href="#tPR10"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR11"><span style="letter-spacing:0.2pt;">PROPOSAL 11. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR11">18</a></span> <a href="#tPR11"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR12"><span style="letter-spacing:0.2pt;">PROPOSAL 12. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR12">19</a></span> <a href="#tPR12"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR13"><span style="letter-spacing:0.2pt;">PROPOSAL 13. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR13">20</a></span> <a href="#tPR13"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPR14"><span style="letter-spacing:0.2pt;">PROPOSAL 14. </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPR14">20</a></span> <a href="#tPR14"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <a href="#tEXOF"><span style="letter-spacing:-0.2pt;">Executive Officers</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tEXOF">22</a></span> <a href="#tEXOF"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <a href="#tCOGO"><span style="letter-spacing:-0.2pt;">Corporate Governance</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tCOGO">22</a></span> <a href="#tCOGO"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tGEN"><span style="letter-spacing:0.2pt;">GENERAL </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tGEN">22</a></span> <a href="#tGEN"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tBOCO"><span style="letter-spacing:0.2pt;">BOARD COMPOSITION </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tBOCO">23</a></span> <a href="#tBOCO"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tDIIN"><span style="letter-spacing:0.2pt;">DIRECTOR INDEPENDENCE </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tDIIN">23</a></span> <a href="#tDIIN"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tDICA"><span style="letter-spacing:0.2pt;">DIRECTOR CANDIDATES </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tDICA">23</a></span> <a href="#tDICA"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCFS"><span style="letter-spacing:0.2pt;">COMMUNICATIONS FROM SHAREHOLDERS </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tCFS">24</a></span> <a href="#tCFS"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tBLSA"><span style="letter-spacing:0.2pt;">BOARD LEADERSHIP STRUCTURE AND ROLE IN RISK OVERSIGHT </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tBLSA">25</a></span> <a href="#tBLSA"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPBE"><span style="letter-spacing:0.2pt;">PERIODIC BOARD EVALUATION </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPBE">25</a></span> <a href="#tPBE"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCOBC"><span style="letter-spacing:0.2pt;">CODE OF BUSINESS CONDUCT AND ETHICS </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tCOBC">25</a></span> <a href="#tCOBC"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tANPO"><span style="letter-spacing:0.2pt;">ANTI-HEDGING POLICY </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tANPO">26</a></span> <a href="#tANPO"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tABMO"><span style="letter-spacing:0.2pt;">ATTENDANCE BY MEMBERS OF THE BOARD OF DIRECTORS AT MEETINGS </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tABMO">26</a></span> <a href="#tABMO"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <a href="#tCOTB"><span style="letter-spacing:-0.2pt;">Committees of the Board</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tCOTB">26</a></span> <a href="#tCOTB"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tAARC"><span style="letter-spacing:0.2pt;">AUDIT AND RISK COMMITTEE </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tAARC">27</a></span> <a href="#tAARC"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tRECO"><span style="letter-spacing:0.2pt;">REMUNERATION COMMITTEE </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tRECO">28</a></span> <a href="#tRECO"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tNACG"><span style="letter-spacing:0.2pt;">NOMINATION AND CORPORATE GOVERNANCE COMMITTEE </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tNACG">28</a></span> <a href="#tNACG"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEADC"><span style="letter-spacing:0.2pt;">Executive and Director Compensation </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tEADC">29</a></span> <a href="#tEADC"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#t2SCT"><span style="letter-spacing:0.2pt;">2023 SUMMARY COMPENSATION TABLE </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#t2SCT">29</a></span> <a href="#t2SCT"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOEAA"><span style="letter-spacing:0.2pt;">OUTSTANDING EQUITY AWARDS AT 2023 FISCAL YEAR END </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tOEAA">31</a></span> <a href="#tOEAA"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#t2DC"><span style="letter-spacing:0.2pt;">2023 DIRECTOR COMPENSATION </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#t2DC">36</a></span> <a href="#t2DC"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:427.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#tSAFI"><span style="letter-spacing:0.2pt;">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tSAFI">38</a></span> <a href="#tSAFI"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">i</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="TOC2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:341.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:269.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:427.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Page </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <a href="#tSOOC"><span style="letter-spacing:-0.2pt;">Security Ownership of Certain Beneficial Owners and Management</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tSOOC">38</a></span> <a href="#tSOOC"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDS1R"><span style="letter-spacing:0.2pt;">Delinquent Section&#160;16(a) Reports </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tDS1R">41</a></span> <a href="#tDS1R"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <a href="#tCERE"><span style="letter-spacing:-0.2pt;">Certain Relationships</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tCERE">41</a></span> <a href="#tCERE"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPAPF"><span style="letter-spacing:0.2pt;">POLICIES AND PROCEDURES FOR RELATED PERSON TRANSACTIONS </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tPAPF">41</a></span> <a href="#tPAPF"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#t2RRA"><span style="letter-spacing:0.2pt;">2016 REGISTRATION RIGHTS AGREEMENT </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#t2RRA">42</a></span> <a href="#t2RRA"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOAAT"><span style="letter-spacing:0.2pt;">OTHER AGREEMENTS AND TRANSACTIONS </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tOAAT">42</a></span> <a href="#tOAAT"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <a href="#tADIN"><span style="letter-spacing:-0.2pt;">Additional Information</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tADIN">43</a></span> <a href="#tADIN"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSRTC"><span style="letter-spacing:0.2pt;">SHAREHOLDERS&#8217; RIGHTS TO CALL A GENERAL MEETING </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tSRTC">43</a></span> <a href="#tSRTC"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSPFT"><span style="letter-spacing:0.2pt;">SHAREHOLDER PROPOSALS FOR THE 2025 ANNUAL GENERAL MEETING </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tSPFT">43</a></span> <a href="#tSPFT"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOTMA"><span style="letter-spacing:0.2pt;">OTHER MATTERS </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tOTMA">43</a></span> <a href="#tOTMA"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSOP"><span style="letter-spacing:0.2pt;">SOLICITATION OF PROXIES </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tSOP">43</a></span> <a href="#tSOP"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tHOU"><span style="letter-spacing:0.2pt;">HOUSEHOLDING </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tHOU">44</a></span> <a href="#tHOU"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tVPAR"><span style="letter-spacing:0.2pt;">VERONA PHARMA&#8217;S ANNUAL REPORT ON FORM 10-K </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tVPAR">44</a></span> <a href="#tVPAR"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#tUSAA"><span style="letter-spacing:0.2pt;">U.K. STATUTORY ANNUAL ACCOUNTS AND REPORTS OF THE BOARD OF
                  <br/>
                  DIRECTORS AND AUDITORS OF VERONA PHARMA PLC FOR THE YEAR ENDED
                  <br/>
                  DECEMBER 31, 2023 </span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <span style="letter-spacing:0.2pt;"><a href="#tUSAA">44</a></span> <a href="#tUSAA"></a></td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:427.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tAATP"><span style="letter-spacing:-0.2pt;">Annex A to Proxy Statement: U.K. Statutory Annual Accounts and Directors&#8217; Report for the year ended December&#160;31, 2023</span></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:normal;">&#8203;</div>
            </td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:normal;">
                <span style="letter-spacing:0.2pt;"><a href="#tAATP">A-1</a></span>
              </div>
            </td>
            <td style="padding:0pt;padding-left:0.315000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">ii</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPRST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:110pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Proxy Statement</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Verona Pharma plc <br/>One Central Square <br/>Cardiff, CF10 1FS <br/>United Kingdom</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">We have sent you this proxy statement and the enclosed form of proxy because the Board of Directors (the &#8220;Board&#8221; or &#8220;Board of Directors&#8221;) of Verona Pharma plc (referred to herein as the &#8220;Company&#8221;, &#8220;Verona&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) is soliciting your proxy to vote at our 2024 Annual General Meeting of Shareholders (referred to herein as the &#8220;AGM&#8221;) to be held on Friday, April&#160;26, 2024 at 11:00&#160;a.m. British Summer Time at the offices of Latham &amp; Watkins at 99 Bishopsgate, London, EC2M 3XF, United Kingdom. </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">This proxy statement summarizes information about the proposals to be considered at the AGM and other information you may find useful in determining how to vote. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">The form of proxy is the means by which you actually authorize another person to vote your shares in accordance with your instructions. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In addition to solicitations by mail, our directors, officers and regular employees, without additional remuneration, may solicit proxies by telephone, e-mail and personal interviews. All costs of solicitation of proxies will be covered by us. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">We are mailing the Notice of AGM, this proxy statement and the form of proxy to our ordinary shareholders of record as of March&#160;13, 2024 (being the latest practicable date before the circulation of this document) for the first time on or about March [&#8199;&#8199;], 2024. In this mailing, we are also including our U.K. statutory annual accounts and reports for the year ended December&#160;31, 2023 (&#8220;2023 U.K. Annual Report&#8221;), which is appended as Annex A to this proxy statement, and our annual report on Form 10-K for the year ended December&#160;31, 2023 (&#8220;Annual Report on Form 10-K&#8221;). In addition, we have provided brokers, dealers, bankers, and their nominees, at our expense, with additional copies of our proxy materials, including the 2023 U.K. Annual Report, and the Annual Report on Form 10-K so that our record holders can supply these materials to the beneficial owners of our ordinary shares. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">While this document is being sent to our ordinary shareholders of record, this document will also be sent to registered holders of American Depositary Shares (&#8220;ADSs&#8221;) as of 5:00&#160;p.m. Eastern Time on Wednesday, March&#160;13, 2024 (the &#8220;ADS Record Date&#8221;) and contains information relevant to holders of ADSs. </span>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 26, 2024</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Our Notice of AGM, this proxy statement, the Annual Report on Form 10-K, the 2023 U.K. Annual Report and our form of proxy (for ordinary shareholders) are available on our investor relations website located at </span><span style="font-style:italic;letter-spacing:0.2pt;">www.veronapharma.com/investors</span><span style="letter-spacing:0.2pt;">. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Our principal executive offices are located at 3 More London Riverside, London SE1 2RE, United Kingdom. </span>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">1</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tQAAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Questions and Answers About the Annual General Meeting</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">WHY AM I RECEIVING THESE MATERIALS? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We have sent you this proxy statement and the enclosed form of proxy because you are an ordinary shareholder of record and our Board of Directors is soliciting your proxy to vote at the AGM, including at any adjournments or postponements of the AGM. However, you do not need to attend the AGM to vote your shares. Instead, please simply complete, sign and return the enclosed form of proxy. All proxies, however submitted, must be received by the Company Secretary no later than 11:00&#160;a.m. British Summer Time (6:00&#160;a.m. Eastern Time) on April&#160;24, 2024, or if the AGM is adjourned, not later than 48 hours before the time fixed for the holding of the adjourned meeting (excluding any day which is not a working day). </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The return of a completed form of proxy will not preclude you from attending in person at the AGM and voting should you wish to do so, but if you appoint a proxy and subsequently attend the AGM in person, the proxy appointment will be terminated, should you subsequently decide to do so. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We intend to mail this proxy statement and the accompanying form of proxy on or about March [&#8199;&#8199;], 2024 to all ordinary shareholders of record as of March&#160;13, 2024 entitled to vote at the AGM. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Materials for ADS holders of record, including this proxy statement, the Annual Report on Form&#160;10-K, the 2023 U.K. Annual Report and an ADS voting instructions, will be mailed on or about March&#160;[&#8199;&#8199;], 2024 to all ADS holders, including banks, brokers and nominees, who are registered as holders of ADSs in the ADS register as of 5:00&#160;p.m. Eastern Time on the ADS Record Date. ADS voting instructions submitted by ADS holders must be received by Citibank, N.A. no later than 10:00&#160;a.m. Eastern Time on April&#160;22, 2024 (the &#8220;ADS Voting Cut-off Time&#8221;). </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">WHO CAN VOTE AT THE AGM? </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Ordinary shareholders</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Only shareholders holding voting ordinary shares of record registered in the register of members at 11:00&#160;a.m. British Summer Time (6:00&#160;a.m. Eastern Time) on April&#160;24, 2024 will be entitled to vote at the AGM. Holders of non-voting ordinary shares have no right to receive notice of, or to attend or vote, at the AGM. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">As of March [&#8199;&#8199;], 2024 (being the last practicable date before the circulation of this proxy statement) there were [&#8199;&#8199;&#8199;&#8199;] ordinary shares issued and entitled to vote. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We encourage you to fill out and return the enclosed form of proxy to ensure your vote is counted. All proxies, however submitted, must be received by the Company Secretary no later than 11:00&#160;a.m. British Summer Time (6:00&#160;a.m. Eastern Time) on April&#160;24, 2024, or if the AGM is adjourned, not later than 48&#160;hours before the time fixed for the holding of the adjourned meeting (excluding any day which is not a working day). </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">If you sell or transfer your ordinary shares in the Company on or prior to April&#160;24, 2024, your form of proxy can no longer be used and if submitted (whether before or after you sell or transfer your ordinary shares) will be treated as invalid. Please pass this document to the person who arranged the sale or transfer for delivery to the purchaser or transferee. The purchaser or transferee should contact Ben Harber, Company Secretary, to request a new form of proxy for use. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Beneficial owners of ordinary shares that are registered in the name of a broker, bank or other agent</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">A record holder holds shares in his or her name. Shares held in &#8220;street name&#8221; means shares that are held in the name of a bank or broker on a person&#8217;s behalf. If your shares are held by a bank or a brokerage firm, you are considered the &#8220;beneficial owner&#8221; of those shares held in &#8220;street name.&#8221; </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">If, on March&#160;24, 2024, your ordinary shares were held in an account at a brokerage firm, bank or other similar organization and you are the beneficial owner of shares, these proxy materials should be forwarded to you by that organization. The organization holding your account is considered the shareholder of record </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">2</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">for purposes of voting at the AGM. As the beneficial owner of voting ordinary shares, you have the right to direct your bank or brokerage firm how to vote your shares, and the bank or brokerage firm is required to vote your shares in accordance with your instructions. If your shares are held by a bank or brokerage firm, you may not vote your shares in person at the AGM, unless you obtain a legal proxy from your bank or brokerage firm. You are encouraged to provide voting instructions to your bank or brokerage firm so that they may submit a proxy. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Holders of American Depositary Shares and beneficial owners of American Depositary Shares</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">You are entitled to exercise your vote as a holder of an interest in the capital of the Company represented by ADSs if you or your brokerage firm, bank or nominee is registered as a holder of ADSs in the ADS register maintained by Citibank, N.A. as of 5:00&#160;p.m. Eastern Time on March&#160;13, 2024, the ADS Record Date. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If you hold ADSs through a brokerage firm, bank or nominee on the ADS Record Date, the materials for ADS holders, including ADS voting instructions, will be sent to that organization. The organization holding your account is considered the ADS holder of record. Please reach out to that organization to provide your voting instructions. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Please note that ADS voting instructions submitted by ADS holders must be received by Citibank, N.A. </span><span style="font-weight:bold;letter-spacing:-0.2pt;">no later than 10:00&#160;a.m. Eastern Time on April&#160;22, 2024, the ADS Voting Cut-Off Time</span><span style="letter-spacing:0.2pt;">. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Citibank, N.A. will collate all votes properly submitted by ADS holders and submit a vote on behalf of all ADS holders. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Contacts for ADS holders</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If you have queries about how you can deliver voting instructions, please contact Citibank, N.A.&#8201;&#8212;&#8201;ADR Shareholder Services at tel: +1-877-248-4237 (toll free within the United States) or +1-781-575-4555 (for international callers) or by email: citibank@shareholders-online.com or at Citibank Shareholder Services, P.O. Box 43099, Providence, RI 02940-5000. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If at any point you require guidance, please contact Verona Pharma General Counsel, on email: legal@veronapharma.com. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">WHAT ARE THE REQUIREMENTS TO ELECT THE DIRECTORS AND APPROVE EACH OF THE PROPOSALS? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The proposed resolutions will be put to vote on a poll. This results in a more accurate reflection of the views of shareholders ensuring that votes by proxy will be fully-counted. On a poll, each shareholder has one vote for every share held. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Proposals 1 to 13 are proposed as ordinary resolutions. On a poll, an ordinary resolution is passed if it is approved by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the resolution. Proposal 14 is proposed as a special resolution. On a poll, a special resolution is passed if it is approved by holders representing not less than 75% of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the resolution. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The results of the voting and any other information required by the U.K. Companies Act 2006 (the &#8220;Companies Act&#8221;) will be made available on our investor relations website located at </span><span style="font-style:italic;letter-spacing:0.2pt;">www.veronapharma.com/</span>&#8203;<span style="font-style:italic;letter-spacing:0.2pt;">investors</span><span style="letter-spacing:0.2pt;"> as soon as reasonably practicable following the AGM and for the required period thereafter. </span></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">WHAT ARE THE VOTING RECOMMENDATIONS OF OUR BOARD REGARDING THE ELECTION OF DIRECTORS AND OTHER PROPOSALS? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The following table summarizes the items that will be brought for a vote of our shareholders at the AGM, along with the Board&#8217;s voting recommendations. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">3</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-bottom:5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:31pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Proposal </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:341pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Description of Proposal </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:60pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Board&#8217;s
                <br/>
                Recommendation </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">1 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341pt;">
              <span style="letter-spacing:0.2pt;">To re-elect Ms.&#160;Lisa Deschamps as a director of the Company </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">2 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:341pt;">
              <span style="letter-spacing:0.2pt;">To re-elect Dr.&#160;Martin Edwards as a director of the Company </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">3 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:341pt;">
              <span style="letter-spacing:0.2pt;">To re-elect Dr.&#160;Sven Anders Ullman as a director of the Company </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">4 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:341pt;">
              <span style="letter-spacing:0.2pt;">To re-elect Ms.&#160;Christina Ackermann as a director of the Company </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">5 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:341pt;">
              <span style="letter-spacing:0.2pt;">To re-elect Mr.&#160;Michael Austwick as a director of the Company </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">6 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:341pt;">
              <span style="letter-spacing:0.2pt;">To receive and adopt the 2023 U.K. Annual Report </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">7 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:341pt;white-space:normal;">
              <span style="letter-spacing:0.2pt;">To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors&#8217; Remuneration Report </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">8 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:341pt;">
              <span style="letter-spacing:0.2pt;">To receive and approve the U.K. Directors&#8217; Remuneration Policy </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">9 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:341pt;white-space:normal;">
              <span style="letter-spacing:0.2pt;">To approve an increase in the maximum aggregate level of Non-Executive Director annual remuneration to &#163;750,000 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">10 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:341pt;white-space:normal;">
              <span style="letter-spacing:0.2pt;">To re-appoint EY as the Company&#8217;s auditors, to hold office until the conclusion of the next annual general meeting of shareholders </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">11 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:341pt;white-space:normal;">
              <span style="letter-spacing:0.2pt;">To authorize the Audit and Risk Committee to determine the auditors&#8217; remuneration for the year ending December&#160;31, 2024 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">12 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:341pt;white-space:normal;">
              <span style="letter-spacing:0.2pt;">To approve, on an advisory (non-binding) basis, the compensation of the Company&#8217;s named executive officers </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">13 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:341pt;white-space:normal;">
              <span style="letter-spacing:0.2pt;">To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of &#163;8,345,745 (being up to a maximum of [&#8199;&#8199;&#8199;&#8199;] shares representing [&#8199;&#8199;&#8199;&#8199;]% of the Company&#8217;s existing ordinary share capital as at the close of business on March&#160;[&#8199;&#8199;], 2024 (being the latest practicable date prior to publication of this document)) </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:31pt;">
              <span style="letter-spacing:0.2pt;">14 </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:341pt;white-space:normal;">
              <span style="letter-spacing:0.2pt;">To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if Section&#160;561(1) of the Companies Act does not apply to any such allotment </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:60pt;text-align:center;">
              <div style="text-align:center;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">WHAT CONSTITUTES A QUORUM? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Under our Articles of Association, a quorum will be present if two shareholders of the Company entitled to vote are present in person or represented by proxy at the AGM. In addition, we will require a quorum of at least 33 1/3% in number of the issued shares (excluding any shares held as treasury shares) entitled to vote on the business to be transacted at the AGM, consistent with the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) rules applicable to us as a U.S. domestic registrant. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If you are a shareholder of record of voting ordinary shares, your shares will be counted towards the quorum only if you are present in person or represented by proxy at the AGM. If you are a beneficial owner of voting ordinary shares held in an account at a brokerage firm, bank or other similar organization your shares will be counted towards the quorum if your broker or nominee submits a proxy for those shares and the proxy represents the holder at the AGM. If a form of proxy does not instruct the proxy how to vote or indicates &#8220;discretion&#8221; with respect to a proposal, the proxy will vote in accordance with the Board of Directors&#8217; recommendations, and the member represented by that proxy at the AGM will be counted towards the quorum requirement. For any other resolution put to the AGM, the proxy may vote or abstain from </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">4</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">voting as he or she sees fit. A member represented by a proxy at the AGM will be counted towards the quorum requirement even where the proxy abstains from voting. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If there is no quorum, within 15 minutes from the time appointed for holding the AGM the AGM will stand adjourned to such time, date and place as may be fixed by the chairperson of the AGM. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">HOW DO I VOTE MY SHARES? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If you are an ordinary &#8220;shareholder of record,&#8221; you may appoint a proxy to vote on your behalf by completing and signing the form of proxy and returning it in the envelope provided. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">All proxies must be received by the Company Secretary no later than 11:00&#160;a.m. British Summer Time (6:00&#160;a.m. Eastern Time) on April&#160;24, 2024, or if the AGM is adjourned, not later than 48 hours before the time fixed for the holding of the adjourned meeting (excluding any day which is not a working day). ADS voting instructions submitted by ADS holders must be received by Citibank, N.A. no later than 10:00&#160;a.m. Eastern Time on April&#160;22, 2024. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If you properly give instructions as to your proxy appointment by executing and returning a form of proxy and your proxy appointment is not subsequently revoked, your shares will be voted in accordance with your instructions. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If your ordinary shares are held in an account at a brokerage firm, bank or similar organization, you should follow directions provided by your broker, bank or other nominee. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">HOW WILL MY SHARES BE VOTED IF I DO NOT SPECIFY HOW THEY SHOULD BE VOTED? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If you sign and send your form of proxy, naming the Chairperson of the AGM as your proxy, but do not indicate how you want your shares to be voted, your shares will be voted in accordance with the Board of Directors&#8217; recommendations. For any other resolution put to the AGM, the Chairperson of the AGM may vote or abstain from voting as he or she sees fit. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In accordance with the terms of the deposit agreement by and among the Company, Citibank, N.A. as depositary and holders and beneficial owners of ADSs issued thereunder dated as of May&#160;2, 2017 (the &#8220;Deposit Agreement&#8221;), holders of ADSs as of 5:00&#160;p.m. Eastern Time on the ADS Record Date who do not provide the depositary bank with voting instructions on or before the ADS Voting Cut-Off Time will be deemed to have instructed the depositary bank to give a discretionary proxy to a person designated by the Company to vote the underlying ordinary shares at the AGM, and such shares, if such discretionary proxy is given, will be voted in accordance with the Board of Directors&#8217; recommendations, provided, however, that no such discretionary proxy shall be given by the Depositary with respect to any matter to be voted upon as to which the Company informs the Depositary that (a)&#160;the Company does not wish such proxy to be given, (b)&#160;substantial opposition exists, or &#169; the rights of holders of deposited securities under the Deposit Agreement may be adversely affected. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">CAN I CHANGE MY VOTE OR REVOKE A PROXY? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">A registered shareholder can revoke his or her proxy before the time of voting at the AGM in several ways by: </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">(1) mailing a revised form of proxy dated later than the prior form of proxy; </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">(2) notifying our Company Secretary in writing that you are revoking your proxy. Your revocation must be received at our registered office (as noted above) before the AGM to be effective; or </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">(3) revoking his or her proxy by voting in person at the AGM. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">If your ordinary shares are held in an account at a brokerage firm, bank or similar organization, to change or revoke your voting instructions you will need to contact the broker, bank or other nominee holding the shares. ADS holders may change or revoke their voting instructions by contacting Citibank, N.A. See also &#8220;What if I plan to attend the AGM?&#8221; </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">5</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">WHO COUNTS THE VOTES? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our Company Secretary will tabulate shareholder votes. If you are an ordinary shareholder of record, you can return your executed form of proxy to the Company Secretary, Verona Pharma plc, c/o&#160;Shakespeare Martineau LLP, 6</span><span style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</span><span style="letter-spacing:0.2pt;"> Floor, 60 Gracechurch Street, London, EC3V 0HR by hand or by post, or by email to ben.harber@shma.co.uk in accordance with the instructions printed thereon for tabulation (see instructions on the form of proxy). </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">If you hold your ordinary shares through a broker, your broker will return the form of proxy to the Company Secretary. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">If you are a holder of record of ADSs, you can return your executed ADS voting instructions to Citibank, N.A. for tabulation. If you hold your ADSs through a broker, bank or other organization, that organization can return the ADS voting instructions to Citibank, N.A. following your instruction. Citibank, N.A. will submit your votes to the Company Secretary for tabulation. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">HOW ARE VOTES COUNTED? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Votes will be counted by the Company Secretary, who will separately count &#8220;for&#8221; and &#8220;against&#8221; votes, and &#8220;votes withheld&#8221;. A &#8220;vote withheld&#8221; is not a vote in law and represents a shareholder&#8217;s affirmative choice to decline to vote on a proposal. Votes withheld are counted as present and entitled to vote for purposes of determining a quorum. Votes withheld have no effect on the proposals. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">As described above, in accordance with the terms of the Deposit Agreement, holders of ADSs as of 5:00&#160;p.m. Eastern Time on the ADS Record Date who do not provide the depositary bank with voting instructions on or before the ADS Voting Cut-Off Time will be deemed to have instructed the depositary bank to give a discretionary proxy to a person designated by the Company to vote the underlying ordinary shares at the AGM. Accordingly, we do not expect any broker non-votes on any of the proposals. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">HOW MANY VOTES DO I HAVE? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">On a poll, each shareholder present in person or by proxy or, in the case of a corporation, by a duly authorized representative has one vote for each share held by the shareholder. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">WHAT IF I PLAN TO ATTEND THE AGM? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Attendance at the AGM is limited to ordinary shareholders of record as of 11:00&#160;a.m. British Summer Time (6:00&#160;a.m. Eastern Time) on April&#160;24, 2024. The AGM will be held on Friday, April&#160;26, 2024 at 11:00&#160;a.m. British Summer Time at the offices of Latham &amp; Watkins at 99 Bishopsgate, London, EC2M 3XF, United Kingdom. Record holders of ADSs who wish to attend the AGM must provide proof of ownership of ADSs as of the ADS Record Date, which can be obtained from Citibank, N.A. or your broker through which you hold ADSs. Record holders of ADSs who attend the AGM will not be able to vote at the AGM. To vote, record holders of ADSs should follow the voting procedures described above in &#8220;Who can vote at the AGM?&#8221;. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">HOW DO YOU SOLICIT PROXIES? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We will solicit proxies and will bear the entire cost of this solicitation. The initial solicitation of proxies may be supplemented by additional mail communications and by telephone, fax, e-mail, internet and personal solicitation by our directors, officers or other employees. No additional compensation for soliciting proxies will be paid to our directors, officers or other employees for their proxy solicitation efforts. We also will reimburse Citibank, N.A. for their expenses in sending materials, including ADS voting instructions, to ADS holders of record. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">WHAT DO I DO IF I RECEIVE MORE THAN ONE NOTICE OR FORM OF PROXY? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">If you hold your ordinary shares in more than one account, you will receive a form of proxy for each account. To ensure that all of your shares are voted, please sign, date and return all forms of proxy. Please be sure to vote all of your shares. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">6</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:504pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">WILL THERE BE ANY OTHER BUSINESS CONDUCTED AT THE AGM? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">No. In accordance with our Articles of Association, no matters other than proposals 1 through 14 may be presented at the AGM. We have not been notified of, and our Board is not aware of, any other matters to be presented for action at the AGM. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">HOW CAN I FIND OUT THE RESULTS OF THE VOTING AT THE AGM? </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">Voting results will be announced by the filing of a Current Report on Form 8-K with the SEC within four business days after the AGM. If final voting results are unavailable at that time, we will file an amended Current Report on Form 8-K within four business days of the day the final results are available. </span>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">7</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPTBV">&#8203;</a><a id="tPR1">&#8203;</a><a id="tPR2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Proposals to be Voted On</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 1. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To re-elect Lisa Deschamps as a Director of the Company</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Lisa Deschamps is currently a member of our Board of Directors and has been nominated for re-election as a director. If elected, she will hold office from the date of her election until such annual general meeting of shareholders where she must retire by rotation and offer herself for re-election in accordance with the Articles, or until her earlier death, resignation or removal. Ms.&#160;Deschamps has agreed to serve if elected, and we have no reason to believe that she will be unable to serve. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Ms.&#160;Deschamps has served as a Non-Executive Director on our Board of Directors since March&#160;2021. Ms.&#160;Deschamps has served as Chief Executive Officer and an executive board member of AviadoBIO, a private gene therapy company, since October&#160;2021. From 1995 to October&#160;2021, Ms.&#160;Deschamps served in various roles at Novartis Pharmaceuticals, a global healthcare company, most recently from September&#160;2019 to October&#160;2021 as the Senior Vice President &amp; Chief Business Officer of AveXis, a biotechnology company that develops treatments for rare neurological genetic disorders, a subsidiary of Novartis and which was renamed Novartis Gene Therapies in September&#160;2020, and from 2017 to September&#160;2019 as Worldwide Business Head Neuroscience of Novartis. Ms.&#160;Deschamps has an M.B.A. in General Management from NYU Stern School of Business and a B.B.A. in marketing from IONA College, Hagan School of Business. We believe that Ms.&#160;Deschamps&#8217; extensive leadership experience in the healthcare industry qualifies her to serve on our Board of Directors. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the re-election of Lisa Deschamps as a Director of the Company</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 2. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To re-elect Martin Edwards as a Director of the Company</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Martin Edwards, M.D., is currently a member of our Board of Directors and has been nominated for re-election as a director. If elected, he will hold office from the date of his election until such annual general meeting of shareholders where he must retire by rotation and offer himself for re-election in accordance with the Articles, or until his earlier death, resignation or removal. Dr.&#160;Edwards has agreed to serve if elected, and we have no reason to believe that he will be unable to serve. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Dr.&#160;Edwards has served as a Non-Executive Director on our Board of Directors since April&#160;2019. From 2003 to September&#160;2020, Dr.&#160;Edwards held various positions at Novo Ventures, a life sciences investment firm, most recently as Senior Partner. Earlier in his career, he was Corporate VP and Global Head of Drug Development for Novo Nordisk, where he led all aspects of pre-clinical and clinical drug development. Dr.&#160;Edwards currently serves on the boards of directors of Inozyme Pharma and Morphic Therapeutics, and previously served on the board of directors of KalVista Pharmaceuticals, from July&#160;2019 to October&#160;2022, and Reata Pharmaceuticals from August&#160;2020 to September&#160;2023. Dr.&#160;Edwards trained in physiology and medicine at the University of Manchester. He is a Member of the Royal College of Physicians, a Member with distinction of the Royal College of General Practitioners, a Fellow of the Faculty of Pharmaceutical Medicine. He received his B.Sc. in physiology and MBChB in medicine from the University of Manchester and his M.B.A from the University of Warwick. We believe that Dr.&#160;Edwards&#8217; extensive experience in the pharmaceuticals industry and his experience in serving on the boards of public and private companies qualify him to serve on our Board of Directors. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">8</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPR3">&#8203;</a><a id="tPR4">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the re-election of Martin Edwards, M.D. as a Director of the Company</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.91pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 3. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To re-elect Sven Anders Ullman as a Director of the Company</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Sven Anders Ullman, M.D. Ph.D., is currently a member of our Board of Directors and has been nominated for re-election as a director. If elected, he will hold office from the date of his election until such annual general meeting of shareholders where he must retire by rotation and offer himself for re-election in accordance with the Articles, or until his earlier death, resignation or removal. Dr.&#160;Ullman has agreed to serve if elected, and we have no reason to believe that he will be unable to serve. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Dr.&#160;Ullman has served as a Non-Executive Director on our Board of Directors since September&#160;2015. Since January&#160;2022, Dr.&#160;Ullman has served as Head of R&amp;D and Chief Medical Officer of Swedish Orphan Biovitrum AB (&#8220;Sobi&#8221;). From 2015 to 2018, Dr.&#160;Ullman served as Head of the chronic obstructive pulmonary disease (&#8220;COPD&#8221;) Centre at Sahlgrenska University Hospital, Sweden. From 2013 to 2014, he was Executive Vice President and Head of Research and Development in the BioScience business unit of Baxter International Inc., a healthcare company, which became Baxalta Inc. From&#160;2007 to 2013, Dr.&#160;Ullman was Executive Vice President, Head of Research and Development at Nycomed Pharma Private Limited (now part of Takeda Pharmaceuticals Company Limited), where he led the development and approval of Daxas, the PDE4 inhibitor used to prevent COPD exacerbations. Earlier in his career, he held a number of roles in AstraZeneca. Dr.&#160;Ullman served on the board of directors of Pexa AB, a company that develops and commercializes respiratory medicine technology, from 2016 to 2018 and on the board of directors of Sobi from May&#160;2021 to December&#160;2021. Dr.&#160;Ullman received a M.D. and a Ph.D. in clinical pharmacology from the University of Gothenburg. We believe that Dr.&#160;Ullman&#8217;s extensive experience in the healthcare and pharmaceuticals industries qualify him to serve on our Board of Directors. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the re-election of Sven Anders Ullman, M.D., PhD., as a Director of the Company</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.91pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 4. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To re-elect Christina Ackermann as a Director of the Company</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Christina Ackermann is currently a member of our Board of Directors and has been nominated for re-election as a director. If elected, she will hold office from the date of her election until such annual general meeting of shareholders where she must retire by rotation and offer herself for re-election in accordance with the Articles, or until her earlier death, resignation or removal. Ms.&#160;Ackermann has agreed to serve if elected, and we have no reason to believe that she will be unable to serve. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Ms.&#160;Ackermann has served as a Non-Executive Director on our Board of Directors since September&#160;2023. From 2016 to April&#160;2023, Ms. Ackermann served in various roles at Bausch + Lomb Corporation, a global </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">9</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPR5">&#8203;</a><a id="tOBOD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">healthcare company, most recently from January&#160;2022 to April&#160;2023 as Executive Vice President, General Counsel and Global President Ophthalmic Pharmaceuticals. Previously, Ms.&#160;Ackermann was part of the Novartis group of companies for 14&#160;years where she served in various roles including Global Head, Legal and General Counsel of Alcon and Sandoz. Ms.&#160;Ackermann currently serves as a Non-Executive Director on the board of Oculis Holding AG, since March&#160;2023, and previously served on the board of directors of Graybug Vision, Inc. Ms.&#160;Ackermann holds a Post Graduate Diploma in EC Competition Law from King&#8217;s College at the University of London, UK, and a LLB from Queen&#8217;s University, Kingston, Canada. We believe that Ms.&#160;Ackermann&#8217;s extensive experience in the pharmaceuticals industry and her experience in serving on the boards of public and private companies qualify her to serve on our Board of Directors. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the re-election of Christina Ackermann as a Director of the Company</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 5. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To re-elect Michael Austwick as a Director of the Company</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Michael Austwick is currently a member of our Board of Directors and has been nominated for re-election as a director. If elected, he will hold office from the date of his election until such annual general meeting of shareholders where he must retire by rotation and offer himself for re-election in accordance with the Articles, or until his earlier death, resignation or removal. Mr.&#160;Austwick has agreed to serve if elected, and we have no reason to believe that he will be unable to serve. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Mr.&#160;Austwick has served as a Non-Executive Director on our Board of Directors since February&#160;2024. From June&#160;2022 to November&#160;2023, Mr.&#160;Austwick served as chief executive officer of Vectura Group Ltd., a pharmaceutical company developing inhaled medicines. From September&#160;2017 to June&#160;2022, Mr.&#160;Austwick worked for Novartis Pharmaceuticals, a global health company, serving as General Manager Nordic Cluster from September 2020 to June&#160;2022, and Global Head of Respiratory from 2017 to September 2020. Prior to that, from 2014 to 2017, Mr.&#160;Austwick served in various roles of increasing responsibility for AstraZeneca, including Vice President Global Inhaled Respiratory and Head of US Respiratory. Mr.&#160;Austwick received an M.Sc. in Information Management from The University of Hull and a B.Sc. in Management and Systems from City University, London. We believe that Mr.&#160;Austwick&#8217;s extensive experience in the healthcare and pharmaceuticals industries qualify him to serve on our Board of Directors. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the re-election of Michael Austwick as a Director of the Company</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Our Board of Directors</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our Board of Directors currently consists of eleven members, including one executive director and ten non-executive directors. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">10</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our Articles of Association require that those directors who were appointed by the Board since our 2023 annual general meeting of shareholders must retire from office and may offer themselves for re-election. Accordingly, Christina Ackermann and Michael Austwick will each retire from office and offer themselves for re-election by our shareholders at the AGM. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">In accordance with our Articles of Association, one-third (or such number nearest to but not exceeding one-third) of the Company&#8217;s directors retire from office at every annual general meeting of shareholders. Retiring directors are eligible for re-election and, if no other director is elected to fill his or her position and the director is willing, shall be re-elected by default. The directors to retire at the annual general meeting in every year shall include (so far as necessary to obtain the number required) any director who wishes to retire and not to offer himself or herself for re-election. Any further directors so to retire shall be the directors who have been longest in office since their last election. As between directors of equal seniority, the directors to retire shall in the absence of agreement be selected from among them by lot. Of the 9 directors subject to retirement by rotation, Lisa Deschamps, Martin Edwards, M.D. and Sven Anders Ullman (Anders Ullman), M.D., Ph.D. will, on this occasion, retire from office and stand for re-election by our shareholders. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Having carried out an evaluation of the individual performance of each of Lisa Deschamps, Martin Edwards, M.D., Anders Ullman, M.D., Ph.D., Christina Ackermann and Michael Austwick with the support of the Nomination and Corporate Governance Committee, our Board of Directors is satisfied that their performance continues to be effective and that they continue to demonstrate commitment to their roles. The Board of Directors considers that it is entirely appropriate for each of Lisa Deschamps, Martin Edwards, M.D., Anders Ullman, M.D., Ph.D., Christina Ackermann and Michael Austwick to seek re-election at the AGM. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Each of the above directors has been nominated for re-election and no other nominees for directors have been presented. Therefore, it is anticipated that following the AGM, if all of the above directors are re-elected, the Board of Directors will be comprised of eleven members, including one executive director and ten non-executive directors. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The following table sets forth information regarding our directors as of the date of this proxy statement: </span>
        </div>
        <table style="width:456pt;height:185.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:174pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Name </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:24pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Age </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Director Since </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:174pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Position(s) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">David Zaccardelli, Pharm.D. </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">59 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2020 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Chief Executive Officer and Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">David Ebsworth, Ph.D. </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">69 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2014 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:174pt;white-space:normal;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Chairperson of the Board of Directors </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">Christina Ackermann </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">59 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2023 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">Michael Austwick </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">54 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2024 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">James Brady </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">61 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2022 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">Ken Cunningham, M.D. </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">71 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2015 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">Lisa Deschamps </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">52 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2021 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">Martin Edwards, M.D. </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">68 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2019 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">Mahendra Shah, Ph.D. </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">79 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2016 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">Vikas Sinha </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">60 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2016 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;text-align:left;">
              <span style="letter-spacing:0.2pt;">Anders Ullman, M.D., Ph.D. </span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">68 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">2015 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:174pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Non-Executive Director</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:6.61pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <span style="font-style:normal;letter-spacing:0.2pt;">Biographical information for Lisa Deschamps, Martin Edwards, M.D., Anders Ullman, M.D., Ph.D., Christina Ackermann and Michael Austwick, nominees to our Board of Directors, is set forth in &#8220;</span><span style="letter-spacing:0.2pt;">Proposal&#160;1&#8201;&#8212;&#8201;To re-elect Lisa Deschamps as a Director of the Company</span><span style="font-style:normal;letter-spacing:0.2pt;">,&#8221; &#8220;</span><span style="letter-spacing:0.2pt;">Proposal 2&#8201;&#8212;&#8201;To re-elect Martin Edwards as a Director of the Company</span><span style="font-style:normal;letter-spacing:0.2pt;">,&#8221; &#8220;</span><span style="letter-spacing:0.2pt;">Proposal 3&#8201;&#8212;&#8201;To re-elect Anders Ullman as a Director of the Company</span><span style="font-style:normal;letter-spacing:0.2pt;">,&#8221; </span><span style="letter-spacing:0.2pt;">Proposal 4&#8201;&#8212;&#8201;To re-elect Christina Ackermann as a Director of the Company,&#8221; and Proposal&#160;5&#8201;&#8212;&#8201;To re-elect Michael Austwick as a Director of the Company&#8221;,</span><span style="font-style:normal;letter-spacing:0.2pt;"> respectively. Biographical information for our other directors is set forth below under &#8220;</span><span style="letter-spacing:0.2pt;">Continuing Members of the Board of Directors</span><span style="font-style:normal;letter-spacing:0.2pt;">.&#8221; </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">CONTINUING MEMBERS OF THE BOARD OF DIRECTORS </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Below is biographical information for those directors who are not standing for re-election at the AGM and who will continue on the Board of Directors following the AGM: </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">11</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <span style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">David Zaccardelli, Pharm.D.</span><span style="letter-spacing:0.2pt;"> Dr.&#160;Zaccardelli has served as our President and Chief Executive Officer and on our Board of Directors since February&#160;2020. From 2018 until its acquisition by Swedish Orphan Biovitrum AB (&#8220;Sobi&#8221;) in November&#160;2019, Dr.&#160;Zaccardelli served as President and CEO and on the board of directors of Dova Pharmaceuticals, a U.S. company developing therapeutics for rare diseases. Previously, he was Acting CEO and on the board of directors of Cempra, Inc., a pharmaceuticals company, from 2016 until the company&#8217;s merger with Melinta Therapeutics in 2017, and he served on the board of directors of Melinta Therapeutics from 2017 to 2020. From 2004 until 2016, Dr.&#160;Zaccardelli served in several senior management roles at United Therapeutics Corporation, a biotechnology company, including as Chief Operating Officer, Chief Manufacturing Officer and Executive Vice President, Pharmaceutical Development and Operations. Prior to United Therapeutics, he founded and led a start-up company focused on contract research positions and held a variety of clinical research positions at Burroughs Wellcome &amp; Co, a non-profit medical research organization, and pharmaceutical companies Glaxo Wellcome and Bausch &amp; Lomb Pharmaceutical. Dr.&#160;Zaccardelli received a Pharm.D. from the University of Michigan. We believe that Dr.&#160;Zaccardelli&#8217;s extensive leadership experience in the pharmaceutical industry qualifies him to serve on our Board of Directors. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">David Ebsworth, PhD.</span><span style="letter-spacing:0.2pt;"> Dr.&#160;Ebsworth has served as the Non-Executive Chairperson of our Board of Directors since December&#160;2014. Dr.&#160;Ebsworth has served as a Visiting Professor at the University of Surrey Business School since April&#160;2016. From 2009 to 2014, Dr.&#160;Ebsworth served as Chief Executive Officer of Vifor Pharma, the specialty pharma division of Galenica AG Group, a pharmaceutical wholesaler and retailer, and as a member of Galenica&#8217;s Executive Committee. In 2012, Dr.&#160;Ebsworth was also named as Chief Executive Officer of Galenica and as Chairperson of Galenica&#8217;s Executive Committee, positions he held until 2014. From 2009 to 2014, he was the Chief Executive Officer of Vifor Pharma AG, a pharmaceutical company. In his earlier career, Dr.&#160;Ebsworth worked with Bayer AG for over 19&#160;years, heading the Canadian, North American and global pharmaceutical business. He also served as Chief Executive Officer of Oxford Glycosciences, a biotech company, listed on the London Stock Exchange and Nasdaq, which was acquired by Celltech plc (now part of UCB, a global biopharmaceutical company) in 2003. Dr.&#160;Ebsworth has served on the boards of directors of Sartorius AG since January&#160;2020 and Synlab AG since January&#160;2021. Dr.&#160;Ebsworth received a B.Sc. and a Ph.D. in industrial relations from the University of Surrey. We believe that Dr.&#160;Ebsworth&#8217;s extensive experience in the pharmaceutical industry and his extensive leadership experience qualify him to serve on our Board of Directors. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">James Brady</span><span style="letter-spacing:0.2pt;"> Mr.&#160;Brady has served as a Non-Executive Director on our Board of Directors since March&#160;2022. From 1988 to 2018, Mr.&#160;Brady served in multiple leadership roles of increasing responsibility for AstraZeneca prior to his retirement in 2018. His more than thirty&#160;years of progressive experience at AstraZeneca included successful national, regional and global finance roles in corporate operations, manufacturing, commercial, marketing, market access, audit, international business, and biologics discovery and development. He most recently served as Chief Financial Officer of MedImmune, the biologics discovery and development division of AstraZeneca, from 2013 to 2018. During his tenure at MedImmune, biologics grew to represent more than half of the product development portfolio of AstraZeneca and five biologics were successfully brought to market. Mr.&#160;Brady is a Certified Public Accountant and previously worked at Arthur Andersen &amp; Company. He holds a B.S. in Accounting from Saint Joseph&#8217;s University and an MBA from Drexel University. We believe that Mr.&#160;Brady&#8217;s extensive experience in senior finance roles in the pharmaceutical industry qualifies him to serve on our Board of Directors. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Kenneth Cunningham, M.D.</span><span style="letter-spacing:0.2pt;"> Dr.&#160;Cunningham has served as a Non-Executive Director on our Board of Directors since September&#160;2015. Dr.&#160;Cunningham has over 30&#160;years&#8217; experience in the pharmaceutical industry including leadership roles at several companies focused on developing respiratory medicines. Between 2006 and 2010, he was at SkyePharma plc, a pharmaceutical company that is now part of Vectura Group plc, initially as Chief Operating Officer and subsequently as Chief Executive Officer where he was involved in the late-stage development of flutiform for asthma. Prior to that, he was the Chief Executive Officer of Arakis Ltd., a pharmaceutical company, from 2001 to 2005, where he was involved in the early clinical development of glcopyrronium bromide, now marketed as Seebri for chronic obstructive pulmonary disease. Earlier in his career, Dr.&#160;Cunningham held a variety of clinical development and commercial strategy roles at pharmaceutical companies GlaxoWellcome plc and Warner-Lambert. Dr.&#160;Cunningham previously served on the board of directors of Abzena plc from 2010 to 2018. Dr.&#160;Cunningham received an M.B.B.S. from </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">12</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tBDM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:48.8200000000001pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">St. Mary&#8217;s, Imperial College, London University. We believe that Dr.&#160;Cunningham&#8217;s extensive leadership experience in the pharmaceutical industry qualifies him to serve on our Board of Directors. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Mahendra Shah</span><span style="letter-spacing:0.2pt;"> Dr.&#160;Shah has served as a Non-Executive Director on our Board of Directors since July&#160;2016. Dr.&#160;Shah was designated for appointment to our Board of Directors by funds affiliated with Vivo Capital, a healthcare investment firm, pursuant to a relationship agreement that we entered into with such funds in 2016. Although such agreement automatically terminated on the closing of the 2020 Private Placement, Dr.&#160;Shah continues to serve as a Non-Executive Director. Dr.&#160;Shah has served as a Senior Fellow of Vivo Capital since January&#160;2021, where he previously served as Managing Director from 2010 to January&#160;2021. Dr.&#160;Shah is also the founder and Executive Chair of Semnur Pharmaceuticals (acquired by Scilex Pharmaceuticals, Inc.), a specialty pharmaceutical company. He previously served as a member of the board of directors of Homology Medicines, Soleno Therapeutics, Crinetics Pharmaceuticals and Impel NeuroPharma, Inc., and currently serves as a member of the board of directors of Bolt Biotherapeutics since 2017 and several private companies in the biopharmaceutical and biotechnology industries. Dr.&#160;Shah received his Ph.D. in industrial pharmacy from St. John&#8217;s University and his Bachelor&#8217;s and Master&#8217;s Degrees in Pharmacy from L.M. College of Pharmacy in Gujarat, India. We believe Dr.&#160;Shah&#8217;s experience in the biomedical and pharmaceutical industries and his experience in serving on the boards of public and private companies qualify him to serve on our Board of Directors. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Vikas Sinha</span><span style="letter-spacing:0.2pt;"> Mr.&#160;Sinha has served as a Non-Executive Director on our Board of Directors since September&#160;2016. Mr.&#160;Sinha has over 20&#160;years&#8217; experience working in executive finance roles in the life sciences industry. Mr.&#160;Sinha is co-founder and has served as the Chief Financial Officer of ElevateBio, Inc., a holding company focused on building cell and gene therapy companies, since February&#160;2019. He has served as President and Chief Financial Officer of AlloVir, Inc., an ElevateBio portfolio company, since September&#160;2019. From 2005 to 2016, Mr.&#160;Sinha was the Chief Financial Officer of Alexion Pharmaceuticals, Inc., a biotechnology company, where he was responsible for finance, business development, strategy, investor relations and IT. Prior to joining Alexion, Mr.&#160;Sinha held various positions with Bayer AG, a pharmaceuticals company, in the United States, Japan, Germany and Canada, including Vice President and Chief Financial Officer of Bayer Pharmaceuticals Corporation in the United States and Vice President and Chief Financial Officer of Bayer Yakuhin Ltd. He currently serves as a member of the board of directors of AlloVir, and previously served on the board of directors of BCLS Acquisition Corp. from October&#160;2020 to December&#160;2022. Mr.&#160;Sinha holds a Bachelor of Commerce degree from Tribhuvan University and an M.B.A. from the Asian Institute of Management. He is also a qualified Chartered Accountant from the Institute of Chartered Accountants of India and a Certified Public Accountant in the United States. We believe Mr.&#160;Sinha&#8217;s experience as a finance professional in the life science industry qualifies him to serve on our Board of Directors. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">BOARD DIVERSITY MATRIX </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">As of the date of this filing, March [&#8199;&#8199;], 2024, the diversity statistics for the eleven members of our Board of Directors are as follows: </span>
        </div>
        <table style="width:456pt;height:68.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Board Diversity Matrix (As of March [&#8199;&#8199;], 2024) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:371.1pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Country of Principal Executive Offices </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:72.9pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:0.2pt;">United Kingdom </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:371.1pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Foreign Private Issuer </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:72.9pt;text-align:center;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">No </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:371.1pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Disclosure Prohibited Under Home Country Law </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:72.9pt;text-align:center;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">No </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:371.1pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Total Number of Directors </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:72.9pt;text-align:center;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">11</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">13</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPR6">&#8203;</a><a id="tPR7">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:119.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:273.31pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Female </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Male </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Non-Binary </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Did Not
                <br/>
                Disclose Gender </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:273.31pt;text-align:left;">
              <span style="letter-spacing:-0.2pt;">Part&#160;I: Gender Identity</span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.31pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Directors </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">9</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.31pt;text-align:left;">
              <span style="letter-spacing:-0.2pt;">Part&#160;II: Demographic Background</span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:273.31pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <span style="letter-spacing:0.2pt;">Underrepresented Individual in Home Country
                <br/>
                Jurisdiction </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.31pt;text-align:left;">
              <div style="margin-left:10pt;">
                <span style="letter-spacing:0.2pt;">LGBTQ+ </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.31pt;text-align:left;">
              <div style="margin-left:10pt;">
                <span style="letter-spacing:0.2pt;">Did Not Disclose Demographic Background </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 6. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To receive and adopt the 2023 U.K. Annual Report</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Companies Act requires the directors of a public company to lay before the company in general meeting copies of the directors&#8217; reports, the independent auditors&#8217; report and the audited financial statements of the company in respect of each financial year. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">At the AGM, our Board of Directors will present our U.K. statutory annual accounts and Directors&#8217; reports for the year ended December&#160;31, 2023 and the report of the auditors thereon (the &#8220;2023 U.K. Annual Report&#8221;). We will provide our shareholders with an opportunity to receive our 2023 U.K. Annual Report and to adopt it. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">In accordance with best practice, the Company proposes an ordinary resolution to receive and adopt the 2023 U.K. Annual Report. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The 2023 U.K. Annual Report is appended as Annex A to this proxy statement and may also be found on our investor relations website located at </span><span style="font-style:italic;letter-spacing:0.2pt;">www.veronapharma.com/investors</span><span style="letter-spacing:0.2pt;">. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the receipt and adoption of the 2023 U.K. Annual Report</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 7. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors&#8217; Remuneration Report</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">At the AGM, our Board of Directors will present our U.K. statutory Directors&#8217; Remuneration Report for the year ended December&#160;31, 2023, as set out on pages [&#8199;&#8199;] to [&#8199;&#8199;] of the 2023 U.K. Annual Report appended as Annex A to this proxy statement. The U.K. statutory Directors&#8217; Remuneration Report includes the annual report on remuneration. This document describes in detail our remuneration policies and procedures and explains how these policies and procedures help to achieve our compensation objectives with regard to our directors and the retention of high-quality directors. Our Board of Directors and the Remuneration Committee of the Board of Directors (the &#8220;Remuneration Committee&#8221;) believe that the policies and procedures as articulated in the directors&#8217; remuneration report are effective and that as a result of these policies and procedures we have and will continue to have high-quality directors. Our Board of Directors has approved and signed the report in accordance with English law. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">At the AGM, the shareholders will vote on the Directors&#8217; Remuneration Report. This vote is advisory and non-binding. Although non-binding, our Board of Directors and Remuneration Committee will review </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">14</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPR8">&#8203;</a><a id="tPR9">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">and consider the voting results when making future decisions regarding our director remuneration program. Following the AGM, and as required under English law, the Directors&#8217; Remuneration Report will be delivered to the U.K. Registrar of Companies. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the receipt and approval, as a non-binding advisory resolution, of the U.K. statutory Directors&#8217; Remuneration Report</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.1pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 8. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To receive and approve the U.K. Directors&#8217; Remuneration Policy, as set out on pages [&#8199;&#8199;] to [&#8199;&#8199;] of the U.K. Annual Report, which, if approved, will take effect upon conclusion of the AGM.</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">At the AGM, our Board of Directors will present our U.K. statutory Directors&#8217; Remuneration Policy as set out on pages [&#8199;&#8199;] to [&#8199;&#8199;] of the 2023 U.K. Annual Report appended as Annex A to this proxy statement, which, if approved, will take effect upon conclusion of the AGM. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our Directors&#8217; Remuneration Policy is used to determine the remuneration of our directors, including our President and Chief Executive Officer (our sole executive director). The policy has as its key objectives the engagement and retention of high-caliber directors with the requisite experience and knowledge. The original remuneration policy was approved by the shareholders at our 2018 annual general meeting and an updated policy was approved by shareholders at our 2021 annual general meeting. As set out on pages [ &#8199;&#8199;] to [&#8199;&#8199;] of the 2023 U.K. Annual Report appended as Annex A to this proxy statement, we submit our new proposed remuneration policy, the aim of which is to enable the Company to offer remuneration packages that are designed to promote the long-term success of the Company. The policy, as proposed, is substantively the same as the prior remuneration policy, as our Board of Directors and Remuneration Committee consider that the prior remuneration policy continues to be appropriate and fit for purpose, with the key changes being that remuneration will be benchmarked against a broader group of life sciences companies, which are no longer limited to clinical development stage companies, and with benchmarking taking into account a broad range of those peer companies&#8217; financial metrics. The Remuneration Committee is committed to reviewing the policy on an ongoing basis in order to ensure that it remains effective and competitive. Our Board of Directors has approved the Directors&#8217; Remuneration Policy and believes it is effective to achieve its objectives. The Directors&#8217; Remuneration Policy, if approved, will take effect immediately upon conclusion of the AGM. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the receipt and adoption of the U.K. Directors&#8217; Remuneration Policy</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <span style="font-style:normal;letter-spacing:0.2pt;">PROPOSAL 9. </span> <br/><span style="letter-spacing:0.2pt;">To approve an increase in the maximum aggregate level of Non-Executive Director annual remuneration to &#163;750,000 per annum</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Article&#160;21.4 of the Company&#8217;s Articles of Association currently allows the payment of non-executive directors&#8217; fees up to &#163;500,000 per annum in aggregate, which limit was set in 2017. Recognising that the </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">15</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPR10">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Company has advanced its development and grown in size and market capitalization since that time, in 2023, the Remuneration Committee engaged external remuneration advisors to review the peer group of companies used for benchmarking the fees payable to the non-executive directors. This review resulted in changes to the peer group to include companies with a similar stage of development, market capitalization and financial profile. In order to properly compensate and retain qualified members of the Board of Directors relative to the peer group, and in recognition of the additional time commitment and responsibilities of the non-executive directors as the Company has advanced, the Remuneration Committee determined to increase the fees payable to the non-executive directors. Accordingly, the shareholders are being asked to approve an increase to the limit on the maximum payment of fees payable by the Company (excluding any remuneration payable to executive directors) for the services of the non-executive directors to an aggregate sum not to exceed &#163;750,000 per annum on an ongoing basis. The Company&#8217;s Articles of Association provide that this increase may be effected by an ordinary resolution. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the increase in the maximum aggregate level of Non-Executive Director annual remuneration of &#163;750,000 per annum</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.1pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 10. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To appoint EY as the Company&#8217;s auditors, to hold office until the conclusion of the next annual general meeting of shareholders</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">At each meeting at which the accounts are laid before shareholders, the Company is required to appoint U.K. statutory auditors to serve until the next such meeting of shareholders. Proposal 10 seeks your approval of the appointment of Ernst &amp; Young LLP (&#8220;EY&#8221;), to serve as our U.K. statutory auditor, to hold office until the conclusion of the next annual general meeting of shareholders. In the event this proposal does not receive approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal, the Board of Directors may appoint an auditor to fill the vacancy. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">EY has indicated its willingness to act as the Company&#8217;s auditors. A representative of EY is expected to be present at the AGM and will have an opportunity to make a statement if he or she desires to do so and to respond to appropriate questions from our shareholders. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">CHANGES IN INDEPENDENT REGISTERED ACCOUNTING FIRM </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">As previously disclosed, on December&#160;14, 2023, the Audit and Risk Committee of the Board of Directors dismissed PricewaterhouseCoopers LLP (&#8220;PwC&#8221;) and approved the engagement of EY as the Company&#8217;s independent registered public accounting firm to audit the Company&#8217;s consolidated financial statements as of and for the fiscal year ending December&#160;31, 2024, contingent upon the appointment of EY as the Company&#8217;s independent auditor by the Company&#8217;s shareholders at the AGM. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The reports of PwC on the Company&#8217;s financial statements for each of the fiscal&#160;years ended December&#160;31, 2022 and 2021 did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">During the fiscal&#160;years ended December&#160;31, 2022 and 2021, and in the subsequent interim period through December&#160;14, 2023, there were no (i)&#160;&#8220;disagreements&#8221; &#8203;(as that term is defined in Item&#160;304(a)(1)(iv) of Regulation&#160;S-K) between the Company and PwC on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures, which, if not resolved to the satisfaction of </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">16</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">PwC, would have caused PwC to make reference to the matter in its report on the financial statements for such&#160;years, and (ii)&#160;no &#8220;reportable events&#8221; &#8203;(as that term is described in Item&#160;304(a)(1)(v) of Regulation S-K). </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Company provided PwC with a copy of the disclosures included in its Current Report on Form&#160;8-K filed with the SEC on December&#160;18, 2023 (the &#8220;Current Report&#8221;) and requested that PwC furnish a letter addressed to the Securities and Exchange Commission stating whether it agrees with the statements made in the Current Report. This letter was filed as Exhibit&#160;16.1 to the Current Report. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">During the Company&#8217;s two most recent fiscal&#160;years ended December&#160;31, 2022 and December&#160;31, 2021, and the subsequent interim period from January&#160;1, 2023 through December&#160;14, 2023, neither the Company nor anyone acting on its behalf consulted with EY regarding either (i)&#160;the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company&#8217;s consolidated financial statements, and neither a written report nor oral advice was provided to the Company that EY concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii)&#160;any matter that was either the subject of a &#8220;disagreement&#8221; &#8203;(as defined in Item&#160;304(a)(1)(iv) of Regulation&#160;S-K and the related instructions thereto) or a &#8220;reportable event&#8221; &#8203;(as described in Item&#160;304(a)(1)(v) of Regulation&#160;S-K). </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the appointment of EY as the Company&#8217;s auditor</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.2pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Report of the Audit Committee of the Board of Directors</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Audit and Risk Committee of the Board (&#8220;Audit Committee&#8221;) has reviewed the audited consolidated financial statements of Verona Pharma plc (the &#8220;Company&#8221;) for the fiscal year ended December&#160;31, 2023 and has discussed these financial statements with management and the Company&#8217;s independent registered public accounting firm. The Audit Committee has also received from, and discussed with, the Company&#8217;s independent registered public accounting firm various communications that such independent registered public accounting firm is required to provide to the Audit Committee, including the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) and the Securities and Exchange Commission. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Company&#8217;s independent registered public accounting firm also provided the Audit Committee with a formal written statement required by PCAOB Rule&#160;3526 (Communications with Audit Committees Concerning Independence) describing all relationships between the independent registered public accounting firm and the Company, including the disclosures required by the applicable requirements of the PCAOB regarding the independent registered public accounting firm&#8217;s communications with the Audit Committee concerning independence. In addition, the Audit Committee discussed with the independent registered public accounting firm its independence from the Company. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Based on its discussions with management and the independent registered public accounting firm, and its review of the representations and information provided by management and the independent registered public accounting firm, the Audit Committee recommended to the Board of Directors that the audited consolidated financial statements be included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023. </span>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Vikas Sinha (Chair) <br/>Christina Ackermann <br/>David Ebsworth, Ph.D. <br/>James Brady </span></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">17</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPR11">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Independent Registered Public Accounting Firm Fees</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Aggregate fees for professional services rendered by our independent registered public accounting firm, PwC, for the years ended December 31, 2023 and 2022 are set forth in the table below. </span>
        </div>
        <table style="width:456pt;height:84pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Fee Category </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">2023 </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">2022 </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Audit Fees </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">900,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">420,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Audit-Related Fees </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">158,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">201,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Tax Fees </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">All Other Fees </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">97,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">403,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.2pt;">Total Fees</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,155,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,024,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.51pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Audit Fees</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">For the&#160;years ended December&#160;31, 2023 and December 31, 2022, Audit Fees consisted of fees for the audit of annual financial statements and statutory audits, and for the year ended December 31, 2023, also consisted of fees for the audit of internal control over financial reporting. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Audit-Related Fees</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">For the&#160;years ended December&#160;31, 2023 and December&#160;31, 2022, Audit-Related Fees consisted of fees for quarterly interim reviews. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">All Other Fees</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">For the&#160;years ended December&#160;31, 2023 and December&#160;31, 2022, &#8220;All Other Fees&#8221; consisted of fees related to capital markets-related services provided by PwC, and for the year ended December 31, 2023, also included technology fees. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Audit Committee Pre-Approval Policy and Procedures</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Audit Committee has adopted a policy (the &#8220;Pre-Approval Policy&#8221;) which sets forth the procedures and conditions pursuant to which audit and non-audit services proposed to be performed by the independent auditor may be pre-approved. The Pre-Approval Policy generally provides that we will not engage our independent registered public accounting firm to render any audit, audit-related, tax or permissible non-audit service unless the service is either (i)&#160;explicitly approved by the Audit Committee (&#8220;specific pre-approval&#8221;) or (ii)&#160;entered into pursuant to the pre-approval policies and procedures described in the Pre-Approval Policy (&#8220;general pre-approval&#8221;). Unless a type of service to be provided by PwC has received general pre-approval under the Pre-Approval Policy, it requires specific pre-approval by the Audit Committee or by a designated member of the Audit Committee to whom the committee has delegated the authority to grant pre-approvals. Any proposed services exceeding pre-approved cost levels or budgeted amounts will also require specific pre-approval. For both types of pre-approval, the Audit Committee will consider whether such services are consistent with the SEC&#8217;s rules on auditor independence. The Audit Committee will also consider whether the independent auditor is best positioned to provide the most effective and efficient service, for reasons such as its familiarity with our business, people, culture, accounting systems, risk profile and other factors, and whether the service might enhance our ability to manage or control risk or improve audit quality. All such factors will be considered as a whole, and no one factor should necessarily be determinative. On an annual basis, the Audit Committee reviews and generally pre-approves the services (and related fee levels or budgeted amounts) that may be provided by our independent registered public accounting firm without first obtaining specific pre-approval from the Audit Committee. The Audit Committee may revise the list of general pre-approved services from time to time, based on subsequent determinations. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 11. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To authorize the Audit and Risk Committee to determine the auditors&#8217; remuneration for the year ending December&#160;31, 2024</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Proposal 11 authorizes the Audit Committee to determine our auditors&#8217; remuneration for the fiscal year ending December&#160;31, 2024. Fees for PwC in respect of the&#160;years ended December&#160;31, 2023 and </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">18</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPR12">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">December&#160;31, 2022, are set forth above under &#8220;Independent Registered Public Accounting Firm Fees and Other Matters.&#8221; The Audit Committee has dismissed PwC as of December&#160;14, 2023 and has appointed EY as the Company&#8217;s independent registered public accounting firm to audit the Company&#8217;s consolidated financial statements as of and for the fiscal year ending December&#160;31, 2024, contingent upon approval of the Company&#8217;s shareholders at the AGM. Additional information regarding the dismissal of PwC and the appointment of EY can be found above under Proposal 10. </span>
        </div>
        <div style="margin-top:10.62pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:10.62pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR authorization of the Audit Committee to determine EY&#8217;s remuneration for the year ending December&#160;31, 2024</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:8.62pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">PROPOSAL 12. </span> <br/><span style="font-style:italic;letter-spacing:0.2pt;">To approve, on an advisory (non-binding) basis, the compensation of the Company&#8217;s named executive officers</span><span style="letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">In accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#8220;Dodd-Frank Act&#8221;) and Rule&#160;14a-21 under the Exchange Act, we request that our shareholders cast a non-binding, advisory vote to approve the compensation of our named executive officers identified in the section titled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">Executive and Director Compensation</span><span style="letter-spacing:0.2pt;">&#8221; set forth below in this proxy statement. This proposal, commonly known as a &#8220;say-on-pay&#8221; proposal, gives our shareholders the opportunity to express their views on our named executive officers&#8217; compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement. </span>
        </div>
        <div style="margin-left:20pt; margin-top:7.61pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Accordingly, we ask our shareholders to vote &#8220;FOR&#8221; the following resolution at the AGM: </span>
        </div>
        <div style="margin-left:40pt; margin-top:7.61pt; width:416pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">&#8220;RESOLVED, that the Company&#8217;s shareholders approve, by a non-binding advisory vote, the compensation of the named executive officers, as disclosed in the Company&#8217;s Proxy Statement for the 2024 Annual General Meeting pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the compensation tables and narrative discussion.&#8221; </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.52pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We believe that our compensation programs and policies for the year ended December&#160;31, 2023 were an effective incentive for the achievement of our goals, aligned with shareholders&#8217; interest and are worthy of shareholder support. Additional details concerning how we structure our compensation programs to meet the objectives of our compensation program are provided in the section titled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">Executive and Director Compensation</span><span style="letter-spacing:0.2pt;">&#8221; set forth below in this proxy statement. </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.51pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This vote is merely advisory and will not be binding upon us, our Board of Directors or our Remuneration Committee, nor will it create or imply any change in the duties of us, our Board of Directors or our Remuneration Committee. The Remuneration Committee will, however, take into account the outcome of the vote when considering future executive compensation decisions. The Board of Directors values constructive dialogue on executive compensation and other significant governance topics with our shareholders and encourages all shareholders to vote their shares on this important matter. At our 2023 annual general meeting of shareholders held on April&#160;27, 2023, our shareholders recommended, on an advisory basis, that the shareholder vote on the compensation of our named executive officers occur every year. In light of the foregoing recommendation, our Board of Directors determined to hold a &#8220;say-on-pay&#8221; advisory vote every year. Accordingly, our next advisory say-on-pay vote (following the non-binding advisory vote at this AGM) is expected to occur at our 2025 annual general meeting of shareholders. </span>
        </div>
        <div style="margin-top:10.52pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">19</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tPR13">&#8203;</a><a id="tPR14">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:27pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 13pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the approval, on an advisory (non-binding) basis, of the compensation of the Company&#8217;s named executive officers</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.7pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <span style="font-style:normal;letter-spacing:0.2pt;">PROPOSAL 13. </span> <br/><span style="letter-spacing:0.2pt;">To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of &#163;8,345,745 (being up to a maximum of [&#8199;&#8199;&#8199;&#8199;] shares representing [&#8199;&#8199;&#8199;&#8199;]% of the Company&#8217;s existing ordinary share capital as at the close of business on March [&#8199;&#8199;], 2024 (being the latest practicable date prior to publication of this document)).</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">To authorize the Board of Directors generally and unconditionally for the purposes of Section&#160;551 of the Companies Act to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company (&#8220;Rights&#8221;) up to an aggregate nominal amount of &#163;8,345,745 (being up to a maximum of [&#8199;&#8199;&#8199;&#8199;] shares representing [&#8199;&#8199;&#8199;&#8199;]% of the Company&#8217;s existing ordinary share capital as at the close of business on March [&#8199;&#8199;], 2024 (being the latest practicable date prior to publication of this document)) to such persons at such times and upon such conditions as the directors may determine (subject to the Company&#8217;s Articles of Association). </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This authority will replace any existing authorities to the extent not utilized at the date this resolution is passed and will, unless previously renewed, revoked or varied by the Company in general meeting, expire on June&#160;1, 2025, provided that the Company may, at any time before such expiry, make an offer or enter into an agreement that would or might require shares to be allotted or Rights to be granted after such expiry and the Board of Directors may allot such shares or grant Rights pursuant to any such offer or agreement as if the authority conferred hereby had not expired. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Withheld votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:75pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the authorization of Directors to exercise all the powers to the Company to allot shares in the Company or grant Rights up to an aggregate nominal amount of &#163;8,345,745 (being up to a maximum of [&#8199;&#8199;&#8199;&#8199;] shares representing [&#8199;&#8199;&#8199;&#8199;]% of the Company&#8217;s existing ordinary share capital as at the close of business on March [&#8199;&#8199;], 2024 (being the latest practicable date prior to publication of this document))</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <span style="font-style:normal;letter-spacing:0.2pt;">PROPOSAL 14. </span> <br/><span style="letter-spacing:0.2pt;">To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if Section&#160;561(1) of the Companies Act does not apply to any such allotment</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">As a U.K.-incorporated company, the Company&#8217;s ordinary shareholders are entitled, under Section&#160;561(1) of the Companies Act, to pre-emption rights, whereby, in the event that the Company wishes to allot new equity securities for cash, those securities must first be offered to existing shareholders in proportion to the number of ordinary shares they each hold before they can be offered to new shareholders. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Subject to and conditioned upon the passing of Proposal 13 above, this Proposal 14 authorizes the Board of Directors pursuant to Section&#160;570 and 573 of the Companies Act to allot equity securities (as defined in Section&#160;560 of the Companies Act) for cash pursuant to the authority conferred by Proposal 13 above and/or to sell ordinary shares held by the Company as treasury shares for cash, as if Section&#160;561(1) of the Companies Act did not apply to any such allotment or sale, provided that this power will be limited to </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">20</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">the allotment of equity securities or sale of treasury shares up to an aggregate nominal amount of &#163;8,345,745 (being up to a maximum of [&#8199;&#8199;&#8199;&#8199;] shares representing [&#8199;&#8199;&#8199;&#8199;]% of the Company&#8217;s existing ordinary share capital as at the close of business on March [&#8199;&#8199;], 2024 (being the latest practicable date prior to publication of this document)), will replace any existing disapplication of Section&#160;561 of the Companies Act to the extent not utilized at the date this resolution is passed and will expire on June&#160;1, 2025, unless previously renewed, varied or revoked by the Company in general meeting, provided that the Company may, before such expiry, make an offer or agreement which would or might require shares in the Company or rights to be allotted or granted or treasury shares to be sold after this authority expires and that the Directors may allot shares in the Company or grant rights or sell treasury shares pursuant to such an offer or agreement as if the authority conferred by this resolution had not expired. </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Board of Directors considers that, at this stage of the development of the Company, the ability to raise new equity funds at relatively short notice and at low cost is vital to the continuing financial health of the business. The Company believes that it is in the best interests of the Company and its shareholders for the Board of Directors to seek to retain the ability to readily raise new equity funds at the appropriate time. In order to facilitate fundraising readiness, on March&#160;7, 2023, the Company filed a shelf registration statement with the SEC. Under U.S. securities law, the Company cannot offer or sell securities in the U.S. for the purpose of accessing capital except under an effective registration statement or under a limited number of exceptions. The filing of a shelf registration statement allows companies to take advantage of fundraising opportunities by having an effective registration statement in place when those opportunities arise. The Company&#8217;s shelf registration statement may be used for three&#160;years from March&#160;7, 2023. The Company may offer and sell an unlimited amount of securities under the shelf registration statement, as long as it qualifies on an annual basis as a &#8220;well-known seasoned issuer,&#8221; meaning that the Company has a public float, as calculated under the U.S. securities rules, of at least $700&#160;million. If the Company ceases to qualify as a well-known seasoned issuer, it will need to file a new shelf registration statement for a fixed dollar amount. The shelf registration statement is available on the SEC&#8217;s website at www.sec.gov. </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">In order to provide the flexibility to expeditiously access capital during the life of the shelf registration statement when market conditions are appropriate, the Board of Directors believe that it is in the best interests of the Company to be prepared in advance and have the authorities available without the need to convene a general meeting should they determine that it is appropriate to do so. The authorities would allow the Company to better compete for capital against other companies incorporated in the U.S. and elsewhere who are not subject to allotment or pre-emption restrictions such as those applicable to the Company as an English company. </span>
        </div>
        <div style="margin-top:9.62pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Anti-takeover Effects of Proposal 14</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Release No. 34-15230 of the staff of the SEC requires disclosure and discussion of the effects of any action that may be used as an anti-takeover mechanism. Because this Proposal 14, if approved, will authorize the Board of Directors to allot new equity securities for cash without first offering them to existing shareholders, it could, under certain circumstances, have an anti-takeover effect, although this is not the purpose or intent of our Board of Directors. A relative increase in the number of our issued shares offered to new shareholders could enable the Board to render more difficult or discourage an attempt by a party attempting to obtain control of the Company. Moreover, the issuance of equity securities to persons friendly to the Board of Directors could make it more difficult to remove incumbent officers and directors from office even if such change were favorable to shareholders generally. </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">As stated above, the Company has no present intent to use any relative increase in the number of issued shares of our equity securities offered to new shareholders for anti-takeover purposes, and Proposal 14 is not part of a plan by the Board of Directors to adopt a series of anti-takeover provisions; however, if Proposal 14 is approved by the shareholders, then a greater number of our equity securities would be available for such purpose than is currently available. The Company is not aware of any pending or threatened efforts to obtain control of the Company, and the Board has no present intent to authorize the issuance of additional ordinary shares to discourage such efforts if they were to arise. </span>
        </div>
        <div style="margin-top:9.63pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VOTE REQUIRED </span>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This proposal requires approval by holders representing not less than 75% of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the proposal. Votes withheld are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal.</span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">21</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tEXOF">&#8203;</a><a id="tCOGO">&#8203;</a><a id="tGEN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">RECOMMENDATION OF THE BOARD OF DIRECTORS </span>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:51pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">
              <div style="position:relative;text-align:center;">
                <img alt="[MISSING IMAGE: ic_arrow-bw.jpg]" src="ic_arrow-bw.jpg" style="height: 19px; width: 17px;"/>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;text-align:left;">
              <div style="line-height:12pt;">
                <span style="letter-spacing:-0.2pt;">The Board of Directors unanimously recommends a vote FOR the authorization of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if Section&#160;561(1) of the Companies Act does not apply to any such allotment</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.7pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Executive Officers</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The following table identifies our current executive officers: </span>
        </div>
        <table style="width:456pt;height:68.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:168pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Name </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:17pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Age </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:247pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Position </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:168pt;">
              <span style="letter-spacing:0.2pt;">David Zaccardelli, Pharm.D.</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">59 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:247pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">President, Chief Executive Officer and Executive Director </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:168pt;">
              <span style="letter-spacing:0.2pt;">Andrew Fisher</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">54 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:247pt;">
              <span style="letter-spacing:0.2pt;">General Counsel </span>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:168pt;">
              <span style="letter-spacing:0.2pt;">Mark W. Hahn</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">61 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:247pt;">
              <span style="letter-spacing:0.2pt;">Chief Financial Officer </span>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:168pt;">
              <span style="letter-spacing:0.2pt;">Kathleen Rickard, M.D.</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:17pt;text-align:center;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">65 </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:247pt;">
              <span style="letter-spacing:0.2pt;">Chief Medical Officer</span>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.21pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(1)</span>
          <br/>
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">See biography on page 12 of this proxy statement. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(2)</span>
          <br/>
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="font-weight:bold;letter-spacing:-0.2pt;">Mark W. Hahn.</span><span style="letter-spacing:0.2pt;"> Mr.&#160;Hahn has served as our Chief Financial Officer since February&#160;2020. From January&#160;2018 until its acquisition by Swedish Orphan Biovitrum for up to $915&#160;million in November&#160;2019, Mr.&#160;Hahn served as CFO of Dova Pharmaceuticals, a company developing therapeutics for rare diseases. Previously, from 2010 until its acquisition by Melinta Therapeutics in 2017, Mr.&#160;Hahn was CFO of Cempra, Inc. Mr.&#160;Hahn served on the board of directors of ALSP Orchid Acquisition Corporation I from November&#160;2021 to November 2023. Mr.&#160;Hahn received a B.B.A. degree in Accounting and Finance from the University of Wisconsin-Milwaukee and is a Certified Public Accountant in Maryland and North Carolina. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(3)</span>
          <br/>
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="font-weight:bold;letter-spacing:-0.2pt;">Andrew Fisher.</span><span style="letter-spacing:0.2pt;"> Mr.&#160;Fisher has served as General Counsel of the Company since March&#160;2024. Prior to joining Verona Pharma, Mr.&#160;Fisher founded and led a consulting practice, Andrew Fisher LLC, where he focused on providing strategic advice to start-up companies since September 2019. Previously, from 2001 until 2018, he held various roles at United Therapeutics Corporation, including Executive Vice President, Chief Strategy Officer and Deputy General Counsel, where he oversaw a variety of intellectual property, litigation, compliance, risk management, and investor and media relations matters, among other things. Mr.&#160;Fisher received a B.A. from University of Michigan and J.D. from George Washington University. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(4)</span>
          <br/>
        </div>
        <div style=" margin-top:3.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="font-weight:bold;letter-spacing:-0.2pt;">Kathleen Rickard, M.D.</span><span style="letter-spacing:0.2pt;"> Dr.&#160;Rickard has served as our Chief Medical Officer since February&#160;2019. Prior to joining Verona Pharma, Dr.&#160;Rickard served in multiple roles at Aerocrine AB, a medical diagnostics product company, including as Chief Medical Officer from 2011 to January&#160;2019, and as Chief Compliance Officer from 2014 to 2019. Prior to Aerocrine, Dr.&#160;Rickard was Vice President Clinical Development and Medical Affairs of the Respiratory Medicines Development Centre at GlaxoSmithKline, a pharmaceutical company, and, over a period of 15&#160;years, held a number of other leadership positions in clinical development across GlaxoSmithKline&#8217;s global respiratory franchise. Dr.&#160;Rickard received an M.D. from Hahnemann University Hospital, Philadelphia. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">There are no family relationships among any of our executive officers or directors. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Corporate Governance</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">GENERAL </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our Board of Directors has adopted, among other policies, Corporate Governance Guidelines, a Code of Business Conduct and Ethics, an Insider Trading Compliance Policy, a Whistleblowing Policy and terms of reference for the Nomination and Corporate Governance Committee, Audit Committee, and Remuneration Committee to assist the Board in the exercise of its responsibilities and to serve as a framework for the effective governance of our Company. You can access our current committee terms of reference, our Corporate Governance Guidelines, Whistleblowing Policy and our Code of Business Conduct and Ethics </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">22</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tBOCO">&#8203;</a><a id="tDIIN">&#8203;</a><a id="tDICA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">in the &#8220;Corporate Governance&#8221; section of our investor relations website located at https://www.veronapharma.com/about#corporate-governance. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">BOARD COMPOSITION </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our Board of Directors currently consists of eleven members, including one executive director and ten non-executive directors. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our Articles of Association require that those directors who were appointed by the Board since our 2023 annual general meeting of shareholders must retire from office and may offer themselves for re-election. Accordingly, Christina Ackermann and Michael Austwick will each retire from office and offer themselves for re-election by our shareholders at the AGM. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">In accordance with our Articles of Association, one-third (or such number nearest to but not exceeding one-third) of the Company&#8217;s directors retire from office at every annual general meeting of shareholders. Retiring directors are eligible for re-election and, if no other director is elected to fill his or her position and the director is willing, shall be re-elected by default. The directors to retire at the AGM in every year shall include (so far as necessary to obtain the number required) any director who wishes to retire and not to offer himself or herself for re-election. Any further directors so to retire shall be the directors who have been longest in office since their last election. As between directors of equal seniority, the directors to retire shall in the absence of agreement be selected from among them by lot. Of the nine directors subject to retirement by rotation, Lisa Deschamps, Martin Edwards, M.D. and Anders Ullman, M.D., Ph.D. will, on this occasion, retire from office and stand for re-election by our shareholders. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Having carried out an evaluation of the individual performance of each of Lisa Deschamps, Martin Edwards, M.D., Anders Ullman, M.D., Ph.D., Christina Ackermann and Michael Austwick with the support of the Nomination and Corporate Governance Committee, our Board of Directors is satisfied that their performance continues to be effective and that they continue to demonstrate commitment to their roles. The Board of Directors considers that it is entirely appropriate for each of Lisa Deschamps, Martin Edwards, M.D., Anders Ullman, M.D., Ph.D., Christina Ackermann and Michael Austwick to seek re-election at the AGM. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Each of the above directors has been nominated for re-election and no other nominees for directors have been presented. Therefore, it is anticipated that following the AGM, if all of the above directors are re-elected, the Board of Directors will be comprised of eleven members, including one executive director and ten non-executive directors. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">DIRECTOR INDEPENDENCE </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">All of our directors, other than David Zaccardelli, Pharm.D., qualify as &#8220;independent&#8221; in accordance with Nasdaq listing requirements. The Nasdaq independence definition includes a series of objective tests, including that the director is not, and has not been for at least three&#160;years, one of our employees and that neither the director nor any of his or her family members has engaged in various types of business dealings with us. In addition, as required by Nasdaq rules, our Board of Directors has made a subjective determination as to each independent director that no relationships exist, which, in the opinion of our Board of Directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In making these determinations, our Board of Directors reviewed and discussed information provided by the directors and us with regard to each director&#8217;s business and personal activities and relationships as they may relate to us and our management, including that Dr.&#160;Shah are affiliated with certain of our significant shareholders. The Board of Directors previously determined that Mr.&#160;Rishi Gupta qualified as an independent director prior to his resignation on January&#160;31, 2024. Dr.&#160;Zaccardelli is not independent because he is the President and Chief Executive Officer of our Company. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">DIRECTOR CANDIDATES </span>
        </div>
        <div style="margin-top:11.92pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Director Nomination Process</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Nomination and Corporate Governance Committee is primarily responsible for searching for qualified director candidates for election to the Board and filling vacancies on the Board of Directors. To </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">23</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tCFS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">facilitate the search process, the Nomination and Corporate Governance Committee may solicit current directors and executives of the Company for the names of potentially qualified candidates or ask directors and executives to pursue their own business contacts for the names of potentially qualified candidates. The Nomination and Corporate Governance Committee may also consult with outside advisors or retain search firms to assist in the search for qualified candidates, or consider director candidates recommended by our shareholders. Once potential candidates are identified, the Nomination and Corporate Governance Committee reviews the backgrounds of those candidates, evaluates candidates&#8217; independence from the Company and potential conflicts of interest and determines if candidates meet the qualifications desired by the Nomination and Corporate Governance Committee for candidates for election as a director. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">In evaluating the suitability of individual candidates (both new candidates and current Board members), the Nomination and Corporate Governance Committee, in recommending candidates for election, and the Board of Directors, in approving (and, in the case of vacancies, appointing) such candidates, may take into account many factors, including but not limited to: personal and professional integrity, ethics and values; experience in corporate management, such as serving as an officer or former officer of a publicly held company; strong finance experience; relevant social policy concerns; experience relevant to the Company&#8217;s industry; experience as a board member or executive officer of another publicly held company; relevant academic expertise or other proficiency in an area of the Company&#8217;s operations; diversity of expertise and experience in substantive matters pertaining to the Company&#8217;s business relative to other board members; diversity of background and perspective, including, but not limited to, with respect to age, gender, race, place of residence and specialized experience; practical and mature business judgment, including, but not limited to, the ability to make independent analytical inquiries; and any other relevant qualifications, attributes or skills. The Board of Directors evaluates each individual in the context of the Board of Directors as a whole, with the objective of assembling a group that can best perpetuate the success of the business and represent shareholder interests through the exercise of sound judgment using its diversity of experience in these various areas. In determining whether to recommend a director for re-election, the Nomination and Corporate Governance Committee may also consider the director&#8217;s past attendance at meetings and participation in and contributions to the activities of the Board of Directors. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Shareholder Recommendations and Nominees</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Nomination and Corporate Governance Committee and the Board have not established a formal policy with regard to the consideration of director candidates recommended by shareholders. This is due to the following factors: (i)&#160;the limited number of such recommendations, (ii)&#160;the need to evaluate such recommendations on a case-by-case basis, and (iii)&#160;the expectation that recommendations from shareholders would be considered in the same manner as recommendations by directors, officers, outside advisors or search firms in the event of a vacancy on the Board. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Shareholders who desire to nominate persons directly for election to the Board of Directors at an annual general meeting of shareholders must meet the deadlines and other requirements set forth under &#8220;Additional Information&#8201;&#8212;&#8201;Shareholder Proposals for 2025 Annual General Meeting.&#8221; Any vacancies on the Board of Directors occurring between our annual general meetings of shareholders may be filled by a majority of the directors then in office, in which case any director so elected will serve until the next annual general meeting of shareholders when such director will offer himself or herself for re-election, or by ordinary resolution of the shareholders of the Company. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">COMMUNICATIONS FROM SHAREHOLDERS </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Board of Directors will give appropriate attention to written communications that are submitted by shareholders, and will respond if and as appropriate. Our Company Secretary and General Counsel are primarily responsible for monitoring communications from shareholders and for providing copies or summaries to the directors as they consider appropriate. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Communications are forwarded to all directors if they relate to important substantive matters and include suggestions or comments that our Company Secretary or General Counsel and Chairperson of the Board consider to be important for the directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances and matters as to which we tend to receive repetitive </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">24</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tBLSA">&#8203;</a><a id="tPBE">&#8203;</a><a id="tCOBC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">or duplicative communications. Shareholders who wish to send communications on any topic to the Board of Directors should address such communications to the Board of Directors in writing: c/o&#160;Company Secretary, Verona Pharma plc, c/o&#160;Shakespeare Martineau LLP, 6</span><span style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</span><span style="letter-spacing:0.2pt;"> Floor, 60 Gracechurch Street, London, EC3V 0HR. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">BOARD LEADERSHIP STRUCTURE AND ROLE IN RISK OVERSIGHT </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our Corporate Governance Guidelines provide our Board of Directors with flexibility to combine or separate the positions of Chairperson of the Board and Chief Executive Officer in accordance with its determination that utilizing one or the other structure would be in the best interests of our Company based on the circumstances at that time. We recognize that different board leadership structures may be appropriate for companies in different situations. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Based on the Company&#8217;s present circumstances, the Board believes that the Company and its shareholders are best served by having Dr.&#160;Ebsworth serve as its Chairperson of the Board and Dr.&#160;Zaccardelli serve as its Chief Executive Officer. Our current leadership structure permits Dr.&#160;Zaccardelli to focus his attention on managing our Company and permits Dr.&#160;Ebsworth to manage the Board of Directors. Accordingly, we believe our current leadership structure is the optimal structure for us at this time. However, our Board of Directors will continue to periodically review our leadership structure and may make such changes in the future as it deems appropriate. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Risk assessment and oversight are an integral part of our governance and management processes. Our Board of Directors encourages management to promote a culture that incorporates risk management into our corporate strategy and day-to-day business operations. Management discusses strategic and operational risks at regular management meetings and conducts specific strategic planning and review sessions during the year that include a focused discussion and analysis of the risks facing us. Throughout the year, senior management reviews these risks with the Audit Committee or Board of Directors at regular meetings as part of management presentations that focus on particular business functions, operations or strategies, and presents the steps taken by management to mitigate or eliminate such risks. As provided in the terms of reference of the Audit Committee, the Audit Committee is responsible for discussing the Company&#8217;s policies with respect to risk assessment and risk management, including guidelines and policies to govern the process by which the Company&#8217;s exposure to risk is handled. In accordance with those policies, the Board and the Board committees have an active role in overseeing management of the Company&#8217;s risks inherent in their respective areas of oversight. In particular, our Board of Directors is responsible for monitoring and assessing strategic risk exposure, including business continuity risks. The Audit Committee monitors compliance with legal and regulatory requirements, discusses the Company&#8217;s policies with respect to risk assessment and risk management, including guidelines and policies to govern the process by which the Company&#8217;s exposure to risk is handled, oversees management of the Company&#8217;s financial and cybersecurity risks, and considers and approves or disapproves any related person transactions. Our Nomination and Corporate Governance Committee monitors the risks relating to our corporate governance framework and succession planning for our Board of Directors and senior management. Our Remuneration Committee assesses and monitors whether any of our remuneration policies and programs has the potential to encourage excessive risk-taking. While each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire Board has an active role in overseeing management of the Company&#8217;s risks and is regularly informed through committee reports about such risks. The Board does not believe that its role in the oversight of our risks adversely affects the Board&#8217;s leadership. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">PERIODIC BOARD EVALUATION </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our Corporate Governance Guidelines require the Nomination and Corporate Governance Committee to oversee a periodic assessment of the Board and its committees. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">CODE OF BUSINESS CONDUCT AND ETHICS </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We have adopted a written Code of Business Conduct and Ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, and others temporarily assigned to perform work or services for us. We have posted a current copy of the Code of Business Conduct and Ethics in the </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">25</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tANPO">&#8203;</a><a id="tABMO">&#8203;</a><a id="tCOTB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:32.35pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">&#8220;Corporate Governance&#8221; section of our website at www.veronapharma.com. Our Board of Directors is responsible for administering the Code of Business Conduct and Ethics. The Board of Directors is allowed to amend, alter or terminate the Code of Business Conduct and Ethics. In addition, we intend to post on our website all disclosures that are required by law or the Nasdaq rules concerning any amendments to, or waivers from, any provision of the Code of Business Conduct and Ethics. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">ANTI-HEDGING POLICY </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">Our Board of Directors has adopted an Insider Trading Compliance Policy, which applies to all of our directors, officers and employees. The policy prohibits our directors, officers and employees and any entities they control from purchasing financial instruments, such as prepaid variable forward contracts, equity swaps, collars, and exchange funds, or otherwise engaging in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of the Company&#8217;s equity securities, or that may cause an officer, director, or employee to no longer have the same objectives as the Company&#8217;s other shareholders. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">CLAWBACK POLICY </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">The Company has adopted a compensation recovery policy as required by Rule&#160;10D-1 under the Securities Exchange Act of 1934, as amended, and the corresponding listing standards of the Nasdaq Stock Exchange. This policy provides for the mandatory recovery (subject to limited exceptions) from current and former officers of incentive-based compensation that was erroneously received during the three&#160;years preceding the date that the Company is required to prepare an accounting restatement. The amount required to be recovered is the excess of the amount of incentive-based compensation received over the amount that otherwise would have been received had it been determined based on the restated financial measure. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">ATTENDANCE BY MEMBERS OF THE BOARD OF DIRECTORS AT MEETINGS </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">There were 8 meetings of the Board of Directors during the fiscal year ended December&#160;31, 2023. During the fiscal year ended December&#160;31, 2023, each director attended at least 75% of the aggregate of all meetings of the Board of Directors and meetings of the committees on which the director served during the period in which he or she served as a director. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">Currently, we do not maintain a formal policy regarding director attendance at the AGM; however, it is expected that directors will attend absent compelling circumstances. All of our then-serving directors attended our annual general meeting of shareholders held in 2023. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Committees of the Board</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">Our Board of Directors has established an Audit Committee, Remuneration Committee, and Nomination and Corporate Governance Committee, each of which operates under written terms of reference that have been approved by our Board and that are available in the &#8220;Corporate Governance&#8221; section of our investor relations website at https://www.veronapharma.com/about#corporate-governance. All of the members of each of these committees are independent as defined under the Nasdaq rules. Our Board of Directors has determined that Christina Ackermann, David Ebsworth, Ph.D., Vikas Sinha and James Brady meet the independence requirements of Rule&#160;10A-3 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All members of the Remuneration Committee meet the heightened standard for independence specific to members of a compensation committee under the Nasdaq rules and each qualifies as a &#8220;non-employee director&#8221; as defined in Rule&#160;16b-3 of the Exchange Act. All members of the Nomination and Corporate Governance Committee are independent under the Nasdaq rules. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">26</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tAARC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The members of each of the Audit, Remuneration and Nomination and Corporate Governance Committees and the committee Chairs are set forth in the following chart. </span>
        </div>
        <table style="width:456pt;height:131.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:288pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Name </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:32.35pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Audit and
                <br/>
                Risk </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:46.32pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Remuneration </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:53.33pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Nomination and
                <br/>
                Corporate
                <br/>
                Governance </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:288pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Christina Ackermann </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:32.35pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">X </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:46.32pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:53.33pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Ken Cunningham, M.D. </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:32.35pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:46.32pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Chair </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:53.33pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">James Brady </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:32.35pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">X </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:46.32pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:53.33pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Lisa Deschamps </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:32.35pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:46.32pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:53.33pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">X </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">David Ebsworth, Ph.D. </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:32.35pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">X </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:46.32pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">X </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:53.33pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Chair </span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Mahendra Shah, Ph.D. </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:32.35pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:46.32pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">X </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:53.33pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Vikas Sinha </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:32.35pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">Chair </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:46.32pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:53.33pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:0.2pt;">X</span>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.51pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">AUDIT AND RISK COMMITTEE </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The Audit Committee&#8217;s responsibilities include, among other things: </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">monitoring the integrity of the financial statements of the Company, including its annual and interim reports, preliminary results&#8217; announcements and any other formal announcement relating to its financial performance; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">reviewing significant financial reporting issues and judgments that they contain; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">reviewing and discussing with the Company&#8217;s management and external auditor the Company&#8217;s audited financial statements and quarterly financial statements to be filed with the SEC, including disclosures under the caption &#8220;management&#8217;s discussion and analysis of financial condition and results of operation&#8221; and the matters required to be discussed by applicable Public Company Accounting Oversight Board (the &#8220;PCAOB&#8221;) standards and SEC rules; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">considering whether it will recommend to the Board of Directors that the Company&#8217;s audited financial statements be included in the Company&#8217;s Annual Report on Form 10-K; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">preparing an annual committee report for inclusion where necessary in the proxy statement of the Company relating to its annual general meeting of shareholders; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">overseeing the appointment, re-appointment, and removal of the Company&#8217;s external auditor; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">overseeing the relationship with the external auditor; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">reviewing and approving the annual audit plan; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">coordinating the Board of Directors&#8217; oversight of the Company&#8217;s internal control over financial reporting and disclosure controls and procedures; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">discussing the Company&#8217;s policies with respect to risk assessment and risk management; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">establishing the Company&#8217;s arrangements for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls or auditing matters; and </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">reviewing the Company&#8217;s policies and procedures for reviewing and approving or ratifying related person transactions. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The current members of the Audit Committee are Christina Ackermann, James Brady, David Ebsworth,&#160;Ph.D. and Vikas Sinha. Mr.&#160;Sinha serves as the Chairperson of the Audit Committee. The members of our Audit Committee meet the requirements for financial literacy under the applicable rules of Nasdaq. Our Board of Directors has determined that each of Vikas Sinha and James Brady is an &#8220;audit committee financial expert&#8221; as defined by Item&#160;407(d)(5)(ii) of Regulation&#160;S-K. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Audit Committee meets as often as one or more members of the Audit Committee deem necessary, but in any event, meets at least four times per year. The Audit Committee meets at least once per year with our independent accountant, without our management being present. The Audit Committee met 6 times in 2023. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">27</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tRECO">&#8203;</a><a id="tNACG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">REMUNERATION COMMITTEE </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The Remuneration Committee&#8217;s responsibilities include, among other things: </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">determining and agreeing with the Board of Directors the framework for the remuneration of the Company&#8217;s chief executive, chairperson, the executive directors, the company secretary and such other members of the Company&#8217;s management as it is designated to consider; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.61pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">approving all service contracts between the Company and its directors or between the Company and any subsidiary and its directors; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.61pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">determining the policy for, and scope of, pension arrangements for each executive director and other senior executives; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.61pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">establishing the selection criteria, selecting, appointing and setting the terms of reference for any remuneration consultants who advise the Remuneration Committee and, when considered necessary, to obtain reliable, up-to-date information about remuneration in other companies; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">making a report each year to the shareholders on behalf of the Board of Directors, which report should form part of, or be annexed to, the Company&#8217;s annual report and accounts; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">to the extent that the Company is required to include a Compensation Discussion and Analysis (&#8220;CD&amp;A&#8221;) in our proxy statement, reviewing and discussing with management our CD&amp;A and considering whether it will recommend to the Board of Directors that the CD&amp;A be included in the proxy statement; and </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">if required, preparing the annual compensation committee report pursuant to the rules of the Exchange Act. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The Remuneration Committee has the authority to retain or obtain the advice of remuneration consultants, legal counsel and other advisors to assist in carrying out its responsibilities, including being directly responsible for the appointment, oversight and compensation of such consultant, counsel or advisor and the ability to cause us, without further action by the Board of Directors, to pay the compensation of such consultant, counsel or advisor as approved by the Remuneration Committee, provided, however, that in retaining or obtaining the advice of such consultant, counsel or advisor, other than in-house legal counsel, the Remuneration Committee shall take into consideration the factors affecting independence required by applicable SEC rules and Nasdaq rules. The Remuneration Committee also has the authority to conduct or authorize investigations into any matters within the scope of its responsibilities as it shall deem appropriate, including the authority to request any officer, employee or advisor of us to meet with the Remuneration Committee or any advisors engaged by the Remuneration Committee. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">During 2023, the Remuneration Committee engaged Aon Consulting, Inc. (&#8220;Aon&#8221;) to provide benchmarking and advice on compensation of our executive officers and non-executive directors. The Remuneration Committee has considered the adviser independence factors required under SEC rules as they relate to (i)&#160;additional services, (ii)&#160;total fees as a&#160;percentage of total revenue, (iii)&#160;conflict of interest policies, (iv)&#160;business or personal relationships with members of the Remuneration Committee, (v)&#160;stock ownership by compensation advisors, and (vi)&#160;business or personal relationships with executives of the company and does not believe Aon&#8217;s work in 2023 raised a conflict of interest. For discussion of the role of compensation consultants in determining executive and non-executive director compensation, please refer to the section entitled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">Executive and Director Compensation</span><span style="letter-spacing:0.2pt;">&#8221; below. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The current members of our Remuneration Committee are Ken Cunningham, M.D., David Ebsworth,&#160;Ph.D. and Mahendra Shah, Ph.D. Dr.&#160;Cunningham serves as the Chairperson of the Remuneration Committee. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The Remuneration Committee met 8 times during 2023. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">NOMINATION AND CORPORATE GOVERNANCE COMMITTEE </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The Nomination and Corporate Governance Committee&#8217;s responsibilities include, among other things: </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">evaluating the structure, size and composition (including the skills, knowledge and experience) of the Board of Directors and make recommendations to the Board of Directors with regard to any adjustments that are deemed necessary; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">28</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tEADC">&#8203;</a><a id="t2SCT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">identifying and nominating, for the approval of the Board of Directors, candidates to fill Board vacancies as and when they arise; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">putting in place plans for the orderly succession of appointments to the Board of Directors and to senior management; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">making recommendations to the Board of Directors on the membership of the Audit and Risk, Remuneration and Nomination and Corporate Governance Committees, in consultation with the chairs of those committees; and </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">overseeing a periodic self-evaluation of the Board of Directors to determine whether it and its committees are functioning effectively. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The current members of our Nomination and Corporate Governance Committee are Lisa Deschamps, David Ebsworth, Ph.D. and Vikas Sinha. Dr.&#160;Ebsworth serves as the Chairperson of the Nomination and Corporate Governance Committee. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The members of the Nomination and Corporate Governance Committee met 6 times during 2023. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Executive and Director Compensation.</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">This section discusses the material components of the executive compensation program for our executive officers who are named in the &#8220;2023 Summary Compensation Table&#8221; below. In 2023, our &#8220;named executive officers&#8221; and their positions were as follows: </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">David Zaccardelli, Pharm.D., President and Chief Executive Officer; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Mark Hahn, Chief Financial Officer; and </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Kathleen Rickard, M.D., Chief Medical Officer </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.02pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">2023 SUMMARY COMPENSATION TABLE </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The following table sets forth information concerning the compensation of our named executive officers for the&#160;years ended December&#160;31, 2023 and December&#160;31, 2022: </span>
        </div>
        <table style="width:456pt;height:128.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:152.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Name and Principal Position </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Year </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Cash Base
                <br/>
                Salary ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Stock
                <br/>
                Awards ($)</span><span style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Non-Equity
                <br/>
                Incentive Plan
                <br/>
                Compensation ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">All Other
                <br/>
                Compensation ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Total ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:152.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">David Zaccardelli, Pharm.D. </span>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">819,568</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5,324,000</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">440,705</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">13,200<span style="position:absolute;"><span style=" position:relative; bottom:3.25pt;font-size:6.5pt;font-weight:bold;">(2)</span> </span></td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">6,597,473</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:152.88pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <span style="letter-spacing:0.2pt;">President and Chief Executive Officer (PEO) </span>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">524,842</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,133,500</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">497,297</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">27,501</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5,183,140</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Mark W. Hahn </span>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">551,291</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5,324,000</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">293,803</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">13,200<span style="position:absolute;"><span style=" position:relative; bottom:3.25pt;font-size:6.5pt;font-weight:bold;">(2)</span> </span></td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">6,182,294</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.88pt;text-align:left;">
              <div style="margin-left:10pt;">
                <span style="letter-spacing:0.2pt;">Chief Financial Officer </span>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">430,450</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,983,498</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">331,531</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">22,401</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,767,880</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Kathleen Rickard, M.D. </span>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">458,333</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,331,000</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">192,500</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,981,833</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.88pt;text-align:left;">
              <div style="margin-left:10pt;">
                <span style="letter-spacing:0.2pt;">Chief Medical Officer </span>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">434,439</td>
            <td style="padding:0pt;padding-left:1.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">863,000</td>
            <td style="padding:0pt;padding-left:1.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">217,220</td>
            <td style="padding:0pt;padding-left:12.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,342</td>
            <td style="padding:0pt;padding-left:15.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,518,001</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.01pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(1)</span>
          <br/>
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Amounts reflect the full grant-date fair value of stock awards granted during 2022 and 2023 computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. For a description of the assumptions used in valuing these awards, see Note 7 to our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(2)</span>
          <br/>
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of Company retirement plan contributions. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.02pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Narrative to 2023 Summary Compensation Table</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">2023 Annual Base Salaries</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The named executive officers receive a base salary to compensate them for services rendered to our Company. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role and responsibilities. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">29</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Our Remuneration Committee periodically reviews named executive officer base salaries in consultation with management to determine whether any adjustments are necessary or appropriate. The following table shows the annual base salaries of our named executive officers for 2023 and 2024. Except as otherwise noted, all annual base salary increases were effective January&#160;1 of the given year. </span>
        </div>
        <table style="width:416pt;height:62.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:289.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Name </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">2023 Annual
                <br/>
                Base Salary ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">2024 Annual
                <br/>
                Base Salary ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:289.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">David Zaccardelli</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">839,437</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">873,015</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Mark W. Hahn</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">559,625</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">582,010</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Kathleen Rickard </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">458,333</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">504,167</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.6pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(1)</span>
          <br/>
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">As further described below in the section entitled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">&#8212; Executive Compensation Arrangements</span><span style="letter-spacing:0.2pt;">,&#8221; prior to February 1, 2023, Dr.&#160;Zaccardelli&#8217;s and Mr.&#160;Hahn&#8217;s annual base salaries were payable in part in cash and in part in restricted stock&#160;units, as agreed by each executive and the Company each year. Beginning on February&#160;1, 2023, 100% of the executives&#8217; annual base salaries was paid in cash. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">2023 Annual Cash Bonuses</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In addition to base salaries, our named executive officers are eligible to receive a discretionary bonus designed to drive the achievement of the Company&#8217;s strategic and corporate objectives. The goals are set at the start of the year by the Board of Directors and performance against objectives is assessed by the remuneration committee at the end of the relevant financial year. Dr.&#160;Zaccardelli and Mr.&#160;Hahn are each eligible to receive an annual bonus targeted at 50% of his base salary, while Dr.&#160;Rickard is eligible to receive an annual bonus targeted at 40% of her base salary. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">For 2023, our corporate bonus objectives were based on operational and financial milestones, which consisted of meeting with the U.S. Food and Drug Administration with respect to the Company&#8217;s New Drug Application (&#8220;NDA&#8221;) for nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease and submission and acceptance for filing of the NDA, advancing and completing certain pre-commercialization activities to support the launch of ensifentrine in the U.S. and, if approved, completing a feasibility study of the ensifentrine/glycopyrrolate fixed dose combination formulation, generating options for partnering for the development and commercialization of ensifentrine outside the U.S., and Company operation at or below an approved budget; however, our remuneration committee did not assign any particular weights to any particular objectives, nor did it have separate goals for any particular executive. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Based on its evaluation of Company performance, the remuneration committee determined that, in the aggregate, the Company&#8217;s corporate bonus objectives were attained at 105% of target levels of performance, and the committee approved annual bonuses that represented 105% of the target annual bonus for each of the named executives. The actual annual cash bonuses awarded to each named executive officer for 2023 performance are set forth above in the 2023 Summary Compensation Table in the column entitled &#8220;Non-Equity Incentive Plan&#160;Compensation.&#8221; </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Equity Compensation</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">We grant equity-based compensation awards from time to time to motivate and retain our executive officers. In 2023, Dr.&#160;Zaccardelli, Mr.&#160;Hahn and Dr.&#160;Rickard were granted awards of time-based restricted stock&#160;units (&#8220;RSUs&#8221;) covering 100,000, 100,000 and 25,000 ADSs, respectively, and performance restricted stock units (&#8220;PRSUs&#8221;) covering 300,000, 300,000 and 75,000 ADSs, respectively. These awards were granted under our 2017 Incentive Plan. The awards of RSUs are scheduled to vest (i)&#160;as to 25%, upon the first anniversary of a specified vesting commencement date and (ii)&#160;as to the remainder, in quarterly installments over the following 3&#160;years, subject generally to continued employment and potential accelerated vesting. The awards of PRSUs are scheduled to vest (i)&#160;as to 33%, upon achievement of a performance condition related to the commercialization of ensifentrine in the U.S. and (ii)&#160;as to the remainder, in eight quarterly installments over the 2&#160;years following the achievement of such performance condition, subject generally to continued employment and potential accelerated vesting. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">30</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tOEAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">Other Elements of Compensation</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <span style="letter-spacing:-0.2pt;">Retirement Plans</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">We currently maintain a 401(k) retirement savings plan for our U.S.-based employees, including our named executive officers, who satisfy certain eligibility requirements. Our named executive officers are eligible to participate in the 401(k) plan on the same terms as other full-time employees. The Internal Revenue Code allows eligible employees to defer a portion of their compensation, within prescribed limits, on a pre-tax basis through contributions to the 401(k) plan. Currently, we match contributions made by participants in the 401(k) plan up to 4% of participants&#8217; eligible earnings, subject to limits under the Internal Revenue Code. Matching contributions made during 2023 vest immediately. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <span style="letter-spacing:-0.2pt;">Employee Benefits and Perquisites</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">We offer the opportunity to participate in various health and welfare programs to our full-time employees, including our named executive officers, who participate on the same basis as other full-time employees. These programs include medical, dental and vision benefits; short-term and long-term disability insurance; and life insurance. We believe the perquisites described above are necessary and appropriate to provide a competitive compensation package to our named executive officers. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">OUTSTANDING EQUITY AWARDS AT 2023 FISCAL YEAR END </span>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">The following table summarizes the number of company securities underlying outstanding equity incentive plan awards for each named executive officer as of December&#160;31, 2023. Awards cover ordinary shares and/or ADSs; however, amounts shown below are expressed in terms of the number of ADSs that are covered by each such award. </span>
        </div>
      </div>
      <div style="margin-top:12pt;margin-bottom:12pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;height:313.41pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:122.44pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="22" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Option Awards </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td colspan="22" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Stock Awards </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt; width:122.44pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Name </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Grant
                <br/>
                Date </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Number of
                <br/>
                Securities
                <br/>
                Underlying
                <br/>
                Unexercised
                <br/>
                Options (#)
                <br/>
                Exercisable </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Number of
                <br/>
                Securities
                <br/>
                Underlying
                <br/>
                Unexercised
                <br/>
                Options (#)
                <br/>
                Unexercisable </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Option
                <br/>
                Exercise
                <br/>
                Price ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Option
                <br/>
                Expiration
                <br/>
                Date </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Number of
                <br/>
                Shares or
                <br/>
                Units of
                <br/>
                Stock That
                <br/>
                Have Not
                <br/>
                Vested (#) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Market
                <br/>
                Value of
                <br/>
                Shares or
                <br/>
                Units of
                <br/>
                Stock That
                <br/>
                Have Not
                <br/>
                Vested ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Equity
                <br/>
                Incentive
                <br/>
                Plan&#160;
                <br/>
                Awards:
                <br/>
                Number of
                <br/>
                Unearned
                <br/>
                Shares,
                <br/>
                Units or
                <br/>
                Other Rights
                <br/>
                That Have
                <br/>
                Not Vested (#) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Equity
                <br/>
                Incentive
                <br/>
                Plan&#160;
                <br/>
                Awards:
                <br/>
                Market or
                <br/>
                Payout
                <br/>
                Value of
                <br/>
                Unearned
                <br/>
                Shares,
                <br/>
                Units or
                <br/>
                Other Rights
                <br/>
                That Have
                <br/>
                Not Vested ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:5.84pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td rowspan="5" style="padding:2.263pt 0pt 1.107pt 0pt; width:122.44pt;text-align:left;vertical-align:top;">
              <div style="white-space:nowrap; line-height:9.6pt; padding-bottom:-0.00666666666667008pt;">
                <span style="letter-spacing:0.16pt;">David Zaccardelli </span>
              </div>
            </td>
            <td rowspan="5" style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:27pt; text-align:right; white-space:nowrap;">5/7/2020<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(1)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:19.5pt; text-align:right; white-space:nowrap;">32,914</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:24pt; text-align:right; white-space:nowrap;">654,330</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; line-height:9.6pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:11.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8/20/2020<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(1)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">111,577</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,218,151</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:11.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9/26/2022<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(2)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">337,500</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">6,709,500</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:11.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10/20/2023<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(3)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">100,000</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,988,000</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:11.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10/20/2023<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(4)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">300,000</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">5,964,000</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:5.59pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td rowspan="5" style="padding:2.503pt 0pt 1.117pt 0pt; width:122.44pt;text-align:left;vertical-align:top;">
              <div style="white-space:nowrap; line-height:9.6pt; padding-bottom:-0.00666666666667008pt;">
                <span style="letter-spacing:0.16pt;">Mark W. Hahn </span>
              </div>
            </td>
            <td rowspan="5" style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:27pt; text-align:right; white-space:nowrap;">5/7/2020<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(1)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:19.5pt; text-align:right; white-space:nowrap;">24,685</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:24pt; text-align:right; white-space:nowrap;">490,738</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; line-height:9.6pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:11.59pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8/20/2020<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(1)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">119,802</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,381,664</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:11.59pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9/26/2022<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(2)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">337,500</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">6,709,500</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:11.59pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10/20/2023<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(3)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">100,000</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,988,000</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:11.59pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10/20/2023<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(4)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">300,000</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">5,964,000</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;height:5.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td rowspan="6" style="padding:2.493pt 0pt 0.5pt 0pt; width:122.44pt;text-align:left;vertical-align:top;">
              <div style="white-space:nowrap; line-height:9.6pt; padding-bottom:-0.00666666666667955pt;">
                <span style="letter-spacing:0.16pt;">Kathleen Rickard </span>
              </div>
            </td>
            <td rowspan="6" style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:27pt; text-align:right; white-space:nowrap;">4/1/2019</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:16.5pt; text-align:right; white-space:nowrap;">70,000</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:10.5pt; text-align:right; white-space:nowrap;">5.99</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:24pt; text-align:right; white-space:nowrap;">3/29/2029</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; line-height:9.6pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; line-height:9.6pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; line-height:9.6pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; line-height:9.6pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;height:11.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">3/3/2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">11719</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">781<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(5)</span> </span></td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">5.64</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3/3/2030</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;height:11.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8/20/2020<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(6)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">71,887</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,429,114</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;height:11.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">9/26/2022<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(2)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">75,000</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,491,000</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;height:11.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10/20/2023<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(3)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">25,000</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">497,000</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;height:16.59pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10/20/2023<span style="position:absolute;"><span style=" position:relative; bottom:2.29166666666667pt;font-size:5pt;font-weight:bold;">(4)</span> </span></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.005pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">75,000</td>
            <td style="padding:0pt;padding-left:11.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; min-width:31.5pt; text-align:right; white-space:nowrap;">1,491,000.00</td>
            <td style="padding:0pt;padding-left:2.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:11.9999999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">(1)</span>
          <br/>
        </div>
        <div style=" margin-top:9.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">The outstanding restricted stock&#160;units cover ADSs and vest on February&#160;1, 2024, provided that the restricted stock&#160;units will immediately vest prior to a change in control, subject, in each case, to the </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">31</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:300pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">holder&#8217;s continued employment with us through the applicable vesting date and potential accelerated vesting as described in the section below titled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">&#8212; Executive Compensation Arrangements</span><span style="letter-spacing:0.2pt;">.&#8221; </span>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(2)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">The outstanding restricted stock&#160;units cover ADSs and vest in twelve equal quarterly installments (with the first such installment occurring on February&#160;1, 2024), provided that the restricted stock&#160;units will immediately vest prior to a change in control, subject, in each case, to the holder&#8217;s continued employment with us through the applicable vesting date and potential accelerated vesting as described in the section below titled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">&#8212; Executive Compensation Arrangements</span><span style="letter-spacing:0.2pt;">.&#8221; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(3)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">The outstanding restricted stock&#160;units cover ADSs and vest (i)&#160;as to 25% of the restricted stock&#160;units, on November&#160;1, 2024, and (ii)&#160;as to the remainder, in twelve equal quarterly installments thereafter, provided that the restricted stock&#160;units will immediately vest prior to a change in control, subject, in each case, to the holder&#8217;s continued employment with us through the applicable vesting date and potential accelerated vesting as described in the section below titled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">&#8212; Executive Compensation Arrangements</span><span style="letter-spacing:0.2pt;">.&#8221; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(4)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">The outstanding PRSUs cover ADSs and vest (i)&#160;as to 33% of the restricted stock&#160;units, upon achievement of a certain performance condition described above in the section entitled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">Narrative to 2023 Summary Compensation Table&#8201;&#8212;&#8201;Equity Compensation</span><span style="letter-spacing:0.2pt;">,&#8221; and (ii)&#160;as to the remainder, in eight equal quarterly installments thereafter, provided that the PRSUs will immediately vest prior to a change in control, subject, in each case, to the holder&#8217;s continued employment with us through the applicable vesting date and potential accelerated vesting as described in the section below titled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">&#8212; Executive Compensation Arrangements</span><span style="letter-spacing:0.2pt;">.&#8221; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(5)</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">The option covers ADSs and the unvested portion of the option vested on March&#160;3, 2024, subject, in each case, to Dr.&#160;Rickard&#8217;s continued employment with us through the applicable vesting date. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(6)</span>
          <br/>
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">The outstanding restricted stock&#160;units cover ADSs and vest in three equal quarterly installments (with the first installment vesting on February&#160;1, 2024), provided that the restricted stock&#160;units will immediately vest prior to a change in control, subject, in each case, to the holder&#8217;s continued employment with us through the applicable vesting date.</span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">32</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Executive Compensation Arrangements</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We have entered into employment and severance agreements with each of our named executive officers. Certain key terms of these agreements are described below. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">David S. Zaccardelli, Pharm.D.</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We entered into an employment agreement with Dr.&#160;Zaccardelli pursuant to which he commenced employment with us on February&#160;1, 2020. This agreement entitles Dr.&#160;Zaccardelli to receive an annual base salary initially equal to $750,000 (which has been subsequently increased, as described in &#8220;2023 Annual Base Salaries&#8221; above) which, prior to February 1, 2023, was payable in part in cash and in part in restricted stock&#160;units (which vest in equal quarterly installments during the calendar year in which the grant occurs, subject to continued employment) and a target annual bonus opportunity of 50% of his annual base salary. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">If Dr.&#160;Zaccardelli&#8217;s employment is terminated by us without &#8220;Cause&#8221; or by Dr.&#160;Zaccardelli for &#8220;Good Reason&#8221; &#8203;(as each such term is defined in his employment agreement), then, subject to his signing and not revoking a general release of claims, he is entitled to receive (i)&#160;12&#160;months of base salary continuation and continued payment of premiums for continued medical coverage under COBRA, (ii)&#160;an amount equal to 100% of Dr.&#160;Zaccardelli&#8217;s full annual discretionary bonus, calculated as though all applicable objectives have been achieved for the year of termination, (iii)&#160;payment of all accrued and unused paid time-off, and (iv)&#160;full accelerated vesting of any outstanding, unvested equity awards under our share and share option schemes (with any performance-vesting awards become vested based on target level attainment). </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Dr.&#160;Zaccardelli has also agreed to refrain from competing with us or soliciting our customers or prospective customers for a period of one year following his termination of employment. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Mark W. Hahn</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We entered into an employment agreement with Mr.&#160;Hahn pursuant to which he commenced employment with us on February&#160;1, 2020 and has served as our Chief Financial Officer since March&#160;1, 2020. This agreement entitles Mr.&#160;Hahn to receive an initial annual base salary of $500,000 (which has been subsequently increased, as described in &#8220;2023 Annual Base Salaries</span><span style="font-style:italic;letter-spacing:0.2pt;">&#8221;</span><span style="letter-spacing:0.2pt;"> above) which, prior to February 1, 2023, was payable in part in cash and in part in restricted stock&#160;units (which vest in equal quarterly installments during the calendar year in which the grant occurs, subject to continued employment) and a target annual bonus opportunity of 50% of his annual base salary. If Mr.&#160;Hahn&#8217;s employment is terminated by us without &#8220;Cause&#8221; or by Mr.&#160;Hahn for &#8220;Good Reason&#8221; &#8203;(as each such term is defined in his employment agreement), then, subject to his signing and not revoking a general release of claims, he is entitled to receive the same severance payments and benefits that Dr.&#160;Zaccardelli is entitled to receive, as described above. Mr.&#160;Hahn has also agreed to refrain from competing with us or soliciting our customers or prospective customers for a period of one year following his termination of employment. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <span style="letter-spacing:0.2pt;">Kathleen Rickard, M.D.</span><span style="font-style:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We entered into an offer letter with Dr.&#160;Rickard on December&#160;13, 2018, pursuant to which she agreed to serve as our Chief Medical Officer, effective February&#160;1, 2019. This agreement entitles Dr.&#160;Rickard to receive an annual base salary (as described above) and a target annual bonus opportunity of 40% of her annual base salary, with the amount of any such bonus based on performance criteria for our company and her individual performance, as determined by the Board of Directors in its sole discretion. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">If Dr.&#160;Rickard&#8217;s employment is terminated by us without &#8220;Cause&#8221; or by Dr.&#160;Rickard for &#8220;Good Reason&#8221; &#8203;(as each such term is defined in her offer agreement), then, subject to her signing and not revoking a general release of claims, she is entitled to receive (i)&#160;four weeks of base salary continuation, (ii)&#160;four weeks of continued payment of premiums for continued medical coverage under COBRA, (iii)&#160;a pro-rated portion of the annual bonus that she otherwise would have earned in the year of termination based on actual performance in such year. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Dr.&#160;Rickard is also entitled to participate in the Verona Pharma plc Employee Change in Control Severance Benefit Plan (the &#8220;Severance Plan&#8221;). Under the Severance Plan, if, upon or within 12&#160;months following a change in control, we terminate the employment of Dr.&#160;Rickard without Cause (as defined in </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">33</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">the Severance Plan) or if Dr.&#160;Rickard resigns voluntarily under the terms of a voluntary reduction in force program established by the administrator of the Severance Plan pursuant to which the participant is eligible to resign and receive benefits under the Severance Plan, then Dr.&#160;Rickard will be entitled to receive (i)&#160;base salary and medical benefit continuation for a period (the &#8220;Severance Period&#8221;) of twelve&#160;months, (ii)&#160;a pro-rated target cash bonus for the year of termination, (iii)&#160;relocation benefits paid to Dr.&#160;Rickard in connection with any relocation that occurred within 12&#160;months prior to the change in control and (iv)&#160;outplacement services until the end of the Severance Period (or, if earlier, until the acceptance of an offer of full-time employment from a subsequent employer). </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">PAY VERSUS PERFORMANCE </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Pay Versus Performance Table</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The following table sets forth information concerning the compensation of our named executive officers (&#8220;NEOs&#8221;) for each of the fiscal&#160;years ended December&#160;31, 2021, 2022 and 2023, and our financial performance for each such fiscal year: </span>
        </div>
        <ix:nonNumeric contextRef="c0" continuedAt="_PvpTableTextBlock-c0_cont_1" escape="true" name="ecd:PvpTableTextBlock" id="ixv-5658"><table style="width:456pt;height:139pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <tr style="line-height:9pt;height:54.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:123.94pt;text-align:left;"> <div style="white-space:nowrap; line-height:9pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Year </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Summary <br/> Compensation <br/> Table Total <br/> for PEO <br/> ($) </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Compensation <br/> Actually Paid <br/> to PEO <br/> ($)</span><span style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Average <br/> Summary <br/> Compensation <br/> Table Total <br/> for Non-PEO <br/> NEOs <br/> ($) </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Average <br/> Compensation <br/> Actually <br/> Paid to <br/> Non-PEO <br/> NEOs <br/> ($)(1) </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center;"> <span style="letter-spacing:-0.16pt;">Value of <br/> Initial <br/> Fixed <br/> $100 <br/> Investment <br/> Based on: </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Net <br/> Income <br/> ($) </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:9pt;height:40.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="text-align:center;"> <span style="letter-spacing:-0.16pt;">Total <br/> Shareholder <br/> Return <br/> ($) </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:123.94pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2023 </span> </div> </td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-8481">6,559,277</ix:nonFraction></td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-8482">558,317</ix:nonFraction></td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-8483">4,082,064</ix:nonFraction></td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-8484">207,291</ix:nonFraction></td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-8485">284.00</ix:nonFraction></td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-8486">54,369,000</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:123.94pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2022 </span> </div> </td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-8487">5,183,140</ix:nonFraction></td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-8488">27,578,945</ix:nonFraction></td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-8489">3,142,941</ix:nonFraction></td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-8490">17,462,808</ix:nonFraction></td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-8491">373.29</ix:nonFraction></td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-8492">68,701,000</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:123.94pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2021 </span> </div> </td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-8493">1,123,304</ix:nonFraction></td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-8494">823,718</ix:nonFraction></td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-8495">650,336</ix:nonFraction></td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-8496">425,254</ix:nonFraction></td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-8497">96.00</ix:nonFraction></td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-8498">55,569,000</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> </table>
        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <ix:nonNumeric contextRef="c0" continuedAt="_NamedExecutiveOfficersFnTextBlock-c0_cont_1" escape="true" name="ecd:NamedExecutiveOfficersFnTextBlock" id="ixv-5859"><div style=" float:left; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;"> <span style="letter-spacing:0.2pt;">(1)</span> <br/> </div></ix:nonNumeric>
        <ix:continuation continuedAt="_NamedExecutiveOfficersFnTextBlock-c0_cont_2" id="_NamedExecutiveOfficersFnTextBlock-c0_cont_1"><div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Amounts represent compensation actually paid to our PEO and the average compensation actually paid to our remaining NEOs for the relevant fiscal year, as determined under SEC rules (and described below), which includes the individuals indicated in the table below for each fiscal year: </span>
        </div></ix:continuation>
        <ix:continuation continuedAt="_NamedExecutiveOfficersFnTextBlock-c0_cont_3" id="_NamedExecutiveOfficersFnTextBlock-c0_cont_2"><div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div></ix:continuation>
        <ix:continuation id="_NamedExecutiveOfficersFnTextBlock-c0_cont_3"><table style="width:416pt;height:53.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:-0.16pt;">Year </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">PEO </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">Non-PEO NEOs </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2023 </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;"><ix:nonNumeric contextRef="c0" name="ecd:PeoName" id="ixv-8499">David Zaccardelli</ix:nonNumeric> </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">Mark W. Hahn and Kathleen Rickard </span> </div> </td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2022 </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">David Zaccardelli </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">Mark W. Hahn and Kathleen Rickard </span> </div> </td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2021 </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">David Zaccardelli </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">Mark W. Hahn and Kathleen Rickard</span> </div> </td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> </table></ix:continuation>
        <div style="margin-left:20pt; margin-top:3.5pt; width:436pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Compensation actually paid to our NEOs represents the &#8220;Total&#8221; compensation reported in the Summary Compensation Table for the applicable fiscal year, as adjusted as follows: </span>
        </div>
        <table style="width:456pt;height:172pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:344.51pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="10" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">2023 </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:344.51pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:-0.16pt;">Adjustments </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">PEO </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="text-align:center;"> <span style="letter-spacing:-0.16pt;">Average <br/> Non-PEO <br/> NEOs </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:1.917pt 0pt 0.5pt 0pt; width:344.51pt;white-space:normal;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; Columns in the Summary Compensation Table for Applicable FY </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-8500">5,324,000</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-8501">3,327,500</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.5pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY <br/> that Remain Unvested as of Applicable FY End, determined as of Applicable <br/> FY End </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-8502">7,952,000</ix:nonFraction></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-8503">4,970,000</ix:nonFraction></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.5pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY <br/> that Vested during Applicable FY, determined as of Vesting Date </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.5pt 0pt; width:344.51pt;white-space:normal;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-8504">3,012,444</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-8505">2,185,934</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> </table></ix:nonNumeric>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">34</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:42pt;margin-left:69.66pt;width:456pt;">
        <ix:continuation id="_PvpTableTextBlock-c0_cont_1"><table style="width:456pt;height:175pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:344.51pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="10" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">2023 </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:344.51pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:-0.16pt;">Adjustments </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">PEO </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="text-align:center;"> <span style="letter-spacing:-0.16pt;">Average <br/> Non-PEO <br/> NEOs </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase/deduction for Awards Granted during Prior FY that Vested During <br/> Applicable FY, determined based on change in ASC 718 Fair Value from Prior <br/> FY End to Vesting Date </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-8506">5,616,516</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-8507">3,331,338</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were <br/> Forfeited during Applicable FY, determined as of Prior FY End </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase based on Dividends or Other Earnings Paid during Applicable FY prior <br/> to Vesting Date </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.51pt;white-space:normal;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:-0.2pt;">TOTAL ADJUSTMENTS</span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-8508">6,000,960</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-8509">3,874,772</ix:nonFraction><span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> </table></ix:continuation>
        <div style="margin-top:21.19pt; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Narrative Disclosure to Pay Versus Performance Table</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Relationship Between Financial Performance Measures</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">The graphs below compare the compensation actually paid to our PEO and the average of the compensation actually paid to our remaining NEOs, with (i)&#160;our cumulative total shareholder return (&#8220;TSR&#8221;), and (ii)&#160;our net income, in each case, for the fiscal&#160;years ended December&#160;31, 2021, 2022 and 2023. TSR amounts reported in the graph assume an initial fixed investment of $100. </span>
        </div>
        <ix:nonNumeric contextRef="c0" escape="true" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="ixv-6179"><div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img alt="[MISSING IMAGE: bc_totalshare-4c.jpg]" src="bc_totalshare-4c.jpg" style="height: 376px; width: 597px;"/>
        </div></ix:nonNumeric>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">35</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="t2DC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <ix:nonNumeric contextRef="c0" escape="true" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="ixv-6201"><div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img alt="[MISSING IMAGE: bc_netincome-4c.jpg]" src="bc_netincome-4c.jpg" style="height: 380px; width: 603px;"/>
        </div></ix:nonNumeric>
        <div style="margin-left:20pt; margin-top:12.6pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">2023 DIRECTOR COMPENSATION </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We have entered into letters of appointment with each of our non-executive directors pursuant to which they are entitled to receive an annual fee for their services as a member of the board, and an additional fee for service on its committees. For 2023, these fees were as follows: </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">each non-executive director received an annual cash retainer of &#163;30,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">the Chairperson of the Board of Directors, each Chairperson of a committee of the Board of Directors or a member of a committee of the Board of Directors, received additional cash compensation as follows: </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">the Chairperson of the Board of Directors received an additional annual retainer of &#163;78,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">the Chairperson of the Audit and Risk Committee received an additional annual retainer of &#163;12,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">the Chairperson of the Remuneration Committee received an additional annual retainer of &#163;10,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">a member of the Audit and Risk Committee received an additional annual retainer of &#163;5,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">a member of the Remuneration Committee received an additional annual retainer of &#163;4,000; and </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">a member of the Nomination and Corporate Governance Committee received an additional annual retainer of &#163;3,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Following an independent benchmarking review of the compensation of our non-executive directors, the fees payable to our non-executive directors were increased, effective as of January&#160;1, 2024, as follows: </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">the Chairperson of the Board of Directors receives an annual cash retainer of &#163;115,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">each other non-executive director receives an annual cash retainer of &#163;40,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">each Chairperson of a committee of the Board of Directors or a member of a committee of the Board of Directors, receives additional cash compensation as follows: </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">36</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:40pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">the Chairperson of the Audit and Risk Committee receives an additional annual retainer of &#163;18,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">the Chairperson of the Remuneration Committee receives an additional annual retainer of &#163;12,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">the Chairperson of the Nomination Committee receives an additional annual retainer of &#163;10,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">a member of the Audit and Risk Committee receives an additional annual retainer of &#163;10,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">a member of the Remuneration Committee receives an additional annual retainer of &#163;6,000; and </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">a member of the Nomination and Corporate Governance Committee receives an additional annual retainer of &#163;4,000; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">The fees are paid monthly in arrears. These letters also provide for reimbursement of reasonable and documented expenses incurred in the performance of board duties, including reimbursement of business class air travel. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">The following table sets forth in summary form information concerning the compensation that we paid or awarded during the year ended December&#160;31, 2023 to each of our non-executive directors. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">2023 Director Compensation Table</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <table style="width:416pt;height:185.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Name </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Fees Earned
                <br/>
                or Paid in
                <br/>
                Cash
                <br/>
                ($)</span><span style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Option
                <br/>
                Awards
                <br/>
                ($)</span><span style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Total
                <br/>
                ($) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">David Ebsworth </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">148,962</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">181,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">330,502</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Christina Ackermann </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">14,106</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">253,807</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">267,913</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">James Brady </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">44,561</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">181,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">226,101</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Kenneth Cunningham </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">50,927</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">181,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">232,467</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Lisa Deschamps </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">42,015</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">181,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">223,555</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Martin Edwards </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">38,195</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">181,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">219,735</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Rishi Gupta </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">38,195</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">181,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">219,735</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Mahendra Shah </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">43,288</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">181,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">224,828</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Vikas Sinha </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">57,293</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">181,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">238,833</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Sven Ullman </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">38,195</td>
            <td style="padding:0pt;padding-left:3.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">181,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">219,735</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.7pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(1)</span>
          <br/>
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Amounts shown in this column are expressed in U.S. dollars. Amounts for 2023 paid in pounds sterling have been converted to U.S. dollars based on the exchange rate ($1.273180 to 1 pound sterling) as of December&#160;31, 2023. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(2)</span>
          <br/>
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Amounts reflect the full grant-date fair value of option awards granted during 2023 computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. For a description of the assumptions used in valuing these awards, see Note 7 to our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <span style="letter-spacing:0.2pt;">The table below shows the aggregate numbers of option awards (exercisable and unexercisable) and unvested stock awards held as of December&#160;31, 2023 by each non-executive director. Awards cover ordinary shares and/or ADSs; however, amounts shown below are expressed in terms of the number of ADSs that are covered by each such award. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">37</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tSAFI">&#8203;</a><a id="tSOOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:203.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Name </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Option
                <br/>
                Awards
                <br/>
                Outstanding at
                <br/>
                2023 Fiscal
                <br/>
                Year End </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Unvested
                <br/>
                Stock
                <br/>
                Awards
                <br/>
                Outstanding
                <br/>
                at 2023 Fiscal
                <br/>
                Year End </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">David Ebsworth </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">39,000</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Christina Ackermann </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">18,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">James Brady </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Ken Cunningham </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">39,000</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Lisa Deschamps </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">39,000</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Martin Edwards </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">39,000</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Rishi Gupta </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">62,200</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Mahendra Shah </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">39,000</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Vikas Sinha </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">54,048</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.78pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Anders Ullman </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">39,000</td>
            <td style="padding:0pt;padding-left:11.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,000</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.5pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The following table sets forth information as of December&#160;31, 2023 regarding ordinary shares that may be issued under our equity compensation plans, consisting of the Verona Pharma plc EMI Option Scheme (the &#8220;EMI Plan&#8221;), the Verona Pharma plc Unapproved Share Option Scheme (the &#8220;Pre-IPO Plan&#8221;) and the Verona Pharma plc 2017 Incentive Award Plan (as it has been amended and/or restated, the &#8220;2017 Incentive Plan&#8221;). We do not have any non-shareholder approved equity compensation plans. </span>
        </div>
        <table style="width:456pt;height:140.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:206.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Plan&#160;Category </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Number of Ordinary
                <br/>
                Shares to be
                <br/>
                Issued Upon Exercise
                <br/>
                of Outstanding
                <br/>
                Options, Warrant
                <br/>
                and Rights (a) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Weighted-
                <br/>
                Average
                <br/>
                Exercise Price of
                <br/>
                Outstanding
                <br/>
                Options,
                <br/>
                Warrant and
                <br/>
                Rights (b) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;">
              <div style="text-align:center;">
                <span style="letter-spacing:-0.16pt;">Number of Ordinary
                <br/>
                Shares
                <br/>
                Remaining Available
                <br/>
                for Future Issuance Under
                <br/>
                Equity Compensation
                <br/>
                Plans (Excluding
                <br/>
                Securities Reflected in
                <br/>
                Column (a)) (c) </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:206.11pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <span style="letter-spacing:0.2pt;">Equity compensation plans approved by shareholders </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">54,922,392<span style="position:absolute;"><span style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</span> </span></td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.56<span style="position:absolute;"><span style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(2)</span> </span></td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.03pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,899,715<span style="position:absolute;"><span style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</span> </span></td>
            <td style="padding:0pt;padding-left:23.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:206.11pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <span style="letter-spacing:0.2pt;">Equity compensation plans not approved by shareholders </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:23.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:206.11pt;text-align:left;">
              <div style="font-weight:bold;">
                <span style="letter-spacing:-0.2pt;">Total</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">54,922,392</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.56 </td>
            <td style="padding:0pt;padding-left:16.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,899,715</td>
            <td style="padding:0pt;padding-left:23.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:6.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(1)</span>
          <br/>
        </div>
        <div style=" margin-top:6.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Includes 19,502,624 ordinary shares underlying outstanding restricted share&#160;units and 10,730,144 ordinary shares underlying performance restricted share&#160;units as of December&#160;31, 2023. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(2)</span>
          <br/>
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Represents the weighted average exercise price of outstanding options. Restricted share units and performance restricted share&#160;units are not taken into account for purposes of determining the weighted average exercise price. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(3)</span>
          <br/>
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Under the terms of the 2017 Incentive Plan, the number of common shares that may be issued under the 2017 Incentive Plan will automatically increase on January&#160;1st of each year, from January&#160;1, 2024 continuing through January&#160;1, 2033, by 4% of the total number of ordinary shares outstanding on December&#160;31st of the preceding calendar year, or a lesser number of shares as may be determined by the Board of Directors. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:10.52pt; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Security Ownership of Certain Beneficial Owners and Management</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The following table sets forth information with respect to the beneficial ownership of our voting ordinary shares (and our ADSs, each of which represents 8 ordinary shares), as of March&#160;1, 2024, by: </span>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">each person or group of affiliated persons known by us to beneficially own more than 5% of ordinary shares; </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">38</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">each of our named executive officers and directors (which includes all nominees); and </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">&#8226;</span>
          <br/>
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">all of our executive officers and directors as a group. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The number of shares beneficially owned by each shareholder is determined under rules issued by the SEC. Under these rules, beneficial ownership includes any shares over which the individual or entity has sole or shared voting power or investment power. Applicable&#160;percentage ownership is based on 647,871,294 voting and non-voting ordinary shares outstanding as of March&#160;1, 2024, including ordinary shares in the form of ADSs. In computing the number of shares beneficially owned by an individual or entity and the&#160;percentage ownership of that person, ordinary shares subject to options, restricted share&#160;units or other rights held by such person that are currently exercisable or will become exercisable or will vest within 60&#160;days of March&#160;1, 2024 are considered outstanding, although these shares are not considered outstanding for purposes of computing the&#160;percentage ownership of any other person. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Unless noted otherwise, the address of all listed shareholders is c/o&#160;Verona Pharma plc, 3 More London Riverside, London SE1 2RE UK. Each of the shareholders listed has sole voting and investment power with respect to the shares beneficially owned by the shareholder unless noted otherwise, subject to community property laws where applicable. </span>
        </div>
        <table style="width:416pt;height:307pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.28pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="10" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Shares beneficially owned </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.16pt;">Name of beneficial owner </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Number </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="4" style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;">
              <div style="white-space:nowrap; text-align:center;">
                <span style="letter-spacing:-0.16pt;">Percent </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <span style="letter-spacing:-0.2pt;">5% or greater shareholders:</span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">RA Capital Management affiliates</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">60,031,808</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.3<span style="position:absolute;">%</span></td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">New Enterprise Associates affiliates</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">46,447,651</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">7.2<span style="position:absolute;">%</span></td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">FMR LLC</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">39,219,016</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">6.1<span style="position:absolute;">%</span></td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <span style="letter-spacing:-0.2pt;">Named Executive Officers, Directors and Director Nominees:</span>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">David Zaccardelli, Pharm.D.</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12,667,592</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.0<span style="position:absolute;">%</span></td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Christina Ackermann </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Michael Austwick </span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Ken Cunningham, M.D.</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">426,584</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Lisa Deschamps</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">430,320</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">David Ebsworth, Ph.D.</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,204,643</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Martin Edwards, M.D.</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">504,800</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Mahendra Shah, Ph.D.</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">433,080</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Anders Ullman, M.D., Ph.D.</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">694,856</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Vikas Sinha</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(11)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">554,824</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">James Brady</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(12)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">384,000 </td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Mark W. Hahn</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(13)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">11,756,576</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">1.8<span style="position:absolute;">%</span></td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">Kathleen Rickard, M.D.</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(14)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,273,224</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:319.28pt;text-align:left;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">All directors and executive officers as a group (14 persons)</span><span style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(15)</span>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31,330,499</td>
            <td style="padding:0pt;padding-left:0.560000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">4.8<span style="position:absolute;">%</span></td>
            <td style="padding:0pt;padding-left:6.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.6pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">*</span>
          <br/>
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Indicates beneficial ownership of less than 1% of the total outstanding ordinary shares. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(1)</span>
          <br/>
        </div>
        <div style=" margin-top:4.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of (a)&#160;50,543,920 ordinary shares held directly by RA Capital Healthcare Fund, L.P., or RA Capital, all of which are held in the form of ADSs, and (b)&#160;9,487,888 non-voting ordinary shares that RA Capital beneficially own based on the right to acquire, upon the redesignation of the non-voting ordinary shares as ordinary shares. RA Capital may elect to have any portion of their non-voting ordinary shares re-designated as voting ordinary shares at any time, unless, immediately following such conversion, they would beneficially own more than 9.99% of the outstanding ordinary shares. If RA Capital would beneficially own more than 9.99% of the outstanding ordinary shares following such re-designation, then the re-designation would occur no earlier than 61&#160;days following the election for such re-designation. RA Capital Management, L.P., or Adviser, is the investment adviser for RA Capital. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">39</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The general partner of the Adviser is RA Capital Management GP, LLC, or Adviser GP, of which Dr.&#160;Peter Kolchinsky and Mr.&#160;Rajeev Shah are the managing members. RA Capital, the Adviser, Dr.&#160;Kolchinsky and Mr.&#160;Shah have shared voting and shared dispositive power with respect to all of the shares reported. The Adviser, the Adviser GP, Dr.&#160;Kolchinsky, and Mr.&#160;Shah disclaim beneficial ownership of securities held by RA Capital except to the extent of their pecuniary interest therein. Beneficial ownership information is based on a Schedule&#160;13G/A filed on February&#160;14, 2024. RA Capital Management&#8217;s mailing address is 200 Berkeley Street, 18</span><span style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</span><span style="letter-spacing:0.2pt;"> Floor, Boston, MA 02116. </span>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(2)</span>
          <br/>
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of (a)&#160;9,757,393 ordinary shares held directly by Growth Equity Opportunities Fund&#160;IV, LLC, or GEO 15, of which 5,333,328 are held in the form of ADSs, (b)&#160;warrants to purchase 1,769,626 ordinary shares held directly by GEO 15, and (c)&#160;34,920,632 ordinary shares held directly by Growth Equity Opportunities 17, LLC, or GEO 17, all of which are held in the form of ADSs. New Enterprise Associates 15, L.P., or NEA 15, is the sole member of GEO 15. NEA Partners 15, L.P., or NEA Partners 15, is the sole general partner of NEA 15. NEA 15 GP, LLC, or NEA 15 LLC, is the sole general partner of NEA Partners 15. Forest Baskett, Anthony Florence, Jr., Mohamad Makhzoumi, Scott D. Sandell, and Peter Sonsini are the managers of NEA 15 LLC. NEA 15, NEA Partners 15, NEA&#160;15 LLC and the managers of NEA 15 LLC share voting and dispositive power with regard to the securities held by GEO 15. Each of NEA 15, NEA Partners 15 and NEA 15 LLC as well as each of the managers of NEA 15 LLC disclaims beneficial ownership of all shares held by GEO 15 except to the extent of their actual pecuniary interest therein. New Enterprise Associates 17, L.P., or NEA 17, is the sole member of GEO 17. NEA Partners 17, L.P., or NEA Partners 17, is the sole general partner of NEA&#160;17. NEA 17 GP, LLC, or NEA 17 LLC, is the sole general partner of NEA Partners 17. Forest Baskett, Ali Behbahani, Carmen Chang, Anthony Florence, Jr., Mohamad Makhzoumi, Edward Mathers, Scott D. Sandell, Paul Walker, Rick Yang, Liza Landsman, and Peter Sonsini, are the managers of NEA 17 LLC. NEA 17, NEA Partners 17, NEA 17 LLC and the managers of NEA 17 LLC share voting and dispositive power with regard to the securities held by GEO 17. Each of NEA 17, NEA Partners 17 and NEA 17 LLC as well as each of the managers of NEA 17 LLC disclaims beneficial ownership of all shares held by GEO 17 except to the extent of their actual pecuniary interest therein. Beneficial ownership information is based on information known to us and a Schedule&#160;13D/A filed with the SEC on September&#160;7, 2022. GEO 15&#8217;s and GEO 17&#8217;s mailing address is 1954 Greenspring Drive, Suite 600, Timonium, MD 21093-4135. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(3)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 39,219,016 ordinary shares over which FMR LLC, or FMR, has sole voting power and sole dispositive power and over which Abigail P. Johnson has sole dispositive power, all of which are held in the form of ADSs. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series&#160;B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series&#160;B shareholders have entered into a shareholders&#8217; voting agreement under which all Series&#160;B voting common shares will be voted in accordance with the majority vote of Series&#160;B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders&#8217; voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Beneficial ownership information is based on a Schedule&#160;13G filed with the SEC on February&#160;9, 2024. The mailing address of FMR is 245 Summer Street, Boston, Massachusetts 02210. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(4)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 12,667,592 ordinary shares, all of which are held in the form of ADSs. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(5)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 66,584 ordinary shares, all of which are held in the form of ADSs, and 360,000 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(6)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 70,320 ordinary shares, all of which are held in the form of ADSs, and 360,000 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(7)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 844,643 ordinary shares, 844,640 of which are held in the form of ADSs, and 360,000 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(8)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 144,800 ordinary shares, all of which are held in the form of ADSs, and 360,000 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">40</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC2" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tDS1R">&#8203;</a><a id="tCERE">&#8203;</a><a id="tPAPF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(9)</span>
          <br/>
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 73,080 ordinary shares, all of which are held in the form of ADSs, and 360,000 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(10)</span>
          <br/>
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 334,856 ordinary shares, all of which are held in the form of ADSs, and 360,000 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(11)</span>
          <br/>
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 74,440 ordinary shares, all of which are held in the form of ADSs, and 480,384 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(12)</span>
          <br/>
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 384,000 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(13)</span>
          <br/>
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 11,756,576 ordinary shares, all of which are held in the form of ADSs. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(14)</span>
          <br/>
        </div>
        <div style=" margin-top:4.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 1,613,224 ordinary shares, all of which are held in the form of ADSs, and 660,000 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <span style="letter-spacing:0.2pt;">(15)</span>
          <br/>
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <span style="letter-spacing:0.2pt;">Consists of 27,646,115 ordinary shares, 27,646,112 of which are held in the form of ADSs, and 3,684,384 ordinary shares underlying options that are exercisable or that will be exercisable within 60&#160;days of March&#160;1, 2024. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Delinquent Section&#160;16(a) Reports</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Section&#160;16(a) of the Exchange Act requires our directors, officers (as defined under Rule&#160;16a-1(f) under the Exchange Act) and stockholders who beneficially own more than 10% of any class of our equity securities registered pursuant to Section&#160;12 of the Exchange Act (collectively, the &#8220;Reporting Persons&#8221;) to file initial statements of beneficial ownership of securities and statements of changes in beneficial ownership of securities with respect to our equity securities with the SEC. To our knowledge, based solely on our review of the copies of such forms filed with the SEC and upon written representations of the Reporting Persons received by us, we believe that there has been a late Form 4 filing in February&#160;2023 for Claire Poll reporting one late transaction and a late Form 4 filing in February&#160;2023 for Kathleen Rickard reporting one late transaction. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Certain Relationships</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">POLICIES AND PROCEDURES FOR RELATED PERSON TRANSACTIONS </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Our Board of Directors has adopted a written Related Person Transaction Policy, setting forth the policies and procedures for the review and approval or ratification of related person transactions. Under the policy, our finance department is primarily responsible for developing and implementing processes and procedures to obtain information regarding related persons with respect to potential related person transactions and then determining, based on the facts and circumstances, whether such potential related person transactions do, in fact, constitute related person transactions requiring compliance with the policy. If our finance department determines that a transaction or relationship is a related person transaction requiring compliance with the policy, our Chief Financial Officer is required to present to the Audit Committee all relevant facts and circumstances relating to the related person transaction. Our Audit Committee must review the relevant facts and circumstances of each related person transaction, including if the transaction is on terms comparable to those that could be obtained in arm&#8217;s length dealings with an unrelated third party and the extent of the related person&#8217;s interest in the transaction, take into account the conflicts of interest and corporate opportunity provisions of our Code of Business Conduct and Ethics, and either approve or disapprove the related person transaction. If advance Audit Committee approval of a related person transaction requiring the Audit Committee&#8217;s approval is not feasible, then the transaction may be preliminarily entered into by management upon prior approval of the transaction by the chair of the Audit Committee subject to ratification of the transaction by the Audit Committee at the Audit Committee&#8217;s next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will make all reasonable efforts to cancel or annul the transaction. If a transaction was not initially recognized as a related person, then upon such recognition the transaction will be presented to the Audit Committee for ratification at the Audit Committee&#8217;s next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will make all reasonable efforts to cancel or annul the transaction. Our management will update the Audit Committee as to any material changes to any approved or ratified related person </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">41</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC2" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="t2RRA">&#8203;</a><a id="tOAAT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">transaction and will provide a status report at least annually of all then current related person transactions. No director may participate in approval of a related person transaction for which he or she is a related person. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The following are certain transactions, arrangements and relationships with persons who are, or were during the period beginning January&#160;1, 2022, our directors, executive officers or shareholders owning 5% or more of our outstanding ordinary shares, or any member of the immediate family of any of the foregoing persons. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">2016 REGISTRATION RIGHTS AGREEMENT </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In July&#160;2016, we entered into a registration rights agreement (the &#8220;2016 Registration Rights Agreement&#8221;), which provides certain demand registration rights to Abingworth Bioventures VI, LP (&#8220;Abingworth&#8221;), Growth Equity Opportunities Fund&#160;IV, LLC, OrbiMed Private Investments VI, LP (&#8220;OrbiMed&#8221;), and Vivo Ventures Fund&#160;VII, L.P., Vivo Ventures VII Affiliates Fund, L.P., Vivo Ventures Fund&#160;VI, L.P., and Vivo Ventures Fund&#160;VI Affiliates Fund, L.P. (collectively, &#8220;Vivo Capital&#8221;), with respect to the ordinary shares and any ADSs held by them. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Demand Registration Rights</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">At any time prior to the termination of the registration rights (as described below), the holders of at least a majority of the registrable securities as defined in the 2016 Registration Rights Agreement had the right to demand that we effect an underwritten public offering of their registrable securities pursuant to an effective registration statement under the Securities Act. These registration rights were subject to specified conditions and limitations including the right of the underwriters, if any, to limit the number of shares included in any such registration under specified circumstances. Upon such a request, we were required to use commercially reasonable efforts to effect the public offering. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Expenses of Registration</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Under the 2016 Registration Rights Agreement we agreed to pay all expenses relating to any registration under the registration rights agreement, other than selling commission, discounts or brokerage fees and stock transfer taxes, subject to specified conditions and limitations. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Termination of Registration Rights</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">The registration rights granted under the 2016 Registration Rights Agreement were to terminate upon the earlier to occur of (i)&#160;the fifth anniversary of the closing of global offering of ordinary shares offered by us, consisting of ordinary shares in the form of ADSs offered in the U.S. offering and ordinary shares offered in the European private placement, as described in our prospectus filed with the SEC on April&#160;28, 2017, and (ii)&#160;the date on which there are no registrable securities remaining pursuant to the registration rights agreement. The registration rights granted under the 2016 Registration Rights Agreement terminated in April&#160;2022. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">OTHER AGREEMENTS AND TRANSACTIONS </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Indemnification Agreements</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">To the extent permitted by the U.K. Companies Act 2006, we are empowered to indemnify our directors against any liability they incur by reason of their directorship. We have also entered into a deed of indemnity with each of our directors and executive officers. In addition to such indemnification, we provide our directors and executive officers with directors&#8217; and officers&#8217; liability insurance. </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">Agreements with Our Executive Officers and Directors</span><span style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">We have entered into employment agreements with certain of our executive officers and service agreements with our non-executive directors, as well as separation agreements with certain of our former executive officers. See the section in this proxy statement entitled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">Executive and Director Compensation.</span><span style="letter-spacing:0.2pt;">&#8221; </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">42</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC2" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tADIN">&#8203;</a><a id="tSRTC">&#8203;</a><a id="tSPFT">&#8203;</a><a id="tOTMA">&#8203;</a><a id="tSOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <span style="letter-spacing:-0.24pt;">Additional Information</span><span style="font-weight:normal;letter-spacing:0.24pt;"> </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">SHAREHOLDERS&#8217; RIGHTS TO CALL A GENERAL MEETING </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Our shareholders have the right to call a meeting of our shareholders. The U.K. Companies Act 2006 generally requires the directors to call a general meeting once we have received requests to do so from shareholders representing at least 5% of our paid-up shares entitled to vote at a general meeting. The U.K. Companies Act 2006 generally prohibits shareholders of a U.K. public limited company from passing written resolutions. However, significant shareholders would, in any case, still have the power to call a general meeting and propose resolutions. These provisions are mandatory under the U.K. Companies Act 2006 and cannot be waived by our shareholders. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">SHAREHOLDER PROPOSALS FOR THE 2025 ANNUAL GENERAL MEETING </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="font-style:italic;letter-spacing:0.2pt;">Rule&#160;14a-8 Proposals</span><span style="letter-spacing:0.2pt;">&#8201;&#8212;&#8201;Pursuant to Rule&#160;14a-8 under the Exchange Act, shareholders who intend to have a proposal considered for inclusion in our proxy materials for presentation at our 2025 annual general meeting of shareholders must submit the proposal to the Company Secretary, Verona Pharma plc, c/o&#160;Shakespeare Martineau LLP, at 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, Attn: Ben Harber, in writing not later than 120&#160;days before the anniversary of the date on which we sent our proxy materials for the AGM, or November&#160;20, 2024, unless the date of the 2025 annual general meeting of shareholders is changed by more than 30&#160;days from the date of the AGM, and must satisfy the requirements of the proxy rules promulgated by the SEC. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="font-style:italic;letter-spacing:0.2pt;">Other Proposals</span><span style="letter-spacing:0.2pt;">&#8201;&#8212;&#8201;Shareholders intending to include a proposal on the agenda for the 2025 annual general meeting of shareholders, irrespective of whether they intend to have the proposal included in our proxy statement, must comply with the requirements under our Articles of Association and English law. Under Section&#160;338 of the U.K. Companies Act 2006, shareholders representing at least 5% of holders entitled to vote on a resolution at an annual general meeting may require the Company to include such resolution in its notice of an annual general meeting. Provided the applicable thresholds are met, notice of the resolution must be received by the Company Secretary, Verona Pharma plc, c/o&#160;Shakespeare Martineau LLP, at 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, Attn: Ben Harber, at least six weeks prior to the date of the annual general meeting, or, if later, at the time notice of the annual general meeting is delivered to shareholders. Additionally, in accordance with our Articles of Association, shareholders who intend to nominate a director to be elected at the 2025 annual general meeting of shareholders must provide the Company Secretary with written notice of such nomination between 7 and 21&#160;days prior to the date of such meeting, together with written notice signed by the director nominee regarding his or her willingness to be elected. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Proposals and nominations that are not received by the dates specified above, or otherwise do not meet all relevant requirements, will be considered untimely or improper, as applicable. You may contact Ben Harber, Company Secretary, c/o&#160;Shakespeare Martineau LLP, 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, for a copy of the relevant provisions of our Articles of Association regarding the requirements for making shareholder proposals. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">In addition to satisfying the foregoing requirements under our Articles of Association, to comply with the universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s nominees must provide notice that sets forth the information required by Rule&#160;14a-19 under the Exchange Act no later than February&#160;25, 2025. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We reserve the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with these or other applicable requirements. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">OTHER MATTERS </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">No business shall be voted on at the AGM, except such items as included in the agenda for the AGM. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">SOLICITATION OF PROXIES </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The accompanying proxy is solicited by and on behalf of our Board of Directors, whose Notice of AGM is attached to this proxy statement, and the entire cost of such solicitation will be borne by us. We </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">43</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC2" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tHOU">&#8203;</a><a id="tVPAR">&#8203;</a><a id="tUSAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">have retained Mackenzie Partners, Inc. to assist in the distribution of proxy materials and the solicitation of proxies from brokerage firms, fiduciaries, custodians, and other similar organizations representing beneficial owners of shares for the AGM. We have agreed to pay Mackenzie Partners, Inc. a fee of approximately $16,500 plus out-of-pocket expenses. You may contact Mackenzie Partners, Inc. at +1-212-929-5500. In addition to the use of mail, proxies may be solicited by personal interview, telephone, e-mail and facsimile by our directors, officers and other employees who will not be specially compensated for these services. We will also request that brokers, nominees, custodians and other fiduciaries forward soliciting materials to the beneficial owners of shares held by such brokers, nominees, custodians and other fiduciaries. We will reimburse such persons for their reasonable expenses in connection therewith. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Certain information contained in this proxy statement relating to the occupations and security holdings of our directors and officers is based upon information received from the individual directors and officers. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">We intend to file a Proxy Statement and WHITE proxy card with the SEC in connection with the solicitation of proxies for our 2025 annual general meeting of shareholders. Shareholders may obtain our Proxy Statement (and any amendments and supplements thereto) and other documents as and when filed by us with the SEC without charge from the SEC&#8217;s website at: </span><span style="font-style:italic;letter-spacing:0.2pt;">www.sec.gov</span><span style="letter-spacing:0.2pt;">. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">HOUSEHOLDING </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">The SEC&#8217;s rules permit us to deliver a single set of proxy materials to one address shared by two or more of our ADS holders. This delivery method is referred to as &#8220;householding&#8221; and can result in significant cost savings. To take advantage of this opportunity, we have delivered only one set of proxy materials to multiple ADS holders who share an address, unless we received contrary instructions from the impacted ADS holders prior to the mailing date. We agree to deliver promptly, upon written or oral request, a separate copy of the proxy materials, as requested, to any ADS holder at the shared address to which a single copy of those documents was delivered. If you are an ADS holder and your household received a single set of proxy materials this year, but you would prefer to receive your own copy, or if you currently share an address with another ADS holder and wish to receive only one copy of proxy materials either now or in future for your household, please contact your bank or broker. If you have requested to be removed from the householding program, you will be removed within 30&#160;days of receipt of your instructions at which time you will then be sent separate copies of the documents. If you hold ADSs and you prefer to receive separate copies of proxy materials either now or in the future, please contact the Depositary, your brokerage firm or bank, as applicable. </span>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">VERONA PHARMA&#8217;S ANNUAL REPORT ON FORM 10-K </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">A copy of Verona Pharma&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023, including financial statements and schedules thereto but not including exhibits, as filed with the SEC, will be sent to any shareholder of record as of the close of business on March&#160;13, 2024 without charge upon written request addressed to: </span>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Verona Pharma plc <br/>Attention: General Counsel <br/>Email: legal@veronapharma.com  <br/>3 More London Riverside <br/>London SE1 2RE <br/>United Kingdom </span></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">A reasonable fee will be charged for copies of exhibits. You also may access our Annual Report on Form 10-K for the year ended December&#160;31, 2023 at </span><span style="font-style:italic;letter-spacing:0.2pt;">www.veronapharma.com/investors</span><span style="letter-spacing:0.2pt;">. </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">U.K. STATUTORY ANNUAL ACCOUNTS AND REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS OF VERONA PHARMA PLC FOR THE YEAR ENDED DECEMBER 31, 2023 </span>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Consistent with its obligations under the U.K. Companies Act 2006, our Board of Directors will present at the AGM our 2023 U.K. Annual Report. Accordingly, our Board of Directors will lay before the Company at the AGM the Company&#8217;s 2023 U.K. Annual Report, which has been approved by and, where appropriate, signed on behalf of our Board of Directors and will be delivered to the Registrar of Companies </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">44</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC2" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:328pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">in the United Kingdom following the AGM. A copy of our U.K. statutory directors&#8217; remuneration report, including the annual report on remuneration, is included within Annex A to this proxy statement. A complete copy of our 2023 U.K. Annual Report will be sent separately to those shareholders who have opted in to receive a printed copy of the document no less than 21&#160;days prior to the AGM. You will be provided an opportunity to raise questions in relation to such accounts and reports at the AGM via teleconference. Full accounts and reports will be available on the Company&#8217;s website prior to and during the AGM. </span>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">EACH SHAREHOLDER IS URGED TO VOTE YOUR SHARES AS DESCRIBED IN THIS PROXY
          <br/>
          STATEMENT. PROMPTLY VOTING YOUR SHARES WILL ENSURE THE PRESENCE OF A
          <br/>
          QUORUM AT THE ANNUAL GENERAL MEETING OF SHAREHOLDERS AND WILL SAVE US
          <br/>
          THE EXPENSE OF FURTHER SOLICITATION.</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">EACH ADS HOLDER IS URGED TO COMPLETE, DATE, SIGN AND PROMPTLY RETURN ADS
          <br/>
          VOTING INSTRUCTIONS TO CITIBANK, N.A., THE DEPOSITARY FOR THE ADSs.</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:24pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">By Order of the Board of Directors </span>
        </div>
        <div style="margin-top:24pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">David Zaccardelli, Pharm.D. <br/>President and Chief Executive Officer </span></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">London, United Kingdom </span>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">March [&#8199;&#8199;], 2024</span>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">45</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC2" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a><a id="tAATP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:590pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:-0.2pt;">Annex A to Proxy Statement: U.K. Statutory Annual Accounts and Directors&#8217; Report for the year ended December&#160;31, 2023</span>
        </div>
        <div style="margin-top:2.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">A-1</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC2" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:45.66pt;width:504pt;">
        <div style="text-align:center; width:504pt; line-height:12.5pt;font-weight:bold;font-size:10pt;">
          <span style="letter-spacing:-0.2pt;">VERONA PHARMA PLC
          <br/>
          FORM OF PROXY</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <table style="width:504pt;margin-top:5pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.25pt 0pt; width:19.98pt;">
              <span style="letter-spacing:0.2pt;">I/We</span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.25pt 0pt; width:478.02pt;">
              <span style="letter-spacing:0.2pt;">&#160;&#160;&#160;</span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:504pt;margin-top:3pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.25pt 0pt; width:8.85pt;">
              <span style="letter-spacing:0.2pt;">of</span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.25pt 0pt; width:489.15pt;">
              <span style="letter-spacing:0.2pt;">&#160;&#160;&#160;</span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:504pt;margin-top:3pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.25pt 0pt; width:207.7pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.2pt;">being a member of the Company, hereby appoint </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.25pt 0pt; width:290.3pt;">
              <span style="letter-spacing:0.2pt;">&#160;&#160;&#160;</span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:14.19pt; width:504pt; line-height:12.5pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">or failing him/her, the Chairperson of the Meeting, as my/our proxy to attend, speak and vote for me/us on my/our behalf at the 2024 Annual General Meeting (the &#8220;AGM&#8221;) of the Company to be held at 11:00&#160;a.m. (British Summer Time) on April&#160;26, 2024 and at any adjournment thereof. </span>
        </div>
        <div style="margin-top:8pt; width:504pt; line-height:12.5pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">I/We direct my/our vote as indicated below in respect of the resolutions which are referred to in the Notice convening the AGM (see note 1 below). </span>
        </div>
        <table style="width:504pt;margin-bottom:5.02999999999997pt;margin-top:10pt;border-collapse: collapse;border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
          <tr style="line-height:9.9pt;min-height:13.42pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.265pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:153.13pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.198pt;">Ordinary Resolutions </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:21.74pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.198pt;">FOR </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:45.88pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.198pt;">AGAINST </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:57.83pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.198pt;">WITHHELD </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:64.93pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.198pt;">DISCRETION </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.5pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:24.78pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:60.75pt;">
              <span style="letter-spacing:0.198pt;">Resolution 1 </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <div style="line-height:11.86pt;">
                <span style="letter-spacing:0.198pt;">To re-elect Lisa Deschamps as a director of the Company. </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:24.78pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:60.75pt;">
              <span style="letter-spacing:0.198pt;">Resolution 2 </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <div style="line-height:11.86pt;">
                <span style="letter-spacing:0.198pt;">To re-elect Martin Edwards as a director of the Company. </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:24.78pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:60.75pt;">
              <span style="letter-spacing:0.198pt;">Resolution 3 </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To re-elect Sven Anders Ullman as a director of the Company. </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:24.78pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:60.75pt;">
              <span style="letter-spacing:0.198pt;">Resolution 4 </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <div style="line-height:11.86pt;">
                <span style="letter-spacing:0.198pt;">To re-elect Christina Ackermann as a director of the Company. </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:24.78pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:60.75pt;">
              <span style="letter-spacing:0.198pt;">Resolution 5 </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To re-elect Michael Austwick as a director of the Company. </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:48.51pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.207pt 0pt 0.343pt 0pt; width:60.75pt;">
              <span style="letter-spacing:0.198pt;">Resolution 6 </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.207pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To receive and adopt the U.K. statutory annual accounts and Directors&#8217; report for the year ended 31 December&#160;2023. </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:60.38pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.207pt 0pt 0.343pt 0pt; width:60.75pt;">
              <span style="letter-spacing:0.198pt;">Resolution 7 </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.207pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors&#8217; Remuneration Report for the year ended 31 December&#160;2023. </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:24.78pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:60.75pt;">
              <span style="letter-spacing:0.198pt;">Resolution 8 </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To receive and approve the U.K. Directors&#8217; Remuneration Policy.</span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:95.97pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.207pt 0pt 0.343pt 0pt; width:60.75pt;">
              <span style="letter-spacing:0.198pt;">Resolution 9 </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.207pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To approve an increase in the maximum aggregate level of Non-Executive Director annual remuneration (by way of fee) in accordance with Article&#160;21.4 of the Company&#8217;s Articles of Association to &#163;750,000 per annum on an ongoing basis.</span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:60.38pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:60.75pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.198pt;">Resolution 10 </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To appoint Ernst &amp; Young LLP as the Company&#8217;s auditors, to hold office until the conclusion of the next annual general meeting of shareholders. </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:53.51pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:60.75pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.198pt;">Resolution 11 </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.197pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To authorize the Audit and Risk Committee to determine the auditors&#8217; remuneration for the year ending December&#160;31, 2024. </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC2" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:45.66pt;width:504pt;">
        <table style="width:504pt;margin-top:0pt;border-collapse: collapse;border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
          <tr style="line-height:9.9pt;min-height:13.42pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.265pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:153.13pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:-0.198pt;">Ordinary Resolutions </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:21.74pt;">
              <div style="white-space:nowrap; text-align:justify;">
                <span style="letter-spacing:-0.198pt;">FOR </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:45.88pt;">
              <div style="white-space:nowrap; text-align:justify;">
                <span style="letter-spacing:-0.198pt;">AGAINST </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:57.83pt;">
              <div style="white-space:nowrap; text-align:justify;">
                <span style="letter-spacing:-0.198pt;">WITHHELD </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.265pt 0pt; width:64.93pt;">
              <div style="white-space:nowrap; text-align:justify;">
                <span style="letter-spacing:-0.198pt;">DISCRETION </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.5pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:48.51pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:60.75pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.198pt;">Resolution 12 </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To approve, on an advisory (non-binding) basis, the compensation of the Company&#8217;s named executive officers. </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:179.01pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:60.75pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.198pt;">Resolution 13 </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of &#163;8,345,745 (being up to a maximum of [&#8199;&#8199;&#8199;&#8199;] shares representing [&#8199;&#8199;&#8199;&#8199;]% of the Company&#8217;s existing ordinary share capital as at the close of business on March [&#8199;&#8199;], 2024 (being the latest practicable date prior to publication of this document)). </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.9pt;min-height:12.92pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.265pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.5pt 0pt 1.265pt 0pt; width:153.13pt;">
              <span style="letter-spacing:-0.198pt;">Special Resolutions</span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.5pt 0pt 1.265pt 0pt; width:21.74pt;">
              <div style="text-align:justify;">
                <span style="letter-spacing:-0.198pt;">FOR</span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.5pt 0pt 1.265pt 0pt; width:45.88pt;">
              <div style="text-align:justify;">
                <span style="letter-spacing:-0.198pt;">AGAINST</span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.5pt 0pt 1.265pt 0pt; width:57.83pt;">
              <div style="text-align:justify;">
                <span style="letter-spacing:-0.198pt;">WITHHELD</span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.5pt 0pt 1.265pt 0pt; width:64.93pt;">
              <div style="text-align:justify;">
                <span style="letter-spacing:-0.198pt;">DISCRETION</span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 1.265pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.87pt;min-height:89.1pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.9pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 0.343pt 0pt; width:60.75pt;">
              <div style="white-space:nowrap;">
                <span style="letter-spacing:0.198pt;">Resolution 14 </span>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.187pt 0pt 1.265pt 0pt; width:153.13pt;white-space:normal;">
              <span style="letter-spacing:0.198pt;">To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if Section 561(1) of the Companies Act does not apply to any such allotment. </span>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.265pt 0pt; width:21.74pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.265pt 0pt; width:45.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.265pt 0pt; width:57.83pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.265pt 0pt; width:64.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:2.75pt;">&#8203;</td>
            <td style="background:#000000;border-bottom:1px solid #000000;padding:0pt 0pt 0.343pt 0pt; width:60.75pt;">&#8203;</td>
            <td style="padding:0pt;background:#000000;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.65pt; width:504pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">Date </span><span style="vertical-align:2pt;border-bottom:1pt #000 solid;letter-spacing:118pt;margin-left:0pt;">&#160;</span><span style="letter-spacing:0.2pt;">, 2024 </span>
        </div>
        <div style="margin-top:8pt; width:504pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">Signature</span><span style="vertical-align:2pt;border-bottom:1pt #000 solid;letter-spacing:142pt;margin-left:0pt;">&#160;</span><span style="letter-spacing:0.2pt;"> </span>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:6.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#9744;</span>
          <br/>
        </div>
        <div style=" margin-top:6.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <!--blacklining:none;-->
          <span style="font-weight:bold;letter-spacing:-0.2pt;">Please tick here if you are appointing more than one proxy</span><span style="letter-spacing:0.2pt;">. </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:504pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <span style="letter-spacing:-0.2pt;">Notes:</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:12pt; width:504pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <span style="letter-spacing:-0.2pt;">(1) Resolutions and voting</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:11.5pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">The proposed resolutions will be put to vote on a poll. This results in a more accurate reflection of the views of Shareholders ensuring that votes by proxy will be fully-counted. On a poll, each Shareholder has one vote for every share held. The Board of Directors recommends you vote FOR each the above proposed resolutions. </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:11.5pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">Resolutions 1 to 13 are proposed as ordinary resolutions. On a poll, an ordinary resolution is passed if it is approved by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the resolution. Resolution 14 is proposed as a special resolution. On a poll, a special resolution is passed if it is approved by holders representing not less than 75% of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the resolution. </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:11.5pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">If you select &#8220;Discretion&#8221; or if no voting indication is given, this proxy will be voted in accordance with the Board of Directors&#8217; recommendations. The vote &#8220;Withheld&#8221; option is to enable you to abstain on any particular resolution. A vote withheld is not a vote in law, which means that the vote will not be counted in the calculation of votes for or against the resolution. The proxy may vote or abstain from voting as he/she thinks fit with respect to any other resolution that is put to the meeting. </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:11.5pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">The results of the voting and any other information required by the U.K. Companies Act 2006 will be made available on our website (https://www.veronapharma.com) as soon as reasonably practicable following the AGM and for the required period thereafter. </span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
    </div><div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a href="#TOC2" style="text-decoration:none;color:#003366;">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:45.66pt;width:504pt;">
        <div style="width:504pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(2) Appointment of proxies</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Generally, members are entitled to appoint a proxy to exercise all or any of their rights to attend and to speak and vote on their behalf at the AGM. A proxy need not be a Shareholder of the Company. A Shareholder may appoint more than one proxy in relation to the AGM provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that Shareholder. </span><span style="font-weight:bold;letter-spacing:-0.2pt;">To be valid, the form of proxy and the power of attorney or other authority (if any) under which it is signed or a certified copy of such power or authority must be lodged at the office of the Company Secretary, Verona Pharma plc, c/o&#160;Shakespeare Martineau LLP, 6th Floor, 60 Gracechurch Street, London EC3V 0HR BY HAND or BY POST, or BY EMAIL to ben.harber@shma.co.uk, so as to be received not less than 48 hours before the time fixed for the holding of the AGM or any adjournment thereof (as the case may be), excluding any part of a day which is not a working day.</span><span style="letter-spacing:0.2pt;"> The attached proxy statement explains proxy voting and the matters to be voted on in more detail. Please read the proxy statement carefully. For specific information regarding the voting of your ordinary shares, please refer to the proxy statement under the section entitled &#8220;</span><span style="font-style:italic;letter-spacing:0.2pt;">Questions and Answers About the Annual General Meeting</span><span style="letter-spacing:0.2pt;">.&#8221; </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In the case of a member that is a corporation, the form of proxy must be executed under its common seal or executed on its behalf by a duly authorized officer or attorney for the company. Any corporation that is a member may also appoint one or more representatives who may exercise on its behalf all of its powers as a member provided they do not do so in relation to the same shares. </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">To change your proxy instructions, simply submit a new form of proxy as set out above. Note that the cut-off times for receipt of proxy appointments (see above) also apply in relation to amended instructions; any amended proxy instructions received after the relevant cut-off time will be disregarded. Please contact the Company Secretary (as noted above) to obtain a new form of proxy. If you submit more than one valid proxy appointment, the appointment validly received last before the latest time for receipt of forms of proxy will take precedence. If the Company is unable to determine which form of proxy was last validly received, none of them shall be treated as valid in respect of that Ordinary Share. </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">Further, the appointment under the form of proxy may be terminated by the member prior to the commencement of the AGM (or any adjournment of the AGM). To be valid, the notice of termination of the authority of the person appointed to act as proxy must be deposited at the offices of the Company Secretary, Verona Pharma plc, 6th Floor, 60 Gracechurch Street, London EC3V 0HR, no less than 48 hours (excluding non-working days) before the time fixed for the holding of the AGM or any adjournment thereof (as the case may be). </span>
        </div>
        <div style="margin-top:12pt; width:504pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(3) Appointment of proxy by joint members</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">In the case of joint holders, where more than one of the joint holders purports to appoint a proxy, only the appointment submitted by the most senior holder will be accepted. Seniority is determined by the order in which the names of the joint holders appear in the Company&#8217;s register of members in respect of the joint holding (the first-named being the most senior). </span>
        </div>
        <div style="margin-top:12pt; width:504pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">(4) Issued shares and total voting rights</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-left:15pt; margin-top:8pt; width:489pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">As at the close of business on March [&#8199;&#8199;], 2024 (being the latest practicable date prior to publication of this document), the Company&#8217;s issued ordinary share capital comprised [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] voting ordinary shares. Each voting ordinary share carries the right to one vote at the AGM and therefore the total number of voting rights at the close of business on March [&#8199;&#8199;], 2024 is [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]. </span>
        </div>
        <div style="margin-top:8pt; width:504pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">This proxy is solicited on behalf of the Board of Directors. The shares represented by this proxy, when properly executed, will be voted in accordance with the specifications indicated herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#8217; recommendations.</span><span style="font-weight:normal;letter-spacing:0.2pt;"> </span>
        </div>
        <div style="margin-top:8pt; width:504pt; line-height:12pt;font-weight:bold;">
          <span style="letter-spacing:-0.2pt;">In accordance with the terms of the deposit agreement by and among the Company, Citibank, N.A. as depositary and holders and beneficial owners of American Depositary Shares (&#8220;ADSs&#8221;) issued thereunder&#160;dated&#160;as of May&#160;2, 2017, holders of ADSs who do not provide the depositary bank with voting instructions on or before the record date for ADS holders will be deemed to have instructed the depositary bank&#160;to&#160;give a discretionary proxy to a person designated by the Company to vote the underlying ordinary shares at the AGM.</span>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <span style="letter-spacing:0.2pt;">&#160;</span>
          <br/>
        </div>
      </div>
      <hr/>
    </div><div>
  </div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentType">PRE 14A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-8513">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-8514">0001657312</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="vrna-20231231.xsd" xlink:type="simple"/></ix:references>
<ix:resources><xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tC7CvZHOJjSUEJbYlSz0QmT1AzchKAjg5AqVJioVI5DWHjMtLc8/Lz1ZC6/9broWCWL+jhcsr1kG2iThsfox7JjEURhfs/S9weoNxZuhp/lgOYfu90TWqtVYxrHNKOojSUffVm+FHyl+OhBZ5nv/zxa48xhzCiWoA46yu7GH9S9+MFyhKNsPNsDAgPYmzl75XLcH6Q7VQmfZgEvHmqhMTZdLyy0aDJXI=] CSR-->
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:NetAdjustmentsForEquityAwardsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001657312</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:NetAdjustmentsForEquityAwardsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>vrna-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 08 18:42:48 UTC 2024 -->
<xs:schema elementFormDefault="qualified" targetNamespace="http://www.veronapharma.com/20231231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:vrna="http://www.veronapharma.com/20231231">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="vrna-20231231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="vrna-20231231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="vrna-20231231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tC7CvZHOJjSUEJbYlSz0QmT1AzchKAjg5AqVJioVI5DWHjMtLc8/Lz1ZC6/9broWCWL+jhcsr1kG2iThsfox7JjEURhfs/S9weoNxZuhp/lgOYfu90TWqtVYxrHNKOojSUffVm+FHyl+OhBZ5nv/zxa48xhzCiWoA46yu7GH9S9+MFyhKNsPNsDAgPYmzl75XLcH6Q7VQmVLN/ogMwcGyeOQlRbbusFc=] CSR-->
  <xs:element name="AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember"/>
  <xs:element name="ChangeInPensionValueAndEquityAwardValueMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_ChangeInPensionValueAndEquityAwardValueMember"/>
  <xs:element name="ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember"/>
  <xs:element name="EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember"/>
  <xs:element name="EquityAwardsAdjustmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_EquityAwardsAdjustmentsMember"/>
  <xs:element name="EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember"/>
  <xs:element name="EquityAwardsValueInCompensationTableForTheApplicableYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember"/>
  <xs:element name="NetAdjustmentsForEquityAwardsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_NetAdjustmentsForEquityAwardsMember"/>
  <xs:element name="NetAdjustmentsForPensionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_NetAdjustmentsForPensionMember"/>
  <xs:element name="PensionAdjustmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_PensionAdjustmentsMember"/>
  <xs:element name="PensionAdjustmentsPriorServiceCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_PensionAdjustmentsPriorServiceCostMember"/>
  <xs:element name="PensionAdjustmentsServiceCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_PensionAdjustmentsServiceCostMember"/>
  <xs:element name="PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember"/>
  <xs:element name="PensionValueInCompensationTableForTheApplicableYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vrna_PensionValueInCompensationTableForTheApplicableYearMember"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>vrna-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 08 18:42:48 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
    <loc xlink:type="locator" xlink:label="ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <loc xlink:type="locator" xlink:label="vrna_NetAdjustmentsForEquityAwardsMember" xlink:href="vrna-20231231.xsd#vrna_NetAdjustmentsForEquityAwardsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="vrna_NetAdjustmentsForEquityAwardsMember" order="1" xbrldt:closed="true"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tC7CvZHOJjSUEJbYlSz0QmT1AzchKAjg5AqVJioVI5DWHjMtLc8/Lz1ZC6/9broWCWL+jhcsr1kG2iThsfox7JjEURhfs/S9weoNxZuhp/lgOYfu90TWqtVYxrHNKOojSUffVm+FHyl+OhBZ5nv/zxa48xhzCiWoA46yu7GH9S9+MFyhKNsPNsDAgPYmzl75XLcH6Q7VQmSaHVOC3Q3LnDuyRiAUVIlc=] CSR-->
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vrna_NetAdjustmentsForEquityAwardsMember" xlink:to="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vrna_NetAdjustmentsForEquityAwardsMember" xlink:to="vrna_EquityAwardsAdjustmentsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vrna_EquityAwardsAdjustmentsMember" xlink:to="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vrna_EquityAwardsAdjustmentsMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vrna_EquityAwardsAdjustmentsMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" order="1" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>vrna-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 08 18:42:48 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="vrna_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember" xlink:href="vrna-20231231.xsd#vrna_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember_lbl" xml:lang="en-US">Average Fair Value At Last Day Of Prior Year Of Equity Awards Forfeited During Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember" xlink:to="vrna_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember_lbl0" xml:lang="en-US">This member represent average fair value at last day of prior year of equity awards forfeited during year member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember" xlink:to="vrna_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_ChangeInPensionValueAndEquityAwardValueMember" xlink:href="vrna-20231231.xsd#vrna_ChangeInPensionValueAndEquityAwardValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_ChangeInPensionValueAndEquityAwardValueMember_lbl" xml:lang="en-US">Change In Pension Value and Equity Award Value [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_ChangeInPensionValueAndEquityAwardValueMember" xlink:to="vrna_ChangeInPensionValueAndEquityAwardValueMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_ChangeInPensionValueAndEquityAwardValueMember_lbl0" xml:lang="en-US">This member presents the total compensation adjustment for change in pension value and equity award value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_ChangeInPensionValueAndEquityAwardValueMember" xlink:to="vrna_ChangeInPensionValueAndEquityAwardValueMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember" xlink:href="vrna-20231231.xsd#vrna_ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember_lbl" xml:lang="en-US">Changes based on Incremental Fair Value of Awards Modified during Applicable Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember" xlink:to="vrna_ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember_lbl0" xml:lang="en-US">This member stands for changes based on incremental fair value of awards modified during applicable year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember" xlink:to="vrna_ChangesBasedOnIncrementalFairValueOfAwardsModifiedDuringApplicableYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl" xml:lang="en-US">Adjustments For Equity Awards Failed To Meet Performance Conditions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" xlink:to="vrna_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on adjustments for equity awards that failed to meet performance conditions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" xlink:to="vrna_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Current Year Awards Vested During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of current  year awards vested during current year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of prior year awards vested during current year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Awards Vested During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of awards vested during current year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl" xml:lang="en-US">Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:to="vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl" xml:lang="en-US">Dividends Or Other Earnings Paid On Equity Awards Not Otherwise Reflected In Fair Value [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" xlink:to="vrna_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on dividends or other earnings paid on equity awards not otherwise reflected in fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" xlink:to="vrna_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl0"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tC7CvZHOJjSUEJbYlSz0QmT1AzchKAjg5AqVJioVI5DWHjMtLc8/Lz1ZC6/9broWCWL+jhcsr1kG2iThsfox7JjEURhfs/S9weoNxZuhp/lgOYfu90TWqtVYxrHNKOojSUffVm+FHyl+OhBZ5nv/zxa48xhzCiWoA46yu7GH9S9+MFyhKNsPNsDAgPYmzl75XLcH6Q7VQmf2rBoOkUIBk+h+0bxmiU7I=] CSR-->
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_EquityAwardsAdjustmentsMember_lbl" xml:lang="en-US">Total Equity Awards Adjustments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsMember" xlink:to="vrna_EquityAwardsAdjustmentsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_EquityAwardsAdjustmentsMember_lbl0" xml:lang="en-US">This member presents the total equity awards adjustments, which may be comprised of adjustments for (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal to the change in value as of the vesting date (from the end of the prior fiscal year); (iv) adjustments for equity awards that failed to meet performance conditions; and (v) dividends or other earnings paid on equity awards not otherwise reflected in fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsMember" xlink:to="vrna_EquityAwardsAdjustmentsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl" xml:lang="en-US">Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:to="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:to="vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl" xml:lang="en-US">Equity Awards Value In Summary Compensation Table (Grant Date Value) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl0" xml:lang="en-US">This member presents the adjustment (deduction) for equity awards value from summary compensation table.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_NetAdjustmentsForEquityAwardsMember" xlink:href="vrna-20231231.xsd#vrna_NetAdjustmentsForEquityAwardsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_NetAdjustmentsForEquityAwardsMember_lbl" xml:lang="en-US">Total Net Adjustments For Equity Awards [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_NetAdjustmentsForEquityAwardsMember" xlink:to="vrna_NetAdjustmentsForEquityAwardsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_NetAdjustmentsForEquityAwardsMember_lbl0" xml:lang="en-US">This member presents the net compensation adjustment for equity awards, which is comprised of equity awards value from summary compensation table, net of total equity awards adjustments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_NetAdjustmentsForEquityAwardsMember" xlink:to="vrna_NetAdjustmentsForEquityAwardsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_NetAdjustmentsForPensionMember" xlink:href="vrna-20231231.xsd#vrna_NetAdjustmentsForPensionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_NetAdjustmentsForPensionMember_lbl" xml:lang="en-US">Total Net Adjustments For Pension [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_NetAdjustmentsForPensionMember" xlink:to="vrna_NetAdjustmentsForPensionMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_NetAdjustmentsForPensionMember_lbl0" xml:lang="en-US">This member presents the net compensation adjustment for pension, which is comprised of pension value from summary compensation table, net of total pension adjustments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_NetAdjustmentsForPensionMember" xlink:to="vrna_NetAdjustmentsForPensionMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_PensionAdjustmentsMember" xlink:href="vrna-20231231.xsd#vrna_PensionAdjustmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_PensionAdjustmentsMember_lbl" xml:lang="en-US">Total Pension Adjustments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionAdjustmentsMember" xlink:to="vrna_PensionAdjustmentsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_PensionAdjustmentsMember_lbl0" xml:lang="en-US">This member presents the total pension adjustments, which may be comprised of adjustments for service cost and prior service cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionAdjustmentsMember" xlink:to="vrna_PensionAdjustmentsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_PensionAdjustmentsPriorServiceCostMember" xlink:href="vrna-20231231.xsd#vrna_PensionAdjustmentsPriorServiceCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_PensionAdjustmentsPriorServiceCostMember_lbl" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionAdjustmentsPriorServiceCostMember" xlink:to="vrna_PensionAdjustmentsPriorServiceCostMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_PensionAdjustmentsPriorServiceCostMember_lbl0" xml:lang="en-US">This member presents the total pension adjustments, prior service cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionAdjustmentsPriorServiceCostMember" xlink:to="vrna_PensionAdjustmentsPriorServiceCostMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_PensionAdjustmentsServiceCostMember" xlink:href="vrna-20231231.xsd#vrna_PensionAdjustmentsServiceCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_PensionAdjustmentsServiceCostMember_lbl" xml:lang="en-US">Pension Adjustments Service Cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionAdjustmentsServiceCostMember" xlink:to="vrna_PensionAdjustmentsServiceCostMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_PensionAdjustmentsServiceCostMember_lbl0" xml:lang="en-US">This member presents the pension adjustments, service cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionAdjustmentsServiceCostMember" xlink:to="vrna_PensionAdjustmentsServiceCostMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="vrna-20231231.xsd#vrna_PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl" xml:lang="en-US">Pension Value And Equity Awards Value In Compensation Table For The Applicable Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="vrna_PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl0" xml:lang="en-US">This member presents the total compensation adjustment for pension value and equity awards value in compensation table for the applicable year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="vrna_PensionValueAndEquityAwardsValueInCompensationTableForTheApplicableYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vrna_PensionValueInCompensationTableForTheApplicableYearMember" xlink:href="vrna-20231231.xsd#vrna_PensionValueInCompensationTableForTheApplicableYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vrna_PensionValueInCompensationTableForTheApplicableYearMember_lbl" xml:lang="en-US">Pension Adjustments Pension Value In Summary Compensation Table [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionValueInCompensationTableForTheApplicableYearMember" xlink:to="vrna_PensionValueInCompensationTableForTheApplicableYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vrna_PensionValueInCompensationTableForTheApplicableYearMember_lbl0" xml:lang="en-US">This member presents the adjustment (deduction) for pension value from summary compensation table.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vrna_PensionValueInCompensationTableForTheApplicableYearMember" xlink:to="vrna_PensionValueInCompensationTableForTheApplicableYearMember_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>vrna-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 08 18:42:48 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure"/>
  <presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure">
    <loc xlink:type="locator" xlink:label="ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <loc xlink:type="locator" xlink:label="NetAdjustmentsForEquityAwardsMember" xlink:href="vrna-20231231.xsd#vrna_NetAdjustmentsForEquityAwardsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="NetAdjustmentsForEquityAwardsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EquityAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="EquityAwardsValueInCompensationTableForTheApplicableYearMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tC7CvZHOJjSUEJbYlSz0QmT1AzchKAjg5AqVJioVI5DWHjMtLc8/Lz1ZC6/9broWCWL+jhcsr1kG2iThsfox7JjEURhfs/S9weoNxZuhp/lgOYfu90TWqtVYxrHNKOojSUffVm+FHyl+OhBZ5nv/zxa48xhzCiWoA46yu7GH9S9+MFyhKNsPNsDAgPYmzl75XLcH6Q7VQmT6pdh7zGIXkU9OXr0t647o=] CSR-->
    <loc xlink:type="locator" xlink:label="EquityAwardsAdjustmentsMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="EquityAwardsAdjustmentsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:href="vrna-20231231.xsd#vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>bc_netincome-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_netincome-4c.jpg
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M Q$!_\0 T  !  (" P$!              8'! 4" P@!"0$!  (# 0$
M          $% P0&!P(0  $$ 0(# @4-"@P% P($!P$  @,$!1$&(1(',1-!
M(I(45%'1,I.STY15%E87-PAA<>$C4[05-75V@9&A0E)BTG.C=#88HC-#PR3!
M<C2Q)8)C@T25\++4)CA($0$  0,! P8+!P,$ P$! 0   1$" P0A,1)!46%Q
M$P6!D:&Q(C)2,Q0T!O#!T4)R4Q7ADK)B@B,6\:)#PB2#_]H # ,!  (1 Q$
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M ]%?F/C/)E]\0/H!Z*_,?&>3+[X@?0#T5^8^,\F7WQ ^@'HK\Q\9Y,OOB!]
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M$! 0$! ]7P #4D\  .TDGL""(?2MTO\ TC)B1O+#NR$+@R:)MR-S8WDZ!KY
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M=O ^%"-Z3]'L_P!'=_V-KY+";2L6>H.)9%^E9+,5[DPLD+/QLAM67.B+2_\
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M$! 05SUF_4^TOWTVS^?M0.@/U*['_9C?=9$%C(" @(" @(" @(" @(" @("
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M7'U2@&1Y;R%QY!V-\"#ZR1[->1Q;KVZ<$#O'\_/S'G]7PH/A<7  \&CV+0
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M$! 0$! 0$! 0$! 0$! 0$%<]9OU/M+]]-L_G[4#H#]2NQ_V8WW61!8R @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(-5N/<V!VCBI,YN2ZS'XF)S(Y+4@<YH?(>5HT8''B?N+XOR6V166?!I\F>_
M@QQ64+_W ]&OG=5]KL>]+7^+Q<_DG\%E_"ZS]N?)^)_N!Z-?.ZK[78]Z3XO%
MS^2?P/X76?MSY/Q/]P/1KYW5?:['O2?%XN?R3^!_"ZS]N?)^)_N!Z-?.ZK[7
M8]Z3XO%S^2?P/X76?MSY/Q/]P/1KYW5?:['O2?%XN?R3^!_"ZS]N?)^)_N!Z
M-?.ZK[78]Z3XO%S^2?P/X76?MSY/Q;#!=9.F.YLM6P6"W'7NY:X7-K58V3!S
MW-:7D NC [&D\2OJW4X[II$^26'-W7JL5DWWV3%L=7XIRME6" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @KGK-^I]I?OIMG\_:@= ?J5V/^S&^ZR(+&0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!3/VIOJ;R
MG^;H^[A:6L]WX72?3GSMO5=YG@54;UH0$! 0$%H?9U^NC:?]_/\ FLRV-/[R
M%%W[\EDZH_RA^B"Z%X\(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""N>LWZGVE^^FV?S]J!T
M!^I78_[,;[K(@L9 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M" @(" @KGK-^I]I?OIMG\_:@= ?J5V/^S&^ZR(+&0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!3/VIOJ;RG^;H
M^[A:6L]WX72?3GSMO5=YG@54;UH0$! 0$%H?9U^NC:?]_/\ FLRV-/[R%%W[
M\EDZH_RA^B"Z%X\(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @XR.+(W/:TO<T$A@[20.S^%1,TA-L5FBBMWW</EKL>]]EV#4WHVE6?
MC8J@ LV;<E@L=4MU@ Z3Q1RNYP.0#4G0+F,^6R^_M,<TNI%*;ZUVQ,<NS[3#
MU'NO%FP63I-7'%I^.[BF[U;;8MK&2R_=&W;%/6W;TQV^R>MU@W2+@#9<AB<9
M:JMUU!BA,D,G+]P/[598:QJKZ[YMB?-'G<[K9MO[FT_!NLRY;9ZYI='D?.IE
MFO%G]A"65K#'FVRR!Q Y8_-Y6<SO4;S$#4J-??;%^.L_F3W!CNNT^KI&_#3P
M\5LTZW;NZ XOJ#M/>$_##-BMXG(6?YE=UIK7UWO([&.>TL+CP!+=>U?6IB+,
M]F6?5W3T;Z>=\=V7]MW=J-+'O*V9+8]KAV71'3$36F^:2P<1>I4-S;YZF9&0
MP[69%4HU+H8]PF918>_D8&@ES.\=R,<W4.T.G!8\5]L9,F>?5V1$\^Z)\O*V
M=3AORZ72=WV17-,WW3;6-G'/HQ/-/#%9B=L5ARR5RC\O-I=0ZTPFVQD\;8Q;
MLB-1#"Z8ML5W2$Z<HD(<S5W8[0'35,E]O;69J^A=%*\V^B-/BR?Q^HT-T4S8
M\EN3AY9IZ-T1SS;LG9OC;"+YS;N5W33ZC;JQ$#YXKMO%R82+E(-J/;X:971C
M35S9'=XV,CV6@TX+5RXKLUN6^W=,Q3IX=DKO1Z[%H[]%ILL\,V6Y8R3[$Y_5
MB>;ACAF[FKM2K+6JV]MY;)?@9!;H8HSYG)6&@\L#'P=U7C>=.$CWN/XL^, T
MDA;5]]NHS8^":Q;Z4]&ZG_C>H=-CN[OT6JC-'#=DX<=D>U,75NF/],1'K;IK
M%$5HM=M_I%F^FKHWOW/7EO8:CCP/QUGS^=[H)HVG36-S)N8O]BT!VNFA6M;?
MP:>[#/KUI3GKRK[-,:KOC%KZ_P##,8\EUW);P6Q%UL_ZHFVG#OFL4WK(QV6V
M]B),5TQLW1^GQBHQ%7#'CO((8^Y+FO+>77Q''377@K.R^RR+<$SZ7#3R.-SZ
M;4YXR=X6V_\ %VLUG9LF9XMV_EC;N5O%YQ2Z-VNFKXR_><4DV BQH!$DKYK!
M,<[0>/<F%XE,OL0 >.HT57%W#IIP_GK2G+OKXJ<NYV5W#D[ZMU\3_P#SS$99
MOY(I;MMG_7QQP\.^M-B28FK!L/J%E)LM,(,3F</0%7(2GD@[_$L=!)"7'@'E
MA;(!X1KIV%;&.(TV:>.:1=;&W],1%/O4VIR7=Y=W8XQ16_%ER5MC?3+/%%W5
M6MO1._>BU;;N1H[=H[XEJS,B^6,^ZK=5T;N_CQEUY@,AC +M6Q\DI;IJ&ZZK
M6[.Z,<99C9Q\7^W9^'B7N378LFIOT<717X6W!;-8I.2R.*E=VVZMM>=-X(V[
MDZKU\[C7ML87 XF2K)>C/-"^[=E#A$QXX/Y(V\SRTGEY@.U;UM,NJX[9K;;;
MOZ=NSQ2YF^Z=)W1.')Z.3-EB[AG?%ED>M,<E;MD5WTF3IU&^3=/4+(1C_P &
M;,,KQ'P&:K6C9-I]YQT/W5.BBN7+/)Q4\,5JCORZ(TFCLGUHQ3,]5U\S;Y%B
M*U<B(" @(" @KGK-^I]I?OIMG\_:@= ?J5V/^S&^ZR(+&0$! 0$! 0$$5R>Z
MKWZ>FV]@:]>2WCY:#,E-=>]L8_27.8XXVQ-+O8MU=(> [ "=40RI,_F'8FK-
M3P;I-Q7))8&XJ6=K(('UW%LDDUD-($0 !:6MYG<P "#IVENJ[GLAE=O9O%_H
MC=&&,+K=6.86:TM>T#W4\$NC26NT((<-04'71W+N;+9-IQ6WH)]H/L.@;N!V
M0C#S%&2U\HK-:7>R!#6ZZD<4$EMVZM"I9R%V40T:D3[%F9W8R*)I<YQ^\ B4
M8I[SLEF OY;'-H87=$C8,5-WI?8AEG89*S;;= T=^T<.0^([1IU[40YV]W6W
MV,\W!8YF1J;7\3+/?*8I); B[^2"J T@OCCTYG/.A<>4>$H.VSO"E-'MYFWP
MS(W=TL,^(:]QCB;5CB$TMB8C5P:QI Y1XQ<>7[J#,P6>;EYLICK,(JYO"6!4
MR55KB^/\8P2Q31.(!,<K#JW4:@Z@]B#AF-P.HY;&;<QT++6?RK)[$4<SG,@@
MJ50.]GF+ 7:<SFL8UO%SCX "@P!OS&5\%G<QEHG5;6VIWTLOCXG"5_G0Y>Z;
M"3IS"</88B0/9<>PH,JIN"]#F\?M_<5*&A>R]:6UC'UYC-$7UPUTU:4N TE8
MUP?S-\5PUT[$&K'4 '$MW<:31L=UP4A?[P^=]T9O-A=,6G+W'>\.77GY?&^X
M@FK@6D@^#U.Q$OB @(" @(" @(" @(" @(" @(" @(" @(" @(" @IG[4WU-
MY3_-T?=PM+6>[\+I/ISYVWJN\SP*J-ZT(" @(""T/LZ_71M/^_G_ #69;&G]
MY"B[]^2R=4?Y0_1!="\>$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$&.*%)MUV1;7C%]T8A=9#1WAC!U#>;MTU6/L[>+BIMYV:<U_
M!V=9X:UIR58&6P3+UVEEZLGFN:Q_.VO9TYFOAFT[V"5NHYHW\K3VZAS0X=G'
M%EP\4Q=;-+K?M2>CS-K3:R<=EV*Z.+'?2L=,;KHYKHK/7$S$MJ8V.U+F@DC1
MW#74>HMBD-"LP^N8U[2QS0YCAREI&H(/#31)BNPB9B:NFS7?+5?7KRFL7-Y6
MR,:TE@_JAP+>SU0OFZVMM(FC)COBV[BNCB^_[W70QE+&X^'%U8@VE"SNVQGQ
M@6^'FU[2>T^JOG'BMLLBR(V0^LVHORY)R73Z4S5E@   #0#@ %E8'%D<<?-W
M; SG)<[E &KCVDZ>$J(B(W)FZ9WG=L+Q(6CO .4/T'-H>.FJ4BM2LTIR,*;%
M0V<I7R=A[I'4VN\TAX!D<CVECI. U+BTEHU.@!/JK#.&+KXOGDW-FW4S9BG'
M;%.+UIYXC;$=5=O2S>[C[SO>0=[IR\^@YN77737U%FI%:M;BFE.0?&R0<LC0
MX @@.&HU'$'BDQ$[R)F-SDI0QK->84WU\:]E24CEBD[L.;'S'BX,! )':/!J
ML5UL\-+-C-9?;QQ=DB;HY=N_PNG"X:E@<=%C*#7"",N>Z20\\DDLKB^221W\
MY[WN+G'U2F+%;CMBV&75ZK)J<DY+]\^*(C9$1S1$;(9ZRM00$! 0$!!7/6;]
M3[2_?3;/Y^U Z _4KL?]F-]UD06,@(" @(" @((!OK:L.5R-#<FV[WZ)WS3N
M5L<R^P&2%_.#)'%<A[)&M!U;X1S(AN=K;O=F=J?*#-UACK=6>>ADJ\!,T;KE
M.8P.%?3B\2/'XMHXZG1!DX3$NK7<EFLNV.'/;B#3-4YP704*K.[BKZ@^-R->
M72O'#G<?4""+7=F8_8^X]NYC9$3L2,ID8\;F,)"YYIW*DS'N?,(G.(:^'EY^
M\;X.U!O.IM*UD^G6[<?C3SWI,98;'&P@OU#>?30<02UIT]5!'=YO9E=D[ @Q
MC@]^3RNWWT.0ZZLA8)GD?<:QCB?44C+V3(S'4^I,=YP9-2S>6M7"_AI!/7$\
M4AU_FF,\"H$2Z>XV[C,OTJER,+HF6=LY*M7#^!;/*]MIL>G@<8CJ!Z@4B:[:
M:7]3>H.2#PVA%'BJ$DA(;'YS% 9'@N.@U:UPU]350/MB-\'6G'3S@B&_MJS7
MHN/89J]EKY6@^KRN#OO(*^WE5L6H^IF8@:?T75W)@GV9![ LQIB-H_=# ]O-
MZFBD3[J%6L9+>^Q:% ZW.]S%S5I[*XHF+F)_HE\C!KZI40(>?_\ 6&*B.-QV
M.CQ(C'L_/_/1 8]/Z?><-%/*+H@BD@K5X)3S30PQ1R'^NQC6N_E"A+F@ZY&V
M"X&&5K&Z<0YG,=?OZA!PY+OI$?M7X4#DN^D1^U?A0.2[Z1'[5^% Y+OI$?M7
MX4#DN^D1^U?A0.2[Z1'[5^% Y+OI$?M7X4#DN^D1^U?A0.2[Z1'[5^% Y+OI
M$?M7X4#DN^D1^U?A0.2[Z1'[5^% Y+OI$?M7X4#DN^D1^U?A0.2[Z1'[5^%
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M@0@\E9'I-T4VOO+<.TM]]3=R[;LXQ]8XMEN4#SRI-79*;+)FP/C<TR.?&&@
MMY..NO E;OV7JFS\?/U H[#S.0W+MB.[CWP[@R+>5L\YKO;)$PF.-SG1 #F<
M1H6N;H.'$AZ"0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M8T_O(47?OR63JC_*'Z(+H7CP@(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(,:]CZ>2A;#<B$C&/;+&>(<R1AU:]CAH6N'JA8\F.V^
M*70S8<]^*:V3393KCFGGAD@:#19&$0==BO!:A=7LQMF@?P?&\!S7 '70@\"%
M\W6Q=%)VP^[+[K)XK9I+L    &@'  +Z? @("#J%:NVPZV(F^=.:(W3:#G+
M=0W7MTU\"^>"*\5-K[G)=P\-=F^CM7T^! 0=%RG!?K25+32^O*.65@<6\S?"
M"6D'0^%?%]D7QPSN9<66['=%UN^-SMBBCAC9#"QL<,;0R.-@#6M:T:  #@
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M^!C= B'$;=P;<C^E11C%[OC;YM7=V+3F\IG$6O=B4CAWG+S?=U0;-$B @("
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M%-M;KZ<--O%%WJS;3?7^F]T8C=V(S-N.C!WU>U/!Y[4BM0O@=/5U [V,/ U
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MAX-40O5 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M0 4%L(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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ML^2C]<>:7J!=,\G$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! )T!)[
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MNB#8;'ZF;*ZDLR,NR<D<K4Q3X8K=H120Q"2PUSVM9WK6EQ ;XW!!+$! 0$!
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ME^;";BI2;KZ&U.G<V6D%'$;EQT,#FLGG#N2"P WO8>]T[MK_  N(:0-4'HA
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M7CP@I?[1_P#IS#?M#_LR*F[T]6WK=S]'_,9/T??#SHN?>G" @(" @M/[/O\
MKR?]G3>ZQ*S[M][X'(?5GR4?KCS2]0+IGDX@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(""O^KN7V5MG"8C=N\K,M27
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M;W6)6?=OO? Y#ZL^2C]<>:7J!=,\G$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MU06J@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MHV" ,>_0 !KYM6N<!V\H=X4%CH" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(*9^U-]3>4_S='W<+2UGN_"Z3Z<^=MZKO,\
M"JC>M" @(" @M#[.OUT;3_OY_P UF6QI_>0HN_?DLG5'^4/T070O'A!2_P!H
M_P#TYAOVA_V9%3=Z>K;UNY^C_F,GZ/OAYT7/O3A 0$! 06G]GW_7D_[.F]UB
M5GW;[WP.0^K/DH_7'FEZ@73/)Q 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0#KH=.)\""C=HWLYN_(VP_-6L=OVC6=^D:;WED5:U'<<6P^;.!8Z%T>@#
M@"2#KS<RY?!VF7)/I3%\1X*\6ZG-3RO3N\\.#0X[:8K;]-?=Z-U*S=;../2X
M]\7Q=R;-NRE%AW<M/F=Z#9]21T-''5&9'-3Q'ED>Z9Y97K!PT+0X-?)(1Q(#
M0.TJXR7SDS=E$TB(K=]T='.Y'#IK<&A^*NBMU]TV8XG=%(K=?TTK%MO36>2$
M4WWN=HW4S"Y3,YC:.%@9''6R]2NUM*S9GXN$EF2.1H# &M;P U+M2M+59_\
MEX;KKK+8W3'+/7]N5?=S]WS.DG+CQ8M3DNF9FRZ[T[;;>:R)B=NV9Z*4AN\U
MD;S=R[5Z?TK\XALUIKN6R7.!<EKTF-:QHD:!H99' R.: =!H--5L9;IX[,,7
M3MBLSRTCIZ:;59I,&.=+J-;?9%;;K;;+*>C%U\[=G^FWU8FNW?N9&SLS>;N;
M=&R\A8DN?H22M9Q]N8ATKJ>0B[P1O<.+C$\.;S.XENFNIU*R:;),9+\4S7AW
M<])_!B[TTN.=+@U=D1;VL76W6QNX[)I6.;BBDTW1-:..>S%S(]0<1L:I:DJ5
M!0GS66?7=R32PLD;!#$'CBQID)<\MXG0#7351FONOS6XHF8BG%-/-^+ZT>EL
MQ=W9-9=;%UW';BLKMB)F.*ZZG+--D5V16O,B]WJ!FMNX3>6'$WGV?P&0K8[$
M6[ #G.CRW(:QET&CG1![M3IXW*->)*T[M7?BLR6UK=;-(GKW>'8N\7<F#59]
M-EIP8LUEU]]L<^*O'P\T74CJK-.1()[>0V=N_:^*=D;.2Q>XH[-*UY[)WKV7
M*L7?1SL.GB]X ]CV-T;[$@!;%;L&6RWBFZ+ZUKSQR^'Q*BS'CUVCSY(LMLOP
M3;='#%*V73PS;//P[)B=^^LHW#N3<.4Z=9/JK6R$\5N.>QD,7CB>6F,=2G=%
MW$D78XRQL>72'QN9P(T  6OQY+L,Y^*8FNR.2E:4F.7E7-^@TV'O*SNVZR)M
MF+;+[OS]I?;7BB[DX;IBENZD4G?,K7KY6M8P\6;&K:<M9MP$]HB='WG_ -%<
M6Y8G'Q\E*_>X._376YIP_FB[A\-:*H.Y-QMZ;#JPZ]/^DN]&2.)YQYE^CC8[
MKS7DTT_Y/C=Y[/O..NG!4W:9.Q[?BGBKN_+2M*4^_>[SX#3?R?\ &\,<%.#C
MIZ?:</%QU_7LX?5X>2NU(XLM9WAOO*[?KWK%/!X''U9)A3>899;F3:Z2-[I&
M^,&QQ#Q6=A<=3KH%L\4Y\TVQ,Q;;')LK,_T\JGNTUNA[OQY[K+;LF:^^(XHK
M$68]DQ3GNNWSS12*;4>K;_SN1P.&V_YSR[CN9^;;.1RD;6L>(J#G.GL1MT+6
MR/B:WP:-<XD=@6M&KONQVV5]*;N&9\59CIVK?)W+I\6HRYN'_BLP6Y[;)W5O
MIPVSRS;%U>F8BB0P6;53?=W8-N[:GQ>3Q;<MC++YB;-::*7N)8VR^S(/B2MY
MM=#S#LT"V8K&6<,W32;:QMVQX?*J+\=M^@MUMMML7X\G9WQ3T;HFWBMF;=W/
M;-*5V3OVMULG<%K,5\EC<HYKLY@;DF-OR,:&-FY 'Q3AH]B)8W-<1X':@< M
MG29IOB;;O6LFD]/3X5;WMHK,%UF3'[O-9%]O179=;7EX;HF.JB4+=4@@(*SZ
MT3;SK8W;]G8NSZ>]LS'D)>]Q61B9)!%7=5>#.'R/8V-P=RM!UX\Q""OMH0=>
M-P;XVU=S?3;!;#P^(N&QD\S0=7$\U)\3XY:@$4TI<)26ZCE]DUIU&B#T:@(*
MYZS?J?:7[Z;9_/VH'0'ZE=C_ +,;[K(@L9 0$'E#K1AKVYNIV5Q%C>FY*.XH
MHA=VYL_ Q2QP3X&G7CEL/AFYF1.LR:6'-#NU[!&=-6H)5]E&;;$U'?3MM9K,
M;C8W*5&39G.!S'SQ-JCN@QCR7-=&>\8_F/$!IX#0(/0J @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""F?M3?4WE/\ -T?=
MPM+6>[\+I/ISYVWJN\SP*J-ZT(" @(""T/LZ_71M/^_G_-9EL:?WD*+OWY+)
MU1_E#]$%T+QX04O]H_\ TYAOVA_V9%3=Z>K;UNY^C_F,GZ/OAYT7/O3A 0$!
M 06G]GW_ %Y/^SIO=8E9]V^]\#D/JSY*/UQYI>H%TSR<0$! 0$! 0$! 0$!
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M 0$%I_9]_P!>3_LZ;W6)6?=OO? Y#ZL^2C]<>:7J!=,\G$! 0$! 0$! 0$!
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MTIWD-0.YL^E.\AJ!W-GTIWD-0.YL>E.\AJ#O0$! 0$! 0$! 0$! 0$! 0$!
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M @(" @(" @(" @(*9^U-]3>4_P W1]W"TM9[OPND^G/G;>J[S/ JHWK0@("
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M._\ 9U79#,::S,+A\>QC*QAE;(97M,;WM/C!H('L?X4%F(" @(" @(" @("
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M[#I;?=XXQXN'DFV^V..L<O%Q3,\\KAPN6DO;6QV<L-_'6:$-V5@&GC20MD(
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MZC0LNAOIQ8_8FD=7(U>_<%O_  ZFV*?$8XNN_7$\-\^&8XNN93E63F! 0$!
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MD_-U1=%)YJV\[(JX#/;7SNX+N K07\?N&1MYL<TO<.JWPP1R%_BNYXI-&O\
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MI\*^-#;6;\GMSLZHW-CO[+%MN#31OP8Z7=%]T\5UO^VL1/35/%9N6$! 0$!
M05SUF_4^TOWTVS^?M0.@/U*['_9C?=9$%C(" @\W]8[&U1N[)QX/HK-U0W:U
MT#MPYAT$CJM>5T+1'6$S8Y=7MB#"6- #=1X24$\Z'6-H3XW+LV_L>?IYGXGU
MF[CVU9A= 0[D>8)XP0T.8\%[><-!U;H1P06H@(" @(" @(" @(" @(" @("
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M%![V"G#$T_BQ$][R\'1Q>=2!P06 @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(-??PF+R8_\NLUS_!*/%D'_ .(:%8;\-E^^
M&W@U>7#ZEW@Y$7O[#D;J_&6><>"&?MT^X]O_ *A:-^BG\LKW!WU&[);X8_!2
MGV@,7D,?TVR(NUGQ?^34 ?IS,/XWP.&H6ADQW6;X=1W;J<>7+'!=$[)^U'D)
M877" @(" @M#[.OUT;3_ +^?\UF6QI_>0HN_?DLG5'^4/T070O'A!2_VC_\
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MS&,C:&,:&L' - T "VHBBJF9F:R^J4" @(" @(" @(" @(" @(" @(" @("
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MTS.7;S*;ZHQV6:*(MB(]./-+TNNE>5" @(" @(" @(" @(" @(" @(" @("
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M" @(" @(" @(" @(" @(" @KGK-^I]I?OIMG\_:@= ?J5V/^S&^ZR(+&0$!
M0$! 0$!!B9#%XS+P-K96I%<@8\21LF;KR2 :!["-"UVGA:04'1C=O87$8^3%
MT:43:<[.[M->T2.L-Y2S\<YVI?XITT=PT1!AMNX#;L;H<#C*^-C>.5S:S.7Q
M==>77B0W^J.")=&.VUCL;N+*;FKUX*^1RC&0SOK,Y'2MC=S=[.[^?*2-->QK
M1HB&72PN&QMF6YCL?!5MSAPEFB8&N(>[F<!X&AQXN#- 3VHDN87#9"U%>OT(
M+-R$-$<\K YVC#S-#O X-/%H<#RGL0=U^A1RL!JY.NRW7+A)R2C721O8]I&A
M:X:^R:04&#E=O8S);?EVV*-,XJ1HC;2L0B2HT!W-S=T/9$'QAKVN[2B':<#B
M7XFGA+59MNA0CBCK"?B]O<L[MKPYI!:XCM+2/4[$&9%5J05&T(:\4=!L9@;4
M:QHA$1&A9R:<O*0>(TXHET8[$8K#QR18JE%39*091$W0O+!HW5Q))#0=&C70
M>!!Q;A<.W)',-H0#*DEQMAGXSG+>4O\ 4YRWQ>?3FT\*#.0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$!!3/VIOJ;RG^;H^[A:6L]WX72?3GSMO5=YG@
M54;UH0$! 0$$YZ45XIMSOFDT+ZU662('^DXM9J/O!Q6#//HM;//HKI6BT1!D
M4LT-OS.R;HG3QL8YCX6N#2[GX#B=1P/%9<5W#=5$X>V]"M&LRG4+<60YHZTC
M,;7/#EK#\9I]V1VI_BT6:[+=+?Q=W8K-_I3T_@BSW.DD,LKG22N]E(\ESC]\
MG4K"L8V12'Q$B @(+3^S[_KR?]G3>ZQ*S[M][X'(?5GR4?KCS2]0+IGDX@("
M @(" @(" @(" @(" @(" @(" @(" @(" @(""#LZG8J9_G5>C;GV_P C7MS$
M3 ]CFNL&OW@B![PQ<PU[P-TTXZ<O%57\C;7U9X:>MX:;M]/M1TT_3^:V.&Z^
MV,M?4F=OJ\5.+U>*GY:]&_8DV4S5;&/JUBUT^1OO,=*G'IWDA8.9[N) #&#B
M]QX#[Y .]ES192-\W;H^WE4NGTMV:+KMUED5NNG='-X9Y(Y>JJ.Y3J31QV3M
M8NO@LYEGTG"*Q:QE!]FJ)2T.+!*' %S==':=AX+5OUT6W3$6W74]F*QYUQI^
MX<F7%;DNRX<?'MB+\D6W4YZ<T\C,BWYB+.$P^9K0V'OS[Q'A\<6!MN=[@YWL
M2[1K0QID<]SN5K>)*^_C+9LMNB)]+='+_P".G<U[NYLUF?)BNFV.QVWW5]&W
MP\LUGAB(BLSL;/!Y^GG6VVPM?!=Q\[JF0I3@-F@F: [1VA(+7-<'L>TEKFG4
M%9\.:,D3R3&R8YOMSM'5Z*_3S;6DVWQQ6W1NNC\8G9,3MB7#.;CI8.2C4D9)
M:RF4E=7QM"N 9IGL:7O/C%H:QC1S/>X@ ?=(!C-GC'2*5F[=$<OVY7UH]#?J
M(ONB8MLQQ6ZZ=T16D=<S.R(C;+HI;QPEK$Y',3RFC7P[YH<O':'))5EKCF>U
MX&NOBD.:6ZAP(+==5\V:FRZR;IV<.^O(RY>Z\]F:S%$<<Y8B;.'==%VZGFFM
M*3$U<,5N^ID;];&6:EG&7;]<WL;%=8UAL5V%H>6\KG:/9S-+XW:/:"#IVZ?.
M+51?=%LQ-LS%8KRQ^/0^M3W9?BQW9+;K<EMEW#=-OY;N3P32:71LFC$M=0\+
M5DN2NCG?A<;:;C\EF6M;YI!:+FL+7$N#BUCG!LCVM+6'M/ Z?%VMMMF=D\,3
M2;N2);&/N3/?%L5CM,EO';C_ #76[^:E9B*VQ,UNC=R5EJWU B4W4+"PR3S.
MCG.#K76XNSFPT>9QW'/;'RDEP<6"1PC=*&\@?P)[=-"=;;$[IX8FG%R5_#I7
M]O<F>Z(BL=I=9VD8_P TV4K7FK2.*+:\4V[:;FPRVZ*N-R<.#KUI\CFIH'W/
M,:H9SLJQN#3*]TCF-:"[Q6:G5SN [#IERZB++HMB)NNI6D<W.T]-W??EQ3FN
MNBS'$Q;Q75VW3MI%(F9V;9YHW\CJ.]]O?)B/=K9W/Q4VC86MC<;#YW/[H0-B
MTYN][S\7R=O,HG58^R[3D\O5ULG\1J?BITU/3C?M]&(I7BXMW#P^E7F*V[8I
MY;]!V/LQ9S'11VI\2_NS.^M,2&RPEKRR0>*YOBN]D.4Z'37YMU5:QPSQ6[>'
MEISQS_CL,G=LVQ9?QVSCOF;8OV\,71OB[96W?$[8W35N,;DJ.8H09/&S-L4K
M+!)#*W70@^J#H00>!!X@\"MG'DMR6Q=;-8E7Y\%^#)./)%+K9VQ]OM+*61@$
M! 0$! 05SUF_4^TOWTVS^?M0.@/U*['_ &8WW61!8R @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(*9^U-]3>4_S
M='W<+2UGN_"Z3Z<^=MZKO,\"JC>M" @(" @GO1C'V<QU&Q.&JS"&7(-LPASA
MJTZ5Y) UVG@)8.*=EVGHPK>\<\8,$Y)BL6T\\0NJS7LTK,M*["ZO<@/+-!(-
M'M</_3U#X55W6S;-)V2U[+[;[8NMFL3NEU$@ DG0#M)4/M]W+@LA3VI5SUII
M@K7[C:]6)X(?(P1N>9>/8W4:#U>WL6SV-T61?.Z=QHM39?J;L5NV;;:ST;:4
MZT)6-T @(" @(+3^S[_KR?\ 9TWNL2L^[?>^!R'U9\E'ZX\TO4"Z9Y.(" @(
M" @(" @(" @(" @(" @(" @(" @(" @("#X[30\WL=..O9HHDA2+HKO2'+S\
MK#G.G3:[7RPD--K%4[%AY\0?]>$2.)(]DUOWN/.T^%R>U93Q1,^7;]H>FQ=9
MWYAC_P".JXMD_ERWVVQO]B[A\$RE>%M')]8=QR2NYF8G$4*M'CXHCNN?8E<T
M=GC%K 3_ %1ZBWL5W'JKI]FV(CPTE0ZO'V/<V&(_^F7)==UV1%L>*L^.6YZ@
MW)J6UK-'&D19/,R1XC'D<-)\B\1%XT_H-<Z4_P#M6;6W<.*;;=]WHQUW*WN3
M%;DU=M^3;9BB<EWZ<<5IX9B+?"C>1HPX[JML/&Q,[O&T<1D8,8P]C7Q,BC<&
M_=$8'\"U;[.#4XK>2(FGBG[ES@S79>Z=7DG;??EQS?X9NG_)D[:Y_I@WT(?_
M (WF>(\ZT[._[J3DU^[R?R+)@K\5DYJ6^:*?>PZ^G\-I*[^/-3]-8KY3*]X>
MMFWA-KYLW!WC5U[._,T8DT^[R<NJC)\Y;7=P[.O:::G\'FIO[;'7JX9IY:J\
MW]S.N]5F-U_1;KFU6W>WN]#R=]]SL[OF5=J]^:FZMGF_%U_<M(L[OG\_!JN'
MGY>'_P#5%B;_ .;Y<=..Y_\ E?I&YIIV]SYF_O?X-.U66KKVV*F^L_=5Q_<O
MR&MKZO9V>/CCA0[;FI^S?F77_P#YSZN:==YNWSGSFQV_=UT6IAI\%/A=%KJ?
M]FQ19ZO%AX?T\-BV=N&]\C,29-3DOT97+^;M[_S=NNNO]96F#B["WGX8\S@M
M?V?QN2GJ=I=_;Q3]RI,<(/\ ;!8+^)./N&8OXN\X-N3FYM>/-WGJ^%55E/@/
MM[3O\_%_VJ*>W93]/!%/!PI'L'SMW4G<QR?-YVW#8(0\_LN0PO,NFO\ ^;S:
M_=6715[:[BW\-O\ C%?*IN^N#^,P=GZO:YZ_W13_ -4'Q_?NEQS9_P!4_2=<
M-;7V&C><PCVWGT^ZM.-\4W=M^%'3Y^&(OX?7_C[*^3B_]:>!8^2Y_INP?F_L
M_P! 7?.].WN/.(^37[G.K*^OQEM/9V]6W[W':>G\%EXOW[.'KX9KY'9TYGDA
MW#OS!M.M.CF?.:S==0PY"%D\C6^H.<N=IZKBIT4TR9+>2+J^.OX/COVR+M/I
M,WYK\7#/3P73;$^*D>!82M7)" @(" @(*YZS?J?:7[Z;9_/VH'0'ZE=C_LQO
MNLB"QD! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M<63';$?\L1$SRQ$3Q4CKF(KU.O/[<JYXT;#I9*F4Q<QM8V_!IWD,KF.C<-'
MAS'M<6O8>#A]W0B,V",E)K28W3]N3G?>BUU^FX[:1=9DCAOMG=,5K'5,3%8G
MD:R?:5>E@,U6KV[_ .E,RXSY#*TW-;D9)G!K 8W:!K UK0QC1HUK?X2M>=/%
MF.Z*W3==OF/6G[<W,W;.\[LFHQ776V<&+9;9=7LXC?MY9K.V9WS/B<8=H6KN
M'P#LO?E&Z\&WFKYAG(^9LDD9CD:_F!;('MT$FH\8CFX'11&FNNQV<4TOMY?M
MOZ>=]7=YV8\V;LK(['-OLVQ%(FL4Y;:3MMYMS+K;)PD>%RF%ML=>BSCYI<S/
M8.LMF6P.5SB6Z<N@ :P,T# !R]BS6Z6R+)MG;Q;YY_MR-?)WMGG/CS6SP3AI
M%D1NMBW='3SW5KQ3,U?,7L^"EDJV7R%ZQEK^/KOI8R6V6?\ CUY.7G(#&M#I
M7AC0^4\2!IPXZ_.+2\-T7773=,;(KR1^//*=1WI=DQ78K++<=M]W%?%M?2NB
MM-^ZV*SPV[HKR[&%:Z=8JTZ[4-B=FWLG:_2&2PC>7S>:R7->[5Q:7MCD<P.D
MC:[1QU]4@_%VBMF9BL\,S6;>GSMC'WYFLX;N&)RX[>"W)MXK;=L1T3=$32VZ
M8K$=4,BWB,K+OBAF*=^[%C*]5\%^@Y[1CGM<'\A;'IS&;F+27=@:W3PJ;L=\
MYXNB9X8C;S?^6+'JL,:"_%=99-]UU;;J?\D;JUG=PTKLY9GH=$O3K$RF>FZQ
M/\F[-W]*6,%JWS9]OO!*=26\PB,C1(8@>7F^YJ%\SH;:S%9X)FO#R5_#H9;>
M_<UM+Z1VMMG!&3;Q1;3AZN+A]'BWTZ=K89;:T5_+19^A<EQ>;CKNHR7(&QO,
MM1SQ)W;V2-<T\KO&8[35I)\!(6;+I^.Z+[9FVZE*]'A:>F[QG'AG#?;&3'-W
M%PS79=2E8F*3MC9,<NSF=3MB;?.UX=ILCDBQU=S)H)V2$6F6HY.^%@2G4][W
MGCEQ[3KKP.BB=)C[+L^3RUY^MDCOC4?%3J9F)ONK$Q3T9MF.'@X?9X=E/O?:
MF$J[?L7MS9">?*9RS#'6EMF,.D[B%SC'!!%$ &@N>7$#V3CJ3V:1;CC%6^Z9
MNNZO)$1]JHRZN_4VV:>R+<>.V9NB*[*SONNNG?LCP1%(Z>K8^W[.'JY+)9-H
M9FL_>ER=Z($.$/>:-B@YAV]W&UK2?"[4C@HTF&;+9NN]:^:ST='@9.]];;GN
MLQX_=X;(LMGGIMNN_P!UTS/51*5O*,0$! 0$!!7/6;]3[2_?3;/Y^U Z _4K
ML?\ 9C?=9$%C(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @IG[4WU-Y3_-T?=PM+6>[\+I/ISYVWJN\SP*J-ZT(
M" @(""T/LZ_71M/^_G_-9EL:?WD*+OWY+)U1_E#]$%T+QX04O]H__3F&_:'_
M &9%3=Z>K;UNY^C_ )C)^C[X>=%S[TX0$! 0$%I_9]_UY/\ LZ;W6)6?=OO?
M Y#ZL^2C]<>:7J!=,\G$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$%<]9OU/M+]]-L_G[4#H#]2NQ_P!F-]UD
M06,@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(""F?M3?4WE/\W1]W"TM9[OPND^G/G;>J[S/ JHWK0@(" @(+0^S
MK]=&T_[^?\UF6QI_>0HN_?DLG5'^4/T070O'A!2_VC_].8;]H?\ 9D5-WIZM
MO6[GZ/\ F,GZ/OAYT7/O3A 0$! 06G]GW_7D_P"SIO=8E9]V^]\#D/JSY*/U
MQYI>H%TSR<0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 05SUF_4^TOWTVS^?M0.@/U*['_ &8WW61!8R @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(*9^U-]3>4_S='W<+2UGN_"Z3Z<^=MZKO,\"JC>M" @(" @M#[.OUT;3_OY_
MS69;&G]Y"B[]^2R=4?Y0_1!="\>$%+_:/_TYAOVA_P!F14W>GJV];N?H_P"8
MR?H^^'G1<^].$! 0$!!:?V??]>3_ +.F]UB5GW;[WP.0^K/DH_7'FEZ@73/)
MQ 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$!!7/6;]3[2_?3;/Y^U Z _4KL?\ 9C?=9$%C(" @(" @(" @(" @
M(" @(" @(" @(" @(" @^@$G0=I[$%?3=<>D=>:2O-NZBR:%[HY&$R:M>PEK
MA[#P$+5^*Q\_G6L=T:N8K&.7#Z=NC_SPH?QR?V$^*Q\_DE]?P^L_;D^G;H_\
M\*'\<G]A/BL?/Y)/X?6?MR?3MT?^>%#^.3^PGQ6/G\DG\/K/VY/IVZ/_ #PH
M?QR?V$^*Q\_DD_A]9^W)].W1_P">%#^.3^PGQ6/G\DG\/K/VY/IWZ/CC\L*'
M\<G]A/BL?/Y)/X?6?MRGE&[4R=*MDJ$S;%&Y$RQ5G9[&2&5H>QXU\!!!"V8F
M)BL*N^R;+IMNBDQLEWJ7P(" @(" @(" @(" @(""F?M3?4WE/\W1]W"TM9[O
MPND^G/G;>J[S/ JHWK0@(" @(+0^SK]=&T_[^?\ -9EL:?WD*+OWY+)U1_E#
M]$%T+QX04O\ :/\ ].8;]H?]F14W>GJV];N?H_YC)^C[X>=%S[TX0$! 0$%I
M_9]_UY/^SIO=8E9]V^]\#D/JSY*/UQYI>H%TSR<0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 05SUF_4^TOWTV
MS^?M0.@/U*['_9C?=9$%C(" @(" @(" @(" @(" @(" @T6\=R,VG@7YAT;)
M'&Q6IQF9Q97CDN3-A;+,YO$1LYN9VB(=> L[FEM11Y*:K?Q<[KK3?AB->2&2
MM,6Q@@/>Q\3V@\KN!&GA[4&A=O[(.VQ<ZA00P'9].T]GF3FN\\EQT$XKRW!+
MS:!_-K(R+ETY!Q/,4$_#F/:U\3@^)[0^-X[',<-6D??!1(@(" @(.4?LV_?'
M_P!4'Y8;C_U#E_\ /6O=G+EWNNF]U;U0UBALB @(" >PJ43N?IWT[^K[:?[&
MQWYK&NBP>[MZH\SP_7?,9/UW>>4E69I.JS.*U::P6\PA8Z3E'#7E!.B^;II$
MR^K+>*Z(YU3LZZUGM#OT#,-1KIYQ'_95'_+Q['E=A/TS=$^\C^V7+Z<ZWQ%-
M\(9_93^6CV/*C_K-W[D>*3Z<ZWQ%-\(9_93^6CV/*?\ 6;OW(\4GTYUOB*;X
M0S^RG\M'L>4_ZS=^Y'BD^G.M\13?"&?V4_EH]CRG_6;OW(\4GTYUOB*;X0S^
MRG\M'L>4_P"LW?N1XI!USK%S6_H*;QG!O_R&?SCI_13^6CV?*?\ 6KOW(\4K
M;5\XX0$! 0$%,_:F^IO*?YNC[N%I:SW?A=)].?.V]5WF>!51O6A 0$! 06A]
MG7ZZ-I_W\_YK,MC3^\A1=^_)9.J/\H?H@NA>/""E_M'_ .G,-^T/^S(J;O3U
M;>MW/T?\QD_1]\/.BY]Z<(" @(""T_L^_P"O)_V=-[K$K/NWWO@<A]6?)1^N
M/-+U NF>3B @(" @\F?:4ZJ]0ME=0H,/M;.S8W&OQE>PZO$R)S3*^24.=J]C
MCQ#1X54:K+?;?2)=_P!P=VZ?4::;LED73Q3'+T*>_P!P?67YVVO:Z_O2U>WR
M<\NC_@]%^W'E_$_W!]9?G;:]KK^])V^3GD_@]%^W'E_$_P!P?67YVVO:Z_O2
M=ODYY/X/1?MQY?Q/]P?67YVVO:Z_O2=ODYY/X/1?MQY?Q/\ <'UE^=MKVNO[
MTG;Y.>3^#T7[<>7\3_<'UE^=MKVNO[TG;Y.>3^#T7[<>7\7J'[+^]MU;YVMF
M[^[,G)E+=7(-@@EE:QI9&8&NY1R-:.TZJRT=]UT36:N%^H='BTV6VW';PQ-O
MWKS6^Y<08$^;PM69U>UD:L,[-.>*2>-CVZC4:@N!'!8IRV1-)F/&V+=-ENBM
MMETQU2Z_E'M[XVI?"(O[2CML?M1XWU\)G]B[^V3Y1[>^-J7PB+^TG;8_:CQG
MPF?V+O[9/E'M[XVI?"(O[2=MC]J/&?"9_8N_MD^4>WOC:E\(B_M)VV/VH\9\
M)G]B[^V3Y1[>^-J7PB+^TG;8_:CQGPF?V+O[9/E'M[XVI?"(O[2=MC]J/&?"
M9_8N_MEG5K=6["+%.>.Q XD"6)[9&$C@>+21P62VZ+HK$U8+[+K)I=$Q/2[5
M]/@0$! 0$ G0$^H@JO [XW=NBNW<&$;5DJ2P=^S!.8XO;&RX^%[7SM/,)PQN
MO+R<O-P_K*AQZO/DGBLI,4KP^&F_G\G0[G6=T:/1W=AFXHNBZG:5V5X(NB8M
M]BLTK6M-O0F>5S\PSU/:F)Y3E[,#[]N9XYFU:,;Q'WA;J.9\CSR1M^XXG@W0
MV67+=QQCLWSMGHC[?U<[IM''P]VIR^I;,66Q[5\Q6G1%L;;IZHY6EGW=D+N6
MW10H7*>.^2L<;Y8[K"]T_/ +!ED(<SNX-#R!S=3P<?4"UK]1DNNOBV8M[..7
MEZ^:.KK6-G=F/'AT]]]MU_Q,S3AGU?2X>&-D\5_+2:<D<\OC]]W+]?:-+&U!
M4S^[H?.FQV@Y[*=:*$33R/#>4N<.9K(VGEYG'CH 5]3JKKHLBW9=DY^2.7KZ
M$QW/9CNU-^2[BQ::>'T?SW3=PVQ&^G/=.VD1L;7;&Y+.1RF<VUEFQC-X"6$2
MRP@MBL5;<?>03-:XDM) <U[=3HYO;H0LVGS777767^M9Y8G=_5H]X:"W%BQ:
MC'7L\T32)WVW6S2ZWIY)B=E8EQW'N6W4SV%VGAFQ_I?,">>2Q,"^.K3JM!?(
M6 M+G.<YK(VZZ:ZD\!H8SY[HOMQV>M=Y(^VY.AT%E^GRZG+7@Q<,4C?=?=NB
MO)$16;I\$;VF?U*;AL/NJ7/P-?F-I3,@L05M0VT+8:ZD]@=S%G?<[6N'C<KM
M>T+#\9-EE_'ZUGEKNZO*L8[@G/FT\8)_X]3$S$W?EX:]I$\_#29B=E8INEG0
M[CSN&W!A,'NCS:4;AAF\VGIL>QM>]68)7UW<[G<[',+N[DX'5IU'$+[LS9+,
MEMN2D\?-R3S=7-RM6[0X,^GRYM/Q1V$VUBZ8GBLNFD7[-TQ-.*W;%)V3LEJ)
M>H.:FP&7WUCH()=KXBU+$RF0XV;5.G)W5BPV3F#6'4/=&PMXAO$CF\7!.KR3
M;.6VG!$[N68YZK&WN3!;J,>CR3,9LML3Q?ELNNBMELQ2LQNXIKOG9&S;8U:S
M!;K16Z[P^O.QLL4@[',>.8'^$%6UMT71$QNEQV3'=9=-MT4F)I/6K<]1<O+M
MFUU%J0P2;/K6W1QTPUQM38Z&?S>6VV3F#0\.#GMCY="P>RYCPJ9U>3@G-%."
MN[EI6E:\]>1V4=Q88U5NANF8SW6UXORQDFWBMLIS4I$W5]:=U(V[RUN?(97=
M+MJ[:D@C-2BS)9#(SL,[&^<.+:\+&->S4O#2]SB>#=-.)X9[\]U^3@QS&ZLS
MOZH^W(J\?=^/#I/B=1$SQ7S9;;$T]7U[IFD[MT1S[]D;=6WJ<^3:E7(1TV#=
M%O*?)MF-<]Q@9EA*8G<SP->Z:&F7737EX<"L?QTSBB8CTYGAIR<7X?\ AO3]
M/Q&KNLFZ>QMQ]MQTVSBI6-F[BFO#S5Z&QBS^=BW%:V5<GKG,/H-RN'R+87,A
MFC;)W<L4T7.2US7<OL'\6.U[05]QERQ?.*9CBI6)IY)C\.1J7:+!=IK=79%W
M9\?9WVUVVS2MMUMU-L3%=\>M'-+=[7W#%N3&.MB/S>[6FEI9*F7!SJ]RL[DE
MC+AV@'BUW\YI!\*V=/F[6VNZ8V3'-,*SO#0SI,O#7BMNB+K+O:LNVVS^,<DU
MAN5LJX0$! 0$!!7/6;]3[2_?3;/Y^U Z _4KL?\ 9C?=9$%C(" @(" @(" @
M(" @(" @(" @P,P[#.I>89]L4F+RDC,=)!9 =#*^SJ&QN!X>,1P^[IX4%>;0
MJ93:>?I;+HW76]IYV++FIC;)+[.'\RD=&',D/C.KR:\OC]C^Q2AJ8>>O]G;(
M;?<S_P"]5X[6VW4CPE=DWW#$V(-[2YW.UP']$Z]B"X*%5]''4:$AYI:E:"O(
M1QU=%$UA_E"A+(0=<D3Y'!S9WQ#33E9II]_B$'#S:7TN7_A]9$'FTOI<O_#Z
MR!YM+Z7+_P /K( KR@@BW*".P^+ZR"N9OL^=)+$TMB?;L3YIGNDE>7RZN>\E
MSC[/PDK5^$Q<WEE<6]\ZR(I&2?)^#K_V[='_ )MP^7+[XH^$Q<WEE]?S6M_<
MGR?@?[=NC_S;A\N7WQ/A,7-Y9/YK6_N3Y/P/]NW1_P";</ER^^)\)BYO+)_-
M:W]R?)^!_MVZ/_-N'RY??$^$Q<WED_FM;^Y/D_ _V[='_FW#Y<OOB?"8N;RR
M?S6M_<GR?@?[=NC_ ,VX?+E]\3X3%S>64?S6M_<GR?@L*AB(,70JXS'RR04*
M4,=:K W3ECAA:&,:-03H&@!;-L1$4A4WWW7W3==-9F:RR/-I?2Y?^'UE]/AP
MDI&:-\4EF5T;P6O:>70M(T([%$Q6*/J)F)K"+#I5LAH &.: . ''UUI? 8/9
MA;?S&L_<GR/OT6;)^+V_R^NGP&#V8/YC6?N2?19LGXO;_+ZZ? 8/9@_F-9^Y
M)]%FR?B]O\OKI\!@]F#^8UG[DGT6;)^+V_R^NGP&#V8/YC6?N2?19LGXO;_+
MZZ? 8/9@_F-9^Y(.EFR@01CVZ@@CM[0=1X4^!P>S"/YC6?N2E?FTGI<O_#ZR
MWE0>;2^ER_\ #ZR!YM+Z7+_P^L@>;2^ER_\ #ZR!YM+Z7+_P^L@>;2^ER_\
M#ZR#4[CVCAMW8J3![D8[(XF5S))*LIT:7QGF:=6<IX'[JQWV6WQ26Q@SY,%_
M'CFDH7_MVZ/_ #;A\N7WQ8/A,7-Y967\UK?W)\GX'^W;H_\ -N'RY??$^$Q<
MWED_FM;^Y/D_ _V[='_FW#Y<OOB?"8N;RR?S6M_<GR?@?[=NC_S;A\N7WQ/A
M,7-Y9/YK6_N3Y/P/]NW1_P";</ER^^)\)BYO+)_-:W]R?)^!_MVZ/_-N'RY?
M?$^$Q<WED_FM;^Y/D_!L<%T3Z;;9RU;.8+#,I9:F2ZM:C=(7,<YI82 YY'$.
M([%]VZ;';-8CRRPYN]-5ELFR^^9MGJ3GS:7TN7_A]9;"K/-I?2Y?^'UD&GW!
MLW![JKPU=PQ'(5Z\G?0QRZ:-DT+>8::<="5BR8;<D4NBK=TFNSZ6Z;L-TV3,
M4FG,T'T+].?B:+^7UUK_  6'V?.LO^P=X?NW>0^A?IS\31?R^NGP6'V?.?\
M8.\/W;O(?0OTY^)HOY?73X+#[/G/^P=X?NW>0^A?IS\31?R^NGP6'V?.?]@[
MP_=N\A]"_3GXFB_E]=/@L/L^<_[!WA^[=Y#Z%^G/Q-%_+ZZ?!8?9\Y_V#O#]
MV[R-G@NG&TMLWG9+ TA1O.C,+IXO9&-Q!+>)/#4!9<>FQXYK;%):FJ[UU>IL
MX,N2;K:UI/.DGFTOI<O_  ^LMA5GFTOI<O\ P^L@>;2^ER_\/K('FTOI<O\
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MVMCU)Z.TZQQ=2U()[$4)+@^0-Y0X\Y<>P:+-CQ6V>K#0U.KRZB8G)=Q3#?\
MFTOI<O\ P^LLK4/-I?2Y?^'UD$1R_2;8F>R,^7S&+CN9*R09[,@U>\M:&C70
MCL  6K?I<5TUF-OA76G[[UN#'&/'ENMMC=#"^A#IE\10>3^%?/P6'V?.S_\
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MC:9 6C0'73M X ]H"B<&.;^.;8XN=-NLSVXNRB^>"?RUV,*UM>E<W12W--#
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M+X;MB&,!TKJK6-+ &CV/>'QSV!!*J\S+->"U&US([$4<S&2#E>ULK0\!P\!
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M3@*#*5R_?R,L!W/G'-M7:\4C9##6KM$4$#>7B6PM.CGZ>,]Q/J(-\B1 0$!
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M$! 0$! 0$%<]9OU/M+]]-L_G[4#H#]2NQ_V8WW61!8R @(" @(" @(" @("
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M<.+B3J3Q0=^"VAM7;$MB;;N'JXR:VUK+,E9A:Z1D9):UQ))T!).B);I 0$!
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M= ?J5V/^S&^ZR(+&0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MQ,$FD8<XDO:S0.\*(9AVGMUS<Q'/1%F'</'-PV'OFCM$-# 7->2 0T!H+=-
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M" @(" @(" @(" @(" @(""N>LWZGVE^^FV?S]J!T!^I78_[,;[K(@L9 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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7$! 0$! 0$! 0$&12_P"<[^YG]Q>@_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>bc_totalshare-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_totalshare-4c.jpg
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M Q$!_\0 R  !  $% 0$!              @#! 4&!P$""0$!  (# 0$
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MS@![@>"OL/;/!=\X >X'@K[#VSP7?. 'N!X*^P]L\%WS@![@>"OL/;/!=\X
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MO @*>AS&"<2ZTX2T$2DF:SH95 ;SP!_!7!_5B?*N .C
M
M
M                   YSQ^_!7./5BO*M@' '\%<']6)\JX Z,
M               P&6YQB&!V]NYYC>&+3$>4;<8G=2WWUD532PPV2G'5?(A)
M@,*?&+AXPRT_=[C)L*)"=40KY;YEK.1T$QO+2"<6?,A)ZOD ;T9&DZ**AERD
M \             >D1J,B(JF?(0# 95FV*83CCV79-<VX>.LFA)S4$J02U.J
MTH2VEHE&LU'WOR@,I;+G;[U;8=YM,A$RU7!EN5!EMUT.L/))2%E6AT,CYP%T
M   #TB-1D1;3/81 +"TWFTWZ*Y-LTQN;$:D/PG7FCJE,F(X;3S9_*A9&0"^
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MU6S*KL=LFWPDG9T.1WUIDZU)01)6A"DD9&M.HC,J5*H#;5$:3-*MAEL,@'@
M   #5F.)&$2,T<X=-W0TYNVE:U6AR.^VLT-M]<:TN*03:DFCMB,E;2Y &T@
M#5+]Q+P;%\BMN)Y%=3M^07E33=IBNQWS1)4^LFT$VZE!MGVYZ3[;8?* VIU7
M4(<6M*CZHE*4E"36L])5,DI34U'LV$7* U;$.)6#9])N4/$+N5QF6<T%=(YL
M/QW(ZG%*0DEI?0@ZZD*(RYJ -J   !H^2\8>&^&WEO'LIN[MLO;^G=8;L&6M
M4@EJT)-@VVE$X2E%I+29[0%Q:^*W#J\7UO%X=_::R5ZG4V>>U(MTMPS*I$AN
M6VT:S,B/8FH#<  !\H<;<U&TXEPD*4VLT*)1$M!Z5),RYTF5#+F,!]
M                        #G/'[\%<X]6*\JV < ?P5P?U8GRK@#HP
M                   /IM.M:4'LU&1?28"''"2\/\6/BXRC(<D_?M8FQ<$8
M["=_>-Q4PI"8C)H2>PC(E+<,Z?ZAZN4$^!*[+L9M6;X]-QG($&];II)J?*MI
MUI9.-NMF?(M"DDI)@AS_ "#BK=[AQH@<%<..+%NNYKN60WR<RJ6F.CJNM;88
M82XV2G%$:#4I:J$2MA5 8O"N-UTS/#N(1HBPH7$7AT4Q,]C2XNVRE0R>-#J$
M&HG$(=-A:#3J,T;#J?( YXY\2'%Y[@U'XS1[1CL>TQ[F=NGP'$RG7Y23<)"5
M-$3A$R2:Z3U*4I7=;"(B,G!L>4\?,^Q/(^'$ZYV:TM8/Q#4R3%K0IYV[1&7C
MCD3KLDE$TI='R62$-TV:3/\ 2!#*Y5Q?XB6GCY$X+6"!9IK-TC;U#N$Y#[*X
MZ5L.._O>K</K.KZLSTI))KV%5/* NN&W&N[7',\VX;<3&8,/)L+:>GKNEJ2Z
MW#E6Z/13B^I=4M2%)0MM?=;2/FIM#5#^)NYIPF-Q96W:D8D_>_NU6):]5Z3:
M=2FM]-TG/]<G$UZKJM&C]+G P;#G7&C-L>XUXUPOQF!:+K:\JB,3(,N;U\=U
MHI!/%V[C:E$:4]5UFQ%5%VO+M 5>%?&?*[_D7$C#\\M\)R]</R??*58T.--2
MV8ZG$J033RW#)1Z$F@]7Z5#+8!*WX0<;,EXJ-6FYVZ19YB'IRF<JQN.PZQ<K
M+"5UA,OMN./&4ELS)LG7=!:35L+EH)?.8<:,XA-<2)MIM[&.PN'RT(A+O\%Y
MUN]KJK633W7,H0:B1J90WK4I)DH^@!B>*7%S++U\+K'%#%#9L$F\MHBW5L];
MLAM#[YPW$PW",B09JJHEJ(U$G85%;0/"QN27O),-^%6QW?(8&.Y+8D0;&S#L
M<F%)-I4)YI*4=>I3]3?;7I43B-)<NSG \+:\BXX.XKA?"RW6"UP6LTXA1[>S
M;(&A:;5;6GTLMJ<ZI!I4IMLW4I;;U%4B.I[-H;'C7%"[%QANW!#+2C.7N/"3
M<;'?X32F&I32FDN*;>C*6O0X@E&9:%Z5$D^0P'+K/\0O%_)+5Q,?M5KQQAWA
MTEQU^<^B4:7VXZWTJ0B.3NU:R9-1*4X24\E#K4@[=P=X@.<4N&]DSF1$3 F7
M$GVY<5HS-I+\5Y3*S;U5/2HTZB(SV5H RN<7BX6FQ=19#IDMZ?:L]B/2:R1,
MFF:>O,BY4QVR<D+^1 "-?PMWBZ\.^)>;\ ,I?6Y(;E/W"S//5(WGV"_>*22C
M,_\ R(^A]/ZI]()EVSB%Q/DX[F^&\,L>;85E>8NK5OLQ*G8\" UJUO&TE2#=
M<5H63:-1)JGMC!#3[CQ)XRL<-N)DR[61C'LHPI;R;=D#L5U,&XPT:_WT5E2U
M?O22E)DK4IOMR.AT,@& X0Y)GV)?#$YG*95JFQ+; G76W1WX\IR6[(*<ZY(W
MMU3]%FX:E&2D$DR,RK4!1R'XF,WM' O$^+L:UVE5POMPDVV=;7&WU,))I;Y-
MN-&3I*(Z,]LE1G6NSD!.&RZSF_$#(K+D6%8G8;.ZMW+24Y-R145V;!MC2&B4
MHU-MJ01G4ZJ-QQ*4([8Z@A@N"/&.[\0L@SC#K^W ?NF'/K::OEGU(A3XYN.L
MI63:EN:3[0E52LR,C^3:'!."O_\ S'QS_P#YTS_:I!+<L0SK.>&GPF8EFV&P
M(%TBVU4E-ZASVWEK3'>FN(2\T;2T4)"S22R,N0Z[* CPNR67.K_E5JX<7/&9
M5O?1EK*YE\4[&=-+$2,SKDJ8)+O:+0Z:8Q)6:BU*K790$.FLTZ]NG)J*GT@E
M!;X=\B;L<[C=$39[C?9ES,XD.U6N$]--YQUV:V2'#;2:&TF:RJIPR*E>@$RW
MSA#9N('PW\",CR"_V"1=;_.GLRK=BL=2G5QR=0E@G9'4DLTU/MEI14Z)36AG
ML$MQB<:LHM'&7&.&61E;KK RV S,;=AQG+=<;5+>;<6<>4RMYXJEH*J5:5D2
MJ\VTA;XYFI.?%1DF%3K!9$3H=M<6O+H\9;-T=C(99>0VZM3BDT(EDA9DGMB2
M7S ,&]Q;S7B_@7%:^XO'M4/AU8X<VUL19:'SN4Y!QUJ=?WA#A(:,FS2M#?5*
M(S/29EW0#9?@[_ :S_\ ]_<?+@F=*YX^<7<WX/2<>NEOAVV5A-YDI@7";*8?
M<DP9!'J4K]VZA*TJ;U+05.5!D"&^O91<DYE*BLRX*\"L]D*\WN<32ERD.NZU
M,H;6ES1I6TVM]7:U(B(OTJ@AQE7Q.7-.$Q^+*V[4C$GKU]VGB>O5>BM.LVM]
M-TG/]<EIKU75:-/Z7."<&P9WQPRW$^,^-\.;+:H-_LN3Q&9=O41.1YFJ2EU+
M:%.FLT$C6A*UN:#,FS5L,R*H668<:>*/#+#8%RXG6:U6:^7C(U6B//AI=G0(
MMF2DEJF&TVXI3KE-75-FM)K(JF1<@#;9?$',H/#G,<X0[9[K$L<1-SQ>]06U
MJMUVA)9UN&MLGE*;=)9*;6DE]H= '-KW\2^<6[@/C7&&+:[0=QN]SDVN=;76
MGS8)+2WDMN-&3I*(RZGMB49UKS4!.&RW;B=QO/!\JPG%)$R'CL7)X)W&?DUQ
MC.38L<S3I;90TAQJFIPNW<6NB$F7S@ATS#;AD=SL29>5QHD:\;Q(;K;5*<@O
MQ4.&4>1'6HU*4VZWI61JV[0%\FU0(4F]7F*T:+G=8Z4SW]536F$PM#*2Z"22
ME'3I,S 19^ Q!.XKG+*DDXV[<(;:VED2D+2METC2HCV&1EL,@3+>K%Q2O-\O
M>:87PI;M\'&>%5M-IM=R8=EKN$J+UB$QTFAUKJ6$]2MO61*5L(^38"&L<2..
M5\S'X8W^(V$K:L,F2_\ <V11UZWI3"GE)9<1$=2:23J)9+)Q1:B0="HK:"<-
MEML',LXX8_#]8LB5:(N4S$6^SQ,=M=GCRFNJCOQTI2J953RUZ*;3:2FJJ%LK
M4$/NU<9\C@\=+=P@R%4"\0K[ 3,AW*#&5;Y<"2;+KJH\ME3[Y5+JC2:=BDZD
MUYP&H</]OQM<2_52O(P 3X'9^-&%WKB'PMR7#L=>ZB]7%AM42JNK2ZJ.ZAXV
M5*/8E+I(T5/9MV[ 0C=BGQ)H9M3G!/XD,=?MC:XI6:5=C9-.EDB-I#DF,I/Z
M.E)I>9KM+42><$X,[\8#AIN7!E=O-,]*9YG#/K22B01.1.K/K2(R(EE3MZ<]
M01#HN*<6<[7QZNW!K.XEI56$=SM=PLZ7VR;+JTO$V[UZC-?:J-)JHGMDUI0Z
M$&&RWCCG,*T<0,BM=LCX[!P2<U"APLA@/F=Z(W#0X;4CKF4DHR2:T(:2NB32
M:C[8@&4S3C??;3P"M/&O'K?$;E3$1')-HGI<D-%O3AL*2A;:VU=JLM23/E3R
ME4!]8_Q5XGS8UKX@9#C=NMO!E=@>O5WN;;QKN:7&8W6DIMDU52EUPJ,M:5?N
MSJI9*[4!KK'Q(W6'8L1XA7W[G+$\LNRK8_C41>J[6R(Z;B8\I;QNGUBBZI2G
M4FRE-%)(J& US(OZC;^-LVL5;B.WU5C2U%7<5+*&T9V\R-QU+?;K2DOT$&DU
M'^D7*"? Z%P:XZS\OQK.KCQ"CQ($WAZ^ZF[R[8E:8[T9I+RC4AMQ2C)9&PHN
MZVU($-=+XALS;X6M<='[;;EX8]>3MW]+H;<3.;MQ.&R3Q33<,E/]8GN3:)%
M,&$^(.Y0KQQ=^'Z[VUSKK=<)+4R([R:F9$N(X@S+F,TJ("'3+CQ:RG(>.,O@
M_P .V[='58HIW&_WN[,O2DFLB0HHS+33K.G:ZVE3AJ,^ZH7:[0Y%\*UU;M.:
M<=;YD!HB-P'SFW7J5&\VV3$J:Z\3:E$DUD6E6DS(C,$RVM/Q,7*/B%FXIW%-
MI1B%WO*K8YBK:ZWF);#6XVB:IXG3U.DII2E-FT2#294/G!#-YGQNS3&>.5OX
M3V>T6^^PKS"3+M1_O(TDW7VG3:0X]K6@FTK:UN.$V9]76A:J .E\.9O$B?C[
MSW%.UP+3DR9LAMB/:W.LCK@IT]4Z?;N4-1ZJ=MM21&9$9T 1J^*Q\HW'7A!(
M43BDLNPW#2RA3KIZ;JDZ(0@C4I6S8E)5,$P^.+]P8^)?BMB>/<).M7-P]3TF
M_P"02FUV\X3:I+7_ &Y!-O&;"FSV$BNM1$7. [OQ/XL_TIFF)\/;0J(QD.6N
M+==NMS,BAVZW,ZC<?4C6V3CB]"R:0:R34MI\A AHLWCGD]RP;BK&L\FV,9UP
MZ4X7WO'0IZ#,MZM9-2H[9*42'S)%#2:UH2JA[2V ,;PBR7/<0^&!6<IDVJ9$
MMEOG72VQGX\E<MU\K@^N3O;IOT7UAJ4:5())D=*U E1R3XF,WLW S$.+L:UV
ME5PO]QDVR=;'&WU,)ZI4CJW&E$Z2D]JQ125&=35LY 3@W+CQQGR?A$WAEQM4
M&'<K=DCI1Y\1YEQ<IM22:6HXZD.H(S4EPTI2HNZ(@0R$_,.-MBL_$7)<GQZS
MVFS8];CNN*:'53%/DPA3KK$DT.I-2M)$E2B2@DK[G4D!RN;\3'%J/PDL?&,[
M)CR;%)NJ[5/MI;TJ3(2DW*+;5KTL$75FC]-1GVW)L!."5D.4U.AQ9S)&EF6R
MU(;2KNB2\@ED1TYR(P0K                        YSQ^_!7./5BO*M@'
M '\%<']6)\JX Z,                       #TC,C(RV&6TC 1NO/"+,>&
MO&UWC5PQM:<AL=Y)Y.3XNRZW&G(*8:3D*C=::4.$:R)]*=5=1:>0ZD'68^89
M7D1,Q\:P^Y69UQ:2EW/*VFH<:(S4C6:667G')#II(TH2BB-6U2Z<I#0+SP^O
M6(_$:UQNM-JE7O&KO 7"O42VI2]/B2R82RAPF5*2;C:R:14T5-)F=2!+!\-.
M$N6XEB7%S*KQ:GE9=Q"1.^ZL:96TY*:9DE(4REY1*)M+BER.W[<R0E-:UV -
M,1PGXGE\*CG"P\3F_P!:'>RE%"UQM&[]83W6];UVC30M/+75S G'99;BIP\X
MC93#X)?<V(W!US"X\961M*5%0IA;"HA*;1J?(G%?N%F6C933T["%/.+C,A?&
MUCMT@6QZYOMV9MW[M:6VS)6V<.3K)OK32@W$I,U$A2DZJ::D9@GP-FX?<)\A
MR3BAQ,XHY=;)&,VW+H,JR62VS.K.>4>8VVRN0\VTM9(HAI-$ZMIF?,53(8K@
MCBW%;AA#F\-+UPWB7GJI;CEES-3D0K>AF1W2Y"UD;JFTG^\2A!=8==%"Y0)9
M?/,%SBZ?$W@V>V['Y4S$,=BQH=RNS),-M=86\:E-LJ=)9H3UJ:T3LVTK0#P/
MGA=A_$7'>+_%K,IF-2[;"RA$M[&I<CJ'4+?;>4ZP3J&W5*3K[4R29?(8#"VG
M@_=I?%[">(.,XE<>']W87OW$)E:F$V:NA)N-PC:=7UAR#-:%(06DB.JB2=:C
M%3R;!>/&7Y-Q28R'&F+Q#N4"3;\%N<F>TU;[?$4:C2B''/761(;)M"G#2A1*
M3VRR29@+SW6\1K[\(Y<+WK"=LS* M#D6W29+!KEH8FG)/2:%&EM2DJ,D)<5M
M,N:H)\*MGF)<3,N^&:U</F,+EQ\FBM6F$W .1%6Z?W:1=>\Z9.DAMM1E^Z(U
MFL^<B!'A4<MX09?=,:X,YA;;/(7E/#AN!'OV,N*91+>CPU,K=W8S<ZM:DJ:5
MH+66M*J\U &V8O@F07_XA[OQSN]ME63'H<!%NL-NGI0BXRW=V2RXZ;*%*-ML
MJN$G6>I1Z0'-L#X8\3+'8N.D:XXC/:DYS'>+&VM451O*D.2B)*S2\9-F1/H4
M>KFKT .R?#9C&1X7PBM.)Y9:WK1?+;(F]?'?-M1*3)D+>0I"FEK2I.E1$>W8
M=2 E<W6TRLVXDHC95B]R3A=BB+;L%Q-9,,/7249E)DFJ-(2\A*64I9:-1=MK
M7LVD"''>,_!G+;5Q/Q+B#P.QB9*NMH-#UW,Y!''=7'6DVOWTR0:UFMLULN$6
MPDD0)AL?&_ N(E\RO!>.7#FRNO9-CB&V[EBLM3;4PFD.J<).Q9I45''&EZ%&
M>DR4FH$.@WYG/.*/"_+;-/QM.)S+S:WH5GMEPEHD2U2%I,S4\IFK;+9GI0@C
MJKE4JA -(X>8/Q!E?#A=.$E]QQ6/WINUW&W1'ITIE294N2ZXZT:$L&YH:H:4
MJ6L^ZY",BJ Y!>N%?&J__#YC/"^+@$MBYX[=GY4Q^1*B(4\3JI"D[NWUFU!$
M[VZU*+;33JKL)QV79>,=KXNY%<>'T?&L<?O'#U*&7,OQ=4MFW+D/MFG]Q/6I
M9D;))21Z>V0H]6HCV AC>#.#\1.'W%;B=?<@Q,V[%D*5R8$FU/L.1J)<<=;C
MQFS-"UF9.$A):$$G2=:%0!JW#/AIQ,QK@;Q2PJ\8C/9R7)W'%VB(A<9Q#I26
MDM%5Q+VE.@RJK49;.0!U_@?A-PA\"X'#?/[,];I!,SK9=H,HVE$XS-<=41M*
M;6M*JH74J;247)L :_\ "YP]OF#8]?H^0RE2C@W:?9;"1F1MMVZ+(-3SC1ES
M2'ZK/]4!W9^4<)E<PF'I1L%K*-%03C[E/T4),TD9_E 1I^&#!>(/#_*\ZEYE
MC$ZTQ<J>:?M\DU1WFD=6](<4ETV7EFC8ZDBV=($NK\;V>)<CAO<X_"8UIS!U
MQE"5,+0U**(:CZ[=UK,B)RE-M25IKI[:@#A$/A;Q1@<2^$^:1>'K5OMEBAIC
MWB#$N,=^0B4:GNOE3GUFDC<=-[K5'^\4=#(S-6P!MMEP3,T_%7D7$.=C<YK!
M+O#=MC%T,V.54=EDW%-DZ;B6S-M5%&GDH=-H'@:I@W#OBIPOPGBEPDCX=*OL
M:_HE.X[D$9^.B"ZVY'-@^M-:R6EPT$C0V2#,UU3L+M@3+K/PSXCEF"<*H>*Y
ME:%VB[1)4E\FUO,/=8W*7UA&74K7IIR&2@1+:>+^!L<2^&]_P]Q!*F2XYO6M
M9\J+A&_>1S(^:JBT'_A48##\*N'MQLG!N)A^5/NGD5XM:V+[(=,G'V528N[-
MLF95KNK.AHBJ?<GT@.5\$<5XK<+X<[AI>N&\2\DU+<<LN9*<B%;T,R.Z7(6L
MC=4VD_WB4(+K#KHH6PP)9G.,+SB?\3>$Y_ QN9-P_&X;4.X72.3"$*=-$A*E
M-,*=)9H2;R.0NFG)M#I?%>V/WNUVZQ2\35F6(7%]YK)[>QU92X\=+)J9EQE+
M<:,G&W"H1(5K57M=I .2<,>".4V;AMQ7Q)A4NW6#+4R(^%VB]J0B4TGJG$)?
MDI;-1-&Z9MI,N6B:J(@,7-;EPKXU7CX>;%PJC8#+9NEAO#\V7(DRHB#>2\N0
MI.[M];VR4D[VZU*(N33JKL)QV7=^)N,_US:;5CF7X'<;OB!V5MW[QMK;)WNS
MWILR;TH0;I&M+B*:DHU)[4C41I/80S7P\87E6 \*[;CF8.+^\VY$F1'A.K2Z
MY#B/*(VHZE(-2=14-9I2HR2:J .C7:2[$M<Q]F&_/>ZEQ#<.(E*WW%+0:2))
M*4DN4]IF8".WPB8'GW#"'DEGSC&IEI<NDF-,A2U*COQC)A#B5H6IEU9H/MBI
M4MH)E\V#ASE?"+,>+$BU8_/R.Q9]$>7C<FUDTZIJ6Z;RMVE)6M!M45(V.'5&
ME-:U.@(6+GPZY=:OA9G\,X!,S,[FS6[Y*A(=239NI<;,XS;JC)!K2VV6VNDU
M5*O."<=EL>3Q^.LCX>K78L'L4C'<UAQ[?:I<4IC'WHJ%'8ZN0ZPMM9):-3A(
MT=OUG5U/M3!#4+1POXF6OC5PWSR/P_9MF/6NU-V^=;X=QCO+B.);D-N.S'UD
MG6Z:GNM6HM:E\FHU -HPG#,WM_Q1YCQ&N.-3HF&W^(["@7)PV#+K$HC))3C:
M736E"NH711IZ*\H'@=9XG-YBO$^LP".4O+(]RMDB%'6X3+*VV9:%/I>69D1-
M&UK)?R .=\9K).XQX8YA_N\N#6:NJ:*#<;FEAJ%:G$K2;KI7)MQ9.-$G41(:
M)1N5+M2YA#4^-O"7,ID?@_CV&6>;D,# DL)NMR0;""-N.<9):2>=0:EJ)E2M
M)%LV%7: S[.(9HY\6CO$IS&IS>#NVXK85U4;%.L.(EO6;9.]82-54UT_+R -
M+R+A]QYS![BHSE.+,W>X7%A<7#KU(N#*(L."A[K-VMT;MJ+D(2@C6?5G5/;J
MV@,CD6 \2;O\*%IX9-XC+1F+*XL<K>3T9:B:B2#?4\XKK"0V2B.B4FHU >%U
MZVXC-R3@3&X>7F.]9+I)QQ%AEMRDIUQY2(Y-:_W:EI4@EE4C2?;) <PX&V7B
MIA5@:X:Y%PTC*FVV0ZU$S.0J$JW)@NNFX:W3*KSQI,U=4EO:JJ25HH9@2R!X
M9FK?Q:IXF%CLU>$,V\[=]ZEU!DIQ,(V=9-=;UF@U["/3\O( PO!;A)EJ+=QA
MQG.[',Q^WY^IQ=MG.FPZE+;QR2V]2ZLR6CKD*TJ+;0P&!/A1Q,?X#Q?A\/')
M#60-WPWW\@4MH[']W]<J3O)2=>H^Z))-Z.LV=R"<=EL/%;A?ERLUX.)P_'IU
MYQKATB(U<[BT;"-;+#L<S-M+KJ5+7H94HTD7+L!#)JPG..'7Q)W/BI8L>EY3
MB&80U1Y+=O7'1*A2G4L]J\E]QLB22V2/76A)4?.FAA@^"G"'/XEQXOQ<[L"[
M%:N(*)4>+.3)8?0TIQR56B4JZQ2?WY&A6@JD7-4"5?@;CG%;AU:'>&=^X:Q)
MS\64[]UYDXN(=M1&DJUK6^LR-YU*%&:T)06M5209)I4"66R'#,V>^*S'.)$7
M&YLG"K1 1;9=U:*.1&[U$AOK$-&Z2S;)3R:F2=A5Y: >!(FFVG_4!%[C]@7$
M',N+^!Y/B^*W"X6/$G8J[C-0<9HG.IG%)7U"77DJ71!;#H53 A5XQ\(<XA\1
M;)QUX'6UP\I<>2K(,?4;<93E4T-QQ+BTIH\BK4A.JM:*+:9F"8E5XT83Q#R?
M)<#XUXAB:Y=ZQ]HHU[P>YFP<CJR<4HTI/4IMQ!DXXC6DZ]RLDGMH0Z#>++E'
M$+A?EUG1BD;"I5ZM;L"SVB2J/OBWS2:M<A<8NK:0HZ(;1M/E4JE2(!J'#[!^
M($OX;KGPDON.*Q^]-6JX6Z(].E,J*5+DONOM&A+!N:&J*2E2UGW7(1D50''[
M]PKXU9#\/F*\,(N 2V+GC=W?E3'I$J(A3W6[R:38;ZS:V1/46M2B[:FG41F9
M$X[+J_Q$X=G.?1^&18KB\^<=ADHN5X29QVE1TD3">J,G'DZG?W:C,DU+DV[0
M1#KW%.+<LAX89;;+-;Y$N[WNT2H4&W(2A,CKYC1H0E9+4E*=)J[<S5L(!%^Y
M\(N*DCX7[)PN8Q":O,(M^=G2HIN14MMQ?WRR<ZPWM*M76)21$=:UZ 3CLI>X
MZ3Z<>M")4=V'*;A1FGXKY$3K3C324*2HDFHJD9<QF"&2
M       !SGC]^"N<>K%>5; . /X*X/ZL3Y5P!T8
M           !S"X<%H<_BW#XQ_U#,9R* A,>)"3'CJAIC$TMDVE$9:U&:7%]
MOJK7;S .H'2NPJ%T /                          !I'$;AE XC'C\A^\
M7&Q7/&9Y72U3[6ILEI>(DD>M#R5H5W)4,RV;2VD9D8;9:[9"LUNBVFW(-N%$
M;)ME*CU*/:9FI2CVJ4I1FI2N<S,P%V
M
M.<\?OP5SCU8KRK8!P!_!7!_5B?*N .C
M
M
M       YSQ^_!7./5BO*M@' '\%<']6)\JX Z,
M
M
M             #G/'[\%<X]6*\JV < ?P5P?U8GRK@#HP        "C+F0[?
M&<FW"0W%ALE5U]Y1(0DOG/GZ"+: ^F),:6PF5%?:?BJ(U)?:6E;="Y3U),R*
MG/T *<*?;[DR<FV3(\Z.E1H4]%=0^@EERI-39F1& ^M\A[W]W[RS]X$GK#A]
M8GK]%*UT5U4IMY.0!6 46YD-Z0]#9DLNS(^V1'0XE3K9<G;)(ZER\X [,AQW
MF(TB4RS)DG2,PXXA#CAUIVB5&1GMV; "7+B0&=XGR&HC&HD=;(6EI&L_T:K,
MMOR *W09&1D9$9&6TC(]I&1ERD8"C(F0H9LIF2F8RI"M$=+[B&S<5T)U&5>7
MF ?<AYF(RY(ENHCQV=KKSRB;0FIT*JE4(JF ^F5MR&VWHZTO,NI);3K:B6A2
M3YTJ34C(!2BS84Y"W($IF6VVKJW%QW$.DE?09H,Z& K
M
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MD J?2 5/I *GT@%3Z0"I](!4^D J?2 5/I *GT@%3Z0"I](!4^D J?2 5/I
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MK)))0BG:E6IF8#8@2          #G/'[\%<X]6*\JV < ?P5P?U8GRK@#HP
M             ]J=*<U:T^7I >    ](Z;2Y>2OR'R@/
M                                          !C+SD-EQYA,B\S6XC:
M]C9+.JUG_A255'^0AXW;]%J,:IP967REW,3A;IFIKD;BQA$A[J3GJ8J="<?9
M<;;/_P!QIH7Y1AT]HV9G#'!9U]A9NF,>;CO3#<V7F9+2'X[B76'"U-N-J)2%
M$?.1E4C(6,3$QC"DJIFF<)C"7V)?(
M                                       .<\?OP5SCU8KRK8!P!_!7
M!_5B?*N .C
M                            "TNEP9M5NEW.1_H1&EO++D,R0DSH7ST'
MG<KBBF:I\#VLVINUTT1IJG!%F\7B??[B]=KFLURGSJ23[EM'Z+:"YDI__<:5
M=NU7*IJJTNLY?+T6+<6Z-$>7=E9#R9#HG"3*)-LO;>//.&JU7'43+:CV-22(
MU$:>@ED1D9=-!;=FYB:*^9.BKSM:[>R5-RU-Z(_-1IW8_P .]#:'/0
M
M    <YX_?@KG'JQ7E6P#@#^"N#^K$^5< =&
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MG'<GE;7$G0Y[1/0WD/-GSH.M/G+E+\HL*:Z:HQB5!=LUVIPKB8E<#[>0
M
M   #G/'[\%<X]6*\JV < ?P5P?U8GRK@#HP
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M=JX7_M/:+&W>HKT2UZ_D[MG6C8V_ R(]F&
M                                       .<\?OP5SCU8KRK8!P!_!7
M!_5B?*N .C
M                   (J?&G_#89^O</S1Q4Y_33P\3?.Z>M<]7WD2A6.A
M   #(V*R7')+O$LEI:ZZ?-<)MI/(DN=2E'S)255*/H$O*Y<BBF:I3,Q/&+=A
MM@BV"V[6F"UR)!E13\A1%UCJOG,MA<R:$/IJURY-RKG2ZGAEBZI!7B4FCSA4
MBH/]%L^57SJ_-\XM<I9P_// U'M;.<Z?A4Z(T[^UP>=N L6N@  P]RQBTW.J
MUL]3(/\ [[/:*K\O,?Y2&-<R]%>^L<OVA>L[$3C&U+4+CAMUA57%I-8+O.U=
M(OU3V'^0Q77,I73HV6Q9?M:S<V*OR3Y/&UY1*0YI41H>0?(=4K2?_0R&'H7$
M3$QL;,2SMMRV[P*(=64R.7Z#W=D7R++;]-1EV\U73NPJLQV79N[,?EG<T>)M
MUMRRTW#2VMS=9)_]IZB:G_A5R&+&WFJ*MR6NYCLR]:V<.=&W#.D9'M+D&4JP
M                                          >+-26W%H;-U:$*6AI)
MT-:DI,R21]*C*@#G.%Y#?\NB_?\ ;;NAZ4@H1W:R&PV4>,M;SJ),2AT<;=:0
M526I1ZC+:6W9*&5SIW-+=;YE_P >NK,?[O-&XV-41$A,]:EI233KJ^W)QTU:
M4):IIV<NT0*V?98C%;/$6]+39YMS=2P5P7'7.9@DE'6/.N(01DHD4T)U&1&9
M@+29DEQQ? I.3S+Q&RN5(4T5EE1V418KJYBTLQT494K4DEJU+56NRFP!??>=
MUL&5V;&KO-^\X]^C238EJ:0RMJXP22MQ"2;(BZIQ!F:$G4TFGE.H#:02
M      #G/'[\%<X]6*\JV < ?P5P?U8GRK@#HP
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M*V=IYI]!.LK2XVKN5H,E$?Y2&=$Q.S"DJIFF<)C"7V)?(
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M&9+))I0E^<VEIA@ZD7[RAJ4M'*DBVB!NX)          !SGC]^"N<>K%>5;
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MN+9"B/OERANSK?*A$M+1KBJ(I$=27#4=4$HE(7^D5:D1D V$$@
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M=B^&U/!/*VR%<8-Q;ZV$^AY'/I/:7SERE^49]%RFO1+7[MBY:G"N)A=#T>(
M                                    \)""=<D$A)2'B2EYXB[=:45T
MDH^4R*IT ?>M??'L+3\M.CY@!*U)V).G/^4N<!Y4S/49]MRUYZ@!J,^4^<S_
M "GRG^4!X           #G/'[\%<X]6*\JV < ?P5P?U8GRK@#HP
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M^A/8 -W=]+=^A/8 -W=]+=^A/8 -W=]+=^A/8 -W=]+=^A/8 -W=]+=^A/8
M-W=]+=^A/8 -W=]+=^A/8 -W=]+=^A/8 -W=]+=^A/8 18^,YM;<;#=3JG:K
MN%-=-FR/T$*G/Z:>'B;[W2UKGJ^\B:*QT(  &Q81B$_-\ACV.#5#:OWLV52J
M6(R#+6X?YDESJ,B$L;,7HM4XRF7:K7 LMMB6>U-%'ML)LFH[9GR(3M-2CYS,
MZJ4KI'TU>JJ:IF9TRB_QDXAEF-Z*U6MW5C5J6I,=2>21([E;Y_)^BW_AV\X^
M9E?Y++_#IYTZ9=(^#9"G,JR8DNJ:I;FC,T4J?[\ND9^2UYWN1K/>SJJ.EQ)B
M;N[Z6[]">P+ES@W=WTMWZ$]@ W=WTMWZ$]@ W=WTMWZ$]@ W=WTMWZ$]@ W=
MWTMWZ$]@ W=WTMWZ$]@ W=WTMWZ$]@ W=WTMWZ$]@ W=WTMWZ$]@!XJ*M:32
MN2XI)[#(R09&7T"$QC&A@9V$6V2:G&'5QWU;:H).BI]*2H7T4&)<RE%6C8E<
M9?M6];V*OSQNZ?&U2XXQ=[;5:FMXCE_WF*JV?*GNB%=<R]=&[#8LOVC9O;&/
M-G:GE8EIUQEPGH[BFGD\CC9FE1&7RD,>)F)QA854Q5&%48PV"#F%T8429KBI
M#/(:D:4N%])4/_H,VWG*HUME29CL>W7LT3S9\<-MMMXM]THF-<7">/E8<)*'
M"_(9;?R"QMWZ*]$M=S&1O6=:-C;C0R>[N^EN_0GL#W8)N[OI;OT)[ !N[OI;
MOT)[ !N[OI;OT)[ !N[OI;OT)[ !N[OI;OT)[ !N[OI;OT)[ !N[OI;OT)[
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M:20VE/>DDB(B+Y %*)!@P&U-0(K,1I:M:T1VTM)4KI,D$5?D 5P
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MC(ZD>TC(9:I
M !SGC]^"N<>K%>5; . /X*X/ZL3Y5P!T8
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M*T&2B/\ *0SJ:HF,84==%5$X51A*H/I\
M                   YSQ^_!7./5BO*M@' '\%<']6)\JX Z,
M                                                           B
MI\:?\-AGZ]P_-'%3G]-/#Q-\[IZUSU?>1*%8Z$WGA;@#N=Y 34A*D6"!I>NK
MZ=E4F?:LI/OW#*GR%4^83#!S>8^%3L:92X<<@VR$IYU3<*V06:J5W+3$=E/_
M $2E);!]-<V9G;F4/^)6=2,\R)<\M3=GBD;%JBJ_09K4UJ+OW#[97Y"YA\ME
MRMB+5.[.EIPAF "3'P9?W7D_JUK_ '!"PR6OP<C1^]G54=+B3(%RYR
M               *;\=B2V;,AM+K2N5"R)1?08^:J8F,)?=%=5$XTSA+5[E@
MT-ZKEL=.*YS-*JMH_P#U(8-S)TSJ["\R_;-=.Q<CG1M^%J-PLUSM9GOD=1-%
MR/H[=L_RER?E%?<LUT:8;%8SEJ]JSL[7A6T29*@N==!?4PL]IF@^U/YRY#'G
M37-,XQ.#VNV:+D85QBVNVYTXBC=U8UEZ0QR_E0?_ *&+"WG9_P!H4&8[&B=F
MU/!/*VV#=(%R;ZR$^ETB[I)'VQ?.D]I"PHN4UZ):_>R]RS.%<8+L>C'
M                   -A$9F9)21&:E&="(BVF9GS$1 -:BYS:I;K:FXLW[I
MD''3$N_4UC.;XM3;*J$>M#:U)HEQ2=)UY@1B]R'.;-C"W#N4:>Y BJ2FY72+
M%4]"AFLR(NO<(RI341JTDK21[: ,I<[S!M90TN&J1*N3A,6R)&(G'I+AH-P]
M!&9$24H+6I:C)*2Y0%!G)[(Y:)U\>D[I M:G6[KO*=#L5V/3K&W$%4]6TM))
MKJJ6FM0'U;L@B7"<JUK8D0+H4=,U$*:@FG7(BU:2=025*(R)7:K374@Z5+:
MRH)          !SGC]^"N<>K%>5; . /X*X/ZL3Y5P!T8
M                                                     !%3XT_X
M;#/U[A^:.*G/Z:>'B;YW3UKGJ^\BQ9[1/OUTB6:UM&_<)KA,L-ELJI7.9\Q$
M6U1\Q"M;]<KBBF:I\"9>&XG;\*Q^-8;?1:D?O)DHBHJ1)41:W#^3]%!<R2'T
MU:[=FY5-4N-\>>(>\.JP2S/?^.PHE7QY![%O).J8Y&7Z*#VK_P 6S]$1*SR.
M7_WJX'"A\KH  $F/@R_NO)_5K7^X(6&2U^#D:/WLZJCI<29 N7.0
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M\SK+S,AI+S#B765E5#B#)25%TD9;#&5$Q,8PKZJ9IG"8PE]B4
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MM'<+(E)H9**BBKL,N4MO* \
M                         $5/C3_AL,_7N'YHXJ<]IIX>)OG=/3<]7WF)
MX(\//Z:M7]3W9K3?KJT6[M+*BHT->TBV\BW>570FA<YBNAL&<S'Q*N;&B/.S
MG%;B C!;!2&LCR.Y$IJVHY3:26Q<@RZ$<B.E7S&)EXY:Q\6K<C3R(C+6MQ:G
M'%&MQ9FI:U'52E&=3,S/E,S'PV>(P?()  !)CX,O[KR?U:U_N"%ADM?@Y&C]
M[.JHZ7$F0+ESD                           !C+EC]JNM526")[F?;[1
MSZ2Y?RCPN6**],,W+YZ]9U9V-J=#4+EA-PBU<@+*6R6W0=$.D7YC_P"@KKF3
MJC5V6Q9?MBW7L5QS9\C6G6G&G#8?;4V\D]K;A&E1'\QC"F)B<)7=-451C3.,
M-+RC)[G=5*M!RW5V>*K2EDU&:7%IV&I1\ID1]R1[!@W[]5?Y<?RPSLMD[5N?
MB13$5SX6N4*E*;.@8C/;9@68R\4NK#2W5*L4IQ+<R,9F:$:STDZ@N8TGW5.4
MAG9/-39KCT9T\JG[4[/IS5N9P_/3&Q/%*20W!S                  ?#[+
M4EAZ,^G4P^VMEU-3*J'$FE15+DJ1@-9CX+"0^TF;<)EQM<8HAQ;?+6E1:X!J
M4R;ZTI2IXD&HE()9\I55J!"^DXRW,E3W95VN;MON9UEVE4DMT,J$E2$=IUB$
M++NT)61'MZ0%U<K)!N905JUQ95K<)ZURXNEMR,O0;9D@C(TFA2#T*09:3(!0
M:Q>QHL\^QO1SE0+JIUVZG(4:G93LBFMQQ94/5L+2::::%II0!]V_'XD"<JZ.
M/R+A=3CI@HFS5I<=1$0>HFDZ4I(JGVRU4U+/E,$LJ      *2941;ZXJ)+*I
M;95<CI<0;R2^5!'J+Z %4   '.>/WX*YQZL5Y5L X _@K@_JQ/E7 '1@ !SO
M.L[X7O*R?AIF4I;RF+ _=K_;T,O*TVG276+0X@J=8DC2XDDGJ+89;0$2VKIP
M!?F(:O?&#,<CQ="R4C%93,TFY"4G5##CJCTFDS(DGVB?G($[*?.DTI0DT$W1
M":-)I1!:2HDJ=!; 0\
M                    ''.,N(P<MR3$G[BI#MOL)RY4B$>TWG7>J)E*B[PC
M;-2NGD%3GL)JCA;?V!75;HN3'^V$8^/'SL7?+W;\>M4R_7AWJX,-!N/*+NE*
M/8E""YU+/M4D*]?T435,4QI0RR[*;CF5_E7ZY'1U\]++!'5#+"-C;2?D27TG
M4Q\MIL6HMTQ3#!B'N    DQ\&7]UY/ZM:_W!"PR6OP<C1^]G54=+B3(%RYR
M                             "VFVZ%<&^KF,(>27)J+:7S'RE^0?%=N
MFK3#VM7[EJ<:)F$4I\9V%<)D)].EZ/(=:6D^4C2LR&C5TS35,3X)==M5Q713
M5&B8B?(MQ\O0ZM;QI8:(U.NJ2VVDMIFM9DE-/RF&&.P8Q3LSHA+B(VMF*PRX
M>IQMM*%*Z321$8WRB,(B'&ZYB:IF-M6'T^
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M=P@7%"W+?+9EMM*T.*CN)=)*N@S29TKS=("X
M                 65VN;%I@N3'MNG8V@N5:SY$E\X\KMR**<99.6R]5^Y%
M%/\ \ARJ1(D3Y3DF0K7(?5J4?-\A%T$1;"%!55-4XSI;_;MTVZ(IIT0BKQIX
MB%E=V*PVA[5CEJ69$M)]K)E%VJG?E2G:EO\ *?./.9;'DLOS(YU6F7*Q"S
M   $F/@R_NO)_5K7^X(6&2U^#D:/WLZJCI<29 N7.0
M             ',^(?#)R_257RP&A%U61%*BN'H;?TE0E$K]%9%LV[#%-G<A
M-R>?1I\,;;:>R>V8L4_"NZO@G:_PY:K!<S2]U!V.4:ZTU$E)H\(E4I^44GRE
M['#FRVR.T\I,8_$I='X?\+9-LFLWW)-&]QSUPX"#UDVYS+<46PU%^B1;"Y:B
MXR?9\T5<^O3&B&L]J]MTW:)M6=$Z:MO<AU<7C4
M       ![HZVK6G42R-)I/D,E;#(_D,@'$+C\6W""R7=5B;D723;XBCCNWFW
MPU.VQKJ3T*T*)1*6A-*:FT&714!T)FTO9)E%DX@M9(4_&X\%Y5BMD9A&[N)N
M3:2.2J3UAJ<,T%VA:2(J@-L   !SGC]^"N<>K%>5; . /X*X/ZL3Y5P!T8
M<>XW\;<$X<H;P_)[;/OTR^PG'9=MM9))UBW+-3?7K6:DFD]23ZO2=2-.JI;
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MI *GT@%3Z0"I](#2\TOIT.RQ5[5$1S%D?(D]I-_EY3^05F;O?Z1PME[)R?\
M^U7J\O(U:U6U^[36X3%4D?;.N%^@V7*?_H7RC!M6YKJPA>YG,4V+<USP;LN5
M?&1%9A6W!XD=.AAE5P2A/R$4?\XR<Y3%/-B-J>)\]U[E5RY=JJTSS?>10%<W
MX      $F/@R_NO)_5K7^X(6&2UYWN1H_>SJJ.EQ)DU/I%RYR5/I *GT@%3Z
M0"I](!4^D J?2 5/I *GT@%3Z0"I](!4^D J?2 5/I *GT@%3Z0"I](!4^D
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M      "3'P9?W7D_JUK_ '!"PR6OP<C1^]G54=+B3(%RYR
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MC&;2J.C'[]<E,*?N!N$OK30;!));22)"DK4DE=M0ZF W,
M                                         !2DR68D=R3(42&6DFM:
MCYB(?-544QC+[MVZJZHIIV9ERF[7-Z[SES':I2?:L-G^@V7(7SGRF*"[<FY5
MC+?\KEJ;%N*(X9VY;+AECU&5ZE)V;2AH/Z#<_+R)&;E+/^\\"C[6SG_XT^MR
M<K=A:-914^-/^&PS]>X?FCBIS^FGAXF^=T]:YZOO(E"L="      !)CX,O[K
MR?U:U_N"%ADM?@Y&C][.JHZ7$F0+ESD
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M"^K;U(3R$>@MA AX
M             Y[F%\WZ1]VQE5B1U?OE%R+=+F^9/Y_F%/FKW.GFQHAM_963
M^'3\2K6JT;D?Y\S'8_9E7J<3:B,H3-%25])<R"^57YAXV+/Q*MQFY_-QE[>,
M:TZ.7@=20A+:$MH(DH21)2DMA$1;"(A>Q&#1)F9G&7HE"*GQI_PV&?KW#\T<
M5.?TT\/$WSNGK7/5]Y$H5CH0      ),?!E_=>3^K6O]P0L,EK\'(T?O9U5'
M2XDR!<N<@
M    'R          #X?>9C1WY4A1HCL-./.K(JFE#:#4HR+G,B(!Q2_\3<FX
M3\)G>)'$*ZLWV]71+2<>L#49F$REZ81N,(6XUV[BD-?O'S*B=AI3S&8A?<*L
MIXPRBQUWBHQ:SC9C&?EVM%N;5&F0'&6MY0U);,S2I+K-5%0]3:B(E5U; [
M  #G/'[\%<X]6*\JV < ?P5P?U8GRK@#HP  T[.(>%V.SWO.KYC46]38D9+C
MJ51&9<N2IDB:CL-FZA=#4I1(339MJ CO<^(F<R&I]L3\.UEM[[3L:)+?EG%)
M$8YZTI:-XNI;-*7"5I)>I)$?/4J ;"7:DZ#)!5+01)H9ZC+21%2O/3DJ ^0
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M=&/,I_UCT88[^J,H_P#O;C_-O?M#S^+7MSXV5\CE_P".CV8/ZHRC_P"]N/\
M-O?M!\6O;GQGR.7_ (Z/9@_JC*/_ +VX_P V]^T'Q:]N?&?(Y?\ CH]F#^J,
MH_\ O;C_ #;W[0?%KVY\9\CE_P".CV8/ZHRC_P"]N/\ -O?M!\6O;GQGR.7_
M (Z/9AXK*,HTG_\ KMQY/2WOV@^+7MSXR,CE_P".CV82[X?O/2<(Q]^2ZMY]
MR"PIQUQ1K6I1H*IJ4=3,S&UY69FU3CM.+]JTQ3F[L1&$15/G;(,E6
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M%I,TI/36M*I*A5Y_G!#Y
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MRP    !XKN3^8"$S>'/]AXYZOC_Y"&WY7JJ=YPWM?ZV[TZO.V<92J
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M%GUB%$1HHD]H&PE6>K82E:UD1$M=-.I1%0SIS5/;0!X
M                                    &9)(U*.B2VF9\E ',,EO9WB;
M1D__  (YFE@N91\AK_+S?)\XH\Q>^)5L:(;SV?D_@4;.M5IY%QB=C^\Y6^R4
MU@QE;",MCCI;2+YD\ICZRMGGSC.B'CVGG/@T<RG6J\D?Y='%TTP   !%3XT_
MX;#/U[A^:.*G/Z:>'B;YW3UKGJ^\B4*QT(      $F/@R_NO)_5K7^X(6&2U
M^#D:/WLZJCI<29 N7.0  0?R3^Y+WZPF>76-*NZ\[[OF3^GM]"G]L,8/-E@
M   #Q7<G\P$)F\.?[#QSU?'_ ,A#;\KU5.\X;VO];=Z=7G;.,I5
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M7M6NFQ#9<JC_ /3Y17V[<UU80V',7Z;%$UU?_9=7A0V($5J)&3I9:3I27/\
M.?RGSB_HHBF,(:!=NU7:YJJTRKC[>0   "*GQI_PV&?KW#\T<5.?TT\/$WSN
MGK7/5]Y$H5CH0      ),?!E_=>3^K6O]P0L,EK\'(T?O9U5'2XDR!<N<@
M@_DG]R7OUA,\NL:5=UYWW?,G]/;Z%/[88P>;+     'BNY/Y@(3-X<_V'CGJ
M^/\ Y"&WY7JJ=YPWM?ZV[TZO.V<92J
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MFLN9$NUO$=N0LCD-ID(5U*E(Y2)9E0C$#4+K(:R7"^'-KMIDJ;.N%H=-A/\
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M<]*=^KV #=W/2G?J]@ W=STIWZO8 -W<]*=^KV #=W/2G?J]@ W=STIWZO8
M-W<]*=^KV #=W/2G?J]@ W=STIWZO8 -W<]*=^KV #=W/2G?J]@ W=STIWZO
M8 -W<]*=^KV #=W/2G?J]@ W=STIWZO8 -W<]*=^KV #=W/2G?J]@ W=STIW
MZO8 8J_W#[F@F_O+JI+G:1VC-/;+^79R%RF,>_=BW3CX6=DLI.8N<WP1IWG-
M5K=>=4XX:G9#JJJ/E4M:C_.9BBF9F=UOD133&$;$1YG1L=QX[7$);CJD3GR)
M3^BE"Z$D9ES"[R]GX=.SIEI':&<^8N;&K&CE9G=W/2G?J]@92L-W<]*=^KV
M#=W/2G?J]@ W=STIWZO8 -W<]*=^KV $6/C.;4W&PW4ZMVJ[A3739LC\E"%3
MG]-/#Q-\[IZUSU>-$T5CH0      )*_!LVIS*LF)+BFZ6YHZHI4_WY=(L,EK
MSO<C1^]G54=+B3$W=STIWZO8%RYR;NYZ4[]7L &[.>E._5[ (0ER,J9'>BK6
MEPE[3Y3_ 'ZQI5W7G?=]R?T]OH4_MAC1YLL     >*[D_F A,?AVPM6"X\HI
M#J2.!'/26FA?NRY-@V_*]53O.&]K_6W>G5YVS;NYZ4[]7L#*51N[GI3OU>P
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M22$)3T$DB(B+Y %*)"A0&U-0(K,1I:M:T,-I:2I729)(J_( K@
M                   "F^^U%9<D/K)#+234M9\A$0^:JHB,9?=%$UU133LS
M+E5YNKMYG+EKJEHNTCM'^BWV3Y3%#=NS<JQ;[E,M&7MQ3&GPSNM@PRQ]:LKS
M*3^[09E#09<I\AN?^B?I&7E+./YYX%1VMG,(^%3ZW)RMY%JU8      $5/C3
M_AL,_7N'YHXJ<_IIX>)OG=/6N>K[R)0K'0@      28^#+^Z\G]6M?[@A89+
M7X.1H_>SJJ.EQ)D"Y<Y  !!_)/[DO?K"9Y=8TJ[KSON^9/Z>WT*?VPQ@\V6
M    /%=R?S 0F;PY_L/'/5\?_(0V_*]53O.&]K_6W>G5YVSC*50
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M*H;+4I7;L:#36H(;XDB2AM)%ITH0DRKJVI21'M/EY.4$O0
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M=YPWM?ZV[TZO.V<92J
M          #TFA9+3J2:%EI+89F:3(B 1E58OB2B2(^.3^-&+P;F\VEI-FE%
M&7+)*TT)!H5'JLR(Z<G; ._X789>)8=8L4F7)VZR;/"9A/W!ZI*>6TFAJTJ-
M1D1<B2,S,DD0#-@   YSQ^_!7./5BO*M@' '\%<']6)\JX Z,  ,)F.2,X;B
M=ZRN1$>GM6:(Y,5"C?ZKW5EL0DZ'2IGM.FPMH#B+W&KXB":6HN!K[!$DS)Y4
MMQTFRIW1H)LC53ET\X"1)4TH-*M9*0E6LBH1FI)&9TY@
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MJG><-[7^MN].KSMG&4J@
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MWCKL)222I*4I-)<A&DB(Z?0"'@
M             +6XSV+9#=FR3HVV52(N52CY$E\IF/.Y7%%.,O>Q9JO5Q13I
MERB=-?N$MV=*/]ZZ=3+F2DN1)?(1"@KKFN<9;_8LTVJ(HIT0W;#K$<5G[UEH
MI*?31A"BVH:/G^=7YA9Y2SS8YTZ9:QVKG.?5\.G5C3NS_AM8L%
M(J?&G_#89^O</S1Q4Y_33P\3?.Z>M<]7WD2A6.A       DQ\&7]UY/ZM:_W
M!"PR6OP<C1^]G54=+B3(%RYR  "#^2?W)>_6$SRZQI5W7G?=\R?T]OH4_MAC
M!YLL     >*[D_F A,WAS_8>.>KX_P#D(;?E>JIWG#>U_K;O3J\[9QE*H
M                                                 .AI61IUZD+2
M2".AF9I,B*O-M 1(?:XP6>Z-8M</B/L5LOB=#)VA_=UO,KY":6M3>U1=SVQU
M,!UKA[@'&NQ94S=N(O$9O*;''CR&V[6U'./^_?224.F:4()1)*M-5>78 ZZ
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M7<G\P$)F\.?[#QSU?'_R$-ORO54[SAO:_P!;=Z=7G;.,I5
M                          /%MH>;<9<(S;=0II9).BM+B32=#YCH8#D]
MFDRN'UQ3AF9)^\,66BWP+-D32=+;"6W7%0F9R"VH7JV)=3VM2*O*)0VG/R,K
MG@>HNW+)V",^?^&?$#(Y9C]TO[$(K1>E669;Y!S&7=V;EM..D@T()U#GZ*=1
MGLV@.?9=D%ZNG#V3:K[&:AWF%D5ML5_*(1[H\RJ2TLW6R/:2'D*09I/DY!(V
M[)UK8XL82N/L<E1;S%E$7Z45"$.%J^1*R*@@;D"0  *F1*425+4E*E$VCNE&
MDC,DE\ITH0")D3)N/-PMEAXH7[B39^'^+7^2\BU61^,TNWQFFD.N-M2%+2CM
ME=4:*:S7\Q]J029PS(YN68?9,BFMI8D72(W)=::-9L&I52UM=825=4Y3K&]1
M5T**H#-    YSQ^_!7./5BO*M@' '\%<']6)\JX Z,  -*XM6+ ;[@%Z]Y4=
M+N+6^.N=(DDDCDQC9*I.1E4-273/M2T]U72>PP$4V,J^&Z#*;DV#@=D$J\L2
M66H3,IIY3"Y"UH-M*DG(<+4HC)24F@ZU+90P2G&Y76=:U/;MV&5>8RYC($/D
M  6\^?!M<1R?<I#<6&UW;SJB2GD,Z%7E/9L(MH#ZBRXD]A,F"^W*CK[EUE:7
M$UZ*I,Z'\G* ^F9,:3UAQGVWR96;3ILK2X2'$T,T*-)F1**NT@%,I\ YRK84
MMD[DE.M4,G$F\2:5VHK7DVTY:;>0!<<NPN4!;L7"!)DOPXTMEZ9&_B([;B5N
M-T.AZDD==A[#Z#V& /SX$:2Q#DRV69DG^'CN.)0XY4Z%I29UVGL+I/80#V;.
M@VUDI%QDM0V#5U:7'UI;(UTKI+4>TZ%4!7(R41*29*2HB4E23(R,C*I&1EL,
MC(!;R[A;X"F43Y;$5<@],=+[B6S69&1=J2C+G.E>0!4E2(\%AR3->1&C-4ZQ
MUY1(0DS.A$9GSF>PBY3 >L/,RF6Y$5U#T=U.MIYM1*;4GI)1'2@"E#N%ON2%
MN6Z6S+;;5H<4PXEPDJY2(])GR\W3S +@                        !C;Y
M=VK-!5)513RNTCM=\L^3\A<ICPO78MTXLW)Y6<Q<BF-'AG<<K===?=6^\HW)
M#JM2U<ZEJZ"_Z$0H9F9G&6^TTTT4Q$;$0Z1B]C^Z8?6OD6_R")3Q]X7,@C^3
MG^4766L\RG&=,M*[1SGQZ\(U:='*SPRU4            BI\:?\ #89^O</S
M1Q4Y_33P\3?.Z>M<]7WD2A6.A       DQ\&7]UY/ZM:_P!P0L,EK\'(T?O9
MU5'2XDR!<N<@  @_DG]R7OUA,\NL:5=UYWW?,G]/;Z%/[88P>;+     'BNY
M/Y@(3-X<_P!AXYZOC_Y"&WY7JJ=YPWM?ZV[TZO.V<92J
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M?%F ;XW]F[XLP#?&_LW?%F ;XW]F[XLP'VW(0ZK0E#B3H9U4@TEL^4P%4$@
M           "SO-J@W^T7"Q71"G;;=([L.:AMQ32U,/I-"R2X@R4DS(]BDF
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M(!4^D J?2 5/I *GT@%3Z0"I](!4^D J?2 5/I *GT@%3Z0"I](!4^D J?2
M5/I *GT@%3Z0"I@/             !6CJW>L0;B#;<)39;341H,M)%\O( A[
M?('Q)8,UC=JNW&*V6NX7^1$M]CL+J4NS"WEU#*"49Q#/2UJ+6X9TV4J9T =)
MP?&N-^+\3<?;XK9Q'RBW38EU*WP8J#:ZM]EE!J=674,ZB)*M)'MH:OE =Y
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M54[SAO:_UMWIU>=LXRE4
M            ](R356DUF25&E)<IJ(CH1?.8")5EX0<*W;C=6^.7$&'>>,>0
MLKCN-/7%HG+0\[_IDQJ,B-]HZ:==$%32E--IC%U7A)P)?X:7R;DN0Y=<,RR)
MR,NVV^1<#<T0X+CB7%H0EUUT]:S0BID9$7-R@.O@   YSQ^_!7./5BO*M@'
M'\%<']6)\JX Z,  ,%FKU_C8A?)&*I<5D3<-Q5O)A"'9!+*FHV6W#)"W4HU&
MTA6Q2Z$8"*4;C;9K)8+[@W#NZY5F/$JYW=B7C;]U;=W]F:MIE+I/]82")I*T
MK2;.C29&==AZB&"9?;4(W"2EPTI-Q*#JDEF1:B(^@CJ \
M                          6\Z:Q;XCLR2K2TTG4?2?01?*9[!\5UQ3&,
MO:S:JNUQ13IERBX3W[G,=G23HMSD3S(07(DOF&OW*YKJQEO^7L4V:(HI\'EG
M;;CAMB-ALKO+31]U-(R#Y4MG^E\ZOS"RREG".=/ UOM;.<Z?A4Z(T[_^/.VX
M6+7@               $5/C3_AL,_7N'YHXJ<_IIX>)OG=/6N>K[R)0K'0@
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MP                 14^-/^&PS]>X?FCBIS^FGAXF^=T]:YZOO(E"L="
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MQ7<G\P$)F\.?[#QSU?'_ ,A#;\KU5.\X;VO];=Z=7G;.,I5
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MS:AQ%4ULMJVJ4OH6JE*<Q#9.S\G-'YZ]/@AH?;?:E-Z/A6IQIB=F=N=S<AU
M735                 !%3XT_X;#/U[A^:.*G/Z:>'B;YW3UKGJ^\B4*QT(
M      $F/@R_NO)_5K7^X(6&2U^#D:/WLZJCI<29 N7.0  0?R3^Y+WZPF>7
M6-*NZ\[[OF3^GM]"G]L,8/-E@    #Q7<G\P$)F\.?[#QSU?'_R$-ORO54[S
MAO:_UMWIU>=LXRE4
M        'ITKU$9EH50D]T9Z3I3Y:\@"-%V7\9N-8Y+OLW),:^[K5%5+EI>2
MT<E,=A!J6;BE,)0:TI+MNVVGS@.X\.;A,NV 8S=;A=&[W<)MN8D2KLQ7JI+K
MI:E+21I09%4Z:326FE*; &S    YSQ^_!7./5BO*M@' '\%<']6)\JX Z,
M,%FMFB9%AU_L5QN!VFW7""^Q.NB5)0<:,::NNZE&1%I02MIG0@$,;3C/PH7J
M_(Q"S<1LFC2W5E#MTR4O1;5ND>E"=2V$EH,RIV^A)]()3L5JV$LB):4I2HB*
MA521%L+\@(>                                        \,B41I41&
MD]AD>TC(P%%F%#CK-<>.TTL^52$)29_E(A\113&B'W5<JJV)F95Q]O@
M             $5/C3_AL,_7N'YHXJ<_IIX>)OG=/6N>K[R)0K'0@      2
M8^#+^Z\G]6M?[@A89+7X.1H_>SJJ.EQ)D"Y<Y  !!_)/[DO?K"9Y=8TJ[KSO
MN^9/Z>WT*?VPQ@\V6     /%=R?S 0F;PY_L/'/5\?\ R$-ORO54[SAO:_UM
MWIU>=LXRE4
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M[E R:)BN0;NY*ND-V;;Y<-"VV^MB&12(ZDK4HSTDHE-KKVQ5J50&Q D
M                                    14^-/^&PS]>X?FCBIS^FGAXF
M^=T]:YZOO(E"L="      !)CX,O[KR?U:U_N"%ADM?@Y&C][.JHZ7$F0+ESD
M  $'\D_N2]^L)GEUC2KNO.^[YD_I[?0I_;#&#S98     \5W)_,!"9O#G^P\
M<]7Q_P#(0V_*]53O.&]K_6W>G5YVSC*50
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MSGI3OU>P ;LYZ4[]7L &[.>E._5[ !NSGI3OU>P ;LYZ4[]7L &[.>E._5[
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MSTIWZO8 -V<]*=^KV #=G/2G?J]@ W9STIWZO8 -V<]*=^KV #=G/2G?J]@
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M-MMI)"$I+F)*2(B+Y %.-$B0FU,PHS,5I2C6I##:&DFH^<R015,!5
M                                   $5/C3_AL,_7N'YHXJ<_IIX>)O
MG=/6N>K[R)0K'0@      28^#+^Z\G]6M?[@A89+7X.1H_>SJJ.EQ)D"Y<Y
M !!_)/[DO?K"9Y=8TJ[KSON^9/Z>WT*?VPQ@\V6     /%=R?S 0F;PY_L/'
M/5\?_(0V_*]53O.&]K_6W>G5YVSC*50
M          #Q:T--K==5H:;2IQQ9[:(01J4>SH(@&H6W-9]S;8NC%GUXY+1"
M>COHD).8B/<'5M-ON-:=)IJDC4A"M22Y:\Q#(Y#D%UMDMNVV"PN9%<^J.3+C
M,R68G4,&HT-J-3W=&M1&1)+F*H#V7D3\5ZRVG<4GE%[;<>1;5O%U49N.@E/N
M//)2=4-FHD=HGME'LZ0%S8+ZQ?H\M26CBS[;*<M]T@K42U,2F:&9:BH2D*2:
M5H5SI/I!+*@            .<\?OP5SCU8KRK8!P!_!7!_5B?*N .C
M
M   (J?&G_#89^O</S1Q4Y_33P\3?.Z>M<]7WD2A6.A       DQ\&7]UY/ZM
M:_W!"PR6OP<C1^]G54=+B3(%RYR  "#^2?W)>_6$SRZQI5W7G?=\R?T]OH4_
MMAC!YLL     >*[D_F A,WAS_8>.>KX_^0AM^5ZJG><-[7^MN].KSMG&4J@
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M!7!_5B?*N .C
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M7E6P#@#^"N#^K$^5< =&
M                             14^-/\ AL,_7N'YHXJ<_IIX>)OG=/6N
M>K[R)0K'0@      28^#+^Z\G]6M?[@A89+7X.1H_>SJJ.EQ)D"Y<Y  !!_)
M/[DO?K"9Y=8TJ[KSON^9/Z>WT*?VPQ@\V6     /%=R?S 0F;PY_L/'/5\?_
M "$-ORO54[SAO:_UMWIU>=LXRE4
M                           YSQ^_!7./5BO*M@' '\%<']6)\JX Z,
M
M       BI\:?\-AGZ]P_-'%3G]-/#Q-\[IZUSU?>1*%8Z$      "3'P9?W7
MD_JUK_<$+#):_!R-'[V=51TN),@7+G(  (/Y)_<E[]83/+K&E7=>=]WS)_3V
M^A3^V&,'FRP    !XKN3^8"$S>'/]AXYZOC_ .0AM^5ZJG><-[7^MN].KSMG
M&4J@
M   '.>/WX*YQZL5Y5L X _@K@_JQ/E7 '1@
M                                           $5/C3_AL,_7N'YHXJ
M<_IIX>)OG=/6N>K[R)0K'0@      28^#+^Z\G]6M?[@A89+7X.1H_>SJJ.E
MQ)D"Y<Y  !!_)/[DO?K"9Y=8TJ[KSON^9/Z>WT*?VPQ@\V6     /%=R?S 0
MF;PY_L/'/5\?_(0V_*]53O.&]K_6W>G5YVSC*50
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M']6RFW7XX_Y/^7W%/T2S?RKW_P"0'SES</ZME-NOQQ_R?\ON*?HEF_E7O_R
M^<N;A_5LIMU^./\ E(GX?N)F0\4<7N=YR1N*U+ASSAM%";4T@VR9;<VDM:S,
MZJ/G&?EKM5R)Q:?VWV?;R=VFBWCA-..SORZT,QKX
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M$I,^4?=&9HKG")V6/F.R<U8HFNY3A3&['*Z ,E4@
M#TB,SH6T^@!CD7ZQNW%RT-W*,JZ-&1+BDZG7J.O:EMHI6PZI+:70 K3+G;+<
MIE%QFL1%R#TL)?<2V:S(R+81GR5.E>2H"[,C29D94,N4@'@
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M!(             YSQ^_!7./5BO*M@' '\%<']6)\JX Z,
M        ,#DD#();;J[*]'6PY"D0Y5LE:T$ZMTJMNM.)J25I[GMBH9'S ABS
MP)FYVW)FKZ\DKCE>[G+7#29-Q506DMQC:-9U6M!I):EJIJ/90B 9"/8+G+OU
MNR+)),=^;:(KL6 S#2M+1O2B2E^2OK*&2E)224H*I)J>TP&Q D
M
M                                     !3D-K>COLMNFRZZVMMM].U3
M:EI-)+(NE)G4!I$O$LCR#_\ 3<F?A*MIG;'9LV*EPWI2[8ZIY)-(7_HJ4K3U
MBM1T+8FO-*&5E8W<X]VOESQR7'B?U*TVFXIDH6KJ)339LE*8)'=&;9D2D+H6
MI)'7E$#+V.S0<=LMOL%M)10+:PB,P:SJM1(+:I1]\HZJ/Y3!*_
M    '.>/WX*YQZL5Y5L X _@K@_JQ/E7 '1@
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MAJ34B):2/E-%2 74V^V6W2D09\]F/+<)"B:69]JEQ6E!K41&E!+5L2:S*O,
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M)I+EU4H H63*<;R14ENP76/<789D4IMA1ZV]7<F:5$D])\RBV& RP
M                           YSQ^_!7./5BO*M@' '\%<']6)\JX Z,
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MK0 QFV,.9;D^804I:MMU1%@Q^K+2B4Y"U==+H6PR-2NK2O\ 2))GR -N!(
M                 #G=]DW"+QBL3ULA;_)_IR:DV.O1&H@Y:*JUK(RV4+9V
M!*&SQ(+62V*:UE-I;CO7I+L6\P#TN&;;2UM-I4X6Q9I01&E9?.0@:;BWWW+=
ME<*;^LY3.-J:7/NAF6JX61SMH32J5/6Y30__ ($&7Z0#J.I6HE%L,J4IS4Y*
M EHV<8Y;KI8(6%6V,VB;,F,28:DI(UQ6XSZ7Y$TU<I&1$:=1G52U$0(5K(ZY
M,XR92X\LS*W6JU1H*5<J&I3BGG3+]=1%JZ: +#A9'C/V.23Z$N-6"^WB-9W'
M=J&(_75[4CV%H(U)(_T4U(3(O\2L<)R=E=_3&0BQY/,8=B0S11IYF(T39RE-
M\G[]9&LMG;)(C/E$"TCS"+BTH[U:7K=<9EH<B6":EQIZ-,CQW>ND=8;>U+B>
MUT(5R)KT@-\!(                                 YSQ^_!7./5BO*M
M@' '\%<']6)\JX Z,                                         ;>
M:E>:O)7Y0&MXOC,['I]^FR+@U,3?YRKFZVVPIDV7E()&A!FM>I!$GGV@AL:E
M/)2:HYH)\BJV;A&I!*YC423(S+YC!+7<(QB3A]E.R/3T7!HI$B4V^EDV%DJ4
MX;JTJ+6LC(C/M:<P(9FY,W"1 D,6J6F!<7$&F/.6UO!,J/\ 3)LU))1D7<U.
ME02URPXSEUH?A-S,J;E6>*LW78,>VMQ'7UG4ZN/]:M1ZE]NX=*J/G!#YE8*3
MT6\V2-.*-BV025S+E!2V9R$*?-)R6H[E=*6WS356I)FFJM/+L"M?,<R>X72+
M-LV01K3;X#9(@6Y=M3,0TLDZ3=U*=35>GM$G3M4["Y3 92!;[S&LST.X75-R
MO#_6DNX.,$RR1.EI)*&&U=JE">0M6T]I@*6)6)[&,;MV.NRDS2MC)1VI26S9
M-;:3,R-2=2J*V\QT 9H$@                   -;LF-3[3DM^R%^>S)3D"
MF%O14,*;-@XK?5MDA9N*U5+NM2?F!#9#-954BG6%M2:JFG5S5IMH"6MXAC,S
M&$75N1/:G(ND]^Z*-#"F%-O23(U(*JUD:"ILYP0S\I,I<9Y$)U#$Q2#3'?=1
MUJ&W#+8HT53JIRTJ0):C:,4S.W+9:DY@W(MW7[Q/:9MC<>5*49ZEZI'6J,E+
MH1*42>YV%0$+J;A[KB[^Q;+B4"UY2KK+PSU6MYMU;9,O.15ZB2DWD%1>LCTG
MVQ= #YO.+7R2];&\=O<>RV>T-(;A6UR F<@G&DZ$.*-;J*FA)41LV<O* \EX
MYF$RQNVQW*T*N,I[7+N/W>DD'&(J%';82Z1(2K_N*U&:JGR +VPVC)K?(-R^
M9 W=(C;),PX,6 W;V6CJ7;*)"UZJ)+2@MA) 9\$@                   -
M:D8Q.>SB'F29[*$0X+MK1;S84>IA]PG%K-WK.[J6RB: ALU:GMY/_0$M9MN,
M3H&8WC+79[+J;S'C1'8*6%(ZIN%JZLT.&X=5'J[:J?F!#9BV<I5^0$M'_I3/
MDRILQC-(S+T]577"L[:W$-%W#3:U/'1+9=P5.6JCJ9F"&9E8]);O;>1V.8B+
M=SA)MDU4MLWVI##2M;3BR0I!]:VK49'6BB49& QDC")L?&H6,8Y>$VZ(RXM^
MY2)41,UR>XZLW7.M3K;227%F:EI+E*B>3E"\AV7,V8L\IF5M2;D\TAJV/)MK
M;,:*I)U4M;!.'UIJ(B3W1:2Y %Y$LTUVY1+U?Y3$NY0&76(3<-E3$9HY)$3S
MI$M2UJ6LDDG:=$ER%MJ S()                                 '.>/
MWX*YQZL5Y5L X _@K@_JQ/E7 '1@
M
M
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M=:(,].PZ$>SYP FW#+423-/+6ATH0 ;:R3J-)DD^0S(Z /2:<,M1(49=)$=
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MT+G-6T,1<EPY&-YC;YC\>1&M.36Y<5IMY2X\9M]<3K.KUJ,TMZEKY>U(S.E
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MH;2ETT$5"3J(JZ2+]'D 6\>Q6*&X3T.TPH[Q+4ZEQJ,TA1..=TLC)-24?.9
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MW&(M-U:6R@T,TY#;2942?RI ?;$"!%==?BQ66)#_ /KO--I0MP^7MU$55?E
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M!P!_!7!_5B?*N .C
M
M                                                    YSQ^_!7.
M/5BO*M@' '\%<']6)\JX Z,              /2(U<A5IM/Y@'A44DEI,E(/
M82TF2DF?R&6P    !Z1&9T(JF?(0#PC(RJE1*3S*29*(_F,M@  $:3,R)1&:
M=BB(R,R/Y2+D_*   #Z2VM152DS*M*ET@/3:<+E2?+3DY^@!\T[HRH9)/2JA
MD=%=!TY#^0!]$TX=#))G7:5"K4OD ?
M
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MVJ(CV[#K02.R61BZQ;+;8M]?3*OC$5ENY24;$N24H(G%%R<I\_.(2O@
M
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M5D9JJHM@"O;\?R5O(X^472Y0'9C=I5:'H<>.ZADS-WK$K2I2S42:D6JM3YB
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MN/H25"6\A1F76&7=&G89[0&3!(
M
M                        .<\?OP5SCU8KRK8!P!_!7!_5B?*N .C
M
M
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M@'O^X*^W%L\)WS8![_N"OMQ;/"=\V >_[@K[<6SPG?-@'O\ N"OMQ;/"=\V
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ic_arrow-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ic_arrow-bw.jpg
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M%!04%!04%!04%/_  !$( !L &P,!$0 "$0$#$0'_Q !Y   " 04
M       '" 8! @0%"0$! 0$                   (!$   ! (( P4%"0
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;6/#*Q4'F_-%ZRJYF7AX/XD/9V5T)IVZ$O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>lg_veronapharma-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_veronapharma-4c.jpg
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M_\0 P@ !  ,!  ,! 0            4&!P@" P0) 0$!  $% 0$
M      ,! @0&!P4($  ! P,# @,$!@,-! D%   " 0,$  4&$1('(1,Q% A!
M46$B<8$R0B,5LW4WD;%28G*",S1TM!8V%Y)3<S6AP=&BLD-CP\0D1"6U=A$
M @$"! (%"04' P4!      $"$0,A,1($!09!46%Q$X&1H;'!(C)"<M%BLA0T
M\.&"PC-S-5(C%?&2HM+#)/_:  P# 0 "$0,1 #\ [^H!0"@% * 4 H!0"@%
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M>[>[;\AH6VA4@L*Y%CXLPS&N-T=O7&9O) @9--WC<;'+4D;&VWUMU!<:5"5
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MW]^97!A8D2U1W2.WV:VF8N>49TT%UTB$2D22'4S30-K:(E 7^A04 H!0"@%
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M5?#06V]$Z_,5"A)P;_8KG+D6^VW2),GQ$$I<6.^TZ\TAJJ"K@ 2D**J+IJE
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MW&;=L<L4&T7&Y" 3WX$=N,KZ-JI#W$:04)44EZJFM 3] * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0'JDQF9D9Z)(128? FG1$B!5
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MBZQB-P:5YK&VR!VULONFCG?A*J*3(&BEJRV79Z[A$5UU%"XT H!0"@% * 4
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M]51!U+W:I[ZK*&DS^,<#N\-TJY*,G.N$:]'75(T&K#7A0"@% * 4 H!0"@%
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M^VT:MD788<=$=R=415%-=.M3S=%4Z;Q_?7=GL9W;5-2TTKCFTCK#,>,,#PW
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'5C''10'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140409688139456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">PRE 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VERONA PHARMA PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001657312<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140409689047408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><table style="width:456pt;height:139pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <tr style="line-height:9pt;height:54.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:123.94pt;text-align:left;"> <div style="white-space:nowrap; line-height:9pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Year </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Summary <br/> Compensation <br/> Table Total <br/> for PEO <br/> ($) </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Compensation <br/> Actually Paid <br/> to PEO <br/> ($)</span><span style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Average <br/> Summary <br/> Compensation <br/> Table Total <br/> for Non-PEO <br/> NEOs <br/> ($) </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Average <br/> Compensation <br/> Actually <br/> Paid to <br/> Non-PEO <br/> NEOs <br/> ($)(1) </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center;"> <span style="letter-spacing:-0.16pt;">Value of <br/> Initial <br/> Fixed <br/> $100 <br/> Investment <br/> Based on: </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"> <div style="text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;"> <span style="letter-spacing:-0.16pt;">Net <br/> Income <br/> ($) </span> </div> </td> <td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:9pt;height:40.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="text-align:center;"> <span style="letter-spacing:-0.16pt;">Total <br/> Shareholder <br/> Return <br/> ($) </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:123.94pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2023 </span> </div> </td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">6,559,277</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">558,317</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,082,064</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">207,291</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">284.00</td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">(54,369,000<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:123.94pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2022 </span> </div> </td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5,183,140</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,578,945</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,142,941</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">17,462,808</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">373.29</td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">(68,701,000<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:123.94pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2021 </span> </div> </td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,123,304</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">823,718</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">650,336</td> <td style="padding:0pt;padding-left:3.46pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">425,254</td> <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">96.00</td> <td style="padding:0pt;padding-left:6.14pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt; width:4.5pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">(55,569,000<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> </table>
        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;"> <span style="letter-spacing:0.2pt;">(1)</span> <br/> </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">

          <span style="letter-spacing:0.2pt;">Amounts represent compensation actually paid to our PEO and the average compensation actually paid to our remaining NEOs for the relevant fiscal year, as determined under SEC rules (and described below), which includes the individuals indicated in the table below for each fiscal year: </span>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:53.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:-0.16pt;">Year </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">PEO </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">Non-PEO NEOs </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2023 </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">David Zaccardelli </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">Mark W. Hahn and Kathleen Rickard </span> </div> </td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2022 </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">David Zaccardelli </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">Mark W. Hahn and Kathleen Rickard </span> </div> </td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2021 </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">David Zaccardelli </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">Mark W. Hahn and Kathleen Rickard</span> </div> </td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> </table>
        <div style="margin-left:20pt; margin-top:3.5pt; width:436pt; line-height:11.5pt;">
          <span style="letter-spacing:0.2pt;">Compensation actually paid to our NEOs represents the &#8220;Total&#8221; compensation reported in the Summary Compensation Table for the applicable fiscal year, as adjusted as follows: </span>
        </div>
        <table style="width:456pt;height:172pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:344.51pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="10" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">2023 </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:344.51pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:-0.16pt;">Adjustments </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">PEO </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="text-align:center;"> <span style="letter-spacing:-0.16pt;">Average <br/> Non-PEO <br/> NEOs </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:1.917pt 0pt 0.5pt 0pt; width:344.51pt;white-space:normal;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; Columns in the Summary Compensation Table for Applicable FY </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(5,324,000<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(3,327,500<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.5pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY <br/> that Remain Unvested as of Applicable FY End, determined as of Applicable <br/> FY End </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">7,952,000</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">4,970,000</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.5pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY <br/> that Vested during Applicable FY, determined as of Vesting Date </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.5pt 0pt; width:344.51pt;white-space:normal;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(3,012,444<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(2,185,934<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> </table><table style="width:456pt;height:175pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:344.51pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="10" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">2023 </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:344.51pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:-0.16pt;">Adjustments </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">PEO </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"> <div style="text-align:center;"> <span style="letter-spacing:-0.16pt;">Average <br/> Non-PEO <br/> NEOs </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase/deduction for Awards Granted during Prior FY that Vested During <br/> Applicable FY, determined based on change in ASC 718 Fair Value from Prior <br/> FY End to Vesting Date </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(5,616,516<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(3,331,338<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were <br/> Forfeited during Applicable FY, determined as of Prior FY End </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase based on Dividends or Other Earnings Paid during Applicable FY prior <br/> to Vesting Date </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.51pt;white-space:normal;text-align:left;"> <div style="margin-left:10pt; text-indent:-10pt;"> <span style="letter-spacing:0.2pt;">Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">&#8212;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:-0.2pt;">TOTAL ADJUSTMENTS</span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(6,000,960<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td> <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(3,874,772<span style="position:absolute;">)</span></td> <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><div style=" float:left; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;"> <span style="letter-spacing:0.2pt;">(1)</span> <br/> </div><div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">

          <span style="letter-spacing:0.2pt;">Amounts represent compensation actually paid to our PEO and the average compensation actually paid to our remaining NEOs for the relevant fiscal year, as determined under SEC rules (and described below), which includes the individuals indicated in the table below for each fiscal year: </span>
        </div><div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div><table style="width:416pt;height:53.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"> <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:-0.16pt;">Year </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">PEO </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td> <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:-0.16pt;">Non-PEO NEOs </span> </div> </td> <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2023 </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">David Zaccardelli </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">Mark W. Hahn and Kathleen Rickard </span> </div> </td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2022 </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">David Zaccardelli </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">Mark W. Hahn and Kathleen Rickard </span> </div> </td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"> <div style="white-space:nowrap;"> <span style="letter-spacing:0.2pt;">2021 </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">David Zaccardelli </span> </div> </td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:0pt; width:6pt;">&#8203;</td> <td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"> <div style="white-space:nowrap; text-align:center;"> <span style="letter-spacing:0.2pt;">Mark W. Hahn and Kathleen Rickard</span> </div> </td> <td style="padding:0pt; width:0pt;">&#8203;</td> </tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 6,559,277<span></span>
</td>
<td class="nump">$ 5,183,140<span></span>
</td>
<td class="nump">$ 1,123,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">558,317<span></span>
</td>
<td class="nump">27,578,945<span></span>
</td>
<td class="nump">823,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">4,082,064<span></span>
</td>
<td class="nump">3,142,941<span></span>
</td>
<td class="nump">650,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 207,291<span></span>
</td>
<td class="nump">17,462,808<span></span>
</td>
<td class="nump">425,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img alt="[MISSING IMAGE: bc_totalshare-4c.jpg]" src="bc_totalshare-4c.jpg" style="height: 376px; width: 597px;"/>
        </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img alt="[MISSING IMAGE: bc_netincome-4c.jpg]" src="bc_netincome-4c.jpg" style="height: 380px; width: 603px;"/>
        </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 284<span></span>
</td>
<td class="nump">373.29<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (54,369,000)<span></span>
</td>
<td class="num">$ (68,701,000)<span></span>
</td>
<td class="num">$ (55,569,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">David Zaccardelli<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Total Net Adjustments For Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (6,000,960)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards Value In Summary Compensation Table (Grant Date Value) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(5,324,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">7,952,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(3,012,444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(5,616,516)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Total Net Adjustments For Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(3,874,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards Value In Summary Compensation Table (Grant Date Value) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(3,327,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">4,970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(2,185,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (3,331,338)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=vrna_NetAdjustmentsForEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=vrna_NetAdjustmentsForEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MX>(;:IQ6GFNMQ\(-C0J9)L?B?&&BLB@&A.L%_D7"D+ I;T:CQHAKPKZ 7T[
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MP%8!JQW@=_- 3;E]PA!6%=.&O<$X$L<8 K7HKM$H0K(3P>U>'^PM"<,X=B.
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M[\GF$U!+ 0(4 Q0    ( %"":%@'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 4()H6/L@A;/O
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ 4()H6)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " !0@FA89'=-'7<"  #S!@  &
M            @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ 4()H6$D[FKJL"@  XTH  !@              ("!NPH  'AL+W=O
M<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( %"":%@0[EPX\@(  "T/
M   -              "  9T5  !X;"]S='EL97,N>&UL4$L! A0#%     @
M4()H6)>*NQS     $P(   L              ( !NA@  %]R96QS+RYR96QS
M4$L! A0#%     @ 4()H6+),^V]4 0  Q0(   \              ( !HQD
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( %"":%B-]RQ:M    (D"   :
M              "  20;  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( %"":%ANIR2\'@$  %<$   3              "  1 <  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     *  H A (  %\=      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>13</ContextCount>
  <ElementCount>16</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>7</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="tm242772d4_pre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tm242772d4_pre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="PRE 14A" isUsgaap="true" original="tm242772d4_pre14a.htm">tm242772d4_pre14a.htm</File>
    <File>vrna-20231231.xsd</File>
    <File>vrna-20231231_def.xml</File>
    <File>vrna-20231231_lab.xml</File>
    <File>vrna-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>bc_netincome-4c.jpg</File>
    <File>bc_totalshare-4c.jpg</File>
    <File>ic_arrow-bw.jpg</File>
    <File>lg_veronapharma-4c.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm242772d4_pre14a.htm": {
   "nsprefix": "vrna",
   "nsuri": "http://www.veronapharma.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "tm242772d4_pre14a.htm"
     ]
    },
    "schema": {
     "local": [
      "vrna-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_def.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_pre.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "vrna-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "vrna-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vrna-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 16,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 5,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 13,
   "entityCount": 1,
   "segmentCount": 7,
   "elementCount": 256,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2023": 30,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://fasb.org/us-gaap/2023": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm242772d4_pre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm242772d4_pre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm242772d4_pre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm242772d4_pre14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r96",
      "r112",
      "r140"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r99",
      "r115",
      "r143"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r100",
      "r116",
      "r135",
      "r144",
      "r148",
      "r156"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r92"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r119"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r119"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92",
      "r136"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92",
      "r136"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.veronapharma.com/20231231",
     "localname": "EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]",
        "documentation": "This member presents the equity awards adjustments on the change in fair value (as of vesting date) of prior year awards vested during current year."
       }
      }
     },
     "auth_ref": []
    },
    "vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.veronapharma.com/20231231",
     "localname": "EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value As Of Vesting Date Of Awards Vested During Current Year [Member]",
        "documentation": "This member presents the equity awards adjustments on the change in fair value (as of vesting date) of awards vested during current year."
       }
      }
     },
     "auth_ref": []
    },
    "vrna_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.veronapharma.com/20231231",
     "localname": "EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]",
        "documentation": "This member presents the equity awards adjustments on the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year."
       }
      }
     },
     "auth_ref": []
    },
    "vrna_EquityAwardsAdjustmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.veronapharma.com/20231231",
     "localname": "EquityAwardsAdjustmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Equity Awards Adjustments [Member]",
        "documentation": "This member presents the total equity awards adjustments, which may be comprised of adjustments for (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal to the change in value as of the vesting date (from the end of the prior fiscal year); (iv) adjustments for equity awards that failed to meet performance conditions; and (v) dividends or other earnings paid on equity awards not otherwise reflected in fair value."
       }
      }
     },
     "auth_ref": []
    },
    "vrna_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.veronapharma.com/20231231",
     "localname": "EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]",
        "documentation": "This member presents the equity awards adjustments on the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year."
       }
      }
     },
     "auth_ref": []
    },
    "vrna_EquityAwardsValueInCompensationTableForTheApplicableYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.veronapharma.com/20231231",
     "localname": "EquityAwardsValueInCompensationTableForTheApplicableYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Value In Summary Compensation Table (Grant Date Value) [Member]",
        "documentation": "This member presents the adjustment (deduction) for equity awards value from summary compensation table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r96",
      "r112",
      "r140"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r93",
      "r109",
      "r137"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r103"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r100",
      "r116",
      "r135",
      "r144",
      "r148",
      "r156"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "vrna_NetAdjustmentsForEquityAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.veronapharma.com/20231231",
     "localname": "NetAdjustmentsForEquityAwardsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Net Adjustments For Equity Awards [Member]",
        "documentation": "This member presents the net compensation adjustment for equity awards, which is comprised of equity awards value from summary compensation table, net of total equity awards adjustments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r174"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r135",
      "r144"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r98",
      "r114",
      "r142"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101",
      "r117",
      "r145"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101",
      "r117",
      "r145"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r93",
      "r109",
      "r137"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r94",
      "r110",
      "r138"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r95",
      "r111",
      "r139"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r102",
      "r118",
      "r146"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r97",
      "r113",
      "r141"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001104659-24-032407-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-032407-xbrl.zip
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M3^/Y_G>!10=UL72:';=@\!<APD,6;3!K)T6QO+5]<X[6SE7ZU&82_DWXQ2]
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M"EH'6HT$/29#/ZF&PEU=C/ETMZH@EM&]2\81,\K<UKL%#X)%!(@;!_/0VY7
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MEOSW<ZY,&E.V7&0N//.J(RYE!:XUO!;7/9*'N$)F%@5YMO6VS[Q@<;?H^\#
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M2TY,F.>KB=;FB<9>O(B@;EP$.#7\,I'&]=@\A,WLO"DE/"(Z>XL3)EJ'@ZV
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MJ%SE-U%M,^LNO")BD,^DU4WYT:/@ATLRE.?>E&\K33&F5+]?X$A),O-4"4M
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M6#C?)8%"5+(^52MV^]2>A'+?,'G_EZ[GAY_Q20O6K'FS9PXG4KRJ.K0ME,.
M=<-&XBWEP^ZGHZYRB+.DX:@JBF6D]%@XTRD ?U4!RROM,CH,-^[/L@D>*U%[
M+I%XR4>6.D ^9==_IFZ-V74^)#LK_UO>>>2_YCG^/^9;"T+Z18$[XQRJ'[_^
MEOIQH0OMGP]ZAC!(:C"_-'?L^QVU/7]";<0F>//!_'@N'JXXIK$OMW^=5;FN
M>YJ_ ]-QUHO:#6<[,FQZJ(%8]?G["WG@/MFMZDD>B6PS]=ENASG3<9D[WX#<
M S_E[(H9^/=1(FJKNTU,U[<=!Y1N'7K14HM3]38?_XMFZRF?( \KR'?*UGRE
M+,2!1YW+^&IL^<T26%%O @  >.@R59)SR,VT<6WSZ3.?9I?@'KZIY13MX/P*
M+Q_^/N4[5\3E_&7HP@]]>;XN[(\I4EOORL!NF<:;@T1SNMM?6#^W(T6C1[^/
M)+&?DIWR]=-,SOA^I*V*A+O_$/<<ZA[<N"_T5Z="79#9?ER?0'W0G25Q'T79
M+%<Y<9#SPUX7U"ZB57(_H4@;?\P@>L:O2:+DR[EX\NZ)>DE)2%?A#!D*8U66
MAWS::ZS3E$Z/?\W.LZ52D<U]S,">'&%X%A86SU;WZ)]MU?TY3-3=/#XW%.UC
MU58Y4ZJH>];" [G*'L_&G5\] PS_*8(Y(\BDY7S78X90=5J56)QZPUNND%\I
M1L7'#+="(L7?SGS_PY;.?Y35$M)[S%!UHW#-V'0<X_,CM,OAD#](9:%NM^CO
M:EN]:NWG9BAY(+!4KZ<^>.U5>[#YYN.?,T2)1^+IL]/_ZME6:Z6 8P9?4) V
M7TI+"T:V25[KF*%/06_@TNA&@^9BKBA6,2-<%KM@Q>0J?.^U,$I^S1I5MX=J
M- ]C<K_@(]3%E34UO^KQM%G&,%'*SNND2Y9-FW)2FP<7[.3K5=!C[45;'C"0
M%NJOG"$CD71OW#F@2/M5>3&;]U_$DS4SP2SGT_K32E?+1'FY\W% H;OM.M$;
M/#DBU>I$^,DPXN.ID!$%8D]=LX8#FEY<-H: C=>V/:!XX2QNF<NP\?D -"R&
M&YO.*=8'/ARIQJJ'+X6H-4T2?(V%'ZP")2'"SXLB50:7_TA(<_#L/1,EJ 1_
M&:ICTOJA\O\7T9Y! @B@E>RZV(Y59L.5(;+48Y9F?;9^#\QU#H^DQK<S(]Z:
M_%U^6S(I[^[?NG7V)W5@E*H?]ED*FNNE@ZTD74-Z2+Y#Z :-,MVGK?K>NC?'
M[GW7DV6H)3.>@Z\>-[NQ7^H+:KKCH= V]B*E^E=\9%U$!.=#;MH[/\[:DVR.
M'_["?F'*WATV;[R]A+;]7(=,KH5;=\6*?<9L*40%+LFZ*IV="584B=^7<!^9
M]U%04,],\QHZE?^12WY\*C=@C3@5ENH^O6OX$WT7  MYL9=I4QON?KJ,Q1,Z
MJM.M;]D]:5WTYNW7WX7"S22J(M?J>8#'"5X[#UYQU;ISY5SOUOJM:'+:[7OA
M+WNX'P0:O>2[%;X3MQ)7JI/3@V";L[@)2AO_Y0VO:"3V52EBO953T\O$5F[=
MW3$-L:;6; 1&6Q"+Q+7B_;_@N=!JYM97>+I[<X&M'X;M=^46NV=;:X/4E(+3
M0-@+ ^+M[.YUL2E88SG@V5.U?-JI,!>]<UK+-9+52(=RW;'> N844)??)HY=
M/RLT\L;C@/K.@QL4LNBPVATS<)^H[T)=O$_ILQ0"<[*ENRW'+I*;SU"1Y]ZT
M0AYO"MSI02 @8O;P+&1@%(]M3Y\-\B97M]?OOT!VGK< .K/"E\YW9[A^OD^6
M^U$$KO<60U\-H"W%#:.R]T6C[SS6O)GB'Q;DP<;VM6U#0LF-S6E2>I5@3K O
M>S!*;K@</MQ^'Q"3Y^/T(N7J]/\%8K1(U@I^SL#18QV\B-F=.JH5(*X_MA>?
M]>K*O,J1CO()N_)5NZAZ@<T=<<SPT?AT;J?CU-U9.5S$HT[@)%PQL6]N]=3I
MKY?(+2/F1/)G$NH,..A(KRP0@-D5<QL2<W(G OE5=1HWY-P^EF=4AQNIT(%U
MHQO?OBJ_O/^9]][[24JCX:WP=E_44S-::$YT8:@<EWYP!'S<:_4P53BNK('-
MB$=1ESML5\>.K_@_F\3@:!Y5/U0,/_SXNU+1,AS/039"YA>.&=(Z?OY.XGT^
M:T9_;SN$.D]LS_Y>XX6[9LFYL(,)QG<_JV;SM_$9-A^LI3M:_[(I"CV5\_5U
M-6[[O.?\BWA/.Z^AE4GG\OEG&W-K7-:,8+7ZW'$&X/R)!IJ8 LS'K9A.<L3Z
M(=$*KA;>:T7/ G@+\^MD1MV+SEBN8@2M6^2?*(A\XWJ2N8C.LN%^+-XY3[65
MT '/6)"KX/G!14S+5%+1^0P245B"3]S'K.V801$_>*J$IZY0/$9LNZB#YY@!
MJDB7BXEA(6^"\ ZX1GE;963\*=/%641Z.-,C3&Y[=KW[[=/ 4&$>XY3&:_[^
MZ5P2_@(]KV)93^-77XT^V!M:"@2( ""SORR#.ZBV[6Y@O+RGN?1%>=_5R,4<
M8^9-9>F#+R#?+#XN7D91",O7W>@$O>D1^_"S!V3:NVKVSK8%QD"KZ3/YU5)+
M0N, <+S>,0.7_HP6M2]EK,XC'</)NP6@03(L0="NS4U-@WI8-RU) BX9UOZ]
MD[S"T8>#W<JRYD@PB]4_M9'4*DLGX50L)G7XAG:+>N2)P]3*9?AA_]X:ZUKL
ME0T:7AHFVB<-ZM[+=$JU5)54:4!)2F3&^!@B.J=AXW<XC7.ZTG,O!%E=>UUC
M&J$OT] D27<WZRN2CG=A2+ZZ1<18.KZ?KL^%"FM0=^9:DAXG.DG:%[@V+9=M
M@Z-7%M-G(Y?<FA)OSU1D)NY,OGG> =8-C$U^R-M]$XIT+U&Z1&=-BJB^JQP)
M^[#C5M%6%4XHW"L8]C@H^F(Y\74B5>W\7>/+&6G(5..;(GBND&A#UR:Y'U*N
MJUF-HJLB3-@OSTOD JXZXG6?Z+0/FY7V"=9\$F=\?H;/J<&%MW.5,;S9U$U*
M:X>2>$-AUX2H'G/&9K4EZ8S!J'L9]FZ7UMCCBY80,A=.4:02/'$YKG+8>-"]
M.=\[$YU\=IY<&VA<8O=K=:MCNOQ:-"[MWH:B@!<LSFMHZLV2[ F[;,<M]L01
M1#>YR. '7IB2T.CL93XZ,V ;U!:$QO55]:(AT13'L1KL;;2<I;SV8<G)JWDH
M9I_O&X)2U6KRF$@?*]E3P>M(,%9(!)"5/4RLDE06NKR,30)-T3W,7#4/XYY0
MOF!?["K-UN1E$F<Q@'MBL^[;UR/:1%UA'_:^%/IBUG<2+I);!PK]1?C#D(BI
M*C1&5][ 31P3_1YQ%@N>CO4AF,<3L>(9)LG8=D@F&L[585W%Z[_)-G 5,$Q7
M' =S2"DG7OD:_UQQDVT^(,Z%A/@@%IL14WC4PRNBU]6])DQ!6D;4EU89;BA%
M8<4R]\30HUX&;90B2'L,'-HUX$1V[S&YH^QFVJUAD#5$H']K"0]ZJ>#85<C.
M^(D!89I2-_<S\$19SNF-C3Z%O(5X/>?PW"4:)/1$D-MJBWPH'IQ=.EMTS"#.
M)W['IWLIT%*DDX"LJ[(MA(!%>@>=9A&94G[D*PY;^L\(!YCJY1G)+K\Y-4)8
MQMK3VQ@UF]MXF9D"8+"0&@UM>(;U.]4P"3J=N2=.Q8$'2Z$&!N X2J&2);(N
MMZ1.$M0^#/R84*EK,:<+77,?+=OBZ6TVGI>D"ZSN($Z#7Q"O@LM6_6@YCK!F
MK9 D"6<HR<$:W(==_ATZ*-0@A*6RNY>-#3A:I#=3XC]FD&(Q</YIUNHE'16P
M0([4V6OAM6%%[KI,KR^D\_B*UG]6%F:H7O$MM,VSL=XK><PDFXAYH/!REU5%
M8>=:A\2\3Q1<^E7?F.^UQ9'05W]%<=[=) <9,?&J 14#F"%")?ZEXQ@!N]=W
MC<+25Z^Q&)]8>L\''U<'!3>:!EX)2;(#KQD,VN%V3WE_0\3>7;#1T G8B5]T
M^7T?,V?7W,T#+W-TCZ5#JE U6_[RCS.O:G-INP]_$7A_):U];!W/Y.4G+CXM
M>^MMV9]4&JQ1E/8@W.<T=!K3ID0'!9F;,:E+_(U*Z]+!);]DTY%_ 3^E$8S"
MG*;W8:XF=I@Z@CX]&?OH^^[2TEI.$O7\[)L]H#\$N:W,YA:@#?AAC7F#/1OG
MWT) Q,U*=[)^VI.AZUY1Y,V.&0W,!,_##&'38@[>%WL[@;<31U-1FVV[^@)Y
M@Q@S#8W6./[#1Q!LDE%0CS$&)LRY0T@,D8+)71GCO0:74'!U47I-JUXL=SN[
MNI:H,MZYN VR;$UT]$Z[>FO32TAI(VK6\R 6> Y>_,D11 :V#BP]-6>">_<2
M'<4I$E/'#/%NS:$<$;:TNNRW]Z)7F)^MJ-D6F#CDW45W4SI,WJB_<DRWHH C
M?R(D^1A_?M$D0+QS/OF>EUH$<$IQ B7[C7;/:,S+3JX)GIY]-<U4S=_TP1L%
M6-[.O>IFNW]5K,X)R;53W6/1XI@0I_89&-:T^<<Q@U]_E3=KH?,UUT,N$V\[
MP>R9$:R*;B1%P*BW.Q0PV/<P9^WG@.-N4QM^ADIT4)<(JBL:&9:)O3Z[QVTK
MP/U')-N1.CU%],7@A.^5]>SV8X;TGSH]6CY\V0V'DRM_.USC>G# ]G*[?\'K
M*WD)XR7Y+UR/'GT4=U$J0#@K7*&M4HHX-YF\MGUO*<#E&D5^R7WX/_.A2&WP
M<?<X8HXY:3=NZXN-A(#E,8.5WX/^X<#F\_D_?>;!2_5=ZT_R T;^[(QU'Z@P
M*9=2'DF.(:2-\ZM9!XX9.#U._,="YH]5<,#S/?#?3M"@D0I"PP<Y)D9O)TE#
MIKJJX"\G)A4UH*I=.7E%:\9/_CMULEXW_V_JA.^5G(['YU:/5>I/)5O O57>
ME9"3I0>8\3V>B*'<F_QE*OT_2#[N_<TM;HLY1O\EIO!??C@8&_U1OCX:UGB"
MB:L1A>I766@[.<__B/6F)O%&95I4^J?;!K^8BO;=*<OVW=_"@F]YIP<)1APS
M7!J4[KH?[,R_+\7K/\K$Q$Z>M*(9[TD9&=B4,UM+=DA*&^9Z?%NT$#EF2&IQ
MBC=G'_7J5I;203I0(,N')?["*=>%*/U->#-Y4 KCJ_C+T>!K&_EO+JS9K,NN
M_+)3.AQJ#'?_TN2<<7OHX1-W9$Q@IC'GYBP!1UIH]6<[^D1L,$?O9C>@A^&^
MWERD>+'Y;5O>H* G(;>DK@7V (Z >%>O;49H[Q!LL&FY=,*PX7&E2.6MA<!P
M(L=2-7IF$(RV]U-67O;=XDN&4*N&,!D"A4^8.A)"'^V<<9:^/X*WPL\N_!&?
MG!0)DD4FO"3P1QHD5-2Z+EV<M)3$4::Q"U.E!B8A2YL_5I[B:F?J:])0MJ.>
M$]%'=PQK,-"5[*:X >V0L>O4IQ/^KS?XI) @Q]NE"N&MS@[BZ3-IZT-Q@?Z-
MAJ8@=>G$I95H__QUMV4TW"CILDCP[]I6(#4<,A7/TSKP>??.P 5S6+>V#J/^
M]?!&HTP\)[;5PS&"(5!6<J]EB*'@F$'><2P)TB.:;ZAB3<AIWRXE():;#5HI
M1S90QH"AG-G#9\3A6$)<"1R"=M:9\3F*9D[LG=J7:S_?M%D^9"D/&P"4>"3>
M5A,VIRJ*X3W@4UC7X&&WVS9&_2CG70.0&6#BF*%V+22;]"F0#(#0[O<XQYYV
MN?-N/E&9VR#.1>W2L_"2 6)TMO3DR&Q]_I'8&?3RC@Y+2BC6@TJJ=/X:\:(=
M%YQ=-5+2/2 0[V3+Y1M!]E])*0!:Z/S(<G *:RFVJ%V-@3[77)DJ-;:VYJLZ
M\OA\=[9JJ,ESPF,A1BP]IW@J]]+(5U*P(2KFJUDV:FX*]^W\C#CO)-03+:^>
M:@UE72\QD#0PG4DO&).DY;\>=HC9-I>VO%SI;:T*@"!5]#+>QY7LN&,0R6]3
MOY!JHG.*N=LIA3.3J_O:16F-+?=WGQE6&3+C18V/&8H"4\C-2X$>43\@V+$$
ME2S>+&N;+P_T*V^;M?A*>SYNYQ6E?+<K+/D\B+WCA:UN#<#J%C8'!92H(3KP
M.<N0B1:/Q!LJ2Y!=(B1DN24X$TG,$"Y;G,8<,]A*78POD?%%U:?_K#_G7#Q<
MCI< @9&NJR4<V!UO>+Z1Q[+8+0KGQ'Z@Q9X<>%,I:%\L<VT WX"Y[_A^;AJM
M0!MOXC-Z&Q,@/+9L<W-HK^KJ*Y08"=$68\IXPU6M)(;GWD%TY][TL*61?B@7
M;_A"5>VF5^@/(LCRB.(.W1/ADQ_/3JV"^5YJ"/W%2;N1<E<U/E3L8==$2S'D
M"]1F5]3;RQ\VN-9IE*0%_4E]CW\MD</?:"_R_+=D1 80JK$1#;? H]8R7;]R
M>IZV&SIU.]310<]4^K45WVB34N'Q/@P\3:<N^R_@1XGYSWT1UYC>[+?S9WY
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M[683^+@?*KTTPEX; 844@LH^50F(=W3P( U,IJ*I'SG>M0I6D%21S@'#J6R
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M7VYK)S-6\\=1:>0CU'7DU=5FEC?5&JO+EW2W.-^/C>SD(1@>4,&'!C5!7^%
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M%&>9XEFW9#]N@,#?!-!$_@V!<H;?W_]SX+?Q_^>4<NMZW=J)^*#[S^QHS@
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MZRC-S!$,&E+>QN>[_DSH ]?5Q#QD63-U4(GV_/%%8QVTY!,#,[]!(B3YJ7R
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MB"%OKJ89^D^39@G%& F,C=VXP\?KBOU-_XWLK+SO.EC,ECOF?(R;;>S%/4(
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M9_(DKK\Z1E;^<@A*PP:E8$EK6CJJ>O,8.9>ZX0ZK%P[0 H*NA%%8>GPMUZ[
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MM'D)_ROS._XWP7_A683_(OA/UV3_S\&_>Y7X7^ JCJMV>\D/KPB05F%R- Y
MJOA/O%C8^K6^096 X7$%3H*;A5,P?'9LS#4S/CWN=3_R/_.9_R8J@&=?[G6%
M73ZI/YY&><;-QK%)=[B&07X3X9.V <5AH&^+OXEHRZ]J\(0+PU5%XF<7 ;^)
MW'.T.$!G\Q&_B4[?>^*+/?_6CL.:@VN_L#_7W%X<VI7^3=0M&.8!"@Z="!Q^
M/7$]_YL()UP'\'H90&(T_&;@^8 *<3A?XB<"UHU3/:]"K.&UYL'=1!R^V7>R
M,I54]YD./O/52BQ#JP;N@+T34:&7?'QY[9%1N^%P,!GV( B*YM1ZZ18>DS9&
M9.-.E8S'11?"Z.+<_2OULN%:!''#J.HN>:]OFBO31S54K"H-N8/%:1'SF2]X
M2EW?U:PXI.N=9A+?%A5AQP?",E2"#)2X[I(BFZ?9^(";I6/MBK-NNL42##=&
MTMAP(/#&?C8YIW0@]D+FS6<*$OI.5_+RR>2DR6^]:.O +"[VA!:H),9K29GL
MJ:'PLQ->:7N\+:&VS,&'059=K69V:*<:09S1SYN\ZQ1H'M1<EX@'^:J*B\EF
M!!7A) $(_M%O+K,1$^H49B#3Z80!OPEG0GXD\=+D'>R6!O'LF[Q?M$ %! ,5
M$/]X)-?Y*? !*\?CD1T8V==PTCT=C O*)UOKL#S1>8GNZ1JL(U%_>XS3">BC
MZB?N/?WXJ1-=]YMN&O)=9<(-TF:%[!Y\EMK'#4?(*H=I[XP]\3,,,#;V-0V%
M2 #AW@Q=WM\&>=X+QVK,/;A1P4,D@^C<R5UF0!JP\;W!I["0 7T>[4S3/.<B
M5^XG551?%?LD;.\8;6;WA7XS\0$KET0FF\X'-RUG?N6=W'&3!5.TZ.PNO#9>
MVE<]V/U]V5Z^\VOL>O+< CK>'\C5]D'34 AV D"-(4,=M7@DP;YC5:21_?UL
M.EGF8^I--W9RX\"OWM>+:U#[-JI3?1_Q\J^<>F12LRF=C:S2=R(ZD8XQO[8*
M)G]7JK)SWS09TN^(.=_/MRL5T,:"JV6<HT>@Q(/QC V)O4E]0:_E^\3T0W/G
M!F<C*'J?:!OT2W5EC)J-] # 7FZU$\TFL<'/59RC7.<;ZU8YMQ93"Z:_I;06
M=3^.!&XIL\_GEG'1_6G0[%*K&@@[I,,B3D3IH=0TBB&4GNGX4["ZJ*N\5\[;
MB=#Y11S_0&PMH8?K7<]5P>E'ZXG I5-A#?S\555P"<Z&W?!4UV;6X$,/7@-.
M\P_DW/,@>V_9#+FP])@++0)S:PFA\\ \#M=\X;"8A)[J67$<;!/8,WH+ /4P
M4MYA#@^*F5UP/"*2.3!;<6O\(B8&3+TENVO]C)AZHWO <WGWL<=TRK=-Z I1
MJO.8QL=Y<JC6!.>MI_THJSB!)Q7JY.O1E-Y5@>#L[+F61*!L(89DNT0A([?_
ML7+Q7',F6PUA=\ AO^K<,X.U99)[?X[W&X']98T,W> *:7OO!^^\)F30[>06
M@%VM!4B?SE7W10,H4]S$>T2'7$0HH>FTJ?:2QO6V'&B3+>D[54]<KT.9'7L_
MC_MNR;R.K3>XSS8U;<L\F).$30B^A%HM-T(E\+;4J<$SX'+YJDG]E$0;R;,I
MM0GU:7^<-%#I9VF3*BEI7S\)!B9@5*2MN1U.?WBX.?@Y<1H"]<%9_8 -@D[:
M/L/Q5KASE!NR<<[8;L$<+N<MF<6;I\+3^9M(OS.V:DO!,+]F>I+D'C;W_(;\
M'S0?%+<"#W;_]!M$-Y'D$NAIL'()LF%'0D#JSGL8BVZMNKC.Y'9M87+F@RDQ
M^2K9CV"$3&U&*AU*CXYZU]JUR-IB\D>/':7,C-E-K'#WRX1$'>;DW#\TO=85
M^PMJ3F_Q5MV#WR1^\B9OVN 6Z0=6NC\]]?'(\2DM4+'8T^ZV4(3&8(EIJW'!
MF9E@>Q.PQ*>M:X&3^;A&IL85X^=?_/HF+08010Q'T$8%/][%*[]/1Z\>7]\_
M#A 6A7Y$/;F06L??ET%QD+U#="@\9WF*N9O&74T<OH20TJ-'@=,!*AD:BS?)
M'",CJ1>ZV5EX?-YN(:9K9 =%7":@CPX;7.7OQ=ZBUI3S-(<H9L>,]0@AIZ*.
M%/]T4L%,9A'N6-[<[#^#AQKCKUX="S<+#YV0WGTH2VP8(.B^+U+N)7^ -/'
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M)>+CV-H!M0U"XPSUE&(-S>\1 8XR!1YAE^:8)9TU45_WU954MZ6GX@3_P[:
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MF>9_I5#./T3RUU;1VTI%/\;_ U!+ P04    " !0@FA8"0;-/$O1  !I#P$
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MY2TGVYY#*85RUZ-D'AE(>&8@B#AP-89=R7S$B2!@<+K=F'6E(4VT<Z!LQS7
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MP7?;,]%35A8\%S:8A&PGL,G/[84MS.RTY 08Y806OO![GVXH&3*+4?1K0-Y
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M#RYBIDW@8LD(J<T@(O%!9XVO@W9XI%,%C=C3S'U-.:3+']76\%U P\>(-G5
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MZ.HJD-W>M)94)VU:% /+-,CN=[F?[B$4$3,C X[M>V<X7]B&;61N"&OD6V,
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M<X$_*P\WGQWH=K)NKHD ^ZGR!-?+U;X>F>F#$)F=(DI@BE\Y__)_2.VF@=V
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M)74-H=N4-$,.@QM>ZW<X;V_OA9Z35#>,$X^5:"K@JY\S*57I\P^X6T)*T=6
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MF)B\&@0*2^D=]01N3*GCSXT%)2QW 1.Y\5_5N,S>DY%6CF"!](RH=R;"T!U
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MAA8F:Y6DS+N7OP'BG\ NK<46? ,TUWT#2.UOGNNH] AV_B\Y<O4&?Z]$SC=
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M^0.,3+T&M>*RN8$A7!W-,SGC(_8]Z'+$%"/!1CJQL;$E&AI65+&A5GUU5F^
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MC"P>.MOPZ^J"^':HG0PL_'WS;#NR,9JI8L"L%+6))VA#V SL3>01DJD9T$R
MZ\]_:@83,WC5(FVVS-A_HB(G+MVKDO^  5UD$RNJ:":H@RT,M*B.*C17D++#
M[>$;IW$J@YVN&9+UI@;;HZ![:G5NR>LJOB)AJ:_$B]WS^<BT>EW.D]K<(+R
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MVUVD:G'M$"N=#!%!"D+1^"XK:+FLR2;?+GTT;K]:A-#:V]"KDH5,3^1/YA!
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MEXRVMX8QM/AD=_V??27R_E[6;^$.IWZ'%P9X9OV.*^3MZ<-R?"BSL 1A_G/
M7X-?1\Q;SY7KD4P:9^36!0W>^%EF7IC';!#F/.8FCJ=;Y5NV<W_OH)_0!!G'
MOR 8?R_I[%]QH'^IP?_<VR'2?2-$K9#NRVARJ=&W,-H_'C']UX<]!KXTOH7Q
ML;"]DC(3>'Q@Y:0U7;MLNL)FC:R_6C1*T$IR<6NM,@3CLIV"=>+D5AE_+=IO
MYGJ5["DCFYWYE7SL !/1SSS)5WH_1A>P++]>@@KVX<6L20@FT=XME&(M.<!N
M2_R'S\4T"\0!I7\[?]74PG24 ,H'/WN'84P.)9&H1)+?K/,88PFRI<:7[' N
M7MLP@S1"2F;=$E59I3EDF7<++38[<ST@]MF^4LD6J2]+8MJ$C4D].$C9 /Z>
ML8P2>X#^^LL>Z(:0"M,K;:!](:5@.[50,G6,LUWP&I</Y7'R;."73UB'([Y2
M5:)TF$C'2BD%Q6,ZV_R(>['32]OH=@)Y5=S"'$4:*3;("2OO-_3:NW4NO8JW
MCJ*;0"FB!5<C/H,H3+%)'ZK%2^BTQS(XCAEAQ?C+82Y:68](&"S^=K3K6%6-
MTG] T RN-2>S +MJ&SVQ244WB*\":^7&2H[>ER1D9?V<1HDP3QU-7JF-9IS]
M#C#\#8)F+(^!%HC+WV(H(D<81$RI6""J@=+3"""7@*BMEN9O #0]2<VD3*/[
MA1(W\/SCN/M4-DC)T4"2FA'-?[:&^?=?9GUR4=4E3ICD%Y&+;YMO%UQ3QW,.
MO;S+%EXOE>N-C"UD"0E8KE4)4OB0E)(>=7C1=-2]83R;-P,7KZE2!VQT&5#E
M25J^";,G;9/HZ+ WADOEQ)<D0.G9JA<*59VE%&?9*.I@U*I@Z($U^-2LG)3=
MQ8>VGO9<AIE^\C7,3'AIM/-@%^JK"B_0<,J9TJC!G1]\>=QU_* .5!BK-"W0
M'T*^3-$V8L+F8YT%F9)P&:;AWKCC1\)_]R7TYX&7_TOT;^\CB69WDZB!Z)XW
MY(I(JN>$DG"96CH4QUV#A#PY^27-A?B%DPK^:LQ+;2]J9GCT&-MXKY4U#*G@
M[K%ACR::;.@_126\-*#6N#)PMLAX]$1W651'72&XVH_,P: \%=STNOMHTY1'
M1LXLV;B[3[?=+9<_,="WV-S:<+2JDJ$690L(K,/TV\+2Q#),RO0U!L[RO)*N
M%Z_@L33(>)0<!%<0%%UQZXP)>^"PQ]_+MYM$/_/W(*I_'C[UOT3_631U  #8
M_3;MT%I_8_S-S+77O2Z__LV1^EW+QA[ &8;EW)FT-X]U=C?93&8#Y_T'<D>G
M/QB=/(WC=/W-M=[%F!W]U3/,,I$/)P/6RI:^ Y(B_GGZRG(0#/W3&G(*"'A>
M1G:BIBUTZ51B"%!C8W%Q):CX_5O\MZRE7--G)CT@?+<S^0W'ZV\GLNHR10LZ
MU!$@D&3A'I+?FT)EE=)/P@[]-1,3(O&"FR!-R[2!"?P$&S=0Y%V=KS-4,R8&
MJFPS@WSM-LA5%GON2')!J7U?X*KD)\94TLPC/,3D2A]!23<T;4;68/N]Q2OW
MIXSYU>JZ]]\;@DH&U4-XX3\H6.=(V>SO O6O9J+_.OU/ '/\@?Y?!9U4_NV)
M?Q^TTW_0O]P\^*_3O_\$]P?Z/]5'];D>KYRCED_0J8NJ+LV!8TQ:M1+YWE@L
M2[M(GE*^3J27@SB2;)'&\2SA=6U#!KE(W3[X2F//01)#E)D0LB=;P76<E_D"
M)&"I(4V2=1Q3+#;RX5GDP)F_N,X\Y[14>6<O@6W-9C3@--@[]6O? Z+1+<^)
MH.[XH&;[II?%+C5/R@?@+@4M7$T',K:/!R>_8 8?+XE5/5P8^ Y8.;S^E6GP
MM&S^FW+W47]F[)N-*=VF4\_O +[3ML7< O,WF. ?"WZ&K,:&%Z9]R(FEQ*.'
M__#*LY7!CF.2D=N;VR]ZOP/N-11_2'5?L?X.V#V[)NIV9ZPZT_?+TC?]HY"N
MA^":%X*'/[3@'3EOCV]$]'1E]YW=%_T[ L>@S".S-Z>A/\J.W'<MFGTN^QV
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MS9>4CXTB\[8,?HV' 2\&6D^X#C:_ Z+_2\]Q?9Z@KZ&T]%%>D2/9+=[L6N]
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M0@ENGJG7%U3.%\T'#%<*SX+Z4M--^T7>TV=%%GX'+.?KE<Q+P\P18\4DMXQ
MK=#[ ;-S3-66+"ON.2X_!9^,W5,4A,@IV3F[SJH4<?'JXBW6Q^IU-7>"-,_#
MC#4JARPF_8+=YGGF5T0_!KC]@N:U:KS:I-X'0Y)]-L#3")='"$FS%+32>UZ1
M;R9C_L+AT@\JAD,L#-!X#0]$:H[(5(2%C&:6PT%)-G!JPG!OFR9[Z;I S?W(
MF8B^6;4V'W;T!R(CT262?M=S44NKB"@@8GQT3GDZX= 1<_YFR=[C9$0JRNM!
M1&H:TX;E#O2E8 :Z=%17D-;[R"4QT(S1\'G2LD)=>!<''A&H(W>9B1LTB;H%
MQ!K!PO ",%^A.OE=6M7%"<:9%,'ZKG[:T63/#KN!YNGHP\=(:((*1,O(R<+G
MCEX&DB:V^XVOPX*?;EO;]LZ"IY!Q8T(O+.*4!XSV%824:45%TRJMU@F.YXGL
ML%!8N%+LK^TP&Z5,>M&6O&XPXK3(#,"34I?VX36@%!R1%Y-,:90&],_,1S]O
M<I ^&5<>5TRRX)/V.V2 PM5C4C.]%%Z3W?)%05TN$%P244N"I^+GZ^+\C*"3
MT>=@ H=OT6V%,"8!T;IFG9GK'RW03"=J3'U-@72H4"$'9H=B4U4^]4>VMM-N
M5CL\#*52XU-$1;=#E@A-3U%G2NT6M'8D[@A@OIH69?]UXR.R@<V-I?EKA00*
MWR.=ZS!$DC?C%!*07$_0;8#7^-ON"\';[[-.CFQ!!@(2QS*1_99.E?>+YHS<
ML(HT;K*+]((\5 0/15DLO7-?7Y]^JQY#V*0?ON.G:F47([UJQ<;[.7_,M P*
MDR(*2%!]E9ZPC&&:VT.7C^[X/!HR=*GJ%_C1PFE*BE3-N'-9%!)>-.),P A8
MA4IO"42(U,]0.\YWA4RY-:K))K-LY/#*I.LV+ #'\?S1VJ4$:\,SQ[O+99A=
M^HRYJ%TC5^!L15S;1J::":$AODS%U%?*Q1]2A(8 *%71AP]LN[&_) ?5V3>4
M,8G>VC(=&]_\2:KNS?4D+6XI9FW*'&7O6G*PG>.55N6??.IF+;&\2_:!C4D9
M2>Z\3T4*/+OA,D902]4P!(@SI33^X=TK+ _\2DR?,PZ&G;AR31R7O1ILL9\B
M]%PMR?0GC=:.0E4:^Y\"3F)]:^LY3]S]O&.>GDXN*L=04,C(2Y-(ROV3V+&Q
M+D.\EN%-'P>\5 F=G#>T@MUQY*9(FJ%;#]. W[3/^+2PH([:NKL%NL#= E/4
M+.=T-K!!+=)CL7;3ASS!IB>LVT(U=3(G-;Y31TAB^1/S>I0[%AF7E3[K<'X(
M;^2YB%H:Q9?/E!<-O?%K<JET<P?!E\+@P3 JT/I3,D+OW!'1?M;-M !4TE/B
M*-7$.1O!36O:^V-"9Y?C]$VR6E-0++-+BEE@%*E>YE<GJAM>0TFFQ%A$#7;E
MCH#/TMKZIGIEH?JBKXB=/W66['P;*>8.8F(J?E]93C'Q5S$B(D<2GYX6J%6(
M^(%K?R5WAR1_!WR08:>K'JG/$G=##E:4)TTGL!ZLIE+JF5(4B^O3+W2UMT?,
MYGQEHB/X1AW1CUTJS/9$R9-'38P'#KQ8<\C75 /.A?X^S_[IIJ]24[?"TK'.
MV7*;9R\@H;ZQ'Q/7[U^M"OGTE1?@8HZA5W=X;\#B/BV"RM4A&*0_MQ 8Z_'%
M$2F(97(-C^0WY1N@CG#%<V/M$A*L/!1=3:1HH9D>)AFC;)#H6 ,.8;*=MJT"
M58LC#R:15^^BC14%N0G&) Y L/1[IT;9M KI+[MS*CZ@[@R5L3S2NH0XH?B4
M[_7Y!48@"IT,HN76@J*X(4 2(R-+._<'&A>E"=>F?-+.Z_2L"!U*KR9"=-]9
MR>A12=RH3=)Y^)(Z7&FUGU[F"@KGUJL"(=)-%D@:09+WMJAG9C,5<R35?DYT
MCZ/<U(F?+'$X1U[O)4@61#5&O64P<J[C<FV(8B0OVXZRVI-I=?E:7=>-6>;
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M%<"^*Z&\H.755_ 7H Y%V")>Y^BF3,N+J4O:\U\6KB$^VK1ZFBH9RJ]R[S?
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M*A3=)YL71/+YRM9 M"KU_?"M4IW+/W]X.-8B."&_0HU,6 Z.K%OO7QYZ]C$
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MUH8?Q3-A?Y ^>!>^O$A14N%#?S7<MGKHA[8J^^FT=[^7XUY5X!Q%NVJ8S#G
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M+[&1F&/"89&F'5[_A\5:XDY=:8D/#[]=*@SQ!JS>P@4-37<L ZM.X!(W$OF
M<B-AD6O\S#4'?%IB648__"QM76<8U_@8;IP4G42?"P[O'"NWS6_<_V[:'CYV
M?,Q.X-?.Q+N%_2RQ"\<>X*7-9J-VR79_!Q/VQC9QNW^!E0P<>%\OX@C@D]SS
MB?MG^GH+/<6HGF,%N(T>;A^L&6\G.!XRO*]/YU*[N'I K],M*C5]GW\7-D8L
M8IR8<TC5>=MH+&\-0RR+HQ>>S1( D. >\,RM+6&1F$<2$WD%C$!X&DLI"#Y
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M,BYM?TE;.YZ0?EJIMPA%D_E+P.$=-SJ%69Z7+-JBRQQYT@$S YV[+*"@#L:
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M!(02=)I"SM(/X5%7A(;)H@\#2X>#(+>H,9YBLX%LOV%ZJ:)F6"1?U>BG=Y4
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M:;;E0HD9'QU5!';$OV.3523D)95"%CS "X8E=N"/V)GE."[\L\*^@/05QBC
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M6T#;,/NN66(X50M&A]GMT"MR5S6[=)K&$8P<YX:C%).%0-9K-S[H&1))!L+
M1B"F8Z=HLKM[< !C2"=Q^PQO5_>:5[TN82!GYN#G#S!8+88^?)G#4]TO'^U'
M@%+;>Y%C4SV,J3EK#A\',_"QNU<EB;<,'0C4P[AI["%-6!@@-B:^F.Q^QQW
M4F&W+3[QQ">F__7(":-;$"L\7T<S&Y:MYQ\]JN:3.OL4)?_-EYQ0 M3&*8ZI
M3AZ8YUCF@/WEC/[W.08[CVC_RRL=C[W[6=KLRPT.>X!']></>Q\>I9K:J#35
M:B'59F7PLID+&6(\RRB:?VNH*M=]#8*4S2+1#.3HCUZ6]H77\36\CC7M):JN
MRSVV;KO]B"LRO,?6%4;@FOZ4M>]MX7HC<X+WV1JP0]RTV8FPQ= T0+E1WU/2
MS26W@8W'L)F%1;ZP*S&+2U[<7SG_)=4J/; J@YR8,-\@ESSZC@WR(OR<YRY_
M/2!\I/A[M]I9L/B[@ W[,X!=8(" :#U)(Z%ZL,6W64=,'-?W"H?C\I&2UT2W
M-0(WR6E[>5%GQ8@;"VZ%_K=2U%NVC$&S\TB=T:B,@5+T.L(B'Q(J@$7W[ +V
M<F!/<E8N["G&VUC8*]!MU3DUU_7KLP5+)F.A/8HN7YVRZTZ[T3R]Z<"?&&'N
M-"_JO29\W.QT,6^Z4[_JUANR848!=@7898.=Y+U<L%.LN;%@5^AX:X."M4YG
MP<3J6J5Z '#WI=7MJ5(''>R! :CXI=-L7C:OBG88!>#EYA@2F^WE==M67+BQ
M@%?@VJIQK5VO+W@)KMT[;W8B$)-:7J''%;"VR T1XK)<6%-,N+&P5NAQZ^RK
MJY\^UI([]-7581'HH^,6:]E(/O+8%;A7X%XV[DG6VLOK6:LX;V-QKX"W5:MS
MW4YOP1MP\0:UN-75P\_:4.VU6:-^<<'J[$L3Z_5=Z-KQA897(%U>J@DQ7B[2
M*;[<6*0K-+SU@<#KLP4MVA@$8KCBNMVM7\AH!7;1J%5J^V#C7MT _A4X6.#@
M@CA(W)>/@Y(Y-Q8'"[A;N0.O=[EHQ1=RX%UBZZ!.X:PK("S764<<E0MABN$V
M%L(*56YML*W;OEY0DZ/,DYX,M[;/4)O['1-1"I K0"[O:L3U/#6-&&]C(:Y
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M!MQB=<, 9O"]1 <E+\S#H>('#/:'VII/!7>9@)G#H\(0X[YP9:D$C;\%_*X
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M[=?%+T.MF&L__$ @ '!_5@O4NC-^1CM@3;.<[8F6;=376_=,]4JHU-'?6;,
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M;3IIVM31S\3$09-W7!^F])L*D"EGB#GN!R[(ZRPSG\9"5<SV9*TC3U7$'&-
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M(D:^M6+!3K/1OKQL7IW6>W"NM<_TI%WOG.(?I\"9C5Z[TWUTSM30(<O,B:\
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MC;E#=4O'B*3K9TBN'?C,H<L=86UKJ96-1.)WR%LP![R7PF7<1+]2GIF!&/+
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M\*)9RVE/&6C^K+IK'D2K$?^!5V>!=M?,0,RC9"L /Z9[!V8$V#,96C?\S9+
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M=!7^[O[.@?/AI$AZ],+2*@G\$R/U(6[LW)S  PM*V=EDQM',&#4>=^B/DT(
M>,F#%R]XF51M#ZY]PD7(DX"0.[:6WIOE5)H&7!6*O!QVO@4[RES4=7QNY2^+
M_&8%,*)SSUZ3'8H68#?]"GT6"7OUJ#:6P9%#NT(B+ 4?E6V1FH)312-V+B$N
MQCD9=,?L^CDBN:?OH0KS1C?-_8L5VJSI/+&X8._*0LBC2H(56V:J"(C3WL;H
MQY)2?E4OQO,0TQ_^/0CW6S\<"F![0^'''SDV>3*, 4D +I!6]Q*P'(;\Q:D
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M$!,7%4$TR,@;6?/B/#,*L_-0=4+V/T#-*"2+ >C']Y(\#:LHXC"O*X23QF*
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M_9CHTQD'@H:/I;'?S>@N;"!5+3]HSO)S^BG W*LJ(EH0DEL:E)<BCJE@";G
MG(FWM:.'YSE?:]#X3,.9JV&UVI@^Q=EPG@]/ZO%ELA@8UG#F5YKN5SN3+P:.
M3<.IG2["(^')14 W9K*?1%[/ Y=Q?#G\#'\%)XAE3XL9=6%;#JYEOV@L)C2(
M#YZ3PAO6[</Q40"E+$3@V7$<@5C$7?7][R2^U'AHY Z%F8-*\BM9F+^9PF>'
MGQ(GN?=!'TADZL*78PG(!BD.(CL*>,Y:+),QLIZN'_@I4,(<ME+\HYJ80<FU
M_T,LV'1LL].#X];!@5'7I_3AF@7*MH2*HZQ[J"5+\:5$T$+@R6&@!-%.NW5T
M\)8@LW/\!*@,]7/\\;^;[_*_<ZML(+>ZH#O>;XD^;.1G$3R*2:+/LW^\W]HM
MP4UD::0_(!N3/]GL@%KQS+EX+DMGM0IHG7XW]ET'MQK VV%W6[1$[:FFCVXF
M2MKD4)HP^>_"&0*'^8^?_N7NZN2G @_O23 )B >58+*[>W" 7)?FOEY]<4ZN
M+N_.+N]N__UO8IE;TMYO'>WGG&-G;RWWHWTX7\YN"I]X D>8EK)K/O(5"+T;
M.<I"R32 $G#DPZ/201D349PU0 WVP9>/2:W<RV4EB!XTO=!0RX*47TJV)EPC
MX *D!(-D[$G8S@CV[SP.)5F=J"B+WE]9DK(A)V(0]R#5DP0%,!J58Q"G8[@I
MJ60!/37J=QC!%LG49-6HN*M%QOJ:>;WPC[V6<_;=D^,4+%<GPCT^^O"^$ S3
M'EQ9D,93RTS0_ 0VE\!RCZ!8.++?1ZD.R_PJX-EXPC36UC;Q +X*R?*<;P94
MC0)N6Z. #W;L2<"YE=.,!FY& ^>L8^?HN+6+5/.ZHX%?;2;8P4JNY/6]_(V.
M]+,LSNDW5 [UR^W25YX@VV!\58SOO5&,KRWM;ZVU80O)F]>V8&K!/VOTWVO)
ME-K1?TO.,=ZK[H,TM5I[OSXN]532?A*S>M*/"S%70.3V_A/BKALQ\F7I$7.[
MQ^[>[HJ-MY\*L0;YKXS\PUUWN[WBF+$U(G]M0NM'E$T;*YKL'LN-5'H]QO3J
MN5/+]_4]=@]V7I\M-:A_>=0?[8!$6C%'=A,E4F-&O0515>ZR\7QE50U/>5L]
M%QIQ\I91O[^]Y[8/7M^Z?9X\[(-\@7>>AGW4>K4$SK4E8M>?85/R-SN)T\]B
MBDAS#G,7DYUE$#UB6!MCM@E&=*/0 >W$3P/X%C&\8Q('ZG+O5*Y?;>X!M4FP
M!KT6<AP[,2@L'#VOS/&K>:M+6VM_<L:QC\G.D?-%=F.,0SLJI]EU3N,6!Z4M
M_ZG).L-0^(5^ &U8ZYN*$#O%O'6N'(!K+.*4L@%$,J1W69_%,DECW\-$;DIF
MYS6RT$]!O1*PP""6G&=.&7=YP![?@WC0V;7T-8?0/TL@$,0^)7JKHZJ0NSYO
M>WO[WW3XW;PT4>>J.990.?#J*!N>LOOR.:@GB-_/49@E;R0%=:5DF?/00?S1
MA82K5* 1=W9N"2:S2&!EODHBS=-5>SXP&8GOQ%O911@BXP&NQRFDO9@2H#&I
MQ1OZ\H$S:!3]JBN0)XF"79/"'?#HDGA1/,;<+MA']R].0TDX<V80B8 WE<C4
M$5QPDJ1X,]6;J1A"U7A\CM :@"].?=AW&L7,%\8R1@N*JDG$0/AADEH+82JL
M2( >DKQ8)+8SC3R3::36EV%/KQ[+0#Z S6:5>/ %KV)6TTR*P4U<HPKFH;GE
M!&TX]D B&X)][#-O&,+FK:P>%Q4K>(E975M(\-BR*^RI%0I)4Y.E.,J+$_X7
ME1G%1)Z3%9_.PCGQ?SQ6#QEP-%:X%@'A*$<FF-; _4% )P1:0)3'91.22& D
M)65"4]X8TL/OK5LL+(IZ])[3.!LXG1YHQ#X1O$DQPQQH*I^**F\'6O'\V_$8
M6![_\(.2WI>G'24L/U(F6"B[&5<Z@1#V^Q(K-D)I:H9&@O*\B?C36(I47TMO
M&$<A7,"H"WO+./=KG 4COM]PVS$[C(Z19-V1GR2X"?P3"%J.4WHA+M+W Y)C
M?"%@=R 4>P\(/_B4;_=H'#"<@,6D D5K++?P6LD8H>S_DT\H<!.4$XZ 2;(Q
M54+A6P.1A0![6*-P1J7G$-!A)=?Q^YQ\]X");]:ZPNG#:3CE? (TE/4F1K):
M+_S;()AXT7@2QU% E6R4"]^+  [PLBY0!>T3F4D6T+]=9R"942 (5,T80@65
M!_@"/]:8Z %/#*(QP5_!I02 \OFB+$TP*U\?TJ7?:77"4"W>5EB#=3^\T@H$
M3C?KP77^Y RC1U@[YEM1P]MZH#6$$:80(DNG)$<\@^_!26.'O56$E](W^:5R
MX?<QO<=/G:%X0)X-#R(@F8TC($J_-A)HL_G*9\TI0.=S)-8"&H1I;%A"QITE
M0TP^*>J&(G4U$8L!J)$# )9;R1+F\3*1XL5BSMW>WF?%D;BY$R#=459I88]:
M.[7$FZ8;6R;@981]PG'@TB:2RC?- O!SM4A!C""B2:JI9TK:AI+M<-TS87)3
M2?/6*U)]):L5,ZM83"9L0<0K;0$^ %8KNG D#>0YM5GZ,2\*LM&TW709A5MG
M_\B0A9R'Z//%K5P'(F19:[^OI>V9C:[.4H>Q-_Y^E>*_2RX_=B2=>HNE?Z&V
M254I]^-HY*3^B%0E_7]'$: ;[Q_7,)$80W8ZK4.W@#IFF*QN604D1:&DK]&=
MUM72:EMXF6 S:N,SK%*C*MS<_IX87<&#>T#R".Q*[&GCZG]P&OD^_;-S>@M\
M7*DG<*A@XDZIT.65G>*BU]6K[NI5=ZU5#^M6)0YA"JV+X,BP%(Y@O[/=/BQ=
M1<5:#,1P,\P1O*'L90$S%>!!J?/!_\A $R37=O;_S76R<12J4NLX(:X&+XXY
ML1]T"P=WZ/=]> N^@E0:E.*P!1+K/4T@'_SBRY5 $$CP,?'\?X#%#V0:8"8^
M&#1!P,4$""[>@*D9V.47H5V!\9R,.+_2.[#D@6H' 0)AACP2=)YH8G2,<90B
M<)#-@M86H#C*]UZ&U?7BP-K=U< J&7NB0"JP+V6&4M( OT\+G=FZ3TFW6P"B
MQ!SFPG7'@J9=F#%MMR892)[*TZP9"TW]8U/_. <RN]M-_>,:ZU5^E/)'>)_?
M@Q=<G74ZEG/VC=1%SLI9V(PR29W?_P0NNU*[BB< Y8HB1F>!ZD*C+-@75_]7
M,7:F*MU6 (/IV7&3MSI!O;$^&K#V+APS+9_]Y[\68 AY61S#\J"VD'L0;1GA
M[&VW/]Q_M'O ).(!?IAP+QBTM5'I1HU,V2"LYDCDM]S-B+Q@,\(+Z$2-'"2U
MI#\QWD#V3+-O+D;KC)<'0^IJF5 %NY7\,>K@2GM41Z+]*\4^P:(^=,$DIEJ6
M.EAMD:%G3L2Z\3D*\Y"Z,CU(T.S@KF"3#%0:+8>Z^1'7"_>Q1MA!WV7>4\J/
M"Y:F2VY@=H3JT&W@CRBBB#HU.4A3\1U=U#XZ8.(H&PR+[7BT$FR=L>6<:,3"
M"NC[3;WRKT8"3M"=Y-#B7E13X,K&N, >^7GL9W7\,3^]B#&0:9DF\#L^C#+5
MTCI(MIP+W"&;45.;S)N$[;(-XH/-T,.JZF"Y,,2K\YHS12#.9S 7^@@8M JN
M90RTGOCIC%#D>V0^<($5443DX4?WP:3B J->&&6),Y0B2#DJ_RB#/E[[<1P-
M8C%*=#N<B@N\'$NRE[89!=^_N8PBL;:D^KHY(^[][CH(:Q58>O IBM)59/ )
M.P'$H.T".Z+O@R@<\%\]/Q&*)8(=F\5H@'[B9\!&_G_LO0MSVTB2+OI7:CTS
M&_:Y$$V [W9/QZ4EVJUI6]**<O?IW=C8 ,&2B#$(</"0K/WU)S.K\")!BJ H
M$23+L=LCDD ]LK+R\5569OI=C0%%1[ 9N3Q\G:5<E8D+$2AH/E,!G>6DJ0KR
M:8!(6H4VD2J'D<%Z?@<G(:;\,K*^^ 9]C@GT[69XT[\X.[_XS ;_\>W\YD_6
M_Z-_?39D_1LA;CZ=#T_[7]B?@_XU&UR<[=,&*\PW08@WM"F23K@1I@R,,SOA
MX44 R^>+DS<2V<ZCV#9A$ *7X-\"-$7FEF ;*8D8,(WQ_F4XO4F&YK)DA7W1
M"D&%S/.A/V3/8 +L2I+R/32/$&'F("M.^(B9--SXY OM@1^H467.1J'EXS.(
M9-+8E#C3P#>HUTSX#J$^-*\M #/Z(O2PX"L8'7&167K837W.5RC(IB$>DES3
MT!LU^ISI]Q"S9W2+8P2/*GN&O#T^?^N^OE#[Q#!J3734%R/T=Y=>X+4;7Y&B
M^:E^2W<VMPQ/SFO+@=C/&H'1*1["TBI955V$?>'5),^&86R<:&/A4D[!K9XG
M[]\4 -<;9^&X%"F4I2[?648-0Z;L?*'57:OY@US?(1WU[GIYMW'33Z7A6L%U
M"VFX5I@2+WK93Z7AFA,FFR=ETG>0E.DS!FLLOEN8CND,T0>UP/NUP!>Q/[WF
M(@\3B&'-%[XE0,3:+_ ?&%,"WO^:;US*@-VW?WFWYAL#T0.YY,K&45R['UR;
M]*'X=D_Y5JQY.2'%UWS\RK<MOML\B(HS7HLS9K8((MH+TTRQQ>LI.G':XOEK
MJQ2;HH?6;9[0@YN)N:Y/\"O>'[KPUGW\=TY7\D E*F[=0V[%Y'-\[;66I>6.
MB[.5>MY+SA97K-9<Z^0JR[J66W+W;,T7!'S[TYI/E]4AX&:8OKNV'R,VIE9N
M6ZZ[BT68ZS7=6EWS%=S#M#O7)8\7*KW#U.[<T>X4.G/]'7%E/GK1"^G8(][Y
M^UX^H%/K=7J9?VE@4:O6Q7.?8\B)N>04S?<>A%1KO9E?):-FM!NIY*JO>VHV
M1X_0*S@8>^I4-W>8*?+*Q6$6DF- PM7K[?1?IUXOF"+UM3*D4(K)A;(%SV7Y
M%82M4 K&?+A*N<;R_%'O)?Q1L'A;#@;:K.M244"M]YWW1MVHY[@G21!NCD!:
M12&'!]=-(0YC[ND9?LT%PB;)Q?-5>M-D?S$[OOXR5XA;>[#EGY, <^\X5A=I
MYLM$KNG&CHB;6>I-S?5GOIZ;CMZIZ9VC8I;>:W'*LTE;,5;IU!J=8V(4O?YZ
M4N69M*T8I^BU5O>H9 I=A7\=H?),TE:,4UJUMG%,C*+W2LF4AJ'U].9.2%LQ
M1H%&&DJD+..3=JNI-1H;EE]Y+FDKQBFZ?FRL4E*H/$__/)>Z%>,6H]8Y+E^Y
MH;\>LSR7N)G%?EF &[D:/QXQPEUA_+2EQVR>N=ZZ]<WT1"^E4-'N>Z.N8-&#
M@T4KP8@*[-PEV%D)%E 0YJX@S$HLOP(F=P=,5H(!%-RX*[BQ$LM?TM_7=5UK
M=38LIJA0Q HR0*G];VB&WM7TEJ[0P>V@@Y5@ 87Y[1+SJP0+*"1/(7G[AN35
M7V7?K.ZE%)+7>V^T$<DS=HOD&0K)VRZ25P5&5$C>3I&\*K" 0O)VAN158?D5
MDK=#)*\*#*"0O)TA>558_K+A@(V.UJIO&.:ED+P*,D"Y*#^M4^]MS@ *R:LD
M"R@D;Z=(7A580"%Y"LE32-X+(WEZ70;E-78+Y344E+==7.J%N7!E#QM >+LD
M595T]S80J5TN?5GH;J>$JM+"/Q^(VNF.+P_9[9!255KW+2!0NUSXTE#=+@E5
MI74_2JA.K]>UNH+JCA6JT[5>M[LY RBHKE*B?P.(;J>TJM+:;P%OVN72;P#-
M[9)4"II3T%PUM.4^0G--!<UM$6^J"">J*#L59?=:ZZ^@NBHNOXJR4U%VKR4
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M-AKU^K.ID&KFF R-+9%AXCE@>5'D6N=#0"K.=B-0E'PZ<[S'*4@FZ#*<L"@
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MM-(+:U9*3NQ@NYS?%O)BXF1EN!WFAR+2=@F0'#TBY^,. +\UYJ)3,PIXS#'
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M8?-EQC$U'QEW@&C8V\0$&]UT'\'D]C/-V_ZJ#GQ^$H\()@#=+1M(2$V'X/C
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MCD2J,E^F(B.!0MMK!K_?HU@#.0,\=8NI'^6U$5_V+3(U9[<-^+7?$H4RD^-
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MY'B/HM;F' %C2"Z.IUYD,+)LN7\/GQ;>]B)1KS5]+0,Y9\HE!!C\)2,%5@\
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MZ4?Y[7"@,^-Z(+[[YA+<\!N,;PRMQ+9NI?9&QN5&&">)YZ"E%_!$*BMCMA3
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MS2TOY4);W+[GHM[+V)N)6C3?:K_5X&TSC,!]?H0?J2J-:5FP"&% #Y])YSI
M$NB=#]#2S/-#*G2#33QRTV?<'?,Q:^CL#+K!JE&RRDS=:"@O_!!85GGA1[BT
MR@L_V*557OC!+JWRPI47KKSP-;QPH%-#'60K+[RT%]Y1+LT!:-"=>^&SF>_=
M<TV<88,8.!EAV5(LO3R^MP/TQ],BI5J1N[[@FE_S:80%98E+KY6??GQ,K?ST
M(UQ:Y:<?[-(J/_U@EU;YZ<I/5WZZ"CA_8;I7T4]_I8#SKG)I#D"#[B;@?,%/
M3QWPU6[W%<S">JPISMM_SE/.]!$NK7*F#W9IE3-]L$NKG&GE3"MG>@UGNM>J
MH3FMG.F#<:9?Z="[IYSI ]"@NSCTCAUH>-IV+9^; 8<_R)^>FC_L:31EYMV=
MS^_,D#.'WW,'+W)?>.[)X >W@/O@W=CGCD/4_:S+_7;TR![,1WSKEO-WV#B&
ML/MCT[4X3"V<L#Z*,H?+XVZ]UIR[*RY=^2!^,,#?^T'@6;;H(_08OMSXT&G5
M-2 IFW$QF"F#7V%JGGOGX>']R SL0+G_![!7E/M_A$NKW/^#75KE_A_LTBKW
M7[G_ROU7,>\O3/<JNO\;GJ5G$F$7\,+&>; S@(%>5WFM#U43[^),WIS-P,$.
MV<!W@Y#]NSF=?6!_ JGOV)<O5QA$7^3.F]'8QJ-Z#1WXB>>,P:^_M2W.(C>T
M'7K%\ES+B0)D68D)N""M8J#ACB/,X+ IYR&Z]_!(,#%]CFUQ/U!1\X? SLK3
M/\*E59[^P2ZM\O0/=FF5IZ\\?>7IK^'I@PVN<LPI3_]5/'U=>?J'JHEWXNE'
MX<3S837(&^^C"T^1^-=V\!T]_*D-[W+TZ,<<&@&A)YZ,G?TX+C\7)#!_#QZ=
M^?PM^(:N,:-N-)5/?PB,JWSZ(UQ:Y=,?[-(JG_Y@EU;Y],JG/UJ?'CZ9(X?'
M7^1<IJSO-C7]._#NP3F'%:MG_QGH^(M?Y:0;+5'.6'Y++-GNU=KX7:PHY\H=
M+^D*I\PR>('%7;"X4W6+K; <$F'D"*/7YWW2U5Z (0F']OBB%?[SR'^?I5R6
M5+D/D_@Y\?7/R6_IYY2;[OC)R.?F]Q/S%@;SD^D\F(]!HG9ZK5ICCI3@GWCQ
M%S[-FKZI.&:2GW3*Q6(B*4/+;BQ8\)%O:PS'ZD#S,+P3ZF/IM!;G3N/HSFV.
M[ASGF6SB\]N_O_G+S>6I\28>(A%ES"U/^&]S5&DTVFUT%OL?OPS8Y2=V>GEQ
M,[BX&?[\WBRSDW38*,CB2::)K6P:O9.U2"NZ18J'/B\UP*#.$*!5;\X1@&17
M7E"*AS)M9A0UK)]CS@+^$XO_BG^A!TD+S(MK^4!&KRYY0FS%XD=6[\V1YXQW
MC&8N 7;%DQE85V_4FL9&L*[0#4](J0I0XMAP76D6Z36CW=J:6:3LX@JX/$:M
MM7QQ$^CTA1'[DQ1:O?1A6*;_R%+L/E#(_3$R7PJ!EN.]K"OPSR@([=O'9_#C
MI\MKQ7['R'XI3+M+]NM_[I]?#&\4"QXC"Z9P\BY9\(_SFU]_'7PY4SQXC#R8
MXMZ[Y,&S\^'I]>#F_/)"<:$"Z F@WYX?NO?P?)F0.U76]<"@F9K>K6K(G:&$
M]8&:#$]PW8OFZ-%D,IND LW;3%V:=R*WC29OS4UGW U$;-V27#JN.>5CQI,D
M/N+JG;HT=QALJ@+LCG!I58#=P2ZM"K [V*55 7;'Y;^K +L-/7B]TZO5E0NO
M7/C7<.$;RH4_5%6\$Q<^=VONHV?ZF.PFK5:#]^7 %_<M.^#,=$3RFYGW  [Y
MG ./3\(#7BA2W01QMM[X9\]G=R"K0D81=]1P$(T"R[='G.[9X54[#Q/KH(QD
M^$K K<BWPT=H"I\N;#::4<=N)ANPZX%P-AUF3H%G0ARF2,+;U1K-EM9IMMC;
M$<>;?/+=)*$P//E?L*)ZK_>A\'_^.QZ#SV?P/]REY#ZK7_G;,IR#_[ #D1PH
M#K"AQIEESNP01Q\P,Q2HB>,%B(.P413 =@D"Q%N^FKXUF>_[O\5=Q'A^^+(#
M% E"-O--"Q4/!EZ.D4@SWQ8$GT4C!WY((1D[8&//BJ8PO7?O%.IR"))%H2Y'
MN+0*=3G8I56HR\$NK4)=%.JB4)>G;[08M=YF-UJ>AES4=19UG>6PY.$.59V^
MX766]<(0AS-NV> L9^ZF*'_UL'EFK5LHV[YQHC#7(^2TM2Z<O,3E$L5M1\AM
M:]TM>9%[)(K=CI#=UKI&\D)71A3#*>QCV\[>X6(?!1$GW5Y-Q9L<$/Q1X7B3
MIHHW.5#S(,MUJ["95X\W$5$D_%\1AG[(&! ;9 D&B5AF,,&TSN]%\$+ '6<N
M@")@$^Z,V>@Q%R:"E9ZPB'24/I8V%S"02$,8 ')\JZV_U=_EHS:P][X5LK$'
M?[@P.',V<T3$"X:I1-9$#!IC)E3$Q"'LC77PIRI,2"WM%I=614P<[-*JB(F#
M75H5,7%,J(&*F%B5")HMS2YKU'#?).*0TJUN/\'L&8862_LW]_P<#F$4[+Z0
M:"S(_6&N?5U'O9S-,1O3*)/0=IT!R@#I>1-]SIM=0L3NRQ-P"-0QP\CG+T'$
MIK$=(I8A'[MU/#,48-0BN5@VBW"MJV>^DE.B?3Z/:L6RIUX,@CT_37*OTVQ^
M*)4G>6[6Z\UKD1X+,\TNEU%_BL/^[>1DY(!0@X9Q0@31G9PLG?]"U-,B>B\H
M<N6 [PP^NVU]!_?:Y^@P/WH1PPL+LL0R7CB8>CXZ]M !=,QFOO?CL01;+7K.
M*RALP8A\3$\\^<"R4I7-9R9?1\*NL_G%^JRQ^Q>BR#;@Q(3P%U[(@Y^*B%@
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M!J@@C[Z^'\[(48^%#J_-;B@$79K_H%]6'5>X-9G)LPUKW2F92_'OP&-/E7I
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M 0!B8U]T;W1A;'-H87)E+31C+FIP9U!+ 0(4 Q0    ( %"":%A+8+,H% 4
M ,D&   /              "  3;? 0!I8U]A<G)O=RUB=RYJ<&=02P$"% ,4
M    " !0@FA8/8IX7F$N   _,0  %@              @ %WY $ ;&=?=F5R
M;VYA<&AA<FUA+31C+FIP9U!+ 0(4 Q0    ( %"":%@A7^_@YU0! +QM#@ 5
M              "  0P3 @!T;3(T,C<W,F0T7W!R93$T82YH=&U02P$"% ,4
M    " !0@FA8EHB40+T%  !-(   $0              @ $F: , =G)N82TR
M,#(S,3(S,2YX<V102P$"% ,4    " !0@FA8L++%T' $   A%@  %0
M        @ $2;@, =G)N82TR,#(S,3(S,5]D968N>&UL4$L! A0#%     @
M4()H6+3<Q%,E"@  )6P  !4              ( !M7(# '9R;F$M,C R,S$R
M,S%?;&%B+GAM;%!+ 0(4 Q0    ( %"":%B4%N1""@0  ,42   5
M      "  0U] P!V<FYA+3(P,C,Q,C,Q7W!R92YX;6Q02P4&      D "0!/
) @  2H$#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>tm242772d4_pre14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:vrna="http://www.veronapharma.com/20231231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vrna-20231231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:NetAdjustmentsForEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001657312</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">vrna:NetAdjustmentsForEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-8480">VERONA PHARMA PLC</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="c0" id="ixv-5658">&lt;table style="width:456pt;height:139pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;tr style="line-height:9pt;height:54.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;td rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:123.94pt;text-align:left;"&gt; &lt;div style="white-space:nowrap; line-height:9pt; padding-bottom:0.333333333333333pt;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Year &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"&gt; &lt;div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Summary &lt;br/&gt; Compensation &lt;br/&gt; Table Total &lt;br/&gt; for PEO &lt;br/&gt; ($) &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"&gt; &lt;div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Compensation &lt;br/&gt; Actually Paid &lt;br/&gt; to PEO &lt;br/&gt; ($)&lt;/span&gt;&lt;span style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;"&gt;(1)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"&gt; &lt;div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Average &lt;br/&gt; Summary &lt;br/&gt; Compensation &lt;br/&gt; Table Total &lt;br/&gt; for Non-PEO &lt;br/&gt; NEOs &lt;br/&gt; ($) &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"&gt; &lt;div style="text-align:center; line-height:9.00000000000003pt; padding-bottom:0.333333333333333pt;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Average &lt;br/&gt; Compensation &lt;br/&gt; Actually &lt;br/&gt; Paid to &lt;br/&gt; Non-PEO &lt;br/&gt; NEOs &lt;br/&gt; ($)(1) &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"&gt; &lt;div style="text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Value of &lt;br/&gt; Initial &lt;br/&gt; Fixed &lt;br/&gt; $100 &lt;br/&gt; Investment &lt;br/&gt; Based on: &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" rowspan="2" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;"&gt; &lt;div style="text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Net &lt;br/&gt; Income &lt;br/&gt; ($) &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td rowspan="2" style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:9pt;height:40.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"&gt; &lt;div style="text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Total &lt;br/&gt; Shareholder &lt;br/&gt; Return &lt;br/&gt; ($) &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; width:123.94pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;2023 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"&gt;6,559,277&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"&gt;558,317&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"&gt;4,082,064&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"&gt;207,291&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:6.14pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;"&gt;284.00&lt;/td&gt; &lt;td style="padding:0pt;padding-left:6.14pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;"&gt;(54,369,000&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:123.94pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;2022 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"&gt;5,183,140&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"&gt;27,578,945&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"&gt;3,142,941&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"&gt;17,462,808&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:6.14pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;"&gt;373.29&lt;/td&gt; &lt;td style="padding:0pt;padding-left:6.14pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;"&gt;(68,701,000&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:123.94pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;2021 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"&gt;1,123,304&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"&gt;823,718&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;"&gt;650,336&lt;/td&gt; &lt;td style="padding:0pt;padding-left:3.46pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;"&gt;425,254&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:6.14pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;"&gt;96.00&lt;/td&gt; &lt;td style="padding:0pt;padding-left:6.14pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:4.5pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;"&gt;(55,569,000&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;
        &lt;div style="margin-top:12pt; width:456pt;"&gt;
          &lt;div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; "&gt;&#x200b;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div style=" float:left; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;(1)&lt;/span&gt; &lt;br/&gt; &lt;/div&gt;
        &lt;div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;"&gt;

          &lt;span style="letter-spacing:0.2pt;"&gt;Amounts represent compensation actually paid to our PEO and the average compensation actually paid to our remaining NEOs for the relevant fiscal year, as determined under SEC rules (and described below), which includes the individuals indicated in the table below for each fiscal year: &lt;/span&gt;
        &lt;/div&gt;
        &lt;div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;"&gt;&#x200b;&lt;/div&gt;
        &lt;table style="width:416pt;height:53.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:156.17pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Year &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:75.21pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;PEO &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:160.62pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Non-PEO NEOs &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;2023 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; width:75.21pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;David Zaccardelli &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; width:160.62pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Mark W. Hahn and Kathleen Rickard &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;2022 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;David Zaccardelli &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Mark W. Hahn and Kathleen Rickard &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;2021 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;David Zaccardelli &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Mark W. Hahn and Kathleen Rickard&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;
        &lt;div style="margin-left:20pt; margin-top:3.5pt; width:436pt; line-height:11.5pt;"&gt;
          &lt;span style="letter-spacing:0.2pt;"&gt;Compensation actually paid to our NEOs represents the &#x201c;Total&#x201d; compensation reported in the Summary Compensation Table for the applicable fiscal year, as adjusted as follows: &lt;/span&gt;
        &lt;/div&gt;
        &lt;table style="width:456pt;height:172pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:344.51pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="10" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;2023 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:344.51pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Adjustments &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;PEO &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"&gt; &lt;div style="text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Average &lt;br/&gt; Non-PEO &lt;br/&gt; NEOs &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:1.917pt 0pt 0.5pt 0pt; width:344.51pt;white-space:normal;text-align:left;"&gt; &lt;div style="margin-left:10pt; text-indent:-10pt;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Deduction for Amounts Reported under the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; Columns in the Summary Compensation Table for Applicable FY &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;(5,324,000&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;(3,327,500&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; width:344.51pt;text-align:left;"&gt; &lt;div style="margin-left:10pt; text-indent:-10pt;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY &lt;br/&gt; that Remain Unvested as of Applicable FY End, determined as of Applicable &lt;br/&gt; FY End &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;7,952,000&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;4,970,000&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; width:344.51pt;text-align:left;"&gt; &lt;div style="margin-left:10pt; text-indent:-10pt;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY &lt;br/&gt; that Vested during Applicable FY, determined as of Vesting Date &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;&#x2014;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;&#x2014;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; width:344.51pt;white-space:normal;text-align:left;"&gt; &lt;div style="margin-left:10pt; text-indent:-10pt;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;(3,012,444&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;(2,185,934&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table style="width:456pt;height:175pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:344.51pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="10" style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;2023 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:344.51pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Adjustments &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;PEO &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td colspan="4" style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;"&gt; &lt;div style="text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Average &lt;br/&gt; Non-PEO &lt;br/&gt; NEOs &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:1.917pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"&gt; &lt;div style="margin-left:10pt; text-indent:-10pt;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Increase/deduction for Awards Granted during Prior FY that Vested During &lt;br/&gt; Applicable FY, determined based on change in ASC 718 Fair Value from Prior &lt;br/&gt; FY End to Vesting Date &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;(5,616,516&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;(3,331,338&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"&gt; &lt;div style="margin-left:10pt; text-indent:-10pt;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were &lt;br/&gt; Forfeited during Applicable FY, determined as of Prior FY End &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;&#x2014;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;&#x2014;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"&gt; &lt;div style="margin-left:10pt; text-indent:-10pt;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Increase based on Dividends or Other Earnings Paid during Applicable FY prior &lt;br/&gt; to Vesting Date &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;&#x2014;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;&#x2014;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.51pt;white-space:normal;text-align:left;"&gt; &lt;div style="margin-left:10pt; text-indent:-10pt;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;&#x2014;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;&#x2014;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.5pt 0pt 0.833pt 0pt; width:344.51pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:-0.2pt;"&gt;TOTAL ADJUSTMENTS&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;(6,000,960&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; "&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;"&gt;(3,874,772&lt;span style="position:absolute;"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding:0pt;padding-left:0pt;width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c0" decimals="0" id="ixv-8481" unitRef="usd">6559277</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c0" decimals="0" id="ixv-8482" unitRef="usd">558317</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c0" decimals="0" id="ixv-8483" unitRef="usd">4082064</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c0" decimals="0" id="ixv-8484" unitRef="usd">207291</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c0" decimals="2" id="ixv-8485" unitRef="usd">284</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" id="ixv-8486" unitRef="usd">-54369000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c1" decimals="0" id="ixv-8487" unitRef="usd">5183140</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c1" decimals="0" id="ixv-8488" unitRef="usd">27578945</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c1" decimals="0" id="ixv-8489" unitRef="usd">3142941</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c1" decimals="0" id="ixv-8490" unitRef="usd">17462808</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c1" decimals="2" id="ixv-8491" unitRef="usd">373.29</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c1" decimals="0" id="ixv-8492" unitRef="usd">-68701000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c2" decimals="0" id="ixv-8493" unitRef="usd">1123304</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c2" decimals="0" id="ixv-8494" unitRef="usd">823718</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c2" decimals="0" id="ixv-8495" unitRef="usd">650336</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c2" decimals="0" id="ixv-8496" unitRef="usd">425254</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c2" decimals="2" id="ixv-8497" unitRef="usd">96</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="0" id="ixv-8498" unitRef="usd">-55569000</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c0" id="ixv-5859">&lt;div style=" float:left; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;(1)&lt;/span&gt; &lt;br/&gt; &lt;/div&gt;&lt;div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;"&gt;

          &lt;span style="letter-spacing:0.2pt;"&gt;Amounts represent compensation actually paid to our PEO and the average compensation actually paid to our remaining NEOs for the relevant fiscal year, as determined under SEC rules (and described below), which includes the individuals indicated in the table below for each fiscal year: &lt;/span&gt;
        &lt;/div&gt;&lt;div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;"&gt;&#x200b;&lt;/div&gt;&lt;table style="width:416pt;height:53.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;"&gt; &lt;td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:156.17pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Year &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:75.21pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;PEO &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:160.62pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:-0.16pt;"&gt;Non-PEO NEOs &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;2023 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; width:75.21pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;David Zaccardelli &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.25pt 0pt 1.5pt 0pt; width:160.62pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Mark W. Hahn and Kathleen Rickard &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;2022 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;David Zaccardelli &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Mark W. Hahn and Kathleen Rickard &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;"&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:156.17pt;text-align:left;"&gt; &lt;div style="white-space:nowrap;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;2021 &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:75.21pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;David Zaccardelli &lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:0pt; width:6pt;"&gt;&#x200b;&lt;/td&gt; &lt;td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.62pt;"&gt; &lt;div style="white-space:nowrap; text-align:center;"&gt; &lt;span style="letter-spacing:0.2pt;"&gt;Mark W. Hahn and Kathleen Rickard&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding:0pt; width:0pt;"&gt;&#x200b;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c0" id="ixv-8499">David Zaccardelli</ecd:PeoName>
    <ecd:AdjToCompAmt contextRef="c3" decimals="0" id="ixv-8500" unitRef="usd">-5324000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c4" decimals="0" id="ixv-8501" unitRef="usd">-3327500</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c5" decimals="0" id="ixv-8502" unitRef="usd">7952000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c6" decimals="0" id="ixv-8503" unitRef="usd">4970000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c7" decimals="0" id="ixv-8504" unitRef="usd">-3012444</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c8" decimals="0" id="ixv-8505" unitRef="usd">-2185934</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c9" decimals="0" id="ixv-8506" unitRef="usd">-5616516</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c10" decimals="0" id="ixv-8507" unitRef="usd">-3331338</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c11" decimals="0" id="ixv-8508" unitRef="usd">-6000960</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c12" decimals="0" id="ixv-8509" unitRef="usd">-3874772</ecd:AdjToCompAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c0" id="ixv-6179">&lt;div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;"&gt;
          &lt;img alt="[MISSING IMAGE: bc_totalshare-4c.jpg]" src="bc_totalshare-4c.jpg" style="height: 376px; width: 597px;"/&gt;
        &lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c0" id="ixv-6201">&lt;div style="position:relative;margin-top:8pt; text-align:center; width:456pt;"&gt;
          &lt;img alt="[MISSING IMAGE: bc_netincome-4c.jpg]" src="bc_netincome-4c.jpg" style="height: 380px; width: 603px;"/&gt;
        &lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <dei:DocumentType contextRef="c0" id="hidden-fact-0">PRE 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c0" id="ixv-8513">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-8514">0001657312</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
